data_2n5z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n5z _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 113.946 1.091 . . . . 99.99 113.946 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -60.04 -31.98 70.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.866 1.432 . . . . 99.99 114.866 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.64 -48.92 58.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.836 -0.62 . . . . 99.99 111.69 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.66 79.25 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 99.99 113.176 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.255 50.8 t -64.66 -31.82 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 113.632 0.975 . . . . 99.99 113.632 174.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.73 88.98 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.194 0.442 . . . . 99.99 112.194 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.08 6.56 7.69 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.578 1.695 . . . . 99.99 115.578 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.33 -34.61 7.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.894 1.278 . . . . 99.99 110.666 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.35 -33.82 10.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.841 2.163 . . . . 99.99 116.841 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -102.35 -36.48 8.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.698 0.799 . . . . 99.99 112.741 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.6 66.64 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 114.958 0.743 . . . . 99.99 114.958 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.55 -90.05 0.08 OUTLIER Glycine 0 CA--C 1.538 1.48 0 CA-C-N 115.51 -0.345 . . . . 99.99 112.707 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -113.72 143.79 44.03 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.96 1.096 . . . . 99.99 113.96 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -63.99 -34.55 78.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.757 1.021 . . . . 99.99 113.757 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.27 64.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.886 1.439 . . . . 99.99 114.886 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.92 71.11 0.34 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.77 1.628 . . . . 99.99 113.902 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -77.05 32.27 0.14 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.551 -2.113 . . . . 99.99 114.725 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -101.48 -14.54 17.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.628 1.971 . . . . 99.99 113.092 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 34.33 85.87 Favored Glycine 0 N--CA 1.48 1.592 0 O-C-N 123.98 0.8 . . . . 99.99 114.961 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.08 19.27 3.17 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.781 1.4 . . . . 99.99 114.781 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.44 24.3 45.56 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 124.022 0.82 . . . . 99.99 114.778 -170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -119.63 146.39 45.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.42 0.688 . . . . 99.99 110.147 -171.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -134.43 164.96 26.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.508 -1.224 . . . . 99.99 114.211 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.73 30.28 62.48 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.868 -1.514 . . . . 99.99 115.338 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.7 23.86 23.09 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.603 1.097 . . . . 99.99 115.782 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.69 10.7 17.99 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.373 2.731 . . . . 99.99 118.373 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 43.17 39.56 2.01 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 123.042 1.401 . . . . 99.99 112.648 -175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -99.14 112.0 24.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.334 -1.303 . . . . 99.99 110.448 -172.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.36 132.45 4.62 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 113.362 -1.745 . . . . 99.99 113.621 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -60.54 -37.05 83.2 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.978 2.452 . . . . 0.0 112.936 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.37 66.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.239 1.015 . . . . 99.99 113.588 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m -72.06 -47.54 50.82 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.651 0.78 . . . . 99.99 111.092 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -60.11 -23.31 63.74 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.292 0.849 . . . . 99.99 113.292 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.22 -29.54 5.82 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.855 1.428 . . . . 99.99 114.855 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.3 -33.58 69.62 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.569 0.952 . . . . 99.99 113.569 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.89 22.58 11.9 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.139 1.376 . . . . 99.99 112.711 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.26 -24.29 26.59 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 115.692 1.037 . . . . 99.99 115.692 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.32 20.36 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 114.718 0.647 . . . . 99.99 114.718 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.45 151.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.794 2.038 . . . . 99.99 109.548 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.08 36.16 0.11 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.448 1.499 . . . . 99.99 115.934 174.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -57.96 -50.51 87.71 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.251 -1.833 . . . . 99.99 110.502 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.38 -16.07 27.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.972 2.448 . . . . 0.0 114.983 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.6 -34.3 58.4 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.441 0.904 . . . . 99.99 113.441 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.1 -35.94 11.7 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.346 1.239 . . . . 99.99 114.346 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.65 122.43 15.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.066 0.946 . . . . 99.99 111.55 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 m -47.15 159.1 0.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.558 -1.201 . . . . 99.99 111.111 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -41.99 -57.22 2.51 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 99.99 113.743 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -67.12 -37.71 84.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.194 1.183 . . . . 99.99 114.194 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -62.11 -39.57 92.97 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.705 0.764 . . . . 99.99 110.887 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -50.93 66.65 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.671 1.188 . . . . 99.99 110.894 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 pt -53.83 -33.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 123.644 0.59 . . . . 99.99 112.531 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.19 -54.64 41.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.134 0.974 . . . . 99.99 113.053 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.11 -41.18 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.138 0.575 . . . . 99.99 110.047 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.42 82.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.281 1.432 . . . . 99.99 114.332 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -59.58 -39.62 84.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.785 1.234 . . . . 99.99 111.618 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -78.98 -37.83 38.43 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.656 0.613 . . . . 99.99 112.656 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.268 0.4 OUTLIER -60.84 -23.59 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 113.9 1.074 . . . . 99.99 113.9 174.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -40.24 88.72 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.344 0.498 . . . . 99.99 112.344 169.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -31.7 65.35 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.841 0.682 . . . . 99.99 112.841 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.12 -49.6 73.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.067 1.136 . . . . 99.99 114.067 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -108.25 -27.34 10.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.097 1.518 . . . . 99.99 115.097 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.0 147.94 9.05 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.548 -1.021 . . . . 99.99 110.548 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.469 0.544 . . . . 99.99 112.469 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.23 -21.24 22.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.076 1.75 . . . . 99.99 114.935 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.64 78.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 99.99 112.603 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -86.02 146.8 43.88 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 124.033 0.833 . . . . 99.99 109.306 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.61 -148.78 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.411 2.741 . . . . 0.0 111.586 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 t -51.38 -30.35 18.63 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.516 0.932 . . . . 99.99 113.516 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.9 m -81.58 131.98 35.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.75 1.22 . . . . 99.99 108.91 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.79 98.98 0.12 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.245 -1.343 . . . . 99.99 111.448 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -20.81 40.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.05 1.5 . . . . 99.99 115.05 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.17 23.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.947 1.299 . . . . 99.99 113.567 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -101.61 -24.17 14.16 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.47 1.108 . . . . 99.99 113.714 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.0 2.91 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 118.933 -0.926 . . . . 99.99 113.631 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 126.695 1.998 . . . . 99.99 113.377 -173.697 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.685 0.995 . . . . 99.99 113.685 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -57.34 -33.66 67.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.294 1.22 . . . . 99.99 114.294 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.66 -53.49 56.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.364 0.666 . . . . 99.99 111.844 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.49 71.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.032 0.753 . . . . 99.99 113.032 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.14 -36.21 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.506 0.722 . . . . 99.99 112.094 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.191 -0.433 . . . . 99.99 111.292 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -0.46 11.59 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.459 1.652 . . . . 99.99 115.459 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -28.74 7.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.49 1.116 . . . . 99.99 113.148 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -100.96 -21.47 15.05 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.181 1.549 . . . . 99.99 115.181 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -122.06 -27.45 4.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.789 1.774 . . . . 99.99 115.789 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.41 6.28 89.36 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 115.962 -0.563 . . . . 99.99 114.354 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.17 76.32 0.27 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 121.775 0.653 . . . . 99.99 112.956 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 176.36 119.78 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.604 1.962 . . . . 99.99 109.405 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -90.29 -67.81 0.82 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 99.99 111.96 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.8 64.72 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.811 1.411 . . . . 99.99 114.811 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.16 72.28 0.22 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.068 1.747 . . . . 99.99 113.952 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -81.74 42.64 0.71 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.397 -1.729 . . . . 99.99 113.387 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -111.37 -17.09 13.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.26 2.224 . . . . 99.99 111.938 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 54.27 21.69 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-N 115.632 -0.713 . . . . 99.99 113.986 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -99.05 23.43 9.03 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.85 0.685 . . . . 99.99 112.85 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.82 30.09 56.09 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 124.154 0.883 . . . . 99.99 114.828 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -127.79 146.97 50.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.509 1.123 . . . . 99.99 109.388 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.55 151.42 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.755 -1.111 . . . . 99.99 112.159 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.88 2.94 8.88 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 114.352 -1.294 . . . . 99.99 115.165 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.12 92.43 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.143 0.877 . . . . 99.99 114.047 -172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.68 19.29 18.2 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.601 1.704 . . . . 99.99 115.601 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 32.54 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.025 2.231 . . . . 99.99 117.025 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -90.99 105.56 17.92 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.521 -1.218 . . . . 99.99 111.173 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -40.41 129.56 1.75 Allowed Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 113.025 -1.898 . . . . 99.99 112.747 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -59.72 -32.52 95.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.075 2.517 . . . . 0.0 113.46 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.29 68.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.732 1.012 . . . . 99.99 113.732 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -72.26 -45.03 61.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.893 0.477 . . . . 99.99 111.272 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -58.54 -21.81 53.62 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.479 0.918 . . . . 99.99 113.479 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.03 -29.13 4.58 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.745 1.387 . . . . 99.99 114.745 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.22 69.09 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.252 0.834 . . . . 99.99 113.252 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -100.07 21.85 12.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.142 1.377 . . . . 99.99 112.779 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.15 30.74 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.658 1.023 . . . . 99.99 115.658 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.41 -1.28 36.38 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 114.827 0.691 . . . . 99.99 114.827 -172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.32 152.19 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.409 1.884 . . . . 99.99 109.305 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.22 36.33 0.09 OUTLIER Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.501 1.524 . . . . 99.99 116.1 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.91 -51.46 81.7 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 115.954 -1.974 . . . . 99.99 110.225 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.78 -11.43 27.73 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.011 2.474 . . . . 0.0 115.442 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.71 -34.29 27.33 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.315 0.857 . . . . 99.99 113.315 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.36 -35.05 10.83 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.702 1.371 . . . . 99.99 114.702 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 129.94 43.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.663 0.785 . . . . 99.99 110.871 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.7 t -53.34 159.88 1.28 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.879 -1.51 . . . . 99.99 110.964 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -43.16 -59.01 2.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.4 1.08 . . . . 99.99 113.7 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -67.47 -34.81 77.92 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.569 0.952 . . . . 99.99 113.569 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -65.81 -37.55 86.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.601 -0.687 . . . . 99.99 111.674 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -52.73 62.21 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.528 1.131 . . . . 99.99 110.127 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 pt -56.06 -30.12 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 113.467 0.914 . . . . 99.99 113.467 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.64 68.6 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.804 0.668 . . . . 99.99 112.804 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.64 -42.5 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.752 0.821 . . . . 99.99 109.774 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -39.51 87.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.588 1.555 . . . . 99.99 114.369 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -56.77 -46.93 81.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.893 1.277 . . . . 99.99 110.669 173.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -35.07 68.54 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.052 1.13 . . . . 99.99 114.052 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.3 OUTLIER -62.38 -22.4 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.962 1.097 . . . . 99.99 113.962 172.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -40.83 89.19 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 119.434 -0.317 . . . . 99.99 111.582 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.79 -30.87 71.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.07 0.767 . . . . 99.99 113.07 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.66 -56.52 7.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.055 1.872 . . . . 99.99 116.055 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -89.37 -25.16 21.73 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.4 0.889 . . . . 99.99 113.4 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.61 154.0 9.8 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.931 -1.268 . . . . 99.99 109.931 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -56.61 -32.12 64.97 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.946 -0.738 . . . . 99.99 112.622 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.35 -2.02 5.54 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.09 1.885 . . . . 99.99 116.09 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -31.77 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.726 1.01 . . . . 99.99 113.726 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -117.71 69.96 6.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.427 -0.806 . . . . 99.99 109.534 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -64.73 -25.38 61.25 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.559 2.173 . . . . 0.0 113.115 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 p -57.73 -28.29 63.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.195 2.198 . . . . 99.99 115.326 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 -60.52 0.19 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.245 0.831 . . . . 99.99 113.245 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.42 99.35 0.19 Allowed Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.366 -1.288 . . . . 99.99 112.154 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.59 54.65 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.412 -0.894 . . . . 99.99 113.274 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.038 1.335 . . . . 99.99 114.083 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -22.55 30.03 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.266 1.58 . . . . 99.99 115.266 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.08 28.02 57.95 Favored Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.283 1.273 . . . . 99.99 116.283 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 117.621 -1.18 . . . . 99.99 113.8 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 119.338 -0.363 . . . . 99.99 110.312 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -52.91 -33.74 51.82 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.441 1.275 . . . . 99.99 114.441 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.34 -42.28 77.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.043 0.937 . . . . 99.99 113.351 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.13 72.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 118.245 -0.884 . . . . 99.99 112.678 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.06 -49.23 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.318 0.647 . . . . 99.99 109.669 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.92 94.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.904 0.705 . . . . 99.99 112.904 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.07 10.91 1.66 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 116.426 2.01 . . . . 99.99 116.426 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.8 -31.53 5.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.114 1.366 . . . . 99.99 111.613 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.25 -43.37 7.0 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.566 1.691 . . . . 99.99 115.566 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 t -88.33 -39.28 14.47 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.42 1.088 . . . . 99.99 112.861 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.37 18.72 58.83 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.104 -0.953 . . . . 99.99 115.108 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.07 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.477 1.374 0 CA-C-O 121.502 0.501 . . . . 99.99 113.124 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -114.1 144.42 43.18 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.184 1.179 . . . . 99.99 114.184 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -65.95 -44.12 85.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.224 -1.353 . . . . 99.99 112.903 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.66 -31.55 70.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.657 0.984 . . . . 99.99 113.657 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.01 76.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.271 1.828 . . . . 99.99 113.586 -172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -81.96 51.97 1.86 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 113.649 -1.614 . . . . 99.99 112.786 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -113.65 -23.79 9.54 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 111.642 -2.526 . . . . 99.99 112.356 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.23 36.82 90.47 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.273 0.869 . . . . 99.99 115.273 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.7 29.55 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.468 0.651 . . . . 99.99 112.726 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.1 41.12 92.44 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.595 -0.729 . . . . 99.99 114.354 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -116.48 146.07 42.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.949 0.9 . . . . 99.99 110.381 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -139.26 134.78 33.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.027 -1.442 . . . . 99.99 112.861 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.98 31.73 40.46 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 125.33 1.644 . . . . 99.99 114.781 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.94 17.32 9.29 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 115.06 0.784 . . . . 99.99 115.06 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.14 19.96 18.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.728 0.811 . . . . 99.99 113.055 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 36.96 40.96 0.16 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.705 2.002 . . . . 99.99 113.723 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.84 99.49 12.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.827 -1.533 . . . . 99.99 111.891 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -37.06 132.45 0.72 Allowed Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 112.682 -2.054 . . . . 99.99 113.665 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -63.35 -39.11 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.212 2.608 . . . . 0.0 113.167 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.55 -35.13 67.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.148 0.979 . . . . 99.99 113.071 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -70.61 -51.07 30.64 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.187 0.995 . . . . 99.99 111.354 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -58.18 -21.1 45.91 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.343 0.868 . . . . 99.99 113.343 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.62 -29.35 4.23 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.799 1.407 . . . . 99.99 114.799 168.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.42 67.76 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.17 0.804 . . . . 99.99 113.17 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -100.52 21.52 13.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.243 1.417 . . . . 99.99 113.277 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.32 -23.71 26.2 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 115.639 1.016 . . . . 99.99 115.639 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.78 -6.14 20.37 Favored Glycine 0 N--CA 1.484 1.875 0 CA-C-N 117.321 0.56 . . . . 99.99 114.462 -172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' ASN . 31.7 t -64.81 150.39 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.076 1.75 . . . . 99.99 109.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 37.28 0.1 OUTLIER Glycine 0 N--CA 1.484 1.879 0 C-N-CA 125.127 1.346 . . . . 99.99 115.748 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' VAL . 14.3 t-20 -56.98 -51.62 80.29 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.304 -1.808 . . . . 99.99 110.465 174.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.44 -20.64 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.328 2.685 . . . . 0.0 115.115 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.01 55.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.252 1.021 . . . . 99.99 113.442 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.95 -32.34 15.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.243 1.201 . . . . 99.99 114.243 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.47 130.59 43.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 99.99 112.525 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -54.73 159.38 2.24 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.404 -1.271 . . . . 99.99 110.742 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.57 -52.27 10.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.057 1.503 . . . . 99.99 115.057 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -63.59 -40.26 96.49 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.604 0.964 . . . . 99.99 113.604 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -63.82 -40.15 95.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.287 0.635 . . . . 99.99 110.774 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -49.9 68.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.627 1.171 . . . . 99.99 111.089 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 pt -55.18 -33.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 118.951 -0.547 . . . . 99.99 112.117 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.19 69.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.235 0.828 . . . . 99.99 113.235 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.24 -44.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.372 0.669 . . . . 99.99 110.373 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.56 78.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.503 1.297 . . . . 99.99 114.503 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -56.3 -50.29 71.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.618 1.167 . . . . 99.99 110.557 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -33.63 70.44 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.978 1.103 . . . . 99.99 113.978 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.286 0.3 OUTLIER -62.5 -21.71 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.768 1.025 . . . . 99.99 113.768 172.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -38.86 91.38 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.417 0.525 . . . . 99.99 112.417 168.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.78 -31.54 71.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.987 0.736 . . . . 99.99 112.987 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.16 -65.93 0.74 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.248 1.573 . . . . 99.99 115.248 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -81.85 -23.02 36.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.273 1.212 . . . . 99.99 114.273 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.38 -169.31 16.21 Favored Glycine 0 N--CA 1.474 1.187 0 N-CA-C 110.093 -1.203 . . . . 99.99 110.093 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 17.73 20.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.871 -1.164 . . . . 99.99 113.32 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.63 -37.75 65.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.546 1.313 . . . . 99.99 114.546 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.31 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.024 0.827 . . . . 99.99 113.039 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -128.56 82.61 68.28 Favored Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 108.129 -1.063 . . . . 99.99 108.129 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.22 -81.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.936 2.424 . . . . 0.0 111.666 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 t -56.22 -44.64 79.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.896 1.278 . . . . 99.99 112.932 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.4 m -80.7 103.4 10.52 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.03 1.332 . . . . 99.99 108.191 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.01 50.55 0.58 Allowed Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.061 -0.518 . . . . 99.99 113.773 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -12.14 27.14 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.917 1.821 . . . . 99.99 115.917 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.77 -30.82 57.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.974 0.91 . . . . 99.99 113.175 165.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 m -93.52 -15.27 25.67 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.03 1.492 . . . . 99.99 115.03 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 36.65 23.77 Favored Glycine 0 CA--C 1.54 1.613 0 N-CA-C 115.467 0.947 . . . . 99.99 115.467 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 114.641 1.349 . . . . 99.99 114.641 178.098 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 119.701 -0.19 . . . . 99.99 111.471 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -50.89 -32.43 20.51 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.678 1.362 . . . . 99.99 114.678 173.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.64 -34.3 71.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.681 0.993 . . . . 99.99 113.681 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.76 71.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.394 -0.812 . . . . 99.99 112.418 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -58.15 -48.75 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.882 -0.785 . . . . 99.99 108.882 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.34 98.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.748 0.648 . . . . 99.99 112.748 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -3.89 22.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.68 1.363 . . . . 99.99 114.68 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -115.73 -29.4 6.44 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.02 1.118 . . . . 99.99 114.02 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -88.86 -32.21 17.89 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.372 1.249 . . . . 99.99 114.372 171.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -115.21 -33.99 5.15 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.001 1.482 . . . . 99.99 115.001 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.54 33.97 Favored Glycine 0 CA--C 1.54 1.607 0 O-C-N 123.321 0.388 . . . . 99.99 112.646 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.33 89.83 0.19 Allowed Glycine 0 N--CA 1.476 1.348 0 N-CA-C 111.002 -0.839 . . . . 99.99 111.002 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.6 86.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.981 1.313 . . . . 99.99 110.285 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -71.47 -34.4 70.17 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.26 0.837 . . . . 99.99 113.26 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.06 32.18 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.672 0.989 . . . . 99.99 113.672 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.3 66.29 1.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.954 1.701 . . . . 99.99 112.923 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.8 35.52 0.37 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.304 -1.771 . . . . 99.99 113.456 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 p -104.69 -18.69 14.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.02 2.128 . . . . 99.99 112.797 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.27 73.79 Favored Glycine 0 N--CA 1.481 1.639 0 C-N-CA 123.753 0.692 . . . . 99.99 114.59 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 19.93 1.9 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.64 1.718 . . . . 99.99 115.64 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.0 30.28 63.34 Favored Glycine 0 CA--C 1.543 1.839 0 C-N-CA 123.79 0.709 . . . . 99.99 114.258 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -126.02 144.24 50.79 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.458 0.703 . . . . 99.99 109.649 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -142.16 151.76 42.53 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.367 -1.288 . . . . 99.99 111.892 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 -11.81 5.36 Favored Glycine 0 N--CA 1.483 1.772 0 CA-C-N 115.166 -0.924 . . . . 99.99 113.925 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 26.67 74.45 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.704 0.642 . . . . 99.99 114.704 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.27 17.91 20.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.432 0.53 . . . . 99.99 112.432 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 42.68 40.3 1.96 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.375 2.27 . . . . 99.99 113.836 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -98.01 113.36 25.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 113.654 -1.612 . . . . 99.99 111.362 -168.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.7 127.59 1.89 Allowed Pre-proline 0 N--CA 1.481 1.081 0 CA-C-N 113.414 -1.721 . . . . 99.99 114.072 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -64.44 -37.83 36.85 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.797 2.332 . . . . 0.0 112.316 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.89 74.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.274 1.03 . . . . 99.99 113.322 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 90.3 m -68.66 -45.78 70.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.99 0.516 . . . . 99.99 111.5 171.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -56.53 -22.34 32.37 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.545 0.943 . . . . 99.99 113.545 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.72 -27.03 6.3 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.075 1.509 . . . . 99.99 115.075 168.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.68 71.39 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.694 0.798 . . . . 99.99 112.97 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.53 19.46 10.99 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.309 1.044 . . . . 99.99 113.657 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.4 -21.29 31.04 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 115.351 0.901 . . . . 99.99 115.351 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 -3.62 29.79 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 114.53 0.572 . . . . 99.99 114.53 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.82 154.07 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.581 1.552 . . . . 99.99 111.303 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.64 39.33 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 114.332 -1.304 . . . . 99.99 115.544 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -48.51 96.75 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 116.455 -1.736 . . . . 99.99 110.211 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.27 -26.2 49.13 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.449 2.099 . . . . 0.0 115.965 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.95 -37.15 67.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.946 1.091 . . . . 99.99 113.946 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.82 16.23 24.62 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.055 1.502 . . . . 99.99 115.055 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.97 143.02 47.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.091 0.948 . . . . 99.99 110.772 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -62.99 156.84 23.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.265 -1.789 . . . . 99.99 110.3 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -60.34 2.61 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.933 0.893 . . . . 99.99 112.936 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.62 -24.17 62.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.308 -1.315 . . . . 99.99 114.298 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -74.14 -46.67 40.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.621 0.724 . . . . 99.99 111.37 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -69.14 -36.84 77.88 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.057 1.132 . . . . 99.99 114.057 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 pt -53.58 -29.42 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 118.262 -0.875 . . . . 99.99 112.876 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.02 99.53 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.99 0.737 . . . . 99.99 112.99 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.99 -42.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.037 0.535 . . . . 99.99 109.702 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.91 -35.76 81.14 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.209 1.188 . . . . 99.99 114.209 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.29 -35.94 80.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.765 1.626 . . . . 99.99 111.844 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -79.17 -37.66 37.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.522 0.564 . . . . 99.99 112.522 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.28 0.5 OUTLIER -60.81 -20.47 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.088 1.144 . . . . 99.99 114.088 175.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -39.92 81.12 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.167 0.432 . . . . 99.99 112.167 168.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.19 69.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.11 0.782 . . . . 99.99 113.11 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.68 -57.62 3.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.313 1.045 . . . . 99.99 113.465 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -87.48 -25.68 23.6 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.945 1.091 . . . . 99.99 113.945 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.79 149.43 8.61 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 110.482 -1.047 . . . . 99.99 110.482 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.84 -26.06 61.51 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.107 0.78 . . . . 99.99 113.107 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 -3.39 23.28 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.167 1.914 . . . . 99.99 116.167 172.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.64 70.57 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.925 1.083 . . . . 99.99 113.925 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -121.83 76.09 38.07 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 108.276 -1.009 . . . . 99.99 108.276 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.46 -34.04 4.87 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.757 2.304 . . . . 0.0 113.082 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.2 p -61.53 -41.11 96.85 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.106 1.762 . . . . 99.99 113.302 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.69 133.9 13.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 99.99 110.377 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.96 57.68 0.55 Allowed Glycine 0 N--CA 1.476 1.317 0 CA-C-N 113.964 -1.471 . . . . 99.99 112.025 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.58 -18.71 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.672 1.73 . . . . 99.99 115.672 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.73 11.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.993 1.317 . . . . 99.99 113.868 165.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.4 p -102.07 -13.14 17.63 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.316 1.447 . . . . 99.99 113.993 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 13.43 46.15 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 116.159 1.223 . . . . 99.99 116.159 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 115.56 1.689 . . . . 99.99 115.56 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.16 0.8 . . . . 99.99 113.16 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -33.6 73.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.117 -1.401 . . . . 99.99 113.483 172.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.36 -34.88 67.06 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.719 1.377 . . . . 99.99 114.719 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.54 72.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.764 0.653 . . . . 99.99 112.764 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.54 -47.83 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.277 0.631 . . . . 99.99 109.606 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.19 81.79 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.411 0.523 . . . . 99.99 112.411 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.58 0.06 21.47 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.093 1.886 . . . . 99.99 116.093 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 t -114.41 -32.93 5.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.788 1.235 . . . . 99.99 111.926 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -98.01 -25.71 14.87 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.859 1.429 . . . . 99.99 114.859 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 t -121.1 -24.91 5.42 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.4 1.259 . . . . 99.99 114.4 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.35 -25.09 22.28 Favored Glycine 0 N--CA 1.483 1.772 0 O-C-N 122.102 -0.374 . . . . 99.99 113.536 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -46.72 0.15 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.694 0.664 . . . . 99.99 113.621 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.68 101.42 0.11 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.862 1.431 . . . . 99.99 114.862 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -64.13 -34.68 78.61 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.68 2.104 . . . . 99.99 116.68 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 19.0 20.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.442 0.905 . . . . 99.99 113.442 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.83 79.14 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.453 1.901 . . . . 99.99 114.757 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.07 41.22 0.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.566 -2.107 . . . . 99.99 112.741 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -114.86 -16.16 11.76 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.572 2.349 . . . . 99.99 112.843 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 36.67 90.56 Favored Glycine 0 CA--C 1.54 1.622 0 N-CA-C 115.292 0.877 . . . . 99.99 115.292 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.35 24.75 6.2 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.658 1.355 . . . . 99.99 114.658 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.76 29.99 51.07 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 114.787 0.675 . . . . 99.99 114.787 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -117.26 154.13 31.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.876 1.271 . . . . 99.99 110.056 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -149.77 166.29 29.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.25 1.204 . . . . 99.99 114.25 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.96 16.98 42.19 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 114.594 -1.185 . . . . 99.99 116.034 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.13 56.43 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.904 0.764 . . . . 99.99 114.424 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mt -116.28 14.62 15.83 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.971 2.212 . . . . 99.99 116.971 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 36.65 27.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.907 2.188 . . . . 99.99 116.907 -169.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.79 98.54 6.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.3 -1.318 . . . . 99.99 111.743 -169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -29.05 132.79 0.2 Allowed Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 113.531 -1.668 . . . . 99.99 114.626 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.38 -41.02 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.34 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.85 -33.09 68.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.172 0.989 . . . . 99.99 113.45 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -75.38 -43.88 47.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.579 0.752 . . . . 99.99 112.036 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -61.97 -21.24 64.66 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.751 0.648 . . . . 99.99 112.751 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.95 -29.2 7.96 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.707 1.373 . . . . 99.99 114.707 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.73 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.459 0.911 . . . . 99.99 113.459 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -102.11 21.24 15.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.539 1.535 . . . . 99.99 113.273 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.65 -22.05 31.15 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 115.792 1.077 . . . . 99.99 115.792 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.24 -0.22 41.35 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 114.692 0.637 . . . . 99.99 114.692 -172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.35 150.51 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.26 1.824 . . . . 99.99 109.331 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.72 37.11 0.08 OUTLIER Glycine 0 CA--C 1.542 1.738 0 C-N-CA 125.446 1.498 . . . . 99.99 116.137 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.81 -53.91 59.73 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 115.177 -2.344 . . . . 99.99 109.744 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.49 -10.71 29.84 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.417 2.745 . . . . 0.0 116.273 176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.9 -35.7 25.92 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.574 0.953 . . . . 99.99 113.574 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.27 -30.87 11.65 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.372 1.249 . . . . 99.99 114.372 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.09 123.36 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.097 1.359 . . . . 99.99 111.637 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.6 t -53.8 152.74 5.17 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 113.45 -1.705 . . . . 99.99 110.659 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -40.33 -58.29 1.56 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.268 1.581 . . . . 99.99 115.268 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.9 -32.12 68.98 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.937 1.088 . . . . 99.99 113.937 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.68 -37.4 59.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.315 0.646 . . . . 99.99 112.387 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -64.92 -50.76 65.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.506 0.722 . . . . 99.99 112.819 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.5 -29.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.206 0.817 . . . . 99.99 113.206 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.89 90.45 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.962 0.905 . . . . 99.99 113.439 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 t -63.39 -44.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.875 0.87 . . . . 99.99 109.55 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.613 1.338 . . . . 99.99 114.613 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -58.09 -37.23 74.11 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.158 1.383 . . . . 99.99 112.429 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -76.89 -40.52 47.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.436 0.636 . . . . 99.99 111.346 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.275 0.4 OUTLIER -59.94 -21.69 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.514 1.302 . . . . 99.99 114.514 177.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 pp -58.26 -37.58 75.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.916 0.71 . . . . 99.99 112.916 168.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.34 -30.81 65.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.456 0.702 . . . . 99.99 112.843 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.16 -60.74 2.36 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.573 1.323 . . . . 99.99 114.573 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -82.63 -37.82 24.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.708 0.633 . . . . 99.99 112.708 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.63 156.18 10.94 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.467 -1.453 . . . . 99.99 109.467 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.2 mt -58.42 -15.14 9.56 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 99.99 114.015 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -64.49 -21.15 66.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.776 1.63 . . . . 99.99 113.335 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.17 87.97 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.866 0.691 . . . . 99.99 112.866 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 80.52 62.89 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.653 -1.24 . . . . 99.99 107.653 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -83.69 -54.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.502 2.135 . . . . 0.0 112.965 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.7 p -64.22 -55.51 21.13 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.836 1.654 . . . . 99.99 111.995 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 86.0 m -90.95 123.73 34.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.495 -1.229 . . . . 99.99 108.074 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.28 46.67 0.32 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.329 1.018 . . . . 99.99 113.599 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.69 18.54 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.701 1.741 . . . . 99.99 115.701 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.14 -43.58 78.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.899 1.28 . . . . 99.99 112.548 168.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 m -79.53 -18.85 50.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.584 1.154 . . . . 99.99 113.778 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.26 -48.27 3.77 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-N 114.825 -1.08 . . . . 99.99 111.712 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.032 -1.461 . . . . 99.99 112.393 -170.297 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.553 0.216 . . . . 99.99 110.941 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -47.78 -33.95 7.89 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.631 1.345 . . . . 99.99 114.631 170.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.61 -33.75 68.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.656 1.724 . . . . 99.99 115.656 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.65 -33.49 74.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.208 1.003 . . . . 99.99 112.317 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.04 -49.53 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 108.784 -0.821 . . . . 99.99 108.784 171.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.4 -42.56 82.46 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.912 0.708 . . . . 99.99 112.912 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.74 4.63 11.17 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 117.618 2.451 . . . . 99.99 117.618 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.78 -43.47 3.44 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.901 0.704 . . . . 99.99 112.901 168.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.55 -44.73 66.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.958 0.903 . . . . 99.99 113.406 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -102.81 -42.79 5.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.036 0.934 . . . . 99.99 112.585 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.52 24.59 64.12 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 115.0 0.76 . . . . 99.99 115.0 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.15 -93.54 0.1 OUTLIER Glycine 0 N--CA 1.477 1.368 0 O-C-N 124.125 0.544 . . . . 99.99 112.164 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -113.53 147.72 37.42 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.93 1.455 . . . . 99.99 114.93 -174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -71.25 -43.44 67.26 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.353 -1.749 . . . . 99.99 112.287 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.2 -24.39 67.35 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.844 1.053 . . . . 99.99 113.844 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.35 71.77 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 99.99 113.962 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.0 32.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.896 -1.957 . . . . 99.99 115.004 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.5 p -109.12 -23.4 11.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.218 2.207 . . . . 99.99 113.251 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.89 35.31 72.34 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 115.911 1.124 . . . . 99.99 115.911 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -90.93 28.38 1.58 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.917 1.451 . . . . 99.99 114.917 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.37 40.44 92.02 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-O 121.518 0.51 . . . . 99.99 113.233 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -120.53 137.15 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 99.99 109.255 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -138.4 147.81 43.78 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.575 1.172 . . . . 99.99 111.431 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.97 -4.51 7.78 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 114.478 -1.237 . . . . 99.99 114.546 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.31 26.98 72.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.418 0.532 . . . . 99.99 112.833 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.42 21.6 16.03 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.403 1.26 . . . . 99.99 114.403 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 44.45 35.12 1.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.534 1.635 . . . . 99.99 113.287 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.11 107.5 20.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.294 -1.321 . . . . 99.99 110.72 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -47.37 133.05 9.96 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.512 -1.676 . . . . 99.99 113.884 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -62.7 -34.43 73.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.918 2.412 . . . . 0.0 113.326 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.27 70.96 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.042 0.937 . . . . 99.99 113.232 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -66.28 -50.72 62.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.168 0.987 . . . . 99.99 111.794 170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -57.35 -22.01 39.52 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.66 0.985 . . . . 99.99 113.66 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.64 -29.06 6.63 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.679 1.363 . . . . 99.99 114.679 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.01 70.49 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.547 0.944 . . . . 99.99 113.547 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.45 25.44 9.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.996 . . . . 99.99 111.761 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.4 -22.84 31.7 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 115.824 1.09 . . . . 99.99 115.824 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.85 -6.0 28.6 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 114.714 0.646 . . . . 99.99 114.714 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.89 149.64 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.317 1.847 . . . . 99.99 109.295 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.23 35.86 0.09 OUTLIER Glycine 0 CA--C 1.544 1.866 0 C-N-CA 125.175 1.369 . . . . 99.99 116.218 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.57 -48.34 97.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 116.058 -1.925 . . . . 99.99 110.874 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.2 -19.81 38.31 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.81 2.34 . . . . 0.0 114.781 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.66 51.19 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 99.99 113.575 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.37 -34.12 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.791 1.404 . . . . 99.99 114.791 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 128.05 34.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.949 0.9 . . . . 99.99 111.542 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -50.82 157.7 0.77 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.849 -1.523 . . . . 99.99 110.597 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -38.92 -61.02 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.112 1.153 . . . . 99.99 114.112 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.79 -24.42 63.49 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.033 1.494 . . . . 99.99 115.033 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -74.51 -41.51 60.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.444 0.698 . . . . 99.99 110.669 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -47.65 84.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.566 1.146 . . . . 99.99 110.572 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -55.31 -31.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.273 0.842 . . . . 99.99 113.273 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.48 68.05 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 99.99 112.534 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.32 -41.5 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.794 0.438 . . . . 99.99 110.26 177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.37 -34.12 74.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.085 1.143 . . . . 99.99 114.085 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.71 -44.77 96.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.164 0.985 . . . . 99.99 111.919 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.58 -38.8 80.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.213 0.53 . . . . 99.99 111.943 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.27 0.4 OUTLIER -59.96 -22.99 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 114.474 1.287 . . . . 99.99 114.474 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.65 80.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.711 0.634 . . . . 99.99 112.711 169.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.0 -29.3 68.28 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.812 0.671 . . . . 99.99 112.812 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -59.97 2.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 99.99 113.52 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -91.18 -21.81 20.96 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.545 1.313 . . . . 99.99 114.545 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 151.58 9.27 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 111.196 -0.762 . . . . 99.99 111.196 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.87 -37.88 86.21 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.63 0.604 . . . . 99.99 112.63 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -7.61 18.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.885 1.809 . . . . 99.99 115.885 174.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.7 67.48 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.482 0.713 . . . . 99.99 112.854 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -99.62 141.14 22.27 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.337 -0.986 . . . . 99.99 108.337 173.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.06 -159.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.684 2.256 . . . . 0.0 111.185 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.2 p -54.14 -24.56 18.32 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.848 1.425 . . . . 99.99 114.848 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.05 67.09 1.69 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.998 1.38 . . . . 99.99 112.494 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.63 50.66 0.84 Allowed Glycine 0 N--CA 1.475 1.243 0 CA-C-N 112.823 -1.989 . . . . 99.99 110.801 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -16.94 27.94 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.858 1.429 . . . . 99.99 114.858 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.65 -33.25 32.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.774 1.23 . . . . 99.99 113.357 165.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.7 m -99.05 -17.36 18.29 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.128 1.371 . . . . 99.99 113.98 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.68 32.54 84.51 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 115.114 0.806 . . . . 99.99 115.114 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.69 1.737 . . . . 99.99 115.69 -179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 115.06 1.504 . . . . 99.99 115.06 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -56.67 -34.23 67.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.777 1.399 . . . . 99.99 114.777 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.79 -44.59 89.47 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.351 0.871 . . . . 99.99 113.351 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.34 -33.55 74.93 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.916 0.486 . . . . 99.99 112.003 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.07 -40.46 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.556 1.142 . . . . 99.99 113.128 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.05 93.14 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 119.45 -0.31 . . . . 99.99 111.787 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.73 0.89 6.12 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.639 1.718 . . . . 99.99 115.639 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.4 -33.12 6.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.113 1.765 . . . . 99.99 111.92 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -104.24 -23.73 13.21 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.649 1.722 . . . . 99.99 115.649 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -117.36 -26.51 6.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.558 1.318 . . . . 99.99 114.558 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.34 -11.53 65.37 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 115.434 -0.803 . . . . 99.99 113.396 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.63 -67.42 0.17 Allowed Glycine 0 N--CA 1.477 1.387 0 N-CA-C 111.665 -0.574 . . . . 99.99 111.665 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -47.29 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.498 2.036 . . . . 99.99 116.498 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -63.93 -49.32 73.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.883 1.068 . . . . 99.99 113.883 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.55 -2.1 21.37 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.619 1.34 . . . . 99.99 114.619 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.19 69.6 0.27 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.122 1.769 . . . . 99.99 114.817 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -82.51 43.81 0.85 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.001 -1.909 . . . . 99.99 112.933 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -114.59 -21.21 10.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.339 2.655 . . . . 99.99 112.128 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.51 32.66 82.32 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 115.529 0.972 . . . . 99.99 115.529 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.11 24.72 4.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.786 1.402 . . . . 99.99 114.786 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.61 37.66 77.25 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 115.855 -0.611 . . . . 99.99 113.888 -173.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -118.15 149.07 41.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.244 0.618 . . . . 99.99 109.82 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -144.63 149.96 36.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.319 -1.31 . . . . 99.99 113.454 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.67 23.73 45.02 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 116.759 1.463 . . . . 99.99 116.759 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.94 60.84 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 114.92 0.728 . . . . 99.99 114.92 -171.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.52 13.24 20.06 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.369 2.729 . . . . 99.99 118.369 -174.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 44.5 33.18 0.85 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 123.392 1.568 . . . . 99.99 114.334 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.21 109.66 21.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.555 -1.202 . . . . 99.99 110.786 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.31 142.65 4.18 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 114.351 -1.295 . . . . 99.99 114.277 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.4 -40.95 17.01 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.741 2.294 . . . . 0.0 112.34 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.01 -29.74 65.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.728 1.211 . . . . 99.99 113.551 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 m -78.03 -45.03 24.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.918 0.887 . . . . 99.99 111.316 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -59.24 -21.36 59.45 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.854 0.687 . . . . 99.99 112.854 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.85 3.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.987 1.477 . . . . 99.99 114.987 168.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.56 68.48 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.173 0.805 . . . . 99.99 113.173 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.85 24.84 10.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.451 1.1 . . . . 99.99 111.781 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -23.58 28.42 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 115.808 1.083 . . . . 99.99 115.808 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.83 -4.21 31.25 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 114.866 0.706 . . . . 99.99 114.866 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.28 158.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.649 1.58 . . . . 99.99 111.716 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.63 32.54 0.13 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 124.949 1.262 . . . . 99.99 116.164 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.76 -51.24 83.19 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-O 116.451 -1.738 . . . . 99.99 110.971 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.72 -19.01 36.89 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.15 2.567 . . . . 0.0 115.195 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.79 -33.66 46.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.623 0.971 . . . . 99.99 113.623 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.83 -35.74 12.58 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.702 1.371 . . . . 99.99 114.702 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.35 128.45 35.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.876 0.871 . . . . 99.99 111.648 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -51.58 159.91 0.69 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.307 -1.315 . . . . 99.99 111.688 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -41.74 -58.26 2.05 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.898 1.444 . . . . 99.99 114.898 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.97 83.46 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.254 1.205 . . . . 99.99 114.254 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.72 -37.49 86.56 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.71 -0.619 . . . . 99.99 111.705 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.54 -50.76 66.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.228 1.011 . . . . 99.99 110.92 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 pt -56.73 -31.46 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 112.996 0.739 . . . . 99.99 112.996 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.04 -48.31 82.07 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 99.99 112.605 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.65 -42.6 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.986 0.514 . . . . 99.99 110.405 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.67 75.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.374 1.07 . . . . 99.99 113.667 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.57 -46.09 84.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.035 1.334 . . . . 99.99 111.319 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -33.93 62.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.016 1.117 . . . . 99.99 114.016 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.4 OUTLIER -59.87 -25.68 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.457 0.91 . . . . 99.99 113.457 173.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -42.09 92.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.927 0.491 . . . . 99.99 112.228 171.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -31.15 66.92 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.031 0.752 . . . . 99.99 113.031 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -67.42 -52.0 44.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.294 1.59 . . . . 99.99 115.294 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.39 10.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.502 1.297 . . . . 99.99 114.502 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.98 155.93 9.22 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.05 0.805 . . . . 99.99 111.515 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.44 16.41 17.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.235 -0.982 . . . . 99.99 113.466 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.46 -29.36 13.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.144 1.378 . . . . 99.99 114.384 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.66 90.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.33 0.863 . . . . 99.99 113.33 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.14 149.31 91.22 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.428 -0.805 . . . . 99.99 111.129 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -64.88 -154.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.891 2.394 . . . . 0.0 111.774 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.2 p -56.03 -29.19 60.04 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.064 0.935 . . . . 99.99 112.98 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 m -68.65 172.23 6.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.484 2.313 . . . . 99.99 110.878 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.23 105.26 1.54 Allowed Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.91 -1.041 . . . . 99.99 111.178 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.75 -15.53 30.45 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.969 1.47 . . . . 99.99 114.969 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.73 -41.89 5.1 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.927 1.291 . . . . 99.99 112.501 163.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.8 m -107.29 -28.11 10.1 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.376 1.048 . . . . 99.99 113.588 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.11 25.42 69.55 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 124.147 0.879 . . . . 99.99 113.587 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.252 1.214 0 CA-C-O 116.277 -1.82 . . . . 99.99 111.887 -177.466 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 99.99 111.692 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -31.56 70.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.85 -1.068 . . . . 99.99 112.341 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -57.34 -35.8 70.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.751 0.821 . . . . 99.99 113.092 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.81 72.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.875 0.694 . . . . 99.99 112.875 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 79' ' ' ALA . 16.0 t -61.86 -47.47 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.664 0.786 . . . . 99.99 109.737 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.6 96.34 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.325 0.861 . . . . 99.99 113.325 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -70.81 -7.49 45.67 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.223 1.194 . . . . 99.99 114.223 173.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.33 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.587 1.555 . . . . 99.99 111.938 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -80.86 -39.09 27.04 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.626 1.713 . . . . 99.99 115.626 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t -105.88 -37.99 6.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.81 1.244 . . . . 99.99 112.619 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.4 16.72 58.72 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.919 0.728 . . . . 99.99 114.919 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.3 -99.66 0.6 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 121.881 0.712 . . . . 99.99 112.453 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.63 150.89 47.18 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.136 -1.032 . . . . 99.99 113.468 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -64.16 -38.69 91.96 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.538 -1.21 . . . . 99.99 112.667 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.04 41.06 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.514 1.149 . . . . 99.99 112.39 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 59.52 0.65 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 122.947 1.356 . . . . 99.99 113.104 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.34 52.86 1.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.109 1.433 . . . . 99.99 111.513 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.3 p -82.92 9.38 10.13 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.349 -1.296 . . . . 99.99 113.786 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.84 26.89 70.43 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.266 1.267 . . . . 99.99 116.266 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -87.11 22.43 2.07 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.573 1.694 . . . . 99.99 115.573 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.2 30.75 48.34 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-N 115.864 -0.607 . . . . 99.99 113.72 -172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -132.32 143.3 49.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.145 0.978 . . . . 99.99 109.285 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -146.28 159.39 43.41 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.836 -1.075 . . . . 99.99 113.598 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.96 33.08 56.67 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 113.731 -1.577 . . . . 99.99 114.449 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.28 22.86 11.14 Favored Glycine 0 CA--C 1.545 1.917 0 N-CA-C 116.674 1.43 . . . . 99.99 116.674 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.54 11.46 24.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.131 2.641 . . . . 99.99 118.131 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? 39.11 27.02 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.765 1.765 . . . . 99.99 115.765 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.2 106.17 11.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.035 -1.439 . . . . 99.99 112.204 -172.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -36.8 129.73 0.72 Allowed Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 113.204 -1.816 . . . . 99.99 113.818 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -63.42 -33.41 69.57 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.033 2.489 . . . . 0.0 113.026 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -35.05 66.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.389 1.076 . . . . 99.99 113.145 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.8 m -70.82 -51.18 28.32 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.871 0.868 . . . . 99.99 111.167 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -58.61 -21.52 53.77 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.204 0.816 . . . . 99.99 113.204 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.86 -28.06 6.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.724 1.379 . . . . 99.99 114.724 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.03 75.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.052 0.76 . . . . 99.99 113.052 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.3 20.26 8.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.636 1.174 . . . . 99.99 113.959 171.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.88 -20.14 36.85 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.914 1.126 . . . . 99.99 115.914 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.86 -6.56 25.68 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 114.737 0.655 . . . . 99.99 114.737 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' ASN . 7.9 p -64.5 154.94 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.087 1.755 . . . . 99.99 111.951 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.91 35.82 0.14 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 125.02 1.295 . . . . 99.99 115.538 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 46' ' ' VAL . 4.3 t-20 -58.42 -51.01 84.89 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 116.159 -1.877 . . . . 99.99 110.068 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.39 -21.4 40.93 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.04 2.494 . . . . 0.0 115.183 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.02 -33.44 57.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.65 0.982 . . . . 99.99 113.65 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 1.5 43.01 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.262 1.208 . . . . 99.99 114.262 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.06 125.0 48.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.039 0.936 . . . . 99.99 109.206 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -53.2 155.36 2.7 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 113.532 -1.667 . . . . 99.99 110.055 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -37.36 -55.66 1.02 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.308 1.443 . . . . 99.99 114.247 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.27 -42.36 75.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.524 1.305 . . . . 99.99 114.524 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.7 -39.24 73.51 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.664 0.785 . . . . 99.99 110.826 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -53.74 37.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.123 -0.941 . . . . 99.99 111.17 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 pt -51.73 -34.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 112.454 0.539 . . . . 99.99 112.454 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -55.04 40.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.066 0.947 . . . . 99.99 113.297 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.52 -37.67 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.165 0.586 . . . . 99.99 110.516 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.15 -42.26 94.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.116 1.367 . . . . 99.99 113.791 174.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.4 -40.94 88.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.005 1.322 . . . . 99.99 111.922 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -71.39 -40.18 70.7 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.994 -0.441 . . . . 99.99 112.148 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.272 0.3 OUTLIER -63.51 -20.3 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.392 1.256 . . . . 99.99 114.392 177.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -44.01 88.23 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.096 0.406 . . . . 99.99 112.096 168.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.1 69.09 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.024 0.749 . . . . 99.99 113.024 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.71 -49.04 33.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.533 1.308 . . . . 99.99 114.533 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -102.09 -25.82 13.6 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.306 1.224 . . . . 99.99 114.306 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.62 154.77 8.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.078 0.847 . . . . 99.99 111.098 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.46 -32.36 72.35 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.33 0.863 . . . . 99.99 113.33 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -11.68 17.62 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.999 1.852 . . . . 99.99 115.999 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.61 -33.61 55.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.674 1.19 . . . . 99.99 114.063 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -113.99 141.09 25.69 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 108.356 -0.979 . . . . 99.99 108.356 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.46 -159.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.034 2.489 . . . . 0.0 112.095 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -52.28 -25.23 8.92 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.71 1.374 . . . . 99.99 114.71 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.2 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.744 2.018 . . . . 99.99 115.214 170.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.56 48.6 1.09 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.317 0.961 . . . . 99.99 111.784 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.92 -15.31 0.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.102 1.519 . . . . 99.99 115.102 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.401 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -46.4 -41.13 13.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.602 1.961 . . . . 99.99 113.305 164.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -95.72 -17.19 21.45 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.858 1.263 . . . . 99.99 113.66 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.31 -44.32 3.33 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 123.921 0.772 . . . . 99.99 112.684 -172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.321 1.848 . . . . 99.99 112.074 -175.279 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.565 1.321 . . . . 99.99 114.565 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -59.55 -35.58 74.5 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.326 -1.761 . . . . 99.99 113.744 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -58.57 -52.82 64.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.572 0.749 . . . . 99.99 112.368 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.46 71.3 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.872 0.733 . . . . 99.99 112.657 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.76 -44.81 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.675 0.79 . . . . 99.99 112.814 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.73 94.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.86 0.362 . . . . 99.99 111.889 171.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.97 15.33 1.86 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.655 1.354 . . . . 99.99 114.655 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.95 -33.63 4.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.884 1.274 . . . . 99.99 111.543 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -88.48 -53.02 4.87 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.229 0.826 . . . . 99.99 113.229 168.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -81.21 -42.73 20.32 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.189 0.811 . . . . 99.99 113.189 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.25 19.87 60.08 Favored Glycine 0 N--CA 1.481 1.679 0 O-C-N 124.244 0.965 . . . . 99.99 115.399 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.56 -98.52 0.24 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-O 121.09 0.272 . . . . 99.99 112.88 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -123.96 153.39 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.483 1.29 . . . . 99.99 114.483 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -70.71 -42.62 70.36 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.353 -1.749 . . . . 99.99 111.353 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.93 40.67 1.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.432 1.11 . . . . 99.99 112.012 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 63.54 2.31 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 123.732 1.729 . . . . 99.99 111.613 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -82.74 30.48 0.43 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.518 -1.674 . . . . 99.99 114.041 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -80.24 27.66 0.33 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.731 2.012 . . . . 99.99 114.024 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.7 43.67 93.81 Favored Glycine 0 CA--C 1.54 1.615 0 N-CA-C 116.127 1.211 . . . . 99.99 116.127 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.96 7.78 38.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.542 1.682 . . . . 99.99 115.542 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.77 10.23 6.17 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 124.273 0.939 . . . . 99.99 115.336 -170.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -131.5 148.24 52.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.654 1.182 . . . . 99.99 109.385 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -139.35 160.21 40.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.411 -1.268 . . . . 99.99 111.764 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.75 -10.59 24.08 Favored Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.624 -1.171 . . . . 99.99 114.943 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.08 25.73 54.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.012 0.339 . . . . 99.99 113.543 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.1 13.01 16.77 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.779 2.14 . . . . 99.99 116.779 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 38.62 52.13 1.78 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 123.75 1.738 . . . . 99.99 113.307 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -105.26 109.39 21.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.88 -1.964 . . . . 99.99 109.798 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -39.94 137.33 1.19 Allowed Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 115.34 1.608 . . . . 99.99 115.34 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.85 -44.74 12.35 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.516 . . . . 0.0 113.301 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.24 67.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.063 0.945 . . . . 99.99 113.506 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -72.12 -48.03 46.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.701 0.8 . . . . 99.99 111.537 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -59.93 -21.87 61.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.829 0.678 . . . . 99.99 112.829 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.92 -28.46 9.76 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.917 1.451 . . . . 99.99 114.917 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.25 -36.12 72.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.931 0.715 . . . . 99.99 112.931 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.5 17.5 13.02 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.727 1.211 . . . . 99.99 113.553 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.29 -22.79 24.21 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 115.445 0.938 . . . . 99.99 115.445 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.28 -6.19 23.63 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 114.681 0.632 . . . . 99.99 114.681 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 48' ' ' ASN . 7.4 p -63.77 154.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.811 1.644 . . . . 99.99 111.721 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.2 0.09 OUTLIER Glycine 0 N--CA 1.482 1.757 0 C-N-CA 124.878 1.228 . . . . 99.99 115.59 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 46' ' ' VAL . 17.9 t30 -58.57 -51.72 79.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 115.94 -1.981 . . . . 99.99 110.384 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.0 -25.07 44.68 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.265 1.977 . . . . 0.0 113.927 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.39 -36.21 76.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.014 1.116 . . . . 99.99 114.014 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.68 -33.89 11.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.484 1.291 . . . . 99.99 114.484 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 119.12 9.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.078 0.951 . . . . 99.99 111.6 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 m -46.87 156.41 0.2 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.201 -1.363 . . . . 99.99 111.429 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -29.34 -67.66 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.327 1.603 . . . . 99.99 115.327 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -63.97 -32.65 74.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.364 1.246 . . . . 99.99 114.364 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -68.89 -40.25 79.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.049 0.54 . . . . 99.99 111.296 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -50.67 67.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.389 1.076 . . . . 99.99 110.484 173.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 pt -54.82 -32.93 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 112.648 0.611 . . . . 99.99 112.648 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -53.58 56.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.98 0.912 . . . . 99.99 113.15 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.54 -41.59 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.135 0.574 . . . . 99.99 109.866 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.46 82.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.452 1.501 . . . . 99.99 114.533 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.29 -37.51 75.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.004 1.322 . . . . 99.99 111.882 174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -33.65 27.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.97 0.73 . . . . 99.99 112.97 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.271 0.4 OUTLIER -60.45 -25.19 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.757 1.021 . . . . 99.99 113.757 173.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -61.78 -38.39 87.86 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.664 0.616 . . . . 99.99 112.664 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.2 71.67 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.89 0.7 . . . . 99.99 112.89 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.06 -62.95 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.041 1.497 . . . . 99.99 115.041 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -82.16 -22.77 35.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.88 1.437 . . . . 99.99 114.88 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 -169.08 15.1 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 109.391 -1.483 . . . . 99.99 109.391 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.03 19.69 7.58 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.205 -0.997 . . . . 99.99 113.198 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.92 -33.41 17.29 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.994 1.479 . . . . 99.99 114.994 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.25 -26.33 51.09 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.774 1.027 . . . . 99.99 113.774 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -122.79 91.13 49.83 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 106.238 -1.764 . . . . 99.99 106.238 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.13 -62.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.525 2.15 . . . . 0.0 113.091 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -61.23 -50.37 73.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.888 1.275 . . . . 99.99 113.03 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.8 m -101.04 175.14 5.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.909 -1.041 . . . . 99.99 110.924 170.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.58 93.24 0.09 OUTLIER Glycine 0 N--CA 1.472 1.075 0 N-CA-C 110.249 -1.14 . . . . 99.99 110.249 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -28.01 19.86 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.628 1.714 . . . . 99.99 115.628 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.59 -37.81 42.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.636 1.175 . . . . 99.99 113.394 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -99.98 -27.49 13.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.386 1.074 . . . . 99.99 112.227 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.34 -37.14 3.51 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 114.881 -1.054 . . . . 99.99 111.264 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.817 1.247 . . . . 99.99 113.529 -175.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.093 0.473 . . . . 99.99 111.556 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -49.07 -37.88 22.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.465 1.283 . . . . 99.99 114.465 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.31 -43.94 95.88 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.948 1.092 . . . . 99.99 113.948 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.3 -34.63 77.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.923 0.889 . . . . 99.99 112.118 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.87 -37.95 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 99.99 112.421 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.92 93.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.466 0.543 . . . . 99.99 112.466 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.55 6.84 7.76 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.652 0.982 . . . . 99.99 113.652 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 t -110.31 -31.96 7.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.934 0.894 . . . . 99.99 112.267 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.66 -32.42 10.34 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.828 1.788 . . . . 99.99 115.828 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 t -98.52 -35.53 10.21 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 112.816 0.672 . . . . 99.99 112.816 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 31.08 67.74 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 115.135 0.814 . . . . 99.99 115.135 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.37 -88.73 0.07 OUTLIER Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.172 0.415 . . . . 99.99 112.509 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -112.83 145.3 40.88 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.374 1.25 . . . . 99.99 114.374 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -66.57 -47.39 72.94 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.441 -1.254 . . . . 99.99 113.107 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 -29.55 69.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.007 1.114 . . . . 99.99 114.007 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 35.35 70.46 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.403 1.881 . . . . 99.99 114.297 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -78.58 56.99 1.91 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.817 1.77 . . . . 99.99 112.401 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -117.53 -24.51 7.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.402 2.681 . . . . 99.99 112.94 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.08 34.42 76.1 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.666 1.026 . . . . 99.99 115.666 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -92.5 25.97 2.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.814 1.413 . . . . 99.99 114.814 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.3 39.17 92.24 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 116.11 -0.496 . . . . 99.99 113.695 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -121.18 146.89 46.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.291 1.036 . . . . 99.99 109.742 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -145.23 146.05 31.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.308 -1.315 . . . . 99.99 113.562 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.18 34.08 31.69 Favored Glycine 0 N--CA 1.483 1.779 0 O-C-N 124.801 1.313 . . . . 99.99 115.843 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.52 52.57 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.356 0.979 . . . . 99.99 115.193 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.3 mt -116.71 8.26 13.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.799 2.518 . . . . 99.99 117.799 -169.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 45.07 36.8 2.17 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.817 1.77 . . . . 99.99 113.07 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -89.69 104.68 17.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.889 -1.505 . . . . 99.99 111.6 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -37.75 130.16 0.91 Allowed Pre-proline 0 N--CA 1.484 1.233 0 CA-C-N 112.986 -1.915 . . . . 99.99 113.331 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -65.0 -39.22 25.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.772 2.315 . . . . 0.0 112.556 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.38 70.04 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.2 1.0 . . . . 99.99 113.088 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 m -73.63 -44.79 56.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.578 0.751 . . . . 99.99 111.5 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -58.7 -20.21 46.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.485 0.92 . . . . 99.99 113.485 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.38 5.04 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.665 1.357 . . . . 99.99 114.665 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.05 69.74 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.128 0.788 . . . . 99.99 113.128 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -98.36 25.73 6.04 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.017 1.327 . . . . 99.99 113.589 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.34 39.57 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 115.433 0.933 . . . . 99.99 115.433 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.3 -4.57 32.71 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 115.077 0.791 . . . . 99.99 115.077 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.2 152.81 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.011 1.724 . . . . 99.99 109.274 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.5 36.01 0.08 OUTLIER Glycine 0 CA--C 1.542 1.768 0 C-N-CA 125.226 1.393 . . . . 99.99 116.58 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.77 -53.94 48.86 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 116.209 -1.853 . . . . 99.99 109.146 171.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.35 -20.89 48.12 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.536 2.824 . . . . 0.0 116.023 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.52 61.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.48 0.918 . . . . 99.99 113.48 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.66 -35.01 10.72 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.34 1.237 . . . . 99.99 114.34 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.54 126.97 29.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.484 1.114 . . . . 99.99 110.821 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -54.63 156.81 3.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.016 -1.447 . . . . 99.99 110.301 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -45.92 -57.74 4.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.146 0.978 . . . . 99.99 112.936 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.79 -30.79 71.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.382 0.882 . . . . 99.99 113.382 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.44 -41.34 76.44 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.824 -0.547 . . . . 99.99 110.851 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -40.77 98.24 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 99.99 111.251 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pt -54.28 -33.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 119.358 -0.353 . . . . 99.99 111.945 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.03 82.54 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.429 0.9 . . . . 99.99 113.429 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.15 -42.18 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.362 0.601 . . . . 99.99 109.673 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.39 79.23 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.502 1.297 . . . . 99.99 114.502 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.4 -47.71 81.0 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.407 1.083 . . . . 99.99 111.296 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -39.71 87.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.001 0.429 . . . . 99.99 111.572 173.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.293 0.4 OUTLIER -61.52 -26.03 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.987 1.477 . . . . 99.99 114.987 177.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.65 -40.3 91.5 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.032 0.382 . . . . 99.99 112.032 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.16 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.274 0.629 . . . . 99.99 112.607 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -66.91 -43.92 82.1 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.009 1.485 . . . . 99.99 115.009 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.82 -29.23 10.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.803 1.038 . . . . 99.99 113.803 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 112.89 155.68 12.15 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 109.535 -1.426 . . . . 99.99 109.535 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.38 21.1 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.043 1.127 . . . . 99.99 114.043 172.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' GLY . 7.4 m-20 -88.33 -30.62 19.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.004 1.722 . . . . 99.99 111.866 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.37 -31.23 65.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 99.99 113.33 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -122.75 89.74 50.06 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 106.224 -1.769 . . . . 99.99 106.224 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.08 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.29 1.993 . . . . 0.0 113.537 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -63.19 -49.56 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.855 1.662 . . . . 99.99 112.95 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -109.79 163.43 13.52 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.776 -1.556 . . . . 99.99 110.027 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.55 101.14 0.15 Allowed Glycine 0 N--CA 1.478 1.469 0 O-C-N 124.563 1.165 . . . . 99.99 111.376 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.56 -28.72 14.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.252 1.575 . . . . 99.99 115.252 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.08 -32.84 36.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.016 1.326 . . . . 99.99 114.074 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.8 p -107.97 -22.0 12.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.903 1.281 . . . . 99.99 113.714 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.7 32.71 84.48 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 124.296 0.95 . . . . 99.99 114.062 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 117.042 -1.456 . . . . 99.99 114.295 178.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 112.022 0.379 . . . . 99.99 112.022 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.91 -34.36 28.14 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.096 1.147 . . . . 99.99 114.096 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.28 -49.57 77.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.991 0.917 . . . . 99.99 112.688 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.497 0.719 . . . . 99.99 112.142 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.9 -38.96 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.176 0.991 . . . . 99.99 112.322 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.35 78.77 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 111.983 0.364 . . . . 99.99 111.983 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.72 6.92 19.3 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.704 1.372 . . . . 99.99 114.704 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -116.38 -35.24 4.35 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.882 0.873 . . . . 99.99 112.888 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.47 -39.27 13.46 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.174 1.176 . . . . 99.99 114.174 170.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -106.42 -24.08 12.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.942 1.09 . . . . 99.99 113.942 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.45 3.62 72.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.697 1.039 . . . . 99.99 115.697 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.52 81.18 0.42 Allowed Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.007 0.813 . . . . 99.99 111.49 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 173.77 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.08 1.752 . . . . 99.99 108.939 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -80.37 -79.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.402 0.439 . . . . 99.99 111.745 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -22.15 55.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.054 1.501 . . . . 99.99 115.054 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.8 70.61 0.5 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.321 1.848 . . . . 99.99 114.383 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.55 33.74 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.957 -1.929 . . . . 99.99 115.222 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.4 t -117.13 -18.01 10.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.388 2.275 . . . . 99.99 112.338 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 46.69 40.76 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 115.669 1.028 . . . . 99.99 115.669 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -89.35 23.24 2.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.739 1.385 . . . . 99.99 114.739 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.1 34.65 58.62 Favored Glycine 0 N--CA 1.482 1.765 0 C-N-CA 123.289 0.471 . . . . 99.99 113.563 -172.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -129.5 138.6 51.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.776 1.23 . . . . 99.99 108.809 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.87 149.46 47.68 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.565 1.166 . . . . 99.99 112.822 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.54 -14.75 1.77 Allowed Glycine 0 N--CA 1.483 1.786 0 CA-C-N 114.339 -1.3 . . . . 99.99 116.235 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.7 30.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.889 0.757 . . . . 99.99 114.815 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.05 28.08 8.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.385 0.883 . . . . 99.99 113.385 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? 43.91 35.18 1.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.156 1.782 . . . . 99.99 114.171 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.04 110.19 22.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.446 -1.706 . . . . 99.99 112.044 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.92 133.14 29.32 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 112.581 -2.1 . . . . 99.99 112.78 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -62.03 -32.23 83.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.171 2.581 . . . . 0.0 113.771 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.02 65.34 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.371 0.878 . . . . 99.99 113.371 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -76.0 -41.04 52.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.705 0.802 . . . . 99.99 111.676 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 38.5 t-105 -58.73 -21.49 55.24 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.163 0.801 . . . . 99.99 113.163 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.86 -29.52 3.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.687 1.366 . . . . 99.99 114.687 168.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.06 -38.36 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.152 0.797 . . . . 99.99 113.152 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.31 18.85 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.77 1.228 . . . . 99.99 113.517 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.73 -21.13 32.84 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 115.594 0.998 . . . . 99.99 115.594 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.56 -2.95 36.34 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 115.044 0.778 . . . . 99.99 115.044 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.47 156.81 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.49 1.516 . . . . 99.99 111.741 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.38 34.28 0.12 Allowed Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.325 1.29 . . . . 99.99 116.325 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -58.46 -52.61 73.37 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-O 115.719 -2.086 . . . . 99.99 110.603 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.25 -16.95 44.8 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.135 2.557 . . . . 0.0 115.475 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.58 -33.67 35.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.583 0.957 . . . . 99.99 113.583 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.74 -34.71 10.41 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.516 1.302 . . . . 99.99 114.516 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.73 121.69 13.48 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.154 0.978 . . . . 99.99 110.876 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -50.85 160.09 0.49 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.057 -1.883 . . . . 99.99 110.732 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.19 -56.63 4.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.179 1.178 . . . . 99.99 114.179 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -70.11 -30.28 67.44 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.538 1.31 . . . . 99.99 114.538 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -68.01 -45.78 73.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.404 0.681 . . . . 99.99 111.165 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -66.0 -45.07 82.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.778 0.831 . . . . 99.99 113.053 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 pt -54.67 -28.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.332 0.864 . . . . 99.99 113.332 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.51 85.99 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.097 0.776 . . . . 99.99 113.097 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.03 -42.61 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.252 0.621 . . . . 99.99 109.997 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.74 78.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.528 0.936 . . . . 99.99 113.528 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -61.01 -39.59 90.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.196 1.399 . . . . 99.99 112.183 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -33.85 52.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.943 0.72 . . . . 99.99 112.943 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.5 OUTLIER -57.15 -26.76 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.767 1.025 . . . . 99.99 113.767 173.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -42.82 94.25 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.544 0.572 . . . . 99.99 112.544 171.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.7 66.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.598 0.592 . . . . 99.99 112.598 173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -52.11 30.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.114 1.524 . . . . 99.99 115.114 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.37 -25.18 14.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.533 0.938 . . . . 99.99 113.533 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 118.77 164.81 13.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.802 -1.319 . . . . 99.99 109.802 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.83 1.85 1.22 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.52 1.304 . . . . 99.99 114.52 170.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 69' ' ' GLY . 24.8 p-10 -67.05 -32.83 74.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.299 1.84 . . . . 99.99 113.88 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.04 -29.68 31.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.181 1.178 . . . . 99.99 114.181 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -128.36 90.44 46.87 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 106.589 -1.634 . . . . 99.99 106.589 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.83 -65.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.542 2.161 . . . . 0.0 113.253 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -61.6 -42.64 99.15 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 99.99 113.875 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -113.62 -164.88 0.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.817 -1.083 . . . . 99.99 110.232 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.59 101.91 0.25 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 110.073 -1.211 . . . . 99.99 110.073 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.49 -25.64 60.09 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.835 1.42 . . . . 99.99 114.835 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.38 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 99.99 113.554 166.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.2 p -94.2 -20.76 19.55 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.464 1.105 . . . . 99.99 113.131 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 21.3 63.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 124.906 1.241 . . . . 99.99 115.136 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.296 0 N-CA-C 115.252 1.575 . . . . 99.99 115.252 176.219 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 122.958 1.361 . . . . 99.99 112.033 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -32.96 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.417 -1.72 . . . . 99.99 112.97 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.25 -48.0 71.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 99.99 112.105 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.65 66.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.503 0.927 . . . . 99.99 113.503 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -33.83 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 99.99 112.627 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.42 94.07 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.018 0.377 . . . . 99.99 112.018 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.26 -4.71 31.2 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.264 1.209 . . . . 99.99 114.264 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -106.93 -25.52 11.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.112 1.153 . . . . 99.99 114.112 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -104.71 -27.82 11.57 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.622 1.712 . . . . 99.99 115.622 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.4 t -110.75 -31.55 7.16 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.713 1.005 . . . . 99.99 113.713 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.61 -24.6 28.67 Favored Glycine 0 N--CA 1.481 1.693 0 CA-C-N 116.785 -0.189 . . . . 99.99 112.881 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.65 83.44 0.07 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.913 -1.275 . . . . 99.99 109.913 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 178.45 98.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.669 1.188 . . . . 99.99 110.869 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -75.6 -25.82 57.32 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.772 1.027 . . . . 99.99 113.772 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.75 48.6 0.95 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.847 1.308 . . . . 99.99 111.847 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 50.92 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.671 1.73 . . . . 99.99 115.671 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.46 26.19 7.53 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.893 -1.049 . . . . 99.99 113.751 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 t -122.75 44.5 2.63 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.424 1.583 . . . . 99.99 111.911 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.95 -93.64 0.1 OUTLIER Glycine 0 N--CA 1.481 1.634 0 CA-C-N 113.035 -1.893 . . . . 99.99 110.824 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.86 28.93 6.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.745 1.387 . . . . 99.99 114.745 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.28 33.66 65.87 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.946 -0.57 . . . . 99.99 114.306 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.3 151.03 31.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 99.99 111.2 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.607 -1.179 . . . . 99.99 113.05 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.1 -25.99 1.83 Allowed Glycine 0 N--CA 1.48 1.591 0 CA-C-N 114.13 -1.395 . . . . 99.99 115.342 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.93 22.94 36.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 114.731 -0.734 . . . . 99.99 113.428 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.71 28.79 8.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.893 0.701 . . . . 99.99 112.893 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 37.19 31.65 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.266 2.226 . . . . 99.99 116.772 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -78.32 109.53 12.54 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.979 -1.464 . . . . 99.99 111.811 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -46.33 132.15 7.68 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 113.474 -1.694 . . . . 99.99 113.175 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.09 -38.85 84.71 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.91 2.407 . . . . 0.0 113.379 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.68 68.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.084 1.142 . . . . 99.99 114.084 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -76.87 -42.39 40.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.604 0.762 . . . . 99.99 111.069 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -60.83 -21.83 63.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.424 0.898 . . . . 99.99 113.424 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.55 -29.94 3.2 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.725 1.38 . . . . 99.99 114.725 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.41 -35.86 70.58 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.557 0.947 . . . . 99.99 113.557 171.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -98.56 25.36 6.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.928 1.291 . . . . 99.99 113.156 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.31 34.27 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 115.246 0.859 . . . . 99.99 115.246 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.9 -11.02 16.24 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.638 0.615 . . . . 99.99 114.638 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.28 151.21 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.472 1.909 . . . . 99.99 109.735 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.82 38.48 0.09 OUTLIER Glycine 0 CA--C 1.545 1.93 0 C-N-CA 125.428 1.489 . . . . 99.99 116.332 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.57 -53.89 54.89 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.233 -1.841 . . . . 99.99 108.617 171.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 -9.41 25.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.876 2.384 . . . . 0.0 116.122 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 -46.4 23.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.798 0.839 . . . . 99.99 113.003 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.43 -34.11 15.74 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.105 1.15 . . . . 99.99 114.105 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.55 115.1 3.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.006 0.922 . . . . 99.99 110.695 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -44.35 159.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.457 -1.701 . . . . 99.99 111.305 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -40.91 -59.41 1.44 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.98 1.312 . . . . 99.99 113.269 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -27.17 66.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.329 -1.305 . . . . 99.99 114.255 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -42.48 65.55 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.339 0.59 . . . . 99.99 110.738 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -48.11 80.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.118 0.967 . . . . 99.99 111.43 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.1 pt -54.35 -33.78 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.995 0.739 . . . . 99.99 112.995 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.4 -50.82 72.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.506 0.722 . . . . 99.99 112.8 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.69 -41.95 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.013 0.525 . . . . 99.99 110.376 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.88 73.44 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.256 1.206 . . . . 99.99 114.256 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.95 -41.92 99.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.05 1.34 . . . . 99.99 111.931 171.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -71.87 -38.54 70.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.419 0.628 . . . . 99.99 111.318 172.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.27 0.5 OUTLIER -59.37 -26.78 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 114.356 1.243 . . . . 99.99 114.356 176.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pp -62.01 -40.52 95.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.353 0.501 . . . . 99.99 112.353 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.79 67.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.133 0.79 . . . . 99.99 113.133 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.67 -53.81 51.15 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.789 1.774 . . . . 99.99 115.789 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -110.7 -23.47 11.04 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.925 1.083 . . . . 99.99 113.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.12 165.04 12.99 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 109.468 -1.453 . . . . 99.99 109.468 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.35 4.67 0.68 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.185 1.55 . . . . 99.99 115.185 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -30.39 71.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.251 1.821 . . . . 99.99 114.203 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.09 -27.04 52.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.341 0.867 . . . . 99.99 113.341 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -119.02 95.95 49.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 106.055 -1.831 . . . . 99.99 106.055 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.78 -58.96 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.306 2.004 . . . . 0.0 114.126 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 p -64.64 -48.49 74.64 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.403 1.481 . . . . 99.99 113.076 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 m -108.4 -165.69 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.786 -1.552 . . . . 99.99 110.746 170.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.92 97.13 0.12 Allowed Glycine 0 N--CA 1.473 1.113 0 N-CA-C 109.271 -1.532 . . . . 99.99 109.271 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.91 -25.34 19.77 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.564 1.32 . . . . 99.99 114.564 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.11 -40.14 14.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.029 1.332 . . . . 99.99 113.569 166.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.3 m -102.42 -21.07 14.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.824 1.25 . . . . 99.99 114.362 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -38.31 2.97 Favored Glycine 0 N--CA 1.48 1.58 0 C-N-CA 124.08 0.848 . . . . 99.99 112.332 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 116.057 -1.925 . . . . 99.99 114.119 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 122.383 1.087 . . . . 99.99 112.745 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -54.91 -31.54 60.21 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.992 -1.458 . . . . 99.99 114.455 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -63.19 -52.61 61.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 99.99 112.388 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.24 65.22 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.85 0.685 . . . . 99.99 112.85 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.75 -38.4 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.404 1.081 . . . . 99.99 112.668 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.31 93.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.552 -0.737 . . . . 99.99 111.892 168.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.87 -0.25 8.75 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.351 1.241 . . . . 99.99 114.351 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 t -108.51 -29.2 8.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.329 1.451 . . . . 99.99 111.874 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -108.23 -27.31 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.562 2.06 . . . . 99.99 116.562 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.5 p -111.79 -25.74 9.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.01 1.115 . . . . 99.99 114.01 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.47 74.5 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 115.199 -0.909 . . . . 99.99 113.803 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.17 -77.79 0.21 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.908 -0.877 . . . . 99.99 110.908 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -44.47 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.993 2.22 . . . . 99.99 116.993 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -63.63 -50.15 70.45 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.886 1.069 . . . . 99.99 113.886 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.77 26.71 0.68 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.012 0.745 . . . . 99.99 113.012 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.81 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.193 2.197 . . . . 99.99 116.086 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 34.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 112.124 -2.307 . . . . 99.99 114.988 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -113.7 -14.93 12.55 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.576 1.951 . . . . 99.99 112.674 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.33 39.77 70.35 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 115.51 0.964 . . . . 99.99 115.51 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.89 12.64 14.68 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.606 1.706 . . . . 99.99 115.606 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.7 23.57 50.5 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 115.171 0.828 . . . . 99.99 115.171 -171.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -125.34 150.65 46.97 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.224 -1.028 . . . . 99.99 108.224 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -144.61 174.79 10.66 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.296 1.591 . . . . 99.99 115.296 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.72 19.83 63.35 Favored Glycine 0 N--CA 1.48 1.583 0 CA-C-N 113.777 -1.556 . . . . 99.99 116.792 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.05 15.36 49.73 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.532 1.373 . . . . 99.99 116.532 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.74 9.33 35.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.438 1.644 . . . . 99.99 115.438 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 30.89 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.562 1.945 . . . . 99.99 116.034 -169.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.69 116.19 23.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.044 -1.434 . . . . 99.99 110.938 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -36.07 126.03 0.68 Allowed Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 113.266 -1.788 . . . . 99.99 113.67 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.71 -35.61 94.22 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.119 2.546 . . . . 0.0 113.39 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.94 64.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.027 1.121 . . . . 99.99 114.027 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 m -75.21 -42.31 55.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.895 0.478 . . . . 99.99 111.138 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.0 t-105 -57.86 -22.63 48.96 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.201 0.815 . . . . 99.99 113.201 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.81 -28.77 3.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.887 1.44 . . . . 99.99 114.887 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.79 78.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.949 0.722 . . . . 99.99 112.949 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -91.52 18.9 6.73 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.222 1.193 . . . . 99.99 114.222 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -21.94 32.22 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.667 1.027 . . . . 99.99 115.667 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.0 44.1 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 114.871 0.708 . . . . 99.99 114.871 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.66 152.8 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.324 1.85 . . . . 99.99 109.361 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 37.18 0.08 OUTLIER Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.505 1.526 . . . . 99.99 116.202 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -57.68 -50.87 85.7 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.151 -1.881 . . . . 99.99 110.365 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.2 -11.83 29.32 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.081 2.52 . . . . 0.0 115.563 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.1 -34.97 32.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 99.99 113.203 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.72 -34.84 10.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.556 1.317 . . . . 99.99 114.556 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.25 118.72 8.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.797 0.839 . . . . 99.99 111.924 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -46.65 161.34 0.06 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 99.99 111.645 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -60.66 1.49 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.988 1.107 . . . . 99.99 113.988 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.63 -28.01 67.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.542 1.312 . . . . 99.99 114.542 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -72.4 -43.6 63.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.05 0.453 . . . . 99.99 110.973 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -44.29 95.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.465 -0.789 . . . . 99.99 111.685 176.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.9 pt -55.29 -30.02 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-O 118.381 -0.819 . . . . 99.99 113.073 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.91 88.08 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.713 0.634 . . . . 99.99 112.713 172.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.36 -42.76 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.763 0.825 . . . . 99.99 110.12 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.72 80.21 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.545 1.138 . . . . 99.99 114.047 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -59.55 -41.86 91.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.928 1.291 . . . . 99.99 111.686 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -33.7 57.57 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.375 0.88 . . . . 99.99 113.375 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.3 OUTLIER -61.43 -24.19 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.45 0.908 . . . . 99.99 113.45 172.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -47.27 79.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.141 0.577 . . . . 99.99 111.337 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -30.13 64.94 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.424 0.898 . . . . 99.99 113.424 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -49.53 77.25 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.679 1.191 . . . . 99.99 113.469 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -103.22 -26.55 12.94 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.698 0.999 . . . . 99.99 113.698 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.17 157.39 13.61 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.503 -1.439 . . . . 99.99 109.503 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -27.68 15.47 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.066 1.136 . . . . 99.99 114.066 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.52 -21.83 18.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.012 1.725 . . . . 99.99 115.2 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.83 -36.06 58.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.138 0.975 . . . . 99.99 113.583 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -118.82 136.92 24.47 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.399 -0.963 . . . . 99.99 108.399 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.93 -85.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.854 2.37 . . . . 0.0 113.885 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -91.55 -53.22 4.41 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.224 1.409 . . . . 99.99 111.477 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.96 160.92 3.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.444 1.898 . . . . 99.99 110.094 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.29 103.81 1.66 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.945 -1.025 . . . . 99.99 111.292 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -18.72 42.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.468 1.284 . . . . 99.99 114.468 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -36.62 -45.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.63 1.572 . . . . 99.99 113.165 160.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -107.29 -30.02 8.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.193 0.997 . . . . 99.99 113.442 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.21 11.69 64.57 Favored Glycine 0 N--CA 1.482 1.749 0 C-N-CA 123.941 0.781 . . . . 99.99 114.268 -173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.89 1.276 . . . . 99.99 113.455 174.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 118.879 -0.581 . . . . 99.99 109.993 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -49.76 -39.47 37.89 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.074 1.138 . . . . 99.99 114.074 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.87 -54.2 49.02 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.602 1.334 . . . . 99.99 114.602 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.96 74.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.128 0.971 . . . . 99.99 112.721 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.14 -31.38 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.068 1.347 . . . . 99.99 112.62 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.36 76.56 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.349 0.977 . . . . 99.99 112.76 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -77.82 5.42 9.58 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.692 0.997 . . . . 99.99 113.692 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.9 t -116.85 -33.41 4.79 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.237 0.829 . . . . 99.99 113.237 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.77 -43.74 45.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.377 1.071 . . . . 99.99 111.764 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 t -104.01 -45.17 4.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.011 1.324 . . . . 99.99 113.246 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.89 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 124.179 0.924 . . . . 99.99 114.347 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.77 -100.54 0.15 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 123.992 0.466 . . . . 99.99 112.795 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.38 139.74 33.89 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.266 1.21 . . . . 99.99 114.266 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -66.92 -15.81 63.92 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.378 1.622 . . . . 99.99 115.378 167.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.54 -35.35 12.97 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.338 0.866 . . . . 99.99 113.338 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.73 43.01 9.24 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.572 2.064 . . . . 99.99 116.572 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.93 32.27 4.28 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.306 -1.315 . . . . 99.99 112.919 -175.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -128.36 26.77 5.66 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.708 1.242 . . . . 99.99 113.084 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.31 -95.53 0.39 Allowed Glycine 0 N--CA 1.481 1.656 0 CA-C-N 113.994 -1.457 . . . . 99.99 110.154 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -105.69 28.96 6.99 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.391 1.256 . . . . 99.99 114.391 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.11 91.67 Favored Glycine 0 CA--C 1.541 1.711 0 CA-C-N 115.952 -0.567 . . . . 99.99 113.678 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.69 165.22 25.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.927 0.891 . . . . 99.99 110.703 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.43 156.86 47.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.32 -1.309 . . . . 99.99 114.001 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.66 10.14 29.36 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-N 114.272 -1.331 . . . . 99.99 116.147 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.59 29.88 54.87 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 115.536 -0.332 . . . . 99.99 112.302 -167.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.32 16.7 19.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.193 1.923 . . . . 99.99 116.193 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 36.0 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.072 1.878 . . . . 99.99 116.072 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -98.57 115.31 28.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.642 -1.163 . . . . 99.99 110.35 -168.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.53 130.46 10.6 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-N 113.289 -1.778 . . . . 99.99 112.963 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.33 -34.68 98.31 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.917 2.411 . . . . 0.0 113.438 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.66 65.16 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.145 1.165 . . . . 99.99 114.145 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -76.23 -46.53 27.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.434 0.694 . . . . 99.99 111.076 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -58.51 -22.37 54.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.248 0.832 . . . . 99.99 113.248 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.65 -30.35 3.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.867 1.432 . . . . 99.99 114.867 169.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.77 72.07 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.328 0.862 . . . . 99.99 113.328 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.01 19.45 12.79 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.144 1.377 . . . . 99.99 113.219 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.47 -21.72 30.07 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.792 1.077 . . . . 99.99 115.792 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.82 -5.77 29.65 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 114.731 0.653 . . . . 99.99 114.731 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.13 155.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.256 1.823 . . . . 99.99 112.061 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 33.96 0.14 Allowed Glycine 0 CA--C 1.541 1.719 0 C-N-CA 124.937 1.256 . . . . 99.99 115.747 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.1 -51.44 81.75 Favored Pre-proline 0 N--CA 1.476 0.858 0 CA-C-O 116.323 -1.799 . . . . 99.99 110.241 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.95 -10.05 24.27 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.69 2.26 . . . . 0.0 115.254 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.43 -33.79 28.45 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.11 0.782 . . . . 99.99 113.11 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.36 -34.06 10.81 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.93 1.455 . . . . 99.99 114.93 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.74 128.0 34.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.874 0.87 . . . . 99.99 111.423 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -49.43 156.09 0.66 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.031 -1.44 . . . . 99.99 110.722 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.74 -57.59 2.69 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.524 1.13 . . . . 99.99 113.994 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.53 -31.5 68.59 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.01 1.485 . . . . 99.99 115.01 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -66.06 -42.07 89.93 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.764 0.826 . . . . 99.99 111.039 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -53.74 49.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.06 1.344 . . . . 99.99 110.607 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.2 pt -54.31 -31.4 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.12 0.785 . . . . 99.99 113.12 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.19 74.49 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.289 0.848 . . . . 99.99 113.289 171.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.98 -42.13 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.514 0.726 . . . . 99.99 109.824 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.61 84.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.284 1.434 . . . . 99.99 114.041 175.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -59.52 -38.94 82.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.06 1.344 . . . . 99.99 112.132 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -80.74 -36.03 32.54 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.452 0.538 . . . . 99.99 112.452 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -20.28 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.739 1.015 . . . . 99.99 113.739 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -40.52 74.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 119.159 -0.448 . . . . 99.99 111.928 169.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.351 0.871 . . . . 99.99 113.351 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.32 -47.32 61.61 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.687 1.365 . . . . 99.99 114.687 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -107.04 -22.71 12.56 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.573 1.323 . . . . 99.99 114.573 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.37 155.15 9.3 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.116 0.865 . . . . 99.99 110.987 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 122.08 -0.659 . . . . 99.99 112.769 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.91 -0.92 8.17 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 116.308 1.966 . . . . 99.99 116.308 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -25.41 58.61 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.23 0.826 . . . . 99.99 113.23 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -118.2 75.53 11.48 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.164 -0.925 . . . . 99.99 111.099 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.17 -20.12 43.91 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.002 2.468 . . . . 0.0 113.828 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.5 p -60.29 -44.38 95.44 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.348 1.859 . . . . 99.99 113.978 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.95 -69.27 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.886 1.274 . . . . 99.99 112.283 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.76 89.13 0.62 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-N 115.138 -0.937 . . . . 99.99 112.32 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.86 -27.06 11.41 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.856 1.798 . . . . 99.99 115.856 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.61 -43.22 36.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.115 1.366 . . . . 99.99 113.505 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.5 m -109.03 -20.97 12.84 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.113 0.883 . . . . 99.99 112.628 166.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 -43.6 3.08 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 114.681 -1.145 . . . . 99.99 110.99 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.848 1.659 . . . . 99.99 113.632 -174.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 121.332 0.587 . . . . 99.99 111.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -33.71 58.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.625 0.972 . . . . 99.99 113.625 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.54 -35.84 72.95 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.444 1.276 . . . . 99.99 114.444 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 -26.6 67.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 118.816 -0.612 . . . . 99.99 112.358 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.68 -42.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.388 0.675 . . . . 99.99 110.267 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.645 0.609 . . . . 99.99 112.645 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -84.63 1.28 46.88 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 114.538 1.31 . . . . 99.99 114.538 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.17 -36.53 5.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.228 1.011 . . . . 99.99 112.338 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -79.31 -51.05 9.95 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.71 1.204 . . . . 99.99 112.645 167.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.59 -23.75 12.37 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.671 1.73 . . . . 99.99 115.671 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.81 -28.87 5.71 Favored Glycine 0 N--CA 1.482 1.721 0 C-N-CA 122.83 0.252 . . . . 99.99 113.416 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.04 93.14 0.09 OUTLIER Glycine 0 N--CA 1.474 1.227 0 N-CA-C 110.493 -1.043 . . . . 99.99 110.493 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -172.15 81.47 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.24 1.016 . . . . 99.99 112.433 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -73.65 -73.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.285 0.846 . . . . 99.99 113.285 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.32 71.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.978 1.103 . . . . 99.99 113.978 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.52 60.84 3.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.014 1.725 . . . . 99.99 114.316 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -77.45 35.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 113.033 -1.894 . . . . 99.99 115.148 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -112.35 -17.67 12.66 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.634 1.973 . . . . 99.99 112.351 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.71 58.04 7.38 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 115.746 -0.661 . . . . 99.99 113.621 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -104.64 20.65 18.24 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.476 -0.862 . . . . 99.99 112.748 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.06 26.78 49.95 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 124.188 0.899 . . . . 99.99 115.157 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -122.51 150.44 42.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.495 1.118 . . . . 99.99 109.451 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.4 ' CE1' ' CE3' ' A' ' 40' ' ' TRP . 10.7 p90 -152.73 139.68 19.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.011 -1.45 . . . . 99.99 112.552 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.34 -0.43 12.49 Favored Glycine 0 N--CA 1.485 1.907 0 CA-C-N 113.572 -1.649 . . . . 99.99 114.654 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.82 25.83 55.12 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 124.525 1.06 . . . . 99.99 114.775 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.16 14.5 27.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.421 1.267 . . . . 99.99 114.421 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 37.91 36.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.929 2.092 . . . . 99.99 116.068 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.69 121.76 36.6 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 112.929 -1.941 . . . . 99.99 108.349 -171.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -41.73 136.41 2.01 Favored Pre-proline 0 N--CA 1.482 1.16 0 N-CA-C 114.115 1.154 . . . . 99.99 114.115 176.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -32.41 51.71 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.635 2.223 . . . . 0.0 112.54 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.4 -34.72 64.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.318 1.047 . . . . 99.99 113.624 172.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.0 m -68.91 -47.06 66.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.914 0.486 . . . . 99.99 111.698 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CE3' ' CE1' ' A' ' 30' ' ' TYR . 33.2 t-105 -57.05 -22.28 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.538 0.94 . . . . 99.99 113.538 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.78 -29.2 4.28 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.462 1.282 . . . . 99.99 114.462 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.21 74.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.874 0.869 . . . . 99.99 113.296 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -95.71 18.4 13.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.169 0.988 . . . . 99.99 111.565 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -23.73 23.52 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 115.639 1.015 . . . . 99.99 115.639 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.12 -0.91 44.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 114.888 0.715 . . . . 99.99 114.888 -172.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.09 153.05 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.361 1.864 . . . . 99.99 109.26 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.83 38.05 0.07 OUTLIER Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.263 1.411 . . . . 99.99 116.418 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.27 -47.65 98.68 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-O 116.256 -1.83 . . . . 99.99 110.931 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.55 -28.09 38.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.202 2.601 . . . . 0.0 114.799 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.06 72.17 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.435 0.902 . . . . 99.99 113.435 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.87 -34.17 14.63 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.177 1.177 . . . . 99.99 114.177 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.73 20.94 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.511 1.148 . . . . 99.99 111.969 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.8 t -53.78 157.55 2.3 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.02 -1.9 . . . . 99.99 110.388 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.42 -58.13 3.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.309 1.226 . . . . 99.99 114.309 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -19.4 62.73 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.795 1.406 . . . . 99.99 114.795 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.46 -38.92 21.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.336 0.655 . . . . 99.99 111.936 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -63.91 -42.85 97.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.752 0.649 . . . . 99.99 112.752 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 pt -54.22 -29.79 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.801 1.037 . . . . 99.99 113.801 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.12 82.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.535 0.734 . . . . 99.99 112.546 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.37 -42.36 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.371 0.668 . . . . 99.99 109.842 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.23 76.97 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.129 1.159 . . . . 99.99 114.129 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.46 -49.38 77.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.72 1.208 . . . . 99.99 110.784 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -65.52 -37.36 86.53 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.208 0.447 . . . . 99.99 112.208 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.28 0.3 OUTLIER -61.29 -22.18 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.365 1.246 . . . . 99.99 114.365 175.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.34 -38.96 88.8 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 111.974 0.361 . . . . 99.99 111.974 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.73 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.132 0.79 . . . . 99.99 113.132 173.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.23 -54.79 24.19 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.286 1.958 . . . . 99.99 116.286 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 -23.56 11.5 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.366 1.247 . . . . 99.99 114.366 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.13 147.99 7.49 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-O 122.038 0.799 . . . . 99.99 111.864 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.46 -29.03 69.65 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.316 -0.942 . . . . 99.99 113.512 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -19.33 15.48 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.373 1.62 . . . . 99.99 115.373 172.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.64 74.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.781 0.832 . . . . 99.99 112.82 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -80.8 140.48 50.74 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.796 0.685 . . . . 99.99 109.214 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.55 -170.06 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.966 2.444 . . . . 0.0 111.493 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.7 p -53.35 -31.81 46.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.38 1.472 . . . . 99.99 114.146 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -39.26 -83.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.043 1.737 . . . . 99.99 113.314 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 41.51 43.63 3.89 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 115.684 1.034 . . . . 99.99 115.684 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.73 -20.2 0.78 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.52 2.044 . . . . 99.99 116.52 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.57 67.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.159 1.783 . . . . 99.99 113.156 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 m -65.54 -19.33 65.88 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.096 1.147 . . . . 99.99 114.096 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.39 27.03 72.81 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 123.853 0.721 . . . . 99.99 113.547 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.909 -1.043 . . . . 99.99 113.335 177.762 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 114.223 1.194 . . . . 99.99 114.223 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -57.55 -33.03 67.69 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.911 -1.495 . . . . 99.99 114.044 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.01 -50.75 70.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.739 0.816 . . . . 99.99 112.644 171.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.8 88.76 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.382 0.426 . . . . 99.99 111.826 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.25 -35.64 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.982 -1.008 . . . . 99.99 112.778 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.42 90.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 118.939 -0.553 . . . . 99.99 112.351 169.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -71.36 -3.6 21.6 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.931 1.085 . . . . 99.99 113.931 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -98.48 -27.53 14.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.29 1.436 . . . . 99.99 111.46 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.55 -43.92 5.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.732 1.012 . . . . 99.99 113.732 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -87.18 -37.87 16.91 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.104 0.779 . . . . 99.99 113.104 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.15 25.08 59.45 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 124.461 1.101 . . . . 99.99 114.189 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.36 -82.16 0.06 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 123.798 0.352 . . . . 99.99 113.728 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.85 139.3 50.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.458 1.281 . . . . 99.99 114.458 -171.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -69.32 -39.01 78.49 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.447 -1.251 . . . . 99.99 114.328 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.56 13.73 2.38 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.505 0.928 . . . . 99.99 113.505 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 30.3 71.72 0.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.598 1.959 . . . . 99.99 114.298 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -81.55 40.81 0.6 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 112.494 -2.139 . . . . 99.99 112.952 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -116.88 -19.33 9.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.036 2.534 . . . . 99.99 112.801 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.39 40.7 96.56 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.615 0.626 . . . . 99.99 114.622 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -109.44 32.75 4.76 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.931 0.872 . . . . 99.99 112.513 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.5 35.89 62.68 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 115.39 -0.823 . . . . 99.99 114.839 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -110.98 147.3 35.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.579 0.704 . . . . 99.99 110.586 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -132.56 145.51 51.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.503 -1.68 . . . . 99.99 114.898 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.24 29.46 29.64 Favored Glycine 0 N--CA 1.482 1.751 0 O-C-N 125.314 1.634 . . . . 99.99 117.111 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 22.73 55.84 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.848 0.737 . . . . 99.99 114.664 -173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.93 16.93 20.13 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.726 2.121 . . . . 99.99 116.726 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 43.39 42.97 4.07 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 124.07 1.89 . . . . 99.99 112.746 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -100.98 108.22 19.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.823 -1.535 . . . . 99.99 111.765 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -43.77 138.15 3.17 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 112.587 -2.097 . . . . 99.99 113.768 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.48 -42.34 9.95 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.709 2.273 . . . . 0.0 112.63 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.32 67.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.405 1.082 . . . . 99.99 112.955 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -71.76 -49.27 40.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.053 0.541 . . . . 99.99 112.179 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -60.2 -21.9 62.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.128 0.788 . . . . 99.99 113.128 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.5 -29.64 17.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.878 1.436 . . . . 99.99 114.878 170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -29.37 63.44 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.547 0.943 . . . . 99.99 113.547 170.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -105.99 25.69 10.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.416 1.486 . . . . 99.99 111.216 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.39 -19.88 52.69 Favored Glycine 0 N--CA 1.479 1.551 0 CA-C-O 119.092 -0.838 . . . . 99.99 115.082 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.65 -5.12 24.72 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 114.947 0.739 . . . . 99.99 114.947 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.89 151.85 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.322 1.849 . . . . 99.99 112.147 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.81 31.34 0.1 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 113.976 -1.466 . . . . 99.99 116.394 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -52.88 -51.51 73.69 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 116.286 -1.816 . . . . 99.99 111.372 169.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.24 -23.71 51.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.873 2.382 . . . . 0.0 115.652 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.07 38.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.142 1.164 . . . . 99.99 114.142 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.53 -36.84 13.48 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.456 1.28 . . . . 99.99 114.456 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 128.05 34.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.989 0.9 . . . . 99.99 110.415 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -52.04 158.34 1.1 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 112.967 -1.924 . . . . 99.99 110.534 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.86 -57.62 3.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.516 0.932 . . . . 99.99 113.516 -177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -68.79 -18.79 64.25 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.915 1.45 . . . . 99.99 114.915 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -81.67 -40.85 22.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.328 0.651 . . . . 99.99 111.418 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -48.09 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.909 0.884 . . . . 99.99 110.531 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 pt -53.97 -31.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.432 0.901 . . . . 99.99 113.432 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.72 72.56 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.252 0.621 . . . . 99.99 111.873 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.61 -48.62 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.899 -0.778 . . . . 99.99 108.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -37.83 68.44 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.438 1.273 . . . . 99.99 114.438 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -62.65 -38.32 89.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.755 1.622 . . . . 99.99 113.307 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -81.27 -35.98 30.46 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.259 -0.9 . . . . 99.99 111.741 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.0 t -50.72 -32.74 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.059 1.744 . . . . 99.99 112.072 171.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -41.61 76.27 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.742 . . . . 99.99 113.005 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.86 -28.93 67.15 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.231 0.826 . . . . 99.99 113.231 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -75.99 -59.91 2.55 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.419 1.266 . . . . 99.99 114.419 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.78 -27.01 36.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.428 1.27 . . . . 99.99 114.428 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.0 168.23 31.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 109.671 -1.371 . . . . 99.99 109.671 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.79 24.77 0.29 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.377 -0.912 . . . . 99.99 113.257 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.8 -45.91 12.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.943 . . . . 99.99 113.03 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.68 -34.3 64.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 99.99 113.152 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.34 94.97 49.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.285 -1.376 . . . . 99.99 107.285 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.61 -89.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.156 2.571 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -64.02 -43.85 94.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.631 0.772 . . . . 99.99 111.998 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.88 140.6 47.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.859 -1.163 . . . . 99.99 107.859 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.15 99.39 0.16 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 124.363 1.039 . . . . 99.99 111.695 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -18.68 54.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.206 1.558 . . . . 99.99 115.206 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.17 -48.2 9.19 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 99.99 112.497 165.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.5 m -95.08 -29.35 14.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.124 0.97 . . . . 99.99 113.469 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.28 67.66 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.169 0.89 . . . . 99.99 113.861 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.006 -1.473 . . . . 99.99 111.83 -178.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 115.264 1.579 . . . . 99.99 115.264 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -61.29 -33.9 74.33 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.728 -1.124 . . . . 99.99 113.831 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.6 -48.88 75.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.927 1.084 . . . . 99.99 113.927 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.84 92.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.913 0.709 . . . . 99.99 112.913 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.98 -32.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 112.815 0.672 . . . . 99.99 112.815 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.46 80.72 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.718 -0.658 . . . . 99.99 111.702 167.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -73.88 4.6 5.08 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.185 1.92 . . . . 99.99 116.185 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -110.83 -33.99 6.37 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.569 0.748 . . . . 99.99 112.301 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.33 -48.07 8.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.269 1.581 . . . . 99.99 115.269 168.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.2 p -94.35 -29.84 14.81 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.565 1.32 . . . . 99.99 114.565 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.41 17.94 60.33 Favored Glycine 0 CA--C 1.541 1.68 0 O-C-N 123.994 0.809 . . . . 99.99 113.618 -173.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.61 67.4 0.51 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.113 0.863 . . . . 99.99 111.676 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.79 76.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.807 0.843 . . . . 99.99 112.181 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -64.44 -38.27 90.42 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.868 1.062 . . . . 99.99 113.868 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.86 -27.9 55.24 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.022 1.119 . . . . 99.99 114.022 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' THR . . . 46.2 69.9 0.43 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.822 1.649 . . . . 99.99 112.769 -173.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -76.0 32.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.518 -1.674 . . . . 99.99 115.319 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' ALA . 4.4 p -96.54 -17.34 20.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.053 2.941 . . . . 99.99 113.921 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.83 37.17 93.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.8 1.08 . . . . 99.99 115.8 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.92 22.47 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.147 1.166 . . . . 99.99 114.147 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.04 24.75 55.37 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.552 1.072 . . . . 99.99 115.5 -172.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -126.22 142.35 51.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.438 0.695 . . . . 99.99 109.135 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -138.74 166.61 23.95 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.46 1.1 . . . . 99.99 112.507 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.37 -1.64 41.86 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 115.193 -0.912 . . . . 99.99 113.17 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.2 12.58 24.47 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 115.136 0.814 . . . . 99.99 115.136 -171.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.82 9.95 12.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.673 0.99 . . . . 99.99 113.673 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 43.38 41.9 3.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.985 2.114 . . . . 99.99 114.458 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.21 118.49 31.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 111.717 -2.492 . . . . 99.99 110.337 -172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.52 135.77 5.8 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 113.455 -1.702 . . . . 99.99 114.954 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.99 -39.97 37.14 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.943 2.429 . . . . 0.0 112.939 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.19 69.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.291 1.036 . . . . 99.99 113.277 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -69.23 -49.71 53.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.365 0.666 . . . . 99.99 110.961 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -59.47 -25.7 64.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.354 0.872 . . . . 99.99 113.354 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.28 -27.29 8.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.854 1.427 . . . . 99.99 114.854 170.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.57 73.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.834 0.679 . . . . 99.99 112.834 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -95.31 22.15 7.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.516 1.126 . . . . 99.99 113.581 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.93 -21.23 40.92 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 115.409 0.924 . . . . 99.99 115.409 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.07 54.29 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 114.753 0.661 . . . . 99.99 114.753 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.1 148.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.928 1.691 . . . . 99.99 109.369 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 35.01 0.16 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 124.881 1.229 . . . . 99.99 115.711 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.14 -45.29 99.38 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.184 -1.865 . . . . 99.99 109.966 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.18 -9.87 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.16 2.573 . . . . 0.0 118.03 169.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.1 -31.77 19.04 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.171 0.804 . . . . 99.99 113.171 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.97 -36.32 8.24 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.207 1.558 . . . . 99.99 115.207 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.976 0.894 . . . . 99.99 111.602 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m -50.3 152.95 1.63 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.59 -1.641 . . . . 99.99 110.276 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -53.78 17.21 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.322 0.86 . . . . 99.99 113.322 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -70.11 -27.15 64.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.358 1.244 . . . . 99.99 114.358 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -42.71 53.96 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.555 0.693 . . . . 99.99 110.907 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -70.54 -35.65 73.26 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.76 1.022 . . . . 99.99 113.76 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 pt -56.07 -28.67 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 118.442 -0.79 . . . . 99.99 112.609 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.21 77.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.032 0.533 . . . . 99.99 112.376 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.75 -41.31 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 116.109 -0.496 . . . . 99.99 109.89 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.37 -35.45 77.5 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.282 1.216 . . . . 99.99 114.282 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -64.88 -36.09 83.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.525 1.53 . . . . 99.99 112.61 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -37.24 28.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.337 0.866 . . . . 99.99 113.337 171.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.54 -24.6 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.675 0.991 . . . . 99.99 113.675 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.87 -46.15 82.01 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.334 0.396 . . . . 99.99 111.723 170.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.5 -33.38 69.2 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.328 0.651 . . . . 99.99 112.693 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.789 1.033 . . . . 99.99 113.789 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -27.7 10.57 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.985 1.476 . . . . 99.99 114.985 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.6 149.86 8.74 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.251 -0.74 . . . . 99.99 111.251 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.72 -33.59 71.02 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.065 1.135 . . . . 99.99 114.065 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.45 -23.29 48.82 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.568 1.692 . . . . 99.99 115.568 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.83 94.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 99.99 112.76 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -72.64 149.71 90.8 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.32 -0.854 . . . . 99.99 110.25 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.077 2.518 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -54.23 -21.44 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.431 1.271 . . . . 99.99 114.431 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 21.2 m -101.26 152.47 20.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.887 1.275 . . . . 99.99 111.503 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.4 107.79 0.22 Allowed Glycine 0 N--CA 1.476 1.302 0 CA-C-N 112.116 -2.311 . . . . 99.99 109.479 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.24 -23.22 13.93 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.937 1.458 . . . . 99.99 114.937 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.78 -39.9 8.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.868 1.667 . . . . 99.99 113.704 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -109.97 -21.04 12.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.5 1.52 . . . . 99.99 113.218 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.57 3.29 Favored Glycine 0 N--CA 1.48 1.581 0 C-N-CA 124.03 0.824 . . . . 99.99 112.466 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.943 -1.503 . . . . 99.99 114.15 179.872 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.772 0.32 . . . . 99.99 111.338 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -53.64 -32.35 51.08 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.923 1.453 . . . . 99.99 114.923 171.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -54.5 45.39 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.41 0.893 . . . . 99.99 113.41 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.67 79.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.496 0.718 . . . . 99.99 112.246 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.14 -31.59 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.372 1.249 . . . . 99.99 114.372 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.36 81.36 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.258 0.466 . . . . 99.99 112.258 168.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.97 5.4 19.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.434 1.272 . . . . 99.99 114.434 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.11 -32.98 7.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.42 1.488 . . . . 99.99 111.448 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -101.79 -27.49 12.99 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.652 1.353 . . . . 99.99 114.652 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -110.8 -38.96 4.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.894 0.877 . . . . 99.99 113.178 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 31.13 77.2 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 114.808 0.683 . . . . 99.99 114.808 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.78 -95.91 0.1 Allowed Glycine 0 N--CA 1.48 1.576 0 O-C-N 124.075 0.514 . . . . 99.99 112.439 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.0 146.4 30.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.536 1.31 . . . . 99.99 114.536 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -65.88 -58.7 4.98 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.401 -1.272 . . . . 99.99 112.832 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.23 -26.49 66.46 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.254 1.205 . . . . 99.99 114.254 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 40.11 78.12 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.053 1.741 . . . . 99.99 113.433 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -83.88 43.41 0.92 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.402 -1.726 . . . . 99.99 112.393 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 p -104.45 -15.87 15.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.804 2.442 . . . . 99.99 112.729 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.39 39.98 80.32 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.054 0.782 . . . . 99.99 115.054 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -95.2 21.4 7.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.251 1.574 . . . . 99.99 115.251 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.37 29.09 56.39 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 114.677 0.631 . . . . 99.99 114.677 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.2 151.36 31.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.643 1.177 . . . . 99.99 110.105 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -132.65 160.7 35.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.455 -1.248 . . . . 99.99 112.236 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 40.12 28.63 0.17 Allowed Glycine 0 N--CA 1.483 1.79 0 N-CA-C 117.494 1.758 . . . . 99.99 117.494 172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.47 34.23 84.61 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.475 1.35 . . . . 99.99 116.475 -172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 mp -108.29 -2.89 18.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 119.197 3.036 . . . . 99.99 119.197 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 42.83 28.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.702 2.112 . . . . 99.99 116.702 -169.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -94.54 108.02 19.99 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.851 -1.068 . . . . 99.99 111.394 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -24.45 126.12 0.16 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-N 112.348 -2.205 . . . . 99.99 114.809 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.44 -35.21 73.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.708 2.272 . . . . 0.0 113.441 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.99 66.89 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.305 1.042 . . . . 99.99 113.394 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 -50.12 62.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.966 0.906 . . . . 99.99 111.097 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -60.02 -22.49 62.7 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.19 0.811 . . . . 99.99 113.19 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -30.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.702 1.371 . . . . 99.99 114.702 168.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.16 75.15 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.075 0.769 . . . . 99.99 113.075 171.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.1 19.38 9.3 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.163 1.385 . . . . 99.99 113.59 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.21 28.95 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 115.619 1.008 . . . . 99.99 115.619 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.23 -5.88 24.85 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 114.771 0.668 . . . . 99.99 114.771 -173.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' ASN . 11.2 p -64.99 148.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.539 1.536 . . . . 99.99 111.923 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 31.47 0.1 OUTLIER Glycine 0 CA--C 1.542 1.724 0 C-N-CA 125.086 1.327 . . . . 99.99 116.245 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' VAL . 64.2 t30 -57.78 -48.64 96.82 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 116.631 -1.652 . . . . 99.99 110.578 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.03 -13.88 26.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.417 2.745 . . . . 0.0 116.131 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.83 53.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.049 0.759 . . . . 99.99 113.049 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.34 -34.06 11.2 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.815 1.413 . . . . 99.99 114.815 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.63 56.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.285 1.034 . . . . 99.99 111.786 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.3 t -55.97 154.19 7.77 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.615 -1.63 . . . . 99.99 110.486 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -59.1 3.02 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.882 1.068 . . . . 99.99 113.882 -175.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -69.24 -26.23 64.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.553 1.316 . . . . 99.99 114.553 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.96 -39.08 63.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.712 -0.618 . . . . 99.99 112.264 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -50.72 72.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.595 1.158 . . . . 99.99 109.588 173.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 pt -55.4 -31.57 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.787 1.032 . . . . 99.99 113.787 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.27 77.77 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.916 0.486 . . . . 99.99 112.278 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.02 -40.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 99.99 110.27 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.95 83.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.608 1.163 . . . . 99.99 114.138 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.9 -38.47 85.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.168 1.387 . . . . 99.99 111.677 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -80.01 -32.2 39.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.912 1.078 . . . . 99.99 113.912 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -22.43 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.441 0.904 . . . . 99.99 113.441 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -39.43 87.11 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.548 0.573 . . . . 99.99 112.548 169.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.72 69.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.874 0.694 . . . . 99.99 112.874 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -58.87 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.096 1.147 . . . . 99.99 114.096 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -91.48 -36.49 13.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.497 1.295 . . . . 99.99 114.497 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.36 150.32 8.15 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.812 -1.315 . . . . 99.99 109.812 -167.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -1.35 55.31 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.474 1.287 . . . . 99.99 114.474 173.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -87.99 -23.75 23.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.603 1.161 . . . . 99.99 113.429 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.38 91.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.145 0.978 . . . . 99.99 113.62 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -60.35 150.12 73.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 118.762 -0.637 . . . . 99.99 110.777 169.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -63.25 -159.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.741 2.294 . . . . 0.0 111.066 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.0 p -51.49 -32.2 26.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 117.0 -1.476 . . . . 99.99 113.208 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.3 m -52.6 -135.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 128.392 3.557 . . . . 99.99 114.063 168.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 102.14 0.25 Allowed Glycine 0 N--CA 1.483 1.799 0 O-C-N 121.71 -0.619 . . . . 99.99 112.065 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.79 -26.16 3.69 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 116.345 1.98 . . . . 99.99 116.345 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.18 -39.15 20.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.784 1.234 . . . . 99.99 113.132 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 m -108.93 -29.65 8.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.289 1.036 . . . . 99.99 113.098 168.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.89 -29.17 5.59 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.236 -0.893 . . . . 99.99 113.649 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.08 -1.438 . . . . 99.99 113.212 173.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.393 1.257 . . . . 99.99 114.393 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -57.77 -34.99 70.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.111 -1.404 . . . . 99.99 113.798 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.57 -48.22 78.32 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.653 0.983 . . . . 99.99 113.653 171.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.88 75.8 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.629 0.603 . . . . 99.99 112.629 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.09 -37.45 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.729 0.811 . . . . 99.99 112.491 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.55 -48.26 69.26 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.177 0.436 . . . . 99.99 112.177 167.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.24 8.3 5.14 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.65 1.352 . . . . 99.99 114.65 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.0 t -114.8 -30.85 6.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.371 1.068 . . . . 99.99 113.485 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.59 -36.85 11.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.62 1.711 . . . . 99.99 115.62 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 p -108.63 -23.4 11.83 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.889 1.44 . . . . 99.99 114.889 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.3 7.93 69.1 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 114.962 0.745 . . . . 99.99 114.962 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.99 83.22 0.54 Allowed Glycine 0 N--CA 1.479 1.505 0 CA-C-O 121.996 0.776 . . . . 99.99 111.355 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 172.16 108.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.334 2.254 . . . . 99.99 108.647 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -93.22 -44.01 8.54 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.317 1.228 . . . . 99.99 114.317 172.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.67 -39.62 61.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.55 0.574 . . . . 99.99 112.55 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 84.81 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.577 1.551 . . . . 99.99 111.658 -173.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.47 58.57 0.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.1 1.429 . . . . 99.99 112.154 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.6 p -107.16 -26.6 11.02 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.29 -2.232 . . . . 99.99 111.973 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 34.39 89.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.226 0.917 . . . . 99.99 114.229 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.73 21.07 6.8 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.067 1.136 . . . . 99.99 114.067 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.07 11.49 9.05 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 124.326 0.965 . . . . 99.99 115.433 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -109.34 161.46 15.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.256 1.822 . . . . 99.99 110.247 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -114.17 119.71 37.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 112.882 -1.963 . . . . 99.99 112.964 -175.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.28 144.51 48.71 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.073 -1.876 . . . . 99.99 110.702 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.19 -36.98 3.9 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 112.943 -1.628 . . . . 99.99 110.806 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.64 -29.37 8.39 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.512 1.301 . . . . 99.99 114.512 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 53.76 36.28 23.5 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 123.628 1.68 . . . . 99.99 112.047 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.76 129.52 44.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.699 -1.592 . . . . 99.99 109.418 -172.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -47.63 141.2 7.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 113.48 -1.691 . . . . 99.99 114.63 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.48 -31.61 92.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.938 2.425 . . . . 0.0 112.868 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.14 63.45 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.61 1.164 . . . . 99.99 114.087 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -67.37 -57.13 7.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.482 0.713 . . . . 99.99 110.472 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -56.94 -21.72 32.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.661 0.986 . . . . 99.99 113.661 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.27 5.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.405 1.261 . . . . 99.99 114.405 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.42 73.72 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.826 1.047 . . . . 99.99 113.826 171.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -95.66 16.69 16.65 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.426 1.49 . . . . 99.99 112.757 172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.63 -22.32 24.3 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 115.985 1.154 . . . . 99.99 115.985 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.2 -2.9 33.56 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 114.63 0.612 . . . . 99.99 114.63 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.22 154.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.733 1.613 . . . . 99.99 111.701 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.1 33.84 0.11 Allowed Glycine 0 N--CA 1.484 1.851 0 C-N-CA 125.098 1.333 . . . . 99.99 115.986 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -59.6 -48.68 94.95 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.485 -1.721 . . . . 99.99 111.207 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.49 -30.86 28.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.603 2.202 . . . . 0.0 114.031 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.38 72.49 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.079 1.14 . . . . 99.99 114.079 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.68 -32.44 16.2 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.306 1.224 . . . . 99.99 114.306 174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 129.72 40.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.14 0.971 . . . . 99.99 111.679 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.1 t -53.77 155.31 3.32 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 113.89 -1.505 . . . . 99.99 109.971 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -46.81 -52.42 14.24 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.886 1.439 . . . . 99.99 114.886 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -37.67 78.22 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.53 0.937 . . . . 99.99 113.53 175.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -64.26 -35.21 80.1 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.67 -0.644 . . . . 99.99 112.031 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -53.72 48.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.393 1.077 . . . . 99.99 109.936 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 pt -53.71 -32.07 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.034 0.753 . . . . 99.99 113.034 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.62 -57.91 10.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.029 0.932 . . . . 99.99 113.116 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.08 -38.0 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.185 0.594 . . . . 99.99 110.452 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.71 90.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.241 1.416 . . . . 99.99 114.021 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -61.0 -30.5 70.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.117 1.367 . . . . 99.99 112.255 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -33.8 21.26 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.094 1.146 . . . . 99.99 114.094 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.258 0.8 OUTLIER -59.51 -24.71 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.262 0.838 . . . . 99.99 113.262 172.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.13 -44.02 92.0 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.588 0.588 . . . . 99.99 112.588 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -31.16 70.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.661 0.615 . . . . 99.99 112.661 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.25 -55.32 14.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.434 1.272 . . . . 99.99 114.434 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -98.54 -26.88 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.153 1.168 . . . . 99.99 114.153 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.75 155.26 8.37 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 110.987 -0.845 . . . . 99.99 110.987 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.06 -35.08 77.56 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 122.399 -0.471 . . . . 99.99 112.163 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.93 -17.84 53.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.618 1.567 . . . . 99.99 114.517 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -44.96 -35.92 3.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.133 1.773 . . . . 99.99 114.38 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -115.94 97.73 49.78 Favored Pre-proline 0 N--CA 1.471 0.59 0 N-CA-C 105.881 -1.896 . . . . 99.99 105.881 171.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.37 -35.81 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.585 2.19 . . . . 0.0 114.012 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -61.94 -52.2 65.03 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.999 1.32 . . . . 99.99 113.693 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 m -139.42 -166.1 1.99 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.706 1.202 . . . . 99.99 110.196 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.06 102.21 0.16 Allowed Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.71 -1.356 . . . . 99.99 109.71 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.8 -27.0 10.91 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.605 1.335 . . . . 99.99 114.605 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.63 11.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.382 1.473 . . . . 99.99 114.236 168.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -109.5 -19.62 13.17 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.764 1.394 . . . . 99.99 114.764 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.56 4.0 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.492 0.568 . . . . 99.99 113.239 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 115.212 1.56 . . . . 99.99 115.212 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.103 0.478 . . . . 99.99 111.762 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -57.61 -30.69 65.53 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.026 -1.443 . . . . 99.99 114.167 170.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.87 -51.04 70.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.212 1.005 . . . . 99.99 112.885 171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.33 78.12 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.506 0.722 . . . . 99.99 112.513 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.2 -42.97 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.519 1.128 . . . . 99.99 111.985 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.2 -44.94 68.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.105 0.562 . . . . 99.99 111.73 168.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.09 -5.61 36.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.678 1.733 . . . . 99.99 115.678 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 t -105.33 -26.82 11.83 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.678 1.191 . . . . 99.99 112.596 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.81 -40.95 7.87 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.334 1.235 . . . . 99.99 114.334 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.6 p -104.83 -23.31 13.04 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.807 1.41 . . . . 99.99 114.807 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.4 -25.82 22.64 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.412 -0.813 . . . . 99.99 112.999 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.79 -40.68 0.2 Allowed Glycine 0 N--CA 1.477 1.432 0 CA-C-N 115.524 -0.338 . . . . 99.99 113.394 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -52.22 100.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.565 1.146 . . . . 99.99 113.21 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -73.77 -22.58 59.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.775 1.769 . . . . 99.99 115.775 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 -25.43 13.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.679 1.363 . . . . 99.99 114.679 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.16 74.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.228 2.211 . . . . 99.99 115.479 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 43.06 88.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.986 -1.915 . . . . 99.99 112.367 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.8 p -58.69 -26.28 63.7 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.319 -1.764 . . . . 99.99 112.871 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.78 -3.54 22.03 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.166 1.365 . . . . 99.99 115.422 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.1 7.91 44.62 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.673 0.99 . . . . 99.99 113.673 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.95 8.16 33.67 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 124.007 0.813 . . . . 99.99 113.516 -172.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -110.7 159.51 17.55 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.749 2.02 . . . . 99.99 110.422 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -122.86 126.48 47.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.169 -2.287 . . . . 99.99 113.363 -175.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 151.03 38.8 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 112.031 -2.35 . . . . 99.99 112.71 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.7 -39.22 2.93 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 111.618 -2.291 . . . . 99.99 110.837 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.44 -32.01 7.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.683 -1.258 . . . . 99.99 114.024 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 56.06 34.33 23.57 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.048 1.739 . . . . 99.99 112.193 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 132.5 41.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.943 -1.48 . . . . 99.99 109.33 -170.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.87 142.4 13.01 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 113.071 -1.877 . . . . 99.99 114.907 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -57.97 -33.04 96.68 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.295 2.663 . . . . 0.0 113.499 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.13 62.53 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.205 1.187 . . . . 99.99 114.205 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -67.24 -56.96 7.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 99.99 110.546 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -60.2 -21.78 62.17 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.904 1.076 . . . . 99.99 113.904 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.61 -30.9 5.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.928 1.291 . . . . 99.99 114.303 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.51 77.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.065 0.765 . . . . 99.99 113.065 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.54 17.64 9.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.156 1.382 . . . . 99.99 113.907 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.48 -21.62 30.24 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.249 1.26 . . . . 99.99 116.249 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.04 49.31 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 114.785 0.674 . . . . 99.99 114.785 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.88 150.2 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.699 1.599 . . . . 99.99 109.135 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.06 40.13 0.07 OUTLIER Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.381 1.467 . . . . 99.99 115.917 170.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.43 -53.46 45.6 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 116.177 -1.868 . . . . 99.99 110.665 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -67.63 -21.15 46.07 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.837 2.358 . . . . 0.0 113.802 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -35.36 79.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.585 1.554 . . . . 99.99 114.673 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.76 -29.5 10.52 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.758 1.392 . . . . 99.99 114.758 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 131.39 50.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.178 0.991 . . . . 99.99 111.21 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -54.19 151.83 6.78 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.608 -1.633 . . . . 99.99 110.072 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -44.69 -57.45 3.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.065 1.505 . . . . 99.99 115.065 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.18 -30.17 69.21 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.209 1.188 . . . . 99.99 114.209 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.75 -38.75 70.36 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.664 -0.648 . . . . 99.99 112.191 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -59.13 -54.97 40.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.434 1.094 . . . . 99.99 109.466 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 pt -55.15 -28.4 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.057 1.132 . . . . 99.99 114.057 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.01 75.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.82 0.674 . . . . 99.99 112.82 170.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.47 -39.88 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.737 0.815 . . . . 99.99 109.849 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.94 81.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.091 1.357 . . . . 99.99 113.715 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.39 -45.49 91.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.78 1.232 . . . . 99.99 110.864 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.28 81.96 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.086 0.773 . . . . 99.99 113.086 173.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.3 OUTLIER -61.12 -19.95 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.788 1.033 . . . . 99.99 113.788 175.204 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -44.48 86.69 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 118.699 -0.667 . . . . 99.99 111.297 169.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -27.76 69.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.662 0.986 . . . . 99.99 113.662 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.78 80.0 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.198 1.555 . . . . 99.99 115.198 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -103.65 -24.69 13.35 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.106 1.15 . . . . 99.99 114.106 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.79 159.96 10.83 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 110.173 -1.171 . . . . 99.99 110.173 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -56.75 -32.81 65.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.269 -0.548 . . . . 99.99 112.433 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.65 2.24 6.86 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.081 1.752 . . . . 99.99 114.965 175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -28.15 52.33 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.266 1.21 . . . . 99.99 114.266 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -118.21 74.8 11.0 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.251 -0.648 . . . . 99.99 109.251 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.8 -21.17 38.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.9 p -57.37 -41.34 79.96 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.182 1.793 . . . . 99.99 113.164 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.07 -86.0 0.17 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.874 -1.512 . . . . 99.99 108.277 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.87 104.26 1.91 Allowed Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.163 -0.775 . . . . 99.99 111.163 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.86 -40.08 9.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.515 1.302 . . . . 99.99 114.515 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.77 81.69 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.278 1.214 . . . . 99.99 114.278 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 -27.5 30.48 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.438 1.273 . . . . 99.99 114.438 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.59 26.21 69.54 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 124.11 0.862 . . . . 99.99 114.48 -172.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 125.671 1.588 . . . . 99.99 112.877 -178.171 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.773 0 N-CA-C 114.748 0.659 . . . . 99.99 114.748 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.73 -64.85 0.86 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.485 -0.857 . . . . 99.99 112.99 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 tpt -112.06 -69.21 0.88 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.875 0.87 . . . . 99.99 110.495 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.82 97.11 0.12 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 117.811 -1.55 . . . . 99.99 110.0 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 134.23 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.079 1.853 . . . . 0.0 112.279 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.7 m -59.99 145.07 85.53 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 114.84 -1.073 . . . . 99.99 113.617 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -60.46 139.06 84.42 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.103 2.535 . . . . 0.0 111.55 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -133.46 95.0 3.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.946 1.091 . . . . 99.99 113.946 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -60.04 -31.98 70.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.866 1.432 . . . . 99.99 114.866 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.64 -48.92 58.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.836 -0.62 . . . . 99.99 111.69 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.66 79.25 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 99.99 113.176 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . 0.255 50.8 t -64.66 -31.82 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 113.632 0.975 . . . . 99.99 113.632 174.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.54 -39.73 88.98 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.194 0.442 . . . . 99.99 112.194 167.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.08 6.56 7.69 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.578 1.695 . . . . 99.99 115.578 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.33 -34.61 7.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.894 1.278 . . . . 99.99 110.666 176.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.35 -33.82 10.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.841 2.163 . . . . 99.99 116.841 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.1 t -102.35 -36.48 8.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.698 0.799 . . . . 99.99 112.741 173.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.6 66.64 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 114.958 0.743 . . . . 99.99 114.958 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.55 -90.05 0.08 OUTLIER Glycine 0 CA--C 1.538 1.48 0 CA-C-N 115.51 -0.345 . . . . 99.99 112.707 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -113.72 143.79 44.03 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.96 1.096 . . . . 99.99 113.96 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.2 m95 -63.99 -34.55 78.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.757 1.021 . . . . 99.99 113.757 171.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.27 64.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.886 1.439 . . . . 99.99 114.886 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.92 71.11 0.34 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.77 1.628 . . . . 99.99 113.902 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -77.05 32.27 0.14 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.551 -2.113 . . . . 99.99 114.725 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -101.48 -14.54 17.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.628 1.971 . . . . 99.99 113.092 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 34.33 85.87 Favored Glycine 0 N--CA 1.48 1.592 0 O-C-N 123.98 0.8 . . . . 99.99 114.961 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -87.08 19.27 3.17 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.781 1.4 . . . . 99.99 114.781 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.44 24.3 45.56 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 124.022 0.82 . . . . 99.99 114.778 -170.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -119.63 146.39 45.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.42 0.688 . . . . 99.99 110.147 -171.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 -134.43 164.96 26.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.508 -1.224 . . . . 99.99 114.211 -176.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.73 30.28 62.48 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.868 -1.514 . . . . 99.99 115.338 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 53.7 23.86 23.09 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.603 1.097 . . . . 99.99 115.782 -178.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 13.2 mt -113.69 10.7 17.99 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.373 2.731 . . . . 99.99 118.373 -174.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 43.17 39.56 2.01 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 123.042 1.401 . . . . 99.99 112.648 -175.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -99.14 112.0 24.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.334 -1.303 . . . . 99.99 110.448 -172.083 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.36 132.45 4.62 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 113.362 -1.745 . . . . 99.99 113.621 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -60.54 -37.05 83.2 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.978 2.452 . . . . 0.0 112.936 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.37 66.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.239 1.015 . . . . 99.99 113.588 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m -72.06 -47.54 50.82 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.651 0.78 . . . . 99.99 111.092 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -60.11 -23.31 63.74 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.292 0.849 . . . . 99.99 113.292 176.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.22 -29.54 5.82 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.855 1.428 . . . . 99.99 114.855 169.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.3 -33.58 69.62 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.569 0.952 . . . . 99.99 113.569 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -100.89 22.58 11.9 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.139 1.376 . . . . 99.99 112.711 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.26 -24.29 26.59 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 115.692 1.037 . . . . 99.99 115.692 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 75.52 -8.32 20.36 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 114.718 0.647 . . . . 99.99 114.718 -172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 24.4 t -62.45 151.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.794 2.038 . . . . 99.99 109.548 -178.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.08 36.16 0.11 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.448 1.499 . . . . 99.99 115.934 174.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -57.96 -50.51 87.71 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.251 -1.833 . . . . 99.99 110.502 174.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -72.38 -16.07 27.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.972 2.448 . . . . 0.0 114.983 176.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -76.6 -34.3 58.4 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.441 0.904 . . . . 99.99 113.441 172.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.1 -35.94 11.7 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.346 1.239 . . . . 99.99 114.346 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.65 122.43 15.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.066 0.946 . . . . 99.99 111.55 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 m -47.15 159.1 0.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.558 -1.201 . . . . 99.99 111.111 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? -41.99 -57.22 2.51 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 99.99 113.743 -179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -67.12 -37.71 84.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.194 1.183 . . . . 99.99 114.194 176.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -62.11 -39.57 92.97 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.705 0.764 . . . . 99.99 110.887 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -50.93 66.65 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.671 1.188 . . . . 99.99 110.894 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.5 pt -53.83 -33.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 123.644 0.59 . . . . 99.99 112.531 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.19 -54.64 41.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.134 0.974 . . . . 99.99 113.053 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.11 -41.18 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.138 0.575 . . . . 99.99 110.047 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.04 -38.42 82.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.281 1.432 . . . . 99.99 114.332 174.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -59.58 -39.62 84.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.785 1.234 . . . . 99.99 111.618 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -78.98 -37.83 38.43 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.656 0.613 . . . . 99.99 112.656 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.268 0.4 OUTLIER -60.84 -23.59 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 113.9 1.074 . . . . 99.99 113.9 174.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -40.24 88.72 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.344 0.498 . . . . 99.99 112.344 169.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -31.7 65.35 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.841 0.682 . . . . 99.99 112.841 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.12 -49.6 73.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.067 1.136 . . . . 99.99 114.067 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -108.25 -27.34 10.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.097 1.518 . . . . 99.99 115.097 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.0 147.94 9.05 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.548 -1.021 . . . . 99.99 110.548 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.469 0.544 . . . . 99.99 112.469 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.23 -21.24 22.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.076 1.75 . . . . 99.99 114.935 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.64 78.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 99.99 112.603 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 25.1 m-90 -86.02 146.8 43.88 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 124.033 0.833 . . . . 99.99 109.306 171.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.61 -148.78 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.411 2.741 . . . . 0.0 111.586 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 t -51.38 -30.35 18.63 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.516 0.932 . . . . 99.99 113.516 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.9 m -81.58 131.98 35.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.75 1.22 . . . . 99.99 108.91 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.79 98.98 0.12 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.245 -1.343 . . . . 99.99 111.448 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.91 -20.81 40.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.05 1.5 . . . . 99.99 115.05 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.17 23.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.947 1.299 . . . . 99.99 113.567 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -101.61 -24.17 14.16 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.47 1.108 . . . . 99.99 113.714 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.0 2.91 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 118.933 -0.926 . . . . 99.99 113.631 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 126.695 1.998 . . . . 99.99 113.377 -173.697 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.291 0 N-CA-C 111.894 -0.482 . . . . 99.99 111.894 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.98 164.01 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.617 1.167 . . . . 99.99 112.593 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.07 -61.67 1.65 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.384 -1.28 . . . . 99.99 112.69 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.19 89.16 2.02 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 110.088 -1.205 . . . . 99.99 110.088 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.52 152.4 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.243 1.962 . . . . 0.0 111.698 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -54.12 139.23 55.25 Favored Pre-proline 0 N--CA 1.483 1.212 0 CA-C-N 114.913 -1.039 . . . . 99.99 112.777 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.73 135.12 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.886 2.391 . . . . 0.0 112.513 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -104.48 90.92 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.888 -1.506 . . . . 99.99 113.685 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -57.34 -33.66 67.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.294 1.22 . . . . 99.99 114.294 174.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.66 -53.49 56.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.364 0.666 . . . . 99.99 111.844 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.49 71.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.032 0.753 . . . . 99.99 113.032 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 94.3 t -60.14 -36.21 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.506 0.722 . . . . 99.99 112.094 172.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.191 -0.433 . . . . 99.99 111.292 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -0.46 11.59 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.459 1.652 . . . . 99.99 115.459 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -28.74 7.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.49 1.116 . . . . 99.99 113.148 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -100.96 -21.47 15.05 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.181 1.549 . . . . 99.99 115.181 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -122.06 -27.45 4.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.789 1.774 . . . . 99.99 115.789 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.41 6.28 89.36 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 115.962 -0.563 . . . . 99.99 114.354 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.17 76.32 0.27 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 121.775 0.653 . . . . 99.99 112.956 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 176.36 119.78 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.604 1.962 . . . . 99.99 109.405 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -90.29 -67.81 0.82 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 99.99 111.96 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.8 64.72 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.811 1.411 . . . . 99.99 114.811 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.16 72.28 0.22 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.068 1.747 . . . . 99.99 113.952 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -81.74 42.64 0.71 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.397 -1.729 . . . . 99.99 113.387 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -111.37 -17.09 13.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.26 2.224 . . . . 99.99 111.938 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 54.27 21.69 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-N 115.632 -0.713 . . . . 99.99 113.986 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -99.05 23.43 9.03 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.85 0.685 . . . . 99.99 112.85 -179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.82 30.09 56.09 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 124.154 0.883 . . . . 99.99 114.828 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -127.79 146.97 50.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.509 1.123 . . . . 99.99 109.388 -173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -138.55 151.42 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.755 -1.111 . . . . 99.99 112.159 178.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 64.88 2.94 8.88 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 114.352 -1.294 . . . . 99.99 115.165 -174.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 65.23 36.12 92.43 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.143 0.877 . . . . 99.99 114.047 -172.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.9 mp -111.68 19.29 18.2 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.601 1.704 . . . . 99.99 115.601 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 32.54 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.025 2.231 . . . . 99.99 117.025 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -90.99 105.56 17.92 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.521 -1.218 . . . . 99.99 111.173 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -40.41 129.56 1.75 Allowed Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 113.025 -1.898 . . . . 99.99 112.747 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -59.72 -32.52 95.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.075 2.517 . . . . 0.0 113.46 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.29 68.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.732 1.012 . . . . 99.99 113.732 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -72.26 -45.03 61.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.893 0.477 . . . . 99.99 111.272 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 39.0 t-105 -58.54 -21.81 53.62 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.479 0.918 . . . . 99.99 113.479 177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.03 -29.13 4.58 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.745 1.387 . . . . 99.99 114.745 168.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.22 69.09 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.252 0.834 . . . . 99.99 113.252 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -100.07 21.85 12.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.142 1.377 . . . . 99.99 112.779 174.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.15 30.74 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.658 1.023 . . . . 99.99 115.658 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.41 -1.28 36.38 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 114.827 0.691 . . . . 99.99 114.827 -172.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.3 t -67.32 152.19 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.409 1.884 . . . . 99.99 109.305 -179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.22 36.33 0.09 OUTLIER Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.501 1.524 . . . . 99.99 116.1 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -58.91 -51.46 81.7 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 115.954 -1.974 . . . . 99.99 110.225 174.581 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -71.78 -11.43 27.73 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.011 2.474 . . . . 0.0 115.442 175.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.71 -34.29 27.33 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.315 0.857 . . . . 99.99 113.315 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.36 -35.05 10.83 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.702 1.371 . . . . 99.99 114.702 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 129.94 43.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.663 0.785 . . . . 99.99 110.871 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.7 t -53.34 159.88 1.28 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.879 -1.51 . . . . 99.99 110.964 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -43.16 -59.01 2.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.4 1.08 . . . . 99.99 113.7 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -67.47 -34.81 77.92 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.569 0.952 . . . . 99.99 113.569 175.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -65.81 -37.55 86.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.601 -0.687 . . . . 99.99 111.674 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -62.6 -52.73 62.21 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.528 1.131 . . . . 99.99 110.127 172.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.2 pt -56.06 -30.12 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 113.467 0.914 . . . . 99.99 113.467 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.64 68.6 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.804 0.668 . . . . 99.99 112.804 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.64 -42.5 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.752 0.821 . . . . 99.99 109.774 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.3 -39.51 87.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.588 1.555 . . . . 99.99 114.369 175.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -56.77 -46.93 81.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.893 1.277 . . . . 99.99 110.669 173.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -35.07 68.54 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.052 1.13 . . . . 99.99 114.052 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.3 OUTLIER -62.38 -22.4 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.962 1.097 . . . . 99.99 113.962 172.933 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -40.83 89.19 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 119.434 -0.317 . . . . 99.99 111.582 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.79 -30.87 71.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.07 0.767 . . . . 99.99 113.07 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.66 -56.52 7.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.055 1.872 . . . . 99.99 116.055 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -89.37 -25.16 21.73 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.4 0.889 . . . . 99.99 113.4 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.61 154.0 9.8 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.931 -1.268 . . . . 99.99 109.931 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -56.61 -32.12 64.97 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.946 -0.738 . . . . 99.99 112.622 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.35 -2.02 5.54 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.09 1.885 . . . . 99.99 116.09 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.52 -31.77 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.726 1.01 . . . . 99.99 113.726 176.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.1 m-90 -117.71 69.96 6.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.427 -0.806 . . . . 99.99 109.534 174.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -64.73 -25.38 61.25 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.559 2.173 . . . . 0.0 113.115 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 p -57.73 -28.29 63.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.195 2.198 . . . . 99.99 115.326 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 -60.52 0.19 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.245 0.831 . . . . 99.99 113.245 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.42 99.35 0.19 Allowed Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.366 -1.288 . . . . 99.99 112.154 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.48 -38.59 54.65 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.412 -0.894 . . . . 99.99 113.274 172.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.038 1.335 . . . . 99.99 114.083 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -22.55 30.03 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.266 1.58 . . . . 99.99 115.266 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.08 28.02 57.95 Favored Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.283 1.273 . . . . 99.99 116.283 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 117.621 -1.18 . . . . 99.99 113.8 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.778 0 N-CA-C 113.96 0.344 . . . . 99.99 113.96 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -154.73 101.88 2.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 99.99 110.14 177.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.7 mtp -156.26 -56.49 0.09 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.801 -1.545 . . . . 99.99 112.425 -178.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.17 150.56 36.67 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-O 118.842 -0.977 . . . . 99.99 113.51 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -63.94 148.01 91.81 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.705 2.27 . . . . 0.0 111.434 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -100.37 131.64 23.68 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.899 -1.046 . . . . 99.99 110.492 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.82 138.83 49.98 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.636 2.224 . . . . 0.0 112.594 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.0 169.99 10.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.707 -1.588 . . . . 99.99 110.312 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -52.91 -33.74 51.82 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.441 1.275 . . . . 99.99 114.441 176.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.34 -42.28 77.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.043 0.937 . . . . 99.99 113.351 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.07 -31.13 72.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 118.245 -0.884 . . . . 99.99 112.678 178.335 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.06 -49.23 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.318 0.647 . . . . 99.99 109.669 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.92 94.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.904 0.705 . . . . 99.99 112.904 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.07 10.91 1.66 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 116.426 2.01 . . . . 99.99 116.426 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.8 -31.53 5.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.114 1.366 . . . . 99.99 111.613 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.25 -43.37 7.0 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.566 1.691 . . . . 99.99 115.566 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 t -88.33 -39.28 14.47 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.42 1.088 . . . . 99.99 112.861 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.37 18.72 58.83 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.104 -0.953 . . . . 99.99 115.108 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.07 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.477 1.374 0 CA-C-O 121.502 0.501 . . . . 99.99 113.124 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -114.1 144.42 43.18 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.184 1.179 . . . . 99.99 114.184 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -65.95 -44.12 85.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.224 -1.353 . . . . 99.99 112.903 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.66 -31.55 70.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.657 0.984 . . . . 99.99 113.657 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.01 76.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.271 1.828 . . . . 99.99 113.586 -172.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -81.96 51.97 1.86 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 113.649 -1.614 . . . . 99.99 112.786 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -113.65 -23.79 9.54 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 111.642 -2.526 . . . . 99.99 112.356 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.23 36.82 90.47 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.273 0.869 . . . . 99.99 115.273 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.7 29.55 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.468 0.651 . . . . 99.99 112.726 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.1 41.12 92.44 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.595 -0.729 . . . . 99.99 114.354 -174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -116.48 146.07 42.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.949 0.9 . . . . 99.99 110.381 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 -139.26 134.78 33.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.027 -1.442 . . . . 99.99 112.861 -173.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.98 31.73 40.46 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 125.33 1.644 . . . . 99.99 114.781 179.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.94 17.32 9.29 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 115.06 0.784 . . . . 99.99 115.06 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -103.14 19.96 18.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.728 0.811 . . . . 99.99 113.055 -176.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 36.96 40.96 0.16 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.705 2.002 . . . . 99.99 113.723 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.84 99.49 12.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.827 -1.533 . . . . 99.99 111.891 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -37.06 132.45 0.72 Allowed Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 112.682 -2.054 . . . . 99.99 113.665 178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -63.35 -39.11 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.212 2.608 . . . . 0.0 113.167 -175.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.55 -35.13 67.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.148 0.979 . . . . 99.99 113.071 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -70.61 -51.07 30.64 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.187 0.995 . . . . 99.99 111.354 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 37.1 t-105 -58.18 -21.1 45.91 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.343 0.868 . . . . 99.99 113.343 177.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.62 -29.35 4.23 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.799 1.407 . . . . 99.99 114.799 168.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.42 67.76 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.17 0.804 . . . . 99.99 113.17 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -100.52 21.52 13.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.243 1.417 . . . . 99.99 113.277 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.32 -23.71 26.2 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 115.639 1.016 . . . . 99.99 115.639 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.78 -6.14 20.37 Favored Glycine 0 N--CA 1.484 1.875 0 CA-C-N 117.321 0.56 . . . . 99.99 114.462 -172.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.406 ' C ' ' H ' ' A' ' 48' ' ' ASN . 31.7 t -64.81 150.39 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.076 1.75 . . . . 99.99 109.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 37.28 0.1 OUTLIER Glycine 0 N--CA 1.484 1.879 0 C-N-CA 125.127 1.346 . . . . 99.99 115.748 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.406 ' H ' ' C ' ' A' ' 46' ' ' VAL . 14.3 t-20 -56.98 -51.62 80.29 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.304 -1.808 . . . . 99.99 110.465 174.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -70.44 -20.64 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.328 2.685 . . . . 0.0 115.115 176.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.01 55.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.252 1.021 . . . . 99.99 113.442 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.95 -32.34 15.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.243 1.201 . . . . 99.99 114.243 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.47 130.59 43.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 99.99 112.525 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -54.73 159.38 2.24 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.404 -1.271 . . . . 99.99 110.742 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.57 -52.27 10.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.057 1.503 . . . . 99.99 115.057 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -63.59 -40.26 96.49 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.604 0.964 . . . . 99.99 113.604 174.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 43.1 tp60 -63.82 -40.15 95.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.287 0.635 . . . . 99.99 110.774 178.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -49.9 68.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.627 1.171 . . . . 99.99 111.089 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 pt -55.18 -33.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 118.951 -0.547 . . . . 99.99 112.117 178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.19 69.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.235 0.828 . . . . 99.99 113.235 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.24 -44.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.372 0.669 . . . . 99.99 110.373 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -64.7 -34.56 78.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.503 1.297 . . . . 99.99 114.503 176.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -56.3 -50.29 71.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.618 1.167 . . . . 99.99 110.557 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -33.63 70.44 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.978 1.103 . . . . 99.99 113.978 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.286 0.3 OUTLIER -62.5 -21.71 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.768 1.025 . . . . 99.99 113.768 172.914 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -38.86 91.38 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.417 0.525 . . . . 99.99 112.417 168.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.78 -31.54 71.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.987 0.736 . . . . 99.99 112.987 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -73.16 -65.93 0.74 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.248 1.573 . . . . 99.99 115.248 175.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -81.85 -23.02 36.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.273 1.212 . . . . 99.99 114.273 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.38 -169.31 16.21 Favored Glycine 0 N--CA 1.474 1.187 0 N-CA-C 110.093 -1.203 . . . . 99.99 110.093 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 17.73 20.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.871 -1.164 . . . . 99.99 113.32 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.63 -37.75 65.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.546 1.313 . . . . 99.99 114.546 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.31 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.024 0.827 . . . . 99.99 113.039 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -128.56 82.61 68.28 Favored Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 108.129 -1.063 . . . . 99.99 108.129 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.22 -81.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.936 2.424 . . . . 0.0 111.666 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 t -56.22 -44.64 79.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.896 1.278 . . . . 99.99 112.932 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.4 m -80.7 103.4 10.52 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.03 1.332 . . . . 99.99 108.191 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.01 50.55 0.58 Allowed Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.061 -0.518 . . . . 99.99 113.773 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -12.14 27.14 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.917 1.821 . . . . 99.99 115.917 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.77 -30.82 57.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.974 0.91 . . . . 99.99 113.175 165.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 m -93.52 -15.27 25.67 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.03 1.492 . . . . 99.99 115.03 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 36.65 23.77 Favored Glycine 0 CA--C 1.54 1.613 0 N-CA-C 115.467 0.947 . . . . 99.99 115.467 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 114.641 1.349 . . . . 99.99 114.641 178.098 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 CA-C-O 121.096 0.276 . . . . 99.99 113.372 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.52 -69.01 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.526 1.13 . . . . 99.99 111.031 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 45.28 85.76 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.942 1.697 . . . . 99.99 113.663 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.01 -91.28 0.08 OUTLIER Glycine 0 CA--C 1.541 1.669 0 CA-C-N 114.001 -1.454 . . . . 99.99 111.935 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.87 130.32 21.55 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.164 1.909 . . . . 0.0 111.407 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -103.16 132.23 21.33 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 114.363 -1.29 . . . . 99.99 111.074 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.97 114.11 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.513 2.142 . . . . 0.0 112.441 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -72.23 164.68 25.83 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.284 -1.325 . . . . 99.99 111.471 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -50.89 -32.43 20.51 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.678 1.362 . . . . 99.99 114.678 173.002 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.64 -34.3 71.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.681 0.993 . . . . 99.99 113.681 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.76 71.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.394 -0.812 . . . . 99.99 112.418 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 15.0 t -58.15 -48.75 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.882 -0.785 . . . . 99.99 108.882 170.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.34 98.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.748 0.648 . . . . 99.99 112.748 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -3.89 22.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.68 1.363 . . . . 99.99 114.68 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -115.73 -29.4 6.44 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.02 1.118 . . . . 99.99 114.02 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 54.6 mm-40 -88.86 -32.21 17.89 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.372 1.249 . . . . 99.99 114.372 171.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -115.21 -33.99 5.15 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.001 1.482 . . . . 99.99 115.001 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.54 33.97 Favored Glycine 0 CA--C 1.54 1.607 0 O-C-N 123.321 0.388 . . . . 99.99 112.646 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.33 89.83 0.19 Allowed Glycine 0 N--CA 1.476 1.348 0 N-CA-C 111.002 -0.839 . . . . 99.99 111.002 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.6 86.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.981 1.313 . . . . 99.99 110.285 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -71.47 -34.4 70.17 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.26 0.837 . . . . 99.99 113.26 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.06 32.18 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.672 0.989 . . . . 99.99 113.672 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.3 66.29 1.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.954 1.701 . . . . 99.99 112.923 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.8 35.52 0.37 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.304 -1.771 . . . . 99.99 113.456 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 p -104.69 -18.69 14.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.02 2.128 . . . . 99.99 112.797 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.27 73.79 Favored Glycine 0 N--CA 1.481 1.639 0 C-N-CA 123.753 0.692 . . . . 99.99 114.59 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 19.93 1.9 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.64 1.718 . . . . 99.99 115.64 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.0 30.28 63.34 Favored Glycine 0 CA--C 1.543 1.839 0 C-N-CA 123.79 0.709 . . . . 99.99 114.258 -171.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -126.02 144.24 50.79 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.458 0.703 . . . . 99.99 109.649 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -142.16 151.76 42.53 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.367 -1.288 . . . . 99.99 111.892 -179.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 -11.81 5.36 Favored Glycine 0 N--CA 1.483 1.772 0 CA-C-N 115.166 -0.924 . . . . 99.99 113.925 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 26.67 74.45 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.704 0.642 . . . . 99.99 114.704 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.27 17.91 20.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.432 0.53 . . . . 99.99 112.432 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 42.68 40.3 1.96 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.375 2.27 . . . . 99.99 113.836 -178.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -98.01 113.36 25.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 113.654 -1.612 . . . . 99.99 111.362 -168.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -40.7 127.59 1.89 Allowed Pre-proline 0 N--CA 1.481 1.081 0 CA-C-N 113.414 -1.721 . . . . 99.99 114.072 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -64.44 -37.83 36.85 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.797 2.332 . . . . 0.0 112.316 -175.172 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.89 74.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.274 1.03 . . . . 99.99 113.322 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 90.3 m -68.66 -45.78 70.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.99 0.516 . . . . 99.99 111.5 171.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.0 t-105 -56.53 -22.34 32.37 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.545 0.943 . . . . 99.99 113.545 177.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.72 -27.03 6.3 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.075 1.509 . . . . 99.99 115.075 168.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.68 71.39 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.694 0.798 . . . . 99.99 112.97 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.53 19.46 10.99 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.309 1.044 . . . . 99.99 113.657 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.4 -21.29 31.04 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 115.351 0.901 . . . . 99.99 115.351 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.22 -3.62 29.79 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 114.53 0.572 . . . . 99.99 114.53 -173.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.82 154.07 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.581 1.552 . . . . 99.99 111.303 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.64 39.33 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 114.332 -1.304 . . . . 99.99 115.544 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -48.51 96.75 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 116.455 -1.736 . . . . 99.99 110.211 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.27 -26.2 49.13 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.449 2.099 . . . . 0.0 115.965 171.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.95 -37.15 67.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.946 1.091 . . . . 99.99 113.946 173.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.82 16.23 24.62 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.055 1.502 . . . . 99.99 115.055 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.97 143.02 47.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.091 0.948 . . . . 99.99 110.772 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 33.9 t -62.99 156.84 23.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.265 -1.789 . . . . 99.99 110.3 -178.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -60.34 2.61 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.933 0.893 . . . . 99.99 112.936 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -70.62 -24.17 62.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.308 -1.315 . . . . 99.99 114.298 177.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -74.14 -46.67 40.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.621 0.724 . . . . 99.99 111.37 175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -69.14 -36.84 77.88 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.057 1.132 . . . . 99.99 114.057 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 pt -53.58 -29.42 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 118.262 -0.875 . . . . 99.99 112.876 171.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.02 99.53 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.99 0.737 . . . . 99.99 112.99 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.99 -42.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.037 0.535 . . . . 99.99 109.702 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.91 -35.76 81.14 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.209 1.188 . . . . 99.99 114.209 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.29 -35.94 80.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.765 1.626 . . . . 99.99 111.844 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -79.17 -37.66 37.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.522 0.564 . . . . 99.99 112.522 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.28 0.5 OUTLIER -60.81 -20.47 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.088 1.144 . . . . 99.99 114.088 175.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -39.92 81.12 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.167 0.432 . . . . 99.99 112.167 168.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.19 69.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.11 0.782 . . . . 99.99 113.11 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.68 -57.62 3.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.313 1.045 . . . . 99.99 113.465 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -87.48 -25.68 23.6 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.945 1.091 . . . . 99.99 113.945 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.79 149.43 8.61 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 110.482 -1.047 . . . . 99.99 110.482 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.84 -26.06 61.51 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.107 0.78 . . . . 99.99 113.107 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 -3.39 23.28 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.167 1.914 . . . . 99.99 116.167 172.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.58 -32.64 70.57 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.925 1.083 . . . . 99.99 113.925 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.0 m-90 -121.83 76.09 38.07 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 108.276 -1.009 . . . . 99.99 108.276 173.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.46 -34.04 4.87 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.757 2.304 . . . . 0.0 113.082 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.2 p -61.53 -41.11 96.85 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.106 1.762 . . . . 99.99 113.302 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.69 133.9 13.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 99.99 110.377 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.96 57.68 0.55 Allowed Glycine 0 N--CA 1.476 1.317 0 CA-C-N 113.964 -1.471 . . . . 99.99 112.025 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -56.58 -18.71 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.672 1.73 . . . . 99.99 115.672 179.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.73 11.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.993 1.317 . . . . 99.99 113.868 165.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.4 p -102.07 -13.14 17.63 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.316 1.447 . . . . 99.99 113.993 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 13.43 46.15 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 116.159 1.223 . . . . 99.99 116.159 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 115.56 1.689 . . . . 99.99 115.56 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 2.008 0 N-CA-C 115.159 0.824 . . . . 99.99 115.159 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.98 108.02 9.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.632 0.773 . . . . 99.99 110.566 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.62 156.85 17.08 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.815 -1.084 . . . . 99.99 112.146 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.66 -111.59 1.51 Allowed Glycine 0 N--CA 1.477 1.415 0 CA-C-O 118.048 -1.418 . . . . 99.99 111.131 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.41 144.79 57.06 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -74.95 125.88 88.86 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.354 -0.839 . . . . 99.99 111.513 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.54 132.24 28.49 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.198 2.599 . . . . 0.0 113.136 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -121.25 119.6 32.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.089 -1.414 . . . . 99.99 113.16 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -33.6 73.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.117 -1.401 . . . . 99.99 113.483 172.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.36 -34.88 67.06 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.719 1.377 . . . . 99.99 114.719 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.02 -31.54 72.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.764 0.653 . . . . 99.99 112.764 175.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.54 -47.83 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.277 0.631 . . . . 99.99 109.606 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.19 81.79 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.411 0.523 . . . . 99.99 112.411 173.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.58 0.06 21.47 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.093 1.886 . . . . 99.99 116.093 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.2 t -114.41 -32.93 5.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.788 1.235 . . . . 99.99 111.926 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -98.01 -25.71 14.87 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.859 1.429 . . . . 99.99 114.859 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 3.8 t -121.1 -24.91 5.42 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.4 1.259 . . . . 99.99 114.4 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.35 -25.09 22.28 Favored Glycine 0 N--CA 1.483 1.772 0 O-C-N 122.102 -0.374 . . . . 99.99 113.536 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -46.72 0.15 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.694 0.664 . . . . 99.99 113.621 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.68 101.42 0.11 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.862 1.431 . . . . 99.99 114.862 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -64.13 -34.68 78.61 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.68 2.104 . . . . 99.99 116.68 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 19.0 20.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.442 0.905 . . . . 99.99 113.442 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.83 79.14 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.453 1.901 . . . . 99.99 114.757 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.07 41.22 0.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.566 -2.107 . . . . 99.99 112.741 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -114.86 -16.16 11.76 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.572 2.349 . . . . 99.99 112.843 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 36.67 90.56 Favored Glycine 0 CA--C 1.54 1.622 0 N-CA-C 115.292 0.877 . . . . 99.99 115.292 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -97.35 24.75 6.2 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.658 1.355 . . . . 99.99 114.658 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.76 29.99 51.07 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 114.787 0.675 . . . . 99.99 114.787 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -117.26 154.13 31.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.876 1.271 . . . . 99.99 110.056 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -149.77 166.29 29.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.25 1.204 . . . . 99.99 114.25 -176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.96 16.98 42.19 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 114.594 -1.185 . . . . 99.99 116.034 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.66 24.13 56.43 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.904 0.764 . . . . 99.99 114.424 -171.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.3 mt -116.28 14.62 15.83 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.971 2.212 . . . . 99.99 116.971 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 36.65 27.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.907 2.188 . . . . 99.99 116.907 -169.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.79 98.54 6.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.3 -1.318 . . . . 99.99 111.743 -169.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -29.05 132.79 0.2 Allowed Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 113.531 -1.668 . . . . 99.99 114.626 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.38 -41.02 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.34 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.85 -33.09 68.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.172 0.989 . . . . 99.99 113.45 173.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -75.38 -43.88 47.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.579 0.752 . . . . 99.99 112.036 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -61.97 -21.24 64.66 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.751 0.648 . . . . 99.99 112.751 174.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.95 -29.2 7.96 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.707 1.373 . . . . 99.99 114.707 169.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.73 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.459 0.911 . . . . 99.99 113.459 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -102.11 21.24 15.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.539 1.535 . . . . 99.99 113.273 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.65 -22.05 31.15 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 115.792 1.077 . . . . 99.99 115.792 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.24 -0.22 41.35 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 114.692 0.637 . . . . 99.99 114.692 -172.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.35 150.51 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.26 1.824 . . . . 99.99 109.331 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.72 37.11 0.08 OUTLIER Glycine 0 CA--C 1.542 1.738 0 C-N-CA 125.446 1.498 . . . . 99.99 116.137 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.81 -53.91 59.73 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 115.177 -2.344 . . . . 99.99 109.744 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -68.49 -10.71 29.84 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.417 2.745 . . . . 0.0 116.273 176.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.9 -35.7 25.92 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.574 0.953 . . . . 99.99 113.574 172.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.27 -30.87 11.65 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.372 1.249 . . . . 99.99 114.372 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.09 123.36 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.097 1.359 . . . . 99.99 111.637 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.6 t -53.8 152.74 5.17 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 113.45 -1.705 . . . . 99.99 110.659 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -40.33 -58.29 1.56 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.268 1.581 . . . . 99.99 115.268 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.9 -32.12 68.98 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.937 1.088 . . . . 99.99 113.937 176.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.68 -37.4 59.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.315 0.646 . . . . 99.99 112.387 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -64.92 -50.76 65.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.506 0.722 . . . . 99.99 112.819 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 39.6 pt -53.5 -29.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.206 0.817 . . . . 99.99 113.206 178.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.89 90.45 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.962 0.905 . . . . 99.99 113.439 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 t -63.39 -44.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.875 0.87 . . . . 99.99 109.55 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.613 1.338 . . . . 99.99 114.613 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -58.09 -37.23 74.11 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.158 1.383 . . . . 99.99 112.429 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -76.89 -40.52 47.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.436 0.636 . . . . 99.99 111.346 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.275 0.4 OUTLIER -59.94 -21.69 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.514 1.302 . . . . 99.99 114.514 177.394 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.5 pp -58.26 -37.58 75.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.916 0.71 . . . . 99.99 112.916 168.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.34 -30.81 65.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.456 0.702 . . . . 99.99 112.843 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.16 -60.74 2.36 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.573 1.323 . . . . 99.99 114.573 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -82.63 -37.82 24.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.708 0.633 . . . . 99.99 112.708 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.63 156.18 10.94 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.467 -1.453 . . . . 99.99 109.467 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.2 mt -58.42 -15.14 9.56 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 99.99 114.015 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -64.49 -21.15 66.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.776 1.63 . . . . 99.99 113.335 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.17 87.97 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.866 0.691 . . . . 99.99 112.866 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 80.52 62.89 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.653 -1.24 . . . . 99.99 107.653 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -83.69 -54.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.502 2.135 . . . . 0.0 112.965 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.7 p -64.22 -55.51 21.13 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.836 1.654 . . . . 99.99 111.995 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 86.0 m -90.95 123.73 34.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.495 -1.229 . . . . 99.99 108.074 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.28 46.67 0.32 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.329 1.018 . . . . 99.99 113.599 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.69 18.54 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.701 1.741 . . . . 99.99 115.701 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.14 -43.58 78.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.899 1.28 . . . . 99.99 112.548 168.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 m -79.53 -18.85 50.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.584 1.154 . . . . 99.99 113.778 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.26 -48.27 3.77 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-N 114.825 -1.08 . . . . 99.99 111.712 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.032 -1.461 . . . . 99.99 112.393 -170.297 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 CA-C-O 121.689 0.605 . . . . 99.99 114.288 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.88 154.98 34.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.228 1.011 . . . . 99.99 109.992 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 mtp -62.49 161.9 11.15 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.528 -1.214 . . . . 99.99 110.884 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.77 88.41 0.54 Allowed Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.009 -1.439 . . . . 99.99 110.87 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.84 145.32 31.97 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.326 2.017 . . . . 0.0 110.596 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.8 m -87.39 108.25 18.81 Favored Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 115.241 -0.89 . . . . 99.99 111.381 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.33 130.02 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.175 1.917 . . . . 0.0 111.276 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -108.46 172.43 6.84 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.08 -1.418 . . . . 99.99 110.941 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -47.78 -33.95 7.89 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.631 1.345 . . . . 99.99 114.631 170.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.61 -33.75 68.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.656 1.724 . . . . 99.99 115.656 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.65 -33.49 74.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.208 1.003 . . . . 99.99 112.317 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.04 -49.53 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 108.784 -0.821 . . . . 99.99 108.784 171.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.4 -42.56 82.46 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.912 0.708 . . . . 99.99 112.912 174.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.74 4.63 11.17 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 117.618 2.451 . . . . 99.99 117.618 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.78 -43.47 3.44 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.901 0.704 . . . . 99.99 112.901 168.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.55 -44.73 66.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.958 0.903 . . . . 99.99 113.406 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -102.81 -42.79 5.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.036 0.934 . . . . 99.99 112.585 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.52 24.59 64.12 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 115.0 0.76 . . . . 99.99 115.0 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.15 -93.54 0.1 OUTLIER Glycine 0 N--CA 1.477 1.368 0 O-C-N 124.125 0.544 . . . . 99.99 112.164 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -113.53 147.72 37.42 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.93 1.455 . . . . 99.99 114.93 -174.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 49.8 m95 -71.25 -43.44 67.26 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.353 -1.749 . . . . 99.99 112.287 173.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.2 -24.39 67.35 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.844 1.053 . . . . 99.99 113.844 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.35 71.77 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 99.99 113.962 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.0 32.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.896 -1.957 . . . . 99.99 115.004 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.5 p -109.12 -23.4 11.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.218 2.207 . . . . 99.99 113.251 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.89 35.31 72.34 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 115.911 1.124 . . . . 99.99 115.911 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -90.93 28.38 1.58 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.917 1.451 . . . . 99.99 114.917 176.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.37 40.44 92.02 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-O 121.518 0.51 . . . . 99.99 113.233 -173.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -120.53 137.15 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 99.99 109.255 -176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -138.4 147.81 43.78 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.575 1.172 . . . . 99.99 111.431 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.97 -4.51 7.78 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 114.478 -1.237 . . . . 99.99 114.546 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 71.31 26.98 72.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.418 0.532 . . . . 99.99 112.833 -173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -111.42 21.6 16.03 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.403 1.26 . . . . 99.99 114.403 176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 44.45 35.12 1.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.534 1.635 . . . . 99.99 113.287 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.11 107.5 20.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.294 -1.321 . . . . 99.99 110.72 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -47.37 133.05 9.96 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.512 -1.676 . . . . 99.99 113.884 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -62.7 -34.43 73.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.918 2.412 . . . . 0.0 113.326 -178.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.27 70.96 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.042 0.937 . . . . 99.99 113.232 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -66.28 -50.72 62.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.168 0.987 . . . . 99.99 111.794 170.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.3 t-105 -57.35 -22.01 39.52 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.66 0.985 . . . . 99.99 113.66 179.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.64 -29.06 6.63 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.679 1.363 . . . . 99.99 114.679 169.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.01 70.49 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.547 0.944 . . . . 99.99 113.547 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.45 25.44 9.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.996 . . . . 99.99 111.761 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.4 -22.84 31.7 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 115.824 1.09 . . . . 99.99 115.824 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.85 -6.0 28.6 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 114.714 0.646 . . . . 99.99 114.714 -173.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.89 149.64 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.317 1.847 . . . . 99.99 109.295 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.23 35.86 0.09 OUTLIER Glycine 0 CA--C 1.544 1.866 0 C-N-CA 125.175 1.369 . . . . 99.99 116.218 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.57 -48.34 97.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 116.058 -1.925 . . . . 99.99 110.874 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.2 -19.81 38.31 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.81 2.34 . . . . 0.0 114.781 175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.66 51.19 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 99.99 113.575 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.37 -34.12 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.791 1.404 . . . . 99.99 114.791 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 128.05 34.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.949 0.9 . . . . 99.99 111.542 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -50.82 157.7 0.77 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.849 -1.523 . . . . 99.99 110.597 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -38.92 -61.02 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.112 1.153 . . . . 99.99 114.112 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 11.0 tt0 -69.79 -24.42 63.49 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.033 1.494 . . . . 99.99 115.033 178.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -74.51 -41.51 60.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.444 0.698 . . . . 99.99 110.669 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -47.65 84.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.566 1.146 . . . . 99.99 110.572 175.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 10.1 pt -55.31 -31.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.273 0.842 . . . . 99.99 113.273 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.48 68.05 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 99.99 112.534 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.32 -41.5 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.794 0.438 . . . . 99.99 110.26 177.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.37 -34.12 74.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.085 1.143 . . . . 99.99 114.085 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.71 -44.77 96.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.164 0.985 . . . . 99.99 111.919 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.58 -38.8 80.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.213 0.53 . . . . 99.99 111.943 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.27 0.4 OUTLIER -59.96 -22.99 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 114.474 1.287 . . . . 99.99 114.474 177.156 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.65 80.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.711 0.634 . . . . 99.99 112.711 169.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.0 -29.3 68.28 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.812 0.671 . . . . 99.99 112.812 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -59.97 2.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 99.99 113.52 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -91.18 -21.81 20.96 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.545 1.313 . . . . 99.99 114.545 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 151.58 9.27 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 111.196 -0.762 . . . . 99.99 111.196 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.87 -37.88 86.21 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.63 0.604 . . . . 99.99 112.63 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -7.61 18.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.885 1.809 . . . . 99.99 115.885 174.206 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.7 67.48 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.482 0.713 . . . . 99.99 112.854 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -99.62 141.14 22.27 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.337 -0.986 . . . . 99.99 108.337 173.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.06 -159.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.684 2.256 . . . . 0.0 111.185 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.2 p -54.14 -24.56 18.32 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.848 1.425 . . . . 99.99 114.848 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.05 67.09 1.69 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.998 1.38 . . . . 99.99 112.494 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.63 50.66 0.84 Allowed Glycine 0 N--CA 1.475 1.243 0 CA-C-N 112.823 -1.989 . . . . 99.99 110.801 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -16.94 27.94 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.858 1.429 . . . . 99.99 114.858 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.65 -33.25 32.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.774 1.23 . . . . 99.99 113.357 165.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.7 m -99.05 -17.36 18.29 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.128 1.371 . . . . 99.99 113.98 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.68 32.54 84.51 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 115.114 0.806 . . . . 99.99 115.114 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.0 pp . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.69 1.737 . . . . 99.99 115.69 -179.88 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.829 0 CA-C-O 121.161 0.312 . . . . 99.99 113.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.01 135.8 12.64 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.451 1.101 . . . . 99.99 109.057 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.4 ttt -119.11 83.27 2.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.664 0.745 . . . . 99.99 109.674 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.78 -155.46 11.61 Favored Glycine 0 CA--C 1.544 1.891 0 CA-C-N 113.212 -1.813 . . . . 99.99 113.743 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.01 145.47 17.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.365 2.044 . . . . 0.0 111.685 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.29 94.49 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-N 114.894 -1.048 . . . . 99.99 112.595 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.29 142.98 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.147 2.565 . . . . 0.0 113.699 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -117.46 97.53 5.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.06 1.504 . . . . 99.99 115.06 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -56.67 -34.23 67.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.777 1.399 . . . . 99.99 114.777 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.79 -44.59 89.47 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.351 0.871 . . . . 99.99 113.351 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.34 -33.55 74.93 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.916 0.486 . . . . 99.99 112.003 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.5 t -62.07 -40.46 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.556 1.142 . . . . 99.99 113.128 174.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.05 93.14 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 119.45 -0.31 . . . . 99.99 111.787 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.73 0.89 6.12 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.639 1.718 . . . . 99.99 115.639 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.4 -33.12 6.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.113 1.765 . . . . 99.99 111.92 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 52.3 mt-10 -104.24 -23.73 13.21 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.649 1.722 . . . . 99.99 115.649 178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 53.3 p -117.36 -26.51 6.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.558 1.318 . . . . 99.99 114.558 169.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.34 -11.53 65.37 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 115.434 -0.803 . . . . 99.99 113.396 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.63 -67.42 0.17 Allowed Glycine 0 N--CA 1.477 1.387 0 N-CA-C 111.665 -0.574 . . . . 99.99 111.665 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -47.29 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.498 2.036 . . . . 99.99 116.498 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 41.9 m95 -63.93 -49.32 73.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.883 1.068 . . . . 99.99 113.883 173.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.55 -2.1 21.37 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.619 1.34 . . . . 99.99 114.619 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.19 69.6 0.27 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.122 1.769 . . . . 99.99 114.817 -173.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -82.51 43.81 0.85 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.001 -1.909 . . . . 99.99 112.933 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -114.59 -21.21 10.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.339 2.655 . . . . 99.99 112.128 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.51 32.66 82.32 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 115.529 0.972 . . . . 99.99 115.529 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.11 24.72 4.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.786 1.402 . . . . 99.99 114.786 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.61 37.66 77.25 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 115.855 -0.611 . . . . 99.99 113.888 -173.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -118.15 149.07 41.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.244 0.618 . . . . 99.99 109.82 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.0 m-85 -144.63 149.96 36.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.319 -1.31 . . . . 99.99 113.454 -173.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 56.67 23.73 45.02 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 116.759 1.463 . . . . 99.99 116.759 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 59.25 25.94 60.84 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 114.92 0.728 . . . . 99.99 114.92 -171.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.52 13.24 20.06 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.369 2.729 . . . . 99.99 118.369 -174.576 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 35.0 tt0 44.5 33.18 0.85 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 123.392 1.568 . . . . 99.99 114.334 -176.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.21 109.66 21.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.555 -1.202 . . . . 99.99 110.786 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.31 142.65 4.18 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 114.351 -1.295 . . . . 99.99 114.277 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -65.4 -40.95 17.01 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.741 2.294 . . . . 0.0 112.34 -176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.01 -29.74 65.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.728 1.211 . . . . 99.99 113.551 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 m -78.03 -45.03 24.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.918 0.887 . . . . 99.99 111.316 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 43.6 t-105 -59.24 -21.36 59.45 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.854 0.687 . . . . 99.99 112.854 174.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.18 -28.85 3.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.987 1.477 . . . . 99.99 114.987 168.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.56 68.48 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.173 0.805 . . . . 99.99 113.173 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.85 24.84 10.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.451 1.1 . . . . 99.99 111.781 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -23.58 28.42 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 115.808 1.083 . . . . 99.99 115.808 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.83 -4.21 31.25 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 114.866 0.706 . . . . 99.99 114.866 -174.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.28 158.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.649 1.58 . . . . 99.99 111.716 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.63 32.54 0.13 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 124.949 1.262 . . . . 99.99 116.164 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.76 -51.24 83.19 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-O 116.451 -1.738 . . . . 99.99 110.971 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -69.72 -19.01 36.89 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.15 2.567 . . . . 0.0 115.195 176.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.79 -33.66 46.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.623 0.971 . . . . 99.99 113.623 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.83 -35.74 12.58 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.702 1.371 . . . . 99.99 114.702 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.35 128.45 35.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.876 0.871 . . . . 99.99 111.648 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -51.58 159.91 0.69 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.307 -1.315 . . . . 99.99 111.688 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 8.1 mtm180 -41.74 -58.26 2.05 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.898 1.444 . . . . 99.99 114.898 179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -36.97 83.46 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.254 1.205 . . . . 99.99 114.254 175.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.72 -37.49 86.56 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.71 -0.619 . . . . 99.99 111.705 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -64.54 -50.76 66.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.228 1.011 . . . . 99.99 110.92 172.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 12.7 pt -56.73 -31.46 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 112.996 0.739 . . . . 99.99 112.996 178.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.04 -48.31 82.07 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 99.99 112.605 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.65 -42.6 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.986 0.514 . . . . 99.99 110.405 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.96 -36.67 75.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.374 1.07 . . . . 99.99 113.667 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.57 -46.09 84.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.035 1.334 . . . . 99.99 111.319 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -33.93 62.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.016 1.117 . . . . 99.99 114.016 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.4 OUTLIER -59.87 -25.68 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.457 0.91 . . . . 99.99 113.457 173.847 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -42.09 92.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.927 0.491 . . . . 99.99 112.228 171.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -31.15 66.92 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.031 0.752 . . . . 99.99 113.031 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -67.42 -52.0 44.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.294 1.59 . . . . 99.99 115.294 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.39 10.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.502 1.297 . . . . 99.99 114.502 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.98 155.93 9.22 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.05 0.805 . . . . 99.99 111.515 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.44 16.41 17.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.235 -0.982 . . . . 99.99 113.466 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.46 -29.36 13.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.144 1.378 . . . . 99.99 114.384 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.66 90.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.33 0.863 . . . . 99.99 113.33 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.14 149.31 91.22 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.428 -0.805 . . . . 99.99 111.129 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -64.88 -154.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.891 2.394 . . . . 0.0 111.774 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.2 p -56.03 -29.19 60.04 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.064 0.935 . . . . 99.99 112.98 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 m -68.65 172.23 6.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.484 2.313 . . . . 99.99 110.878 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.23 105.26 1.54 Allowed Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.91 -1.041 . . . . 99.99 111.178 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.75 -15.53 30.45 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.969 1.47 . . . . 99.99 114.969 -178.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.73 -41.89 5.1 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.927 1.291 . . . . 99.99 112.501 163.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.8 m -107.29 -28.11 10.1 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.376 1.048 . . . . 99.99 113.588 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.11 25.42 69.55 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 124.147 0.879 . . . . 99.99 113.587 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.252 1.214 0 CA-C-O 116.277 -1.82 . . . . 99.99 111.887 -177.466 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 N-CA-C 112.209 -0.357 . . . . 99.99 112.209 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.25 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.242 1.417 . . . . 99.99 113.658 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -73.72 150.31 41.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.133 -1.394 . . . . 99.99 112.097 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.42 -134.63 3.49 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.918 -1.492 . . . . 99.99 111.583 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -65.98 167.59 17.52 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.939 2.426 . . . . 0.0 112.092 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.4 m -46.58 134.99 7.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.666 1.186 . . . . 99.99 113.069 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -63.25 144.03 90.77 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.82 2.347 . . . . 0.0 112.54 -179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.53 121.33 43.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.079 -1.419 . . . . 99.99 111.692 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.56 -31.56 70.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.85 -1.068 . . . . 99.99 112.341 171.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -57.34 -35.8 70.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.751 0.821 . . . . 99.99 113.092 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.81 72.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.875 0.694 . . . . 99.99 112.875 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.401 ' CG2' ' H ' ' A' ' 79' ' ' ALA . 16.0 t -61.86 -47.47 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.664 0.786 . . . . 99.99 109.737 172.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.06 -40.6 96.34 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.325 0.861 . . . . 99.99 113.325 174.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -70.81 -7.49 45.67 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.223 1.194 . . . . 99.99 114.223 173.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.33 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.587 1.555 . . . . 99.99 111.938 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -80.86 -39.09 27.04 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.626 1.713 . . . . 99.99 115.626 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t -105.88 -37.99 6.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.81 1.244 . . . . 99.99 112.619 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.4 16.72 58.72 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.919 0.728 . . . . 99.99 114.919 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.3 -99.66 0.6 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 121.881 0.712 . . . . 99.99 112.453 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.63 150.89 47.18 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.136 -1.032 . . . . 99.99 113.468 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 39.3 m95 -64.16 -38.69 91.96 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.538 -1.21 . . . . 99.99 112.667 171.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.04 41.06 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.514 1.149 . . . . 99.99 112.39 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 59.52 0.65 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 122.947 1.356 . . . . 99.99 113.104 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.34 52.86 1.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.109 1.433 . . . . 99.99 111.513 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.3 p -82.92 9.38 10.13 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.349 -1.296 . . . . 99.99 113.786 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.84 26.89 70.43 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.266 1.267 . . . . 99.99 116.266 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -87.11 22.43 2.07 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.573 1.694 . . . . 99.99 115.573 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.2 30.75 48.34 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-N 115.864 -0.607 . . . . 99.99 113.72 -172.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -132.32 143.3 49.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.145 0.978 . . . . 99.99 109.285 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -146.28 159.39 43.41 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.836 -1.075 . . . . 99.99 113.598 -175.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.96 33.08 56.67 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 113.731 -1.577 . . . . 99.99 114.449 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 52.28 22.86 11.14 Favored Glycine 0 CA--C 1.545 1.917 0 N-CA-C 116.674 1.43 . . . . 99.99 116.674 -176.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.7 mt -109.54 11.46 24.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.131 2.641 . . . . 99.99 118.131 -175.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? 39.11 27.02 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.765 1.765 . . . . 99.99 115.765 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -79.2 106.17 11.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.035 -1.439 . . . . 99.99 112.204 -172.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -36.8 129.73 0.72 Allowed Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 113.204 -1.816 . . . . 99.99 113.818 177.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -63.42 -33.41 69.57 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.033 2.489 . . . . 0.0 113.026 -175.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -35.05 66.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.389 1.076 . . . . 99.99 113.145 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.8 m -70.82 -51.18 28.32 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.871 0.868 . . . . 99.99 111.167 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.8 t-105 -58.61 -21.52 53.77 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.204 0.816 . . . . 99.99 113.204 177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.86 -28.06 6.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.724 1.379 . . . . 99.99 114.724 169.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.03 75.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.052 0.76 . . . . 99.99 113.052 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.3 20.26 8.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.636 1.174 . . . . 99.99 113.959 171.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.88 -20.14 36.85 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.914 1.126 . . . . 99.99 115.914 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.86 -6.56 25.68 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 114.737 0.655 . . . . 99.99 114.737 -174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.402 ' C ' ' H ' ' A' ' 48' ' ' ASN . 7.9 p -64.5 154.94 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.087 1.755 . . . . 99.99 111.951 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.91 35.82 0.14 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 125.02 1.295 . . . . 99.99 115.538 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 46' ' ' VAL . 4.3 t-20 -58.42 -51.01 84.89 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 116.159 -1.877 . . . . 99.99 110.068 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -68.39 -21.4 40.93 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.04 2.494 . . . . 0.0 115.183 174.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.02 -33.44 57.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.65 0.982 . . . . 99.99 113.65 174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 1.5 43.01 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.262 1.208 . . . . 99.99 114.262 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.06 125.0 48.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.039 0.936 . . . . 99.99 109.206 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -53.2 155.36 2.7 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 113.532 -1.667 . . . . 99.99 110.055 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 51.5 mtt85 -37.36 -55.66 1.02 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.308 1.443 . . . . 99.99 114.247 -176.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -69.27 -42.36 75.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.524 1.305 . . . . 99.99 114.524 176.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.7 -39.24 73.51 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.664 0.785 . . . . 99.99 110.826 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -53.74 37.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.123 -0.941 . . . . 99.99 111.17 173.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 pt -51.73 -34.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 112.454 0.539 . . . . 99.99 112.454 179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -55.04 40.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.066 0.947 . . . . 99.99 113.297 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.52 -37.67 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.165 0.586 . . . . 99.99 110.516 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.15 -42.26 94.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.116 1.367 . . . . 99.99 113.791 174.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.4 -40.94 88.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.005 1.322 . . . . 99.99 111.922 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -71.39 -40.18 70.7 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.994 -0.441 . . . . 99.99 112.148 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.272 0.3 OUTLIER -63.51 -20.3 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.392 1.256 . . . . 99.99 114.392 177.199 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -44.01 88.23 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.096 0.406 . . . . 99.99 112.096 168.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.1 69.09 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.024 0.749 . . . . 99.99 113.024 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.71 -49.04 33.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.533 1.308 . . . . 99.99 114.533 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -102.09 -25.82 13.6 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.306 1.224 . . . . 99.99 114.306 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.62 154.77 8.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.078 0.847 . . . . 99.99 111.098 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.46 -32.36 72.35 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.33 0.863 . . . . 99.99 113.33 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -11.68 17.62 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.999 1.852 . . . . 99.99 115.999 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.61 -33.61 55.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.674 1.19 . . . . 99.99 114.063 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 21.1 m-90 -113.99 141.09 25.69 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 108.356 -0.979 . . . . 99.99 108.356 172.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.46 -159.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.034 2.489 . . . . 0.0 112.095 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -52.28 -25.23 8.92 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.71 1.374 . . . . 99.99 114.71 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.2 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.744 2.018 . . . . 99.99 115.214 170.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.56 48.6 1.09 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.317 0.961 . . . . 99.99 111.784 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.92 -15.31 0.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.102 1.519 . . . . 99.99 115.102 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.401 ' H ' ' CG2' ' A' ' 12' ' ' VAL . . . -46.4 -41.13 13.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.602 1.961 . . . . 99.99 113.305 164.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -95.72 -17.19 21.45 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.858 1.263 . . . . 99.99 113.66 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.31 -44.32 3.33 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 123.921 0.772 . . . . 99.99 112.684 -172.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.321 1.848 . . . . 99.99 112.074 -175.279 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.907 0 N-CA-C 113.91 0.324 . . . . 99.99 113.91 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.82 97.04 2.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 99.99 110.142 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpp? 49.78 86.61 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.194 1.398 . . . . 99.99 114.664 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.55 -86.82 0.52 Allowed Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.683 -1.599 . . . . 99.99 111.579 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.99 151.03 78.16 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.716 2.278 . . . . 0.0 112.139 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m -56.11 144.84 58.17 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 113.713 1.005 . . . . 99.99 113.713 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -63.98 130.75 28.43 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.936 2.424 . . . . 0.0 113.013 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -99.22 78.78 2.26 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.565 1.321 . . . . 99.99 114.565 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.2 m95 -59.55 -35.58 74.5 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.326 -1.761 . . . . 99.99 113.744 173.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -58.57 -52.82 64.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.572 0.749 . . . . 99.99 112.368 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.02 -35.46 71.3 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.872 0.733 . . . . 99.99 112.657 176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.76 -44.81 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.675 0.79 . . . . 99.99 112.814 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.73 94.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.86 0.362 . . . . 99.99 111.889 171.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.97 15.33 1.86 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.655 1.354 . . . . 99.99 114.655 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 4.5 t -116.95 -33.63 4.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.884 1.274 . . . . 99.99 111.543 177.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -88.48 -53.02 4.87 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.229 0.826 . . . . 99.99 113.229 168.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -81.21 -42.73 20.32 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.189 0.811 . . . . 99.99 113.189 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.25 19.87 60.08 Favored Glycine 0 N--CA 1.481 1.679 0 O-C-N 124.244 0.965 . . . . 99.99 115.399 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.56 -98.52 0.24 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-O 121.09 0.272 . . . . 99.99 112.88 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -123.96 153.39 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.483 1.29 . . . . 99.99 114.483 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.7 m95 -70.71 -42.62 70.36 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.353 -1.749 . . . . 99.99 111.353 173.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.93 40.67 1.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.432 1.11 . . . . 99.99 112.012 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 63.54 2.31 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 123.732 1.729 . . . . 99.99 111.613 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -82.74 30.48 0.43 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.518 -1.674 . . . . 99.99 114.041 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -80.24 27.66 0.33 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.731 2.012 . . . . 99.99 114.024 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.7 43.67 93.81 Favored Glycine 0 CA--C 1.54 1.615 0 N-CA-C 116.127 1.211 . . . . 99.99 116.127 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.96 7.78 38.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.542 1.682 . . . . 99.99 115.542 175.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.77 10.23 6.17 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 124.273 0.939 . . . . 99.99 115.336 -170.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp -131.5 148.24 52.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.654 1.182 . . . . 99.99 109.385 -173.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -139.35 160.21 40.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.411 -1.268 . . . . 99.99 111.764 -178.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.75 -10.59 24.08 Favored Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.624 -1.171 . . . . 99.99 114.943 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.08 25.73 54.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.012 0.339 . . . . 99.99 113.543 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mp -115.1 13.01 16.77 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.779 2.14 . . . . 99.99 116.779 177.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 38.62 52.13 1.78 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 123.75 1.738 . . . . 99.99 113.307 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -105.26 109.39 21.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.88 -1.964 . . . . 99.99 109.798 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -39.94 137.33 1.19 Allowed Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 115.34 1.608 . . . . 99.99 115.34 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.85 -44.74 12.35 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.516 . . . . 0.0 113.301 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.33 -33.24 67.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.063 0.945 . . . . 99.99 113.506 173.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -72.12 -48.03 46.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.701 0.8 . . . . 99.99 111.537 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 33.6 t-105 -59.93 -21.87 61.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.829 0.678 . . . . 99.99 112.829 175.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -50.92 -28.46 9.76 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.917 1.451 . . . . 99.99 114.917 170.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.25 -36.12 72.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.931 0.715 . . . . 99.99 112.931 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.5 17.5 13.02 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.727 1.211 . . . . 99.99 113.553 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.29 -22.79 24.21 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 115.445 0.938 . . . . 99.99 115.445 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.28 -6.19 23.63 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 114.681 0.632 . . . . 99.99 114.681 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.404 ' C ' ' H ' ' A' ' 48' ' ' ASN . 7.4 p -63.77 154.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.811 1.644 . . . . 99.99 111.721 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.2 0.09 OUTLIER Glycine 0 N--CA 1.482 1.757 0 C-N-CA 124.878 1.228 . . . . 99.99 115.59 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' H ' ' C ' ' A' ' 46' ' ' VAL . 17.9 t30 -58.57 -51.72 79.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 115.94 -1.981 . . . . 99.99 110.384 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -67.0 -25.07 44.68 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.265 1.977 . . . . 0.0 113.927 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.39 -36.21 76.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.014 1.116 . . . . 99.99 114.014 176.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.68 -33.89 11.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.484 1.291 . . . . 99.99 114.484 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 119.12 9.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.078 0.951 . . . . 99.99 111.6 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 m -46.87 156.41 0.2 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.201 -1.363 . . . . 99.99 111.429 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.5 mtt180 -29.34 -67.66 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.327 1.603 . . . . 99.99 115.327 174.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 22.5 tt0 -63.97 -32.65 74.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.364 1.246 . . . . 99.99 114.364 178.039 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -68.89 -40.25 79.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.049 0.54 . . . . 99.99 111.296 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.84 -50.67 67.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.389 1.076 . . . . 99.99 110.484 173.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 pt -54.82 -32.93 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 112.648 0.611 . . . . 99.99 112.648 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -53.58 56.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.98 0.912 . . . . 99.99 113.15 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.54 -41.59 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.135 0.574 . . . . 99.99 109.866 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.19 -39.46 82.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.452 1.501 . . . . 99.99 114.533 175.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -58.29 -37.51 75.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.004 1.322 . . . . 99.99 111.882 174.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -33.65 27.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.97 0.73 . . . . 99.99 112.97 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.271 0.4 OUTLIER -60.45 -25.19 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.757 1.021 . . . . 99.99 113.757 173.912 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.3 pp -61.78 -38.39 87.86 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.664 0.616 . . . . 99.99 112.664 168.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.2 71.67 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.89 0.7 . . . . 99.99 112.89 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.06 -62.95 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.041 1.497 . . . . 99.99 115.041 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -82.16 -22.77 35.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.88 1.437 . . . . 99.99 114.88 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 -169.08 15.1 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 109.391 -1.483 . . . . 99.99 109.391 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.03 19.69 7.58 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.205 -0.997 . . . . 99.99 113.198 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.92 -33.41 17.29 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.994 1.479 . . . . 99.99 114.994 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.25 -26.33 51.09 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.774 1.027 . . . . 99.99 113.774 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 6.3 m-90 -122.79 91.13 49.83 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 106.238 -1.764 . . . . 99.99 106.238 172.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.13 -62.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.525 2.15 . . . . 0.0 113.091 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -61.23 -50.37 73.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.888 1.275 . . . . 99.99 113.03 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.8 m -101.04 175.14 5.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.909 -1.041 . . . . 99.99 110.924 170.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.58 93.24 0.09 OUTLIER Glycine 0 N--CA 1.472 1.075 0 N-CA-C 110.249 -1.14 . . . . 99.99 110.249 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -28.01 19.86 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.628 1.714 . . . . 99.99 115.628 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.59 -37.81 42.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.636 1.175 . . . . 99.99 113.394 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -99.98 -27.49 13.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.386 1.074 . . . . 99.99 112.227 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.34 -37.14 3.51 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 114.881 -1.054 . . . . 99.99 111.264 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.817 1.247 . . . . 99.99 113.529 -175.823 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 CA-C-O 121.578 0.543 . . . . 99.99 113.998 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.42 147.5 29.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.374 -0.913 . . . . 99.99 109.36 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mtt 61.85 -174.91 0.13 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.402 1.481 . . . . 99.99 112.821 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.14 101.2 2.47 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.968 -1.462 . . . . 99.99 110.431 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.08 143.12 52.96 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.455 2.103 . . . . 0.0 111.912 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 143.15 74.84 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 114.787 -1.097 . . . . 99.99 112.798 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.26 133.22 27.86 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.065 1.844 . . . . 0.0 112.694 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -101.23 174.38 6.02 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 112.809 -1.996 . . . . 99.99 111.556 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.1 m95 -49.07 -37.88 22.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.465 1.283 . . . . 99.99 114.465 171.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.31 -43.94 95.88 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.948 1.092 . . . . 99.99 113.948 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.3 -34.63 77.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.923 0.889 . . . . 99.99 112.118 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.87 -37.95 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 99.99 112.421 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.92 93.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.466 0.543 . . . . 99.99 112.466 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.55 6.84 7.76 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.652 0.982 . . . . 99.99 113.652 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 t -110.31 -31.96 7.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.934 0.894 . . . . 99.99 112.267 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.66 -32.42 10.34 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.828 1.788 . . . . 99.99 115.828 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.8 t -98.52 -35.53 10.21 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 112.816 0.672 . . . . 99.99 112.816 173.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 31.08 67.74 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 115.135 0.814 . . . . 99.99 115.135 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.37 -88.73 0.07 OUTLIER Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.172 0.415 . . . . 99.99 112.509 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -112.83 145.3 40.88 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.374 1.25 . . . . 99.99 114.374 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -66.57 -47.39 72.94 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.441 -1.254 . . . . 99.99 113.107 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 -29.55 69.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.007 1.114 . . . . 99.99 114.007 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 35.35 70.46 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.403 1.881 . . . . 99.99 114.297 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -78.58 56.99 1.91 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.817 1.77 . . . . 99.99 112.401 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -117.53 -24.51 7.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.402 2.681 . . . . 99.99 112.94 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.08 34.42 76.1 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.666 1.026 . . . . 99.99 115.666 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -92.5 25.97 2.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.814 1.413 . . . . 99.99 114.814 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.3 39.17 92.24 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 116.11 -0.496 . . . . 99.99 113.695 -173.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -121.18 146.89 46.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.291 1.036 . . . . 99.99 109.742 -175.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -145.23 146.05 31.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.308 -1.315 . . . . 99.99 113.562 -175.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 51.18 34.08 31.69 Favored Glycine 0 N--CA 1.483 1.779 0 O-C-N 124.801 1.313 . . . . 99.99 115.843 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.12 23.52 52.57 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.356 0.979 . . . . 99.99 115.193 -174.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.3 mt -116.71 8.26 13.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.799 2.518 . . . . 99.99 117.799 -169.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 45.07 36.8 2.17 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.817 1.77 . . . . 99.99 113.07 -176.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -89.69 104.68 17.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.889 -1.505 . . . . 99.99 111.6 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -37.75 130.16 0.91 Allowed Pre-proline 0 N--CA 1.484 1.233 0 CA-C-N 112.986 -1.915 . . . . 99.99 113.331 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -65.0 -39.22 25.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.772 2.315 . . . . 0.0 112.556 -177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.38 70.04 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.2 1.0 . . . . 99.99 113.088 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 m -73.63 -44.79 56.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.578 0.751 . . . . 99.99 111.5 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 42.9 t-105 -58.7 -20.21 46.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.485 0.92 . . . . 99.99 113.485 175.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.39 -28.38 5.04 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.665 1.357 . . . . 99.99 114.665 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.05 69.74 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.128 0.788 . . . . 99.99 113.128 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -98.36 25.73 6.04 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.017 1.327 . . . . 99.99 113.589 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.34 39.57 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 115.433 0.933 . . . . 99.99 115.433 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.3 -4.57 32.71 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 115.077 0.791 . . . . 99.99 115.077 -173.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 61.7 t -72.2 152.81 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.011 1.724 . . . . 99.99 109.274 -177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.5 36.01 0.08 OUTLIER Glycine 0 CA--C 1.542 1.768 0 C-N-CA 125.226 1.393 . . . . 99.99 116.58 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -52.77 -53.94 48.86 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 116.209 -1.853 . . . . 99.99 109.146 171.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -67.35 -20.89 48.12 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.536 2.824 . . . . 0.0 116.023 177.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.52 61.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.48 0.918 . . . . 99.99 113.48 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.66 -35.01 10.72 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.34 1.237 . . . . 99.99 114.34 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.54 126.97 29.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.484 1.114 . . . . 99.99 110.821 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -54.63 156.81 3.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.016 -1.447 . . . . 99.99 110.301 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.5 mtt-85 -45.92 -57.74 4.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.146 0.978 . . . . 99.99 112.936 -176.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -66.79 -30.79 71.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.382 0.882 . . . . 99.99 113.382 176.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.44 -41.34 76.44 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.824 -0.547 . . . . 99.99 110.851 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.73 -40.77 98.24 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 99.99 111.251 174.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.3 pt -54.28 -33.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 119.358 -0.353 . . . . 99.99 111.945 177.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.03 82.54 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.429 0.9 . . . . 99.99 113.429 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.15 -42.18 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.362 0.601 . . . . 99.99 109.673 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.95 -36.39 79.23 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.502 1.297 . . . . 99.99 114.502 174.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.4 -47.71 81.0 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.407 1.083 . . . . 99.99 111.296 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -39.71 87.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.001 0.429 . . . . 99.99 111.572 173.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.293 0.4 OUTLIER -61.52 -26.03 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.987 1.477 . . . . 99.99 114.987 177.591 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.65 -40.3 91.5 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.032 0.382 . . . . 99.99 112.032 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.16 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.274 0.629 . . . . 99.99 112.607 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -66.91 -43.92 82.1 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.009 1.485 . . . . 99.99 115.009 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.82 -29.23 10.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.803 1.038 . . . . 99.99 113.803 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.465 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 112.89 155.68 12.15 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 109.535 -1.426 . . . . 99.99 109.535 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.38 21.1 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.043 1.127 . . . . 99.99 114.043 172.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 69' ' ' GLY . 7.4 m-20 -88.33 -30.62 19.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.004 1.722 . . . . 99.99 111.866 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.37 -31.23 65.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 99.99 113.33 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -122.75 89.74 50.06 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 106.224 -1.769 . . . . 99.99 106.224 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.08 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.29 1.993 . . . . 0.0 113.537 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -63.19 -49.56 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.855 1.662 . . . . 99.99 112.95 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -109.79 163.43 13.52 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.776 -1.556 . . . . 99.99 110.027 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.55 101.14 0.15 Allowed Glycine 0 N--CA 1.478 1.469 0 O-C-N 124.563 1.165 . . . . 99.99 111.376 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.56 -28.72 14.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.252 1.575 . . . . 99.99 115.252 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.08 -32.84 36.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.016 1.326 . . . . 99.99 114.074 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.8 p -107.97 -22.0 12.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.903 1.281 . . . . 99.99 113.714 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.7 32.71 84.48 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 124.296 0.95 . . . . 99.99 114.062 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 117.042 -1.456 . . . . 99.99 114.295 178.285 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.897 0 N-CA-C 115.23 0.852 . . . . 99.99 115.23 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.44 93.27 2.95 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.245 0.618 . . . . 99.99 111.558 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -85.84 141.71 29.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.211 -1.358 . . . . 99.99 111.638 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.94 106.21 0.22 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-O 118.189 -1.339 . . . . 99.99 111.559 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.66 140.6 47.53 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.325 2.016 . . . . 0.0 111.661 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -62.11 136.89 95.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 CA-C-N 114.359 -1.291 . . . . 99.99 112.505 -178.367 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -59.61 139.55 89.51 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.73 2.287 . . . . 0.0 112.584 -176.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -125.31 -178.43 4.21 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.386 -2.188 . . . . 99.99 112.022 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -50.91 -34.36 28.14 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.096 1.147 . . . . 99.99 114.096 170.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.28 -49.57 77.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.991 0.917 . . . . 99.99 112.688 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.497 0.719 . . . . 99.99 112.142 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 77.0 t -63.9 -38.96 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.176 0.991 . . . . 99.99 112.322 173.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.35 78.77 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 111.983 0.364 . . . . 99.99 111.983 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.72 6.92 19.3 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.704 1.372 . . . . 99.99 114.704 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -116.38 -35.24 4.35 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.882 0.873 . . . . 99.99 112.888 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -89.47 -39.27 13.46 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.174 1.176 . . . . 99.99 114.174 170.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -106.42 -24.08 12.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.942 1.09 . . . . 99.99 113.942 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.45 3.62 72.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.697 1.039 . . . . 99.99 115.697 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.52 81.18 0.42 Allowed Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.007 0.813 . . . . 99.99 111.49 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 173.77 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.08 1.752 . . . . 99.99 108.939 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -80.37 -79.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.402 0.439 . . . . 99.99 111.745 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -22.15 55.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.054 1.501 . . . . 99.99 115.054 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.8 70.61 0.5 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.321 1.848 . . . . 99.99 114.383 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.55 33.74 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.957 -1.929 . . . . 99.99 115.222 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.4 t -117.13 -18.01 10.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.388 2.275 . . . . 99.99 112.338 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 46.69 40.76 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 115.669 1.028 . . . . 99.99 115.669 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -89.35 23.24 2.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.739 1.385 . . . . 99.99 114.739 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.1 34.65 58.62 Favored Glycine 0 N--CA 1.482 1.765 0 C-N-CA 123.289 0.471 . . . . 99.99 113.563 -172.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.1 mttp -129.5 138.6 51.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.776 1.23 . . . . 99.99 108.809 -174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -136.87 149.46 47.68 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.565 1.166 . . . . 99.99 112.822 177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.54 -14.75 1.77 Allowed Glycine 0 N--CA 1.483 1.786 0 CA-C-N 114.339 -1.3 . . . . 99.99 116.235 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.7 30.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.889 0.757 . . . . 99.99 114.815 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.05 28.08 8.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.385 0.883 . . . . 99.99 113.385 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? 43.91 35.18 1.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.156 1.782 . . . . 99.99 114.171 -179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.04 110.19 22.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.446 -1.706 . . . . 99.99 112.044 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.92 133.14 29.32 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 112.581 -2.1 . . . . 99.99 112.78 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -62.03 -32.23 83.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.171 2.581 . . . . 0.0 113.771 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.02 65.34 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.371 0.878 . . . . 99.99 113.371 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -76.0 -41.04 52.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.705 0.802 . . . . 99.99 111.676 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 38.5 t-105 -58.73 -21.49 55.24 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.163 0.801 . . . . 99.99 113.163 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.86 -29.52 3.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.687 1.366 . . . . 99.99 114.687 168.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.06 -38.36 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.152 0.797 . . . . 99.99 113.152 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.31 18.85 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.77 1.228 . . . . 99.99 113.517 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.73 -21.13 32.84 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 115.594 0.998 . . . . 99.99 115.594 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.56 -2.95 36.34 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 115.044 0.778 . . . . 99.99 115.044 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.47 156.81 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.49 1.516 . . . . 99.99 111.741 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.38 34.28 0.12 Allowed Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.325 1.29 . . . . 99.99 116.325 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -58.46 -52.61 73.37 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-O 115.719 -2.086 . . . . 99.99 110.603 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.25 -16.95 44.8 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.135 2.557 . . . . 0.0 115.475 175.744 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.58 -33.67 35.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.583 0.957 . . . . 99.99 113.583 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.74 -34.71 10.41 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.516 1.302 . . . . 99.99 114.516 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.73 121.69 13.48 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.154 0.978 . . . . 99.99 110.876 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -50.85 160.09 0.49 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.057 -1.883 . . . . 99.99 110.732 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.19 -56.63 4.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.179 1.178 . . . . 99.99 114.179 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 29.1 tt0 -70.11 -30.28 67.44 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.538 1.31 . . . . 99.99 114.538 174.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -68.01 -45.78 73.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.404 0.681 . . . . 99.99 111.165 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -66.0 -45.07 82.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.778 0.831 . . . . 99.99 113.053 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.4 pt -54.67 -28.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.332 0.864 . . . . 99.99 113.332 176.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.51 85.99 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.097 0.776 . . . . 99.99 113.097 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.03 -42.61 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.252 0.621 . . . . 99.99 109.997 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.74 78.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.528 0.936 . . . . 99.99 113.528 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -61.01 -39.59 90.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.196 1.399 . . . . 99.99 112.183 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -33.85 52.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.943 0.72 . . . . 99.99 112.943 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.5 OUTLIER -57.15 -26.76 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.767 1.025 . . . . 99.99 113.767 173.526 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.79 -42.82 94.25 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.544 0.572 . . . . 99.99 112.544 171.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.7 66.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.598 0.592 . . . . 99.99 112.598 173.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -52.11 30.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.114 1.524 . . . . 99.99 115.114 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.37 -25.18 14.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.533 0.938 . . . . 99.99 113.533 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.424 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 118.77 164.81 13.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.802 -1.319 . . . . 99.99 109.802 -174.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.83 1.85 1.22 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.52 1.304 . . . . 99.99 114.52 170.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.424 ' H ' ' C ' ' A' ' 69' ' ' GLY . 24.8 p-10 -67.05 -32.83 74.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.299 1.84 . . . . 99.99 113.88 -179.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.04 -29.68 31.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.181 1.178 . . . . 99.99 114.181 174.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.2 m-90 -128.36 90.44 46.87 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 106.589 -1.634 . . . . 99.99 106.589 174.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.83 -65.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.542 2.161 . . . . 0.0 113.253 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -61.6 -42.64 99.15 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 99.99 113.875 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -113.62 -164.88 0.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.817 -1.083 . . . . 99.99 110.232 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.59 101.91 0.25 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 110.073 -1.211 . . . . 99.99 110.073 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.49 -25.64 60.09 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.835 1.42 . . . . 99.99 114.835 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -49.01 -42.38 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 99.99 113.554 166.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.2 p -94.2 -20.76 19.55 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.464 1.105 . . . . 99.99 113.131 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 21.3 63.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 124.906 1.241 . . . . 99.99 115.136 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.296 0 N-CA-C 115.252 1.575 . . . . 99.99 115.252 176.219 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.8 0 N-CA-C 114.37 0.508 . . . . 99.99 114.37 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 157.6 41.11 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.895 0.878 . . . . 99.99 111.317 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ttm -94.03 95.74 9.22 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.445 -0.798 . . . . 99.99 110.273 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.99 172.16 43.71 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 113.734 -1.575 . . . . 99.99 113.164 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.57 152.46 78.27 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.118 2.545 . . . . 0.0 112.084 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.3 m -57.38 108.92 1.41 Allowed Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.922 0.889 . . . . 99.99 113.05 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.24 137.73 44.69 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.745 2.297 . . . . 0.0 111.083 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -95.78 74.4 3.14 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.958 1.361 . . . . 99.99 112.033 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -57.57 -32.96 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.417 -1.72 . . . . 99.99 112.97 176.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.25 -48.0 71.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 99.99 112.105 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.65 66.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.503 0.927 . . . . 99.99 113.503 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 89.7 t -63.22 -33.83 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 99.99 112.627 175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.42 94.07 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.018 0.377 . . . . 99.99 112.018 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.26 -4.71 31.2 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.264 1.209 . . . . 99.99 114.264 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -106.93 -25.52 11.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.112 1.153 . . . . 99.99 114.112 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -104.71 -27.82 11.57 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.622 1.712 . . . . 99.99 115.622 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.4 t -110.75 -31.55 7.16 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.713 1.005 . . . . 99.99 113.713 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.61 -24.6 28.67 Favored Glycine 0 N--CA 1.481 1.693 0 CA-C-N 116.785 -0.189 . . . . 99.99 112.881 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.65 83.44 0.07 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.913 -1.275 . . . . 99.99 109.913 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 178.45 98.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.669 1.188 . . . . 99.99 110.869 -177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 76.3 m95 -75.6 -25.82 57.32 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.772 1.027 . . . . 99.99 113.772 177.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.75 48.6 0.95 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.847 1.308 . . . . 99.99 111.847 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -70.05 50.92 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.671 1.73 . . . . 99.99 115.671 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.46 26.19 7.53 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.893 -1.049 . . . . 99.99 113.751 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 t -122.75 44.5 2.63 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.424 1.583 . . . . 99.99 111.911 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.95 -93.64 0.1 OUTLIER Glycine 0 N--CA 1.481 1.634 0 CA-C-N 113.035 -1.893 . . . . 99.99 110.824 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -103.86 28.93 6.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.745 1.387 . . . . 99.99 114.745 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.28 33.66 65.87 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.946 -0.57 . . . . 99.99 114.306 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 91.2 mttt -79.3 151.03 31.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 99.99 111.2 -176.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.607 -1.179 . . . . 99.99 113.05 177.272 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.1 -25.99 1.83 Allowed Glycine 0 N--CA 1.48 1.591 0 CA-C-N 114.13 -1.395 . . . . 99.99 115.342 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.93 22.94 36.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 114.731 -0.734 . . . . 99.99 113.428 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -116.71 28.79 8.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.893 0.701 . . . . 99.99 112.893 176.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 37.19 31.65 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.266 2.226 . . . . 99.99 116.772 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -78.32 109.53 12.54 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.979 -1.464 . . . . 99.99 111.811 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -46.33 132.15 7.68 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 113.474 -1.694 . . . . 99.99 113.175 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.09 -38.85 84.71 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.91 2.407 . . . . 0.0 113.379 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.68 68.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.084 1.142 . . . . 99.99 114.084 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -76.87 -42.39 40.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.604 0.762 . . . . 99.99 111.069 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 40.1 t-105 -60.83 -21.83 63.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.424 0.898 . . . . 99.99 113.424 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.55 -29.94 3.2 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.725 1.38 . . . . 99.99 114.725 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.41 -35.86 70.58 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.557 0.947 . . . . 99.99 113.557 171.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -98.56 25.36 6.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.928 1.291 . . . . 99.99 113.156 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.31 34.27 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 115.246 0.859 . . . . 99.99 115.246 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.9 -11.02 16.24 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.638 0.615 . . . . 99.99 114.638 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.5 t -65.28 151.21 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.472 1.909 . . . . 99.99 109.735 -178.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.82 38.48 0.09 OUTLIER Glycine 0 CA--C 1.545 1.93 0 C-N-CA 125.428 1.489 . . . . 99.99 116.332 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -54.57 -53.89 54.89 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.233 -1.841 . . . . 99.99 108.617 171.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -70.66 -9.41 25.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.876 2.384 . . . . 0.0 116.122 178.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.34 -46.4 23.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.798 0.839 . . . . 99.99 113.003 170.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.43 -34.11 15.74 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.105 1.15 . . . . 99.99 114.105 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.55 115.1 3.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.006 0.922 . . . . 99.99 110.695 176.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -44.35 159.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.457 -1.701 . . . . 99.99 111.305 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.9 mtt85 -40.91 -59.41 1.44 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.98 1.312 . . . . 99.99 113.269 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -27.17 66.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.329 -1.305 . . . . 99.99 114.255 177.25 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.26 -42.48 65.55 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.339 0.59 . . . . 99.99 110.738 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -62.75 -48.11 80.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.118 0.967 . . . . 99.99 111.43 176.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.1 pt -54.35 -33.78 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.995 0.739 . . . . 99.99 112.995 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.4 -50.82 72.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.506 0.722 . . . . 99.99 112.8 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.69 -41.95 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.013 0.525 . . . . 99.99 110.376 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.88 73.44 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.256 1.206 . . . . 99.99 114.256 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 54.9 t30 -62.95 -41.92 99.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.05 1.34 . . . . 99.99 111.931 171.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -71.87 -38.54 70.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.419 0.628 . . . . 99.99 111.318 172.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.27 0.5 OUTLIER -59.37 -26.78 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 114.356 1.243 . . . . 99.99 114.356 176.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.6 pp -62.01 -40.52 95.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.353 0.501 . . . . 99.99 112.353 169.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.79 67.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.133 0.79 . . . . 99.99 113.133 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -61.67 -53.81 51.15 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.789 1.774 . . . . 99.99 115.789 179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -110.7 -23.47 11.04 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.925 1.083 . . . . 99.99 113.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.12 165.04 12.99 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 109.468 -1.453 . . . . 99.99 109.468 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.35 4.67 0.68 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.185 1.55 . . . . 99.99 115.185 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -30.39 71.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.251 1.821 . . . . 99.99 114.203 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.09 -27.04 52.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.341 0.867 . . . . 99.99 113.341 177.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 7.2 m-90 -119.02 95.95 49.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 106.055 -1.831 . . . . 99.99 106.055 174.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.78 -58.96 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.306 2.004 . . . . 0.0 114.126 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 p -64.64 -48.49 74.64 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.403 1.481 . . . . 99.99 113.076 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 m -108.4 -165.69 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.786 -1.552 . . . . 99.99 110.746 170.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.92 97.13 0.12 Allowed Glycine 0 N--CA 1.473 1.113 0 N-CA-C 109.271 -1.532 . . . . 99.99 109.271 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -53.91 -25.34 19.77 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.564 1.32 . . . . 99.99 114.564 177.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -47.11 -40.14 14.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.029 1.332 . . . . 99.99 113.569 166.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.3 m -102.42 -21.07 14.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.824 1.25 . . . . 99.99 114.362 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -38.31 2.97 Favored Glycine 0 N--CA 1.48 1.58 0 C-N-CA 124.08 0.848 . . . . 99.99 112.332 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 116.057 -1.925 . . . . 99.99 114.119 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.706 0 N-CA-C 114.29 0.476 . . . . 99.99 114.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 150.73 30.66 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.931 1.292 . . . . 99.99 109.205 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.5 mtt 49.65 84.98 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.293 1.437 . . . . 99.99 113.518 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.8 -73.63 0.08 OUTLIER Glycine 0 CA--C 1.542 1.746 0 CA-C-N 113.387 -1.733 . . . . 99.99 111.289 -173.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.16 131.96 32.37 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.204 1.936 . . . . 0.0 111.471 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.2 m -55.96 141.72 66.66 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 114.393 -1.276 . . . . 99.99 112.945 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.38 135.1 59.23 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 122.812 2.341 . . . . 0.0 111.287 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.28 94.1 4.65 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.344 -1.298 . . . . 99.99 112.745 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 31.4 m95 -54.91 -31.54 60.21 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.992 -1.458 . . . . 99.99 114.455 175.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -63.19 -52.61 61.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 99.99 112.388 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.24 65.22 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.85 0.685 . . . . 99.99 112.85 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.75 -38.4 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.404 1.081 . . . . 99.99 112.668 175.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.31 93.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.552 -0.737 . . . . 99.99 111.892 168.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.87 -0.25 8.75 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.351 1.241 . . . . 99.99 114.351 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 t -108.51 -29.2 8.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.329 1.451 . . . . 99.99 111.874 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -108.23 -27.31 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.562 2.06 . . . . 99.99 116.562 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 54.5 p -111.79 -25.74 9.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.01 1.115 . . . . 99.99 114.01 171.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.47 74.5 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 115.199 -0.909 . . . . 99.99 113.803 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.17 -77.79 0.21 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.908 -0.877 . . . . 99.99 110.908 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.2 m-80 -44.47 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.993 2.22 . . . . 99.99 116.993 -178.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 40.8 m95 -63.63 -50.15 70.45 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.886 1.069 . . . . 99.99 113.886 175.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.77 26.71 0.68 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.012 0.745 . . . . 99.99 113.012 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.81 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.193 2.197 . . . . 99.99 116.086 -172.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 34.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 112.124 -2.307 . . . . 99.99 114.988 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -113.7 -14.93 12.55 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.576 1.951 . . . . 99.99 112.674 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.33 39.77 70.35 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 115.51 0.964 . . . . 99.99 115.51 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -88.89 12.64 14.68 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.606 1.706 . . . . 99.99 115.606 177.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.7 23.57 50.5 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 115.171 0.828 . . . . 99.99 115.171 -171.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.2 mttt -125.34 150.65 46.97 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.224 -1.028 . . . . 99.99 108.224 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 m-85 -144.61 174.79 10.66 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.296 1.591 . . . . 99.99 115.296 -177.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 63.72 19.83 63.35 Favored Glycine 0 N--CA 1.48 1.583 0 CA-C-N 113.777 -1.556 . . . . 99.99 116.792 -179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 62.05 15.36 49.73 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.532 1.373 . . . . 99.99 116.532 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -104.74 9.33 35.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.438 1.644 . . . . 99.99 115.438 179.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 30.89 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.562 1.945 . . . . 99.99 116.034 -169.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.69 116.19 23.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.044 -1.434 . . . . 99.99 110.938 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -36.07 126.03 0.68 Allowed Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 113.266 -1.788 . . . . 99.99 113.67 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.71 -35.61 94.22 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.119 2.546 . . . . 0.0 113.39 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.94 64.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.027 1.121 . . . . 99.99 114.027 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 m -75.21 -42.31 55.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.895 0.478 . . . . 99.99 111.138 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 30.0 t-105 -57.86 -22.63 48.96 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.201 0.815 . . . . 99.99 113.201 177.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.81 -28.77 3.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.887 1.44 . . . . 99.99 114.887 168.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.79 78.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.949 0.722 . . . . 99.99 112.949 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -91.52 18.9 6.73 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.222 1.193 . . . . 99.99 114.222 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -21.94 32.22 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.667 1.027 . . . . 99.99 115.667 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 72.41 0.0 44.1 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 114.871 0.708 . . . . 99.99 114.871 -173.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.66 152.8 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.324 1.85 . . . . 99.99 109.361 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 37.18 0.08 OUTLIER Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.505 1.526 . . . . 99.99 116.202 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -57.68 -50.87 85.7 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.151 -1.881 . . . . 99.99 110.365 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -71.2 -11.83 29.32 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.081 2.52 . . . . 0.0 115.563 175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.1 -34.97 32.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 99.99 113.203 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.72 -34.84 10.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.556 1.317 . . . . 99.99 114.556 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.25 118.72 8.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.797 0.839 . . . . 99.99 111.924 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -46.65 161.34 0.06 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 99.99 111.645 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -42.73 -60.66 1.49 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.988 1.107 . . . . 99.99 113.988 179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 15.9 tt0 -67.63 -28.01 67.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.542 1.312 . . . . 99.99 114.542 177.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -72.4 -43.6 63.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.05 0.453 . . . . 99.99 110.973 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -44.29 95.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.465 -0.789 . . . . 99.99 111.685 176.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 16.9 pt -55.29 -30.02 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-O 118.381 -0.819 . . . . 99.99 113.073 179.882 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.91 88.08 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.713 0.634 . . . . 99.99 112.713 172.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.36 -42.76 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.763 0.825 . . . . 99.99 110.12 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.99 -36.72 80.21 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.545 1.138 . . . . 99.99 114.047 174.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -59.55 -41.86 91.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.928 1.291 . . . . 99.99 111.686 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -33.7 57.57 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.375 0.88 . . . . 99.99 113.375 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.3 OUTLIER -61.43 -24.19 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.45 0.908 . . . . 99.99 113.45 172.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -47.27 79.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.141 0.577 . . . . 99.99 111.337 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -30.13 64.94 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.424 0.898 . . . . 99.99 113.424 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -60.14 -49.53 77.25 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.679 1.191 . . . . 99.99 113.469 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -103.22 -26.55 12.94 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.698 0.999 . . . . 99.99 113.698 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.17 157.39 13.61 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.503 -1.439 . . . . 99.99 109.503 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -27.68 15.47 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.066 1.136 . . . . 99.99 114.066 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.52 -21.83 18.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.012 1.725 . . . . 99.99 115.2 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.83 -36.06 58.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.138 0.975 . . . . 99.99 113.583 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.2 m-90 -118.82 136.92 24.47 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.399 -0.963 . . . . 99.99 108.399 175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.93 -85.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.854 2.37 . . . . 0.0 113.885 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -91.55 -53.22 4.41 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.224 1.409 . . . . 99.99 111.477 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.96 160.92 3.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.444 1.898 . . . . 99.99 110.094 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.29 103.81 1.66 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.945 -1.025 . . . . 99.99 111.292 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -18.72 42.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.468 1.284 . . . . 99.99 114.468 -179.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -36.62 -45.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.63 1.572 . . . . 99.99 113.165 160.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.6 m -107.29 -30.02 8.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.193 0.997 . . . . 99.99 113.442 170.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.21 11.69 64.57 Favored Glycine 0 N--CA 1.482 1.749 0 C-N-CA 123.941 0.781 . . . . 99.99 114.268 -173.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.89 1.276 . . . . 99.99 113.455 174.815 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.835 0 N-CA-C 114.649 0.62 . . . . 99.99 114.649 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.63 167.3 21.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.538 -0.831 . . . . 99.99 111.059 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.9 ttt -53.66 143.08 21.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.188 0.595 . . . . 99.99 110.954 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.51 -73.75 0.04 OUTLIER Glycine 0 CA--C 1.542 1.778 0 CA-C-N 114.128 -1.396 . . . . 99.99 111.272 -173.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.4 146.13 73.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.447 2.098 . . . . 0.0 112.455 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.1 m -68.58 136.08 90.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-N 114.604 -1.18 . . . . 99.99 112.829 176.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.09 126.38 14.36 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.624 2.216 . . . . 0.0 111.46 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -127.12 156.54 41.59 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.912 -1.949 . . . . 99.99 109.993 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 3.9 m95 -49.76 -39.47 37.89 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.074 1.138 . . . . 99.99 114.074 174.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.87 -54.2 49.02 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.602 1.334 . . . . 99.99 114.602 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.96 74.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.128 0.971 . . . . 99.99 112.721 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.6 t -61.14 -31.38 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.068 1.347 . . . . 99.99 112.62 175.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.36 76.56 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.349 0.977 . . . . 99.99 112.76 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -77.82 5.42 9.58 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.692 0.997 . . . . 99.99 113.692 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.9 t -116.85 -33.41 4.79 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.237 0.829 . . . . 99.99 113.237 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 12.8 mm-40 -75.77 -43.74 45.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.377 1.071 . . . . 99.99 111.764 171.083 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 t -104.01 -45.17 4.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.011 1.324 . . . . 99.99 113.246 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.89 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 124.179 0.924 . . . . 99.99 114.347 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.77 -100.54 0.15 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 123.992 0.466 . . . . 99.99 112.795 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.38 139.74 33.89 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.266 1.21 . . . . 99.99 114.266 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -66.92 -15.81 63.92 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.378 1.622 . . . . 99.99 115.378 167.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.54 -35.35 12.97 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.338 0.866 . . . . 99.99 113.338 168.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.73 43.01 9.24 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.572 2.064 . . . . 99.99 116.572 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.93 32.27 4.28 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.306 -1.315 . . . . 99.99 112.919 -175.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -128.36 26.77 5.66 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.708 1.242 . . . . 99.99 113.084 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.31 -95.53 0.39 Allowed Glycine 0 N--CA 1.481 1.656 0 CA-C-N 113.994 -1.457 . . . . 99.99 110.154 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -105.69 28.96 6.99 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.391 1.256 . . . . 99.99 114.391 177.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.11 91.67 Favored Glycine 0 CA--C 1.541 1.711 0 CA-C-N 115.952 -0.567 . . . . 99.99 113.678 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 66.3 mttm -74.69 165.22 25.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.927 0.891 . . . . 99.99 110.703 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -137.43 156.86 47.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.32 -1.309 . . . . 99.99 114.001 -176.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.66 10.14 29.36 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-N 114.272 -1.331 . . . . 99.99 116.147 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 55.59 29.88 54.87 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 115.536 -0.332 . . . . 99.99 112.302 -167.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.32 16.7 19.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.193 1.923 . . . . 99.99 116.193 -175.471 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.8 pt20 36.0 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.072 1.878 . . . . 99.99 116.072 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -98.57 115.31 28.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.642 -1.163 . . . . 99.99 110.35 -168.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.53 130.46 10.6 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-N 113.289 -1.778 . . . . 99.99 112.963 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.33 -34.68 98.31 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.917 2.411 . . . . 0.0 113.438 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.66 65.16 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.145 1.165 . . . . 99.99 114.145 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -76.23 -46.53 27.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.434 0.694 . . . . 99.99 111.076 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 31.6 t-105 -58.51 -22.37 54.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.248 0.832 . . . . 99.99 113.248 176.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.65 -30.35 3.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.867 1.432 . . . . 99.99 114.867 169.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.77 72.07 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.328 0.862 . . . . 99.99 113.328 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 -97.01 19.45 12.79 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.144 1.377 . . . . 99.99 113.219 173.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.47 -21.72 30.07 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.792 1.077 . . . . 99.99 115.792 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.82 -5.77 29.65 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 114.731 0.653 . . . . 99.99 114.731 -173.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.2 p -64.13 155.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.256 1.823 . . . . 99.99 112.061 -178.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 33.96 0.14 Allowed Glycine 0 CA--C 1.541 1.719 0 C-N-CA 124.937 1.256 . . . . 99.99 115.747 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -58.1 -51.44 81.75 Favored Pre-proline 0 N--CA 1.476 0.858 0 CA-C-O 116.323 -1.799 . . . . 99.99 110.241 174.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -72.95 -10.05 24.27 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.69 2.26 . . . . 0.0 115.254 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.43 -33.79 28.45 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.11 0.782 . . . . 99.99 113.11 172.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.36 -34.06 10.81 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.93 1.455 . . . . 99.99 114.93 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.74 128.0 34.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.874 0.87 . . . . 99.99 111.423 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -49.43 156.09 0.66 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.031 -1.44 . . . . 99.99 110.722 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.74 -57.59 2.69 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.524 1.13 . . . . 99.99 113.994 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -70.53 -31.5 68.59 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.01 1.485 . . . . 99.99 115.01 175.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -66.06 -42.07 89.93 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.764 0.826 . . . . 99.99 111.039 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.05 -53.74 49.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.06 1.344 . . . . 99.99 110.607 176.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 20.2 pt -54.31 -31.4 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.12 0.785 . . . . 99.99 113.12 179.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.19 74.49 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.289 0.848 . . . . 99.99 113.289 171.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.98 -42.13 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.514 0.726 . . . . 99.99 109.824 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.44 -39.61 84.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.284 1.434 . . . . 99.99 114.041 175.259 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -59.52 -38.94 82.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.06 1.344 . . . . 99.99 112.132 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -80.74 -36.03 32.54 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.452 0.538 . . . . 99.99 112.452 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.9 -20.28 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.739 1.015 . . . . 99.99 113.739 172.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -40.52 74.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 119.159 -0.448 . . . . 99.99 111.928 169.109 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.351 0.871 . . . . 99.99 113.351 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.32 -47.32 61.61 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.687 1.365 . . . . 99.99 114.687 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -107.04 -22.71 12.56 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.573 1.323 . . . . 99.99 114.573 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.37 155.15 9.3 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.116 0.865 . . . . 99.99 110.987 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 122.08 -0.659 . . . . 99.99 112.769 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.91 -0.92 8.17 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 116.308 1.966 . . . . 99.99 116.308 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.05 -25.41 58.61 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.23 0.826 . . . . 99.99 113.23 175.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.8 m-90 -118.2 75.53 11.48 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.164 -0.925 . . . . 99.99 111.099 174.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.17 -20.12 43.91 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.002 2.468 . . . . 0.0 113.828 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.5 p -60.29 -44.38 95.44 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.348 1.859 . . . . 99.99 113.978 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -139.95 -69.27 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.886 1.274 . . . . 99.99 112.283 172.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.76 89.13 0.62 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-N 115.138 -0.937 . . . . 99.99 112.32 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.86 -27.06 11.41 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.856 1.798 . . . . 99.99 115.856 177.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.61 -43.22 36.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.115 1.366 . . . . 99.99 113.505 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 58.5 m -109.03 -20.97 12.84 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.113 0.883 . . . . 99.99 112.628 166.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 -43.6 3.08 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 114.681 -1.145 . . . . 99.99 110.99 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 8.2 mp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.848 1.659 . . . . 99.99 113.632 -174.869 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 CA-C-O 120.333 -0.148 . . . . 99.99 112.992 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.07 80.15 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.372 1.469 . . . . 99.99 112.917 -173.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.1 ttt -115.69 125.62 53.07 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.217 -1.356 . . . . 99.99 110.508 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.28 164.94 11.7 Favored Glycine 0 CA--C 1.547 2.063 0 O-C-N 125.518 1.761 . . . . 99.99 111.958 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.12 149.64 64.89 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.683 2.255 . . . . 0.0 112.713 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -56.37 145.43 58.13 Favored Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 113.799 1.037 . . . . 99.99 113.799 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -67.49 138.44 45.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.322 2.015 . . . . 0.0 111.834 174.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.57 174.54 5.96 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 112.942 -1.935 . . . . 99.99 111.248 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -33.71 58.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.625 0.972 . . . . 99.99 113.625 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.54 -35.84 72.95 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.444 1.276 . . . . 99.99 114.444 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.54 -26.6 67.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 118.816 -0.612 . . . . 99.99 112.358 175.555 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.68 -42.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.388 0.675 . . . . 99.99 110.267 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.645 0.609 . . . . 99.99 112.645 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -84.63 1.28 46.88 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 114.538 1.31 . . . . 99.99 114.538 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -112.17 -36.53 5.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.228 1.011 . . . . 99.99 112.338 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -79.31 -51.05 9.95 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.71 1.204 . . . . 99.99 112.645 167.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.59 -23.75 12.37 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.671 1.73 . . . . 99.99 115.671 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.81 -28.87 5.71 Favored Glycine 0 N--CA 1.482 1.721 0 C-N-CA 122.83 0.252 . . . . 99.99 113.416 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.04 93.14 0.09 OUTLIER Glycine 0 N--CA 1.474 1.227 0 N-CA-C 110.493 -1.043 . . . . 99.99 110.493 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -172.15 81.47 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.24 1.016 . . . . 99.99 112.433 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -73.65 -73.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.285 0.846 . . . . 99.99 113.285 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.32 71.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.978 1.103 . . . . 99.99 113.978 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.52 60.84 3.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.014 1.725 . . . . 99.99 114.316 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -77.45 35.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 113.033 -1.894 . . . . 99.99 115.148 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -112.35 -17.67 12.66 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.634 1.973 . . . . 99.99 112.351 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.71 58.04 7.38 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 115.746 -0.661 . . . . 99.99 113.621 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -104.64 20.65 18.24 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.476 -0.862 . . . . 99.99 112.748 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.06 26.78 49.95 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 124.188 0.899 . . . . 99.99 115.157 -173.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.1 mttm -122.51 150.44 42.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.495 1.118 . . . . 99.99 109.451 -173.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.4 ' CE1' ' CE3' ' A' ' 40' ' ' TRP . 10.7 p90 -152.73 139.68 19.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.011 -1.45 . . . . 99.99 112.552 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.34 -0.43 12.49 Favored Glycine 0 N--CA 1.485 1.907 0 CA-C-N 113.572 -1.649 . . . . 99.99 114.654 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.82 25.83 55.12 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 124.525 1.06 . . . . 99.99 114.775 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.16 14.5 27.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.421 1.267 . . . . 99.99 114.421 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.4 mt-30 37.91 36.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.929 2.092 . . . . 99.99 116.068 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -94.69 121.76 36.6 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 112.929 -1.941 . . . . 99.99 108.349 -171.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -41.73 136.41 2.01 Favored Pre-proline 0 N--CA 1.482 1.16 0 N-CA-C 114.115 1.154 . . . . 99.99 114.115 176.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -65.23 -32.41 51.71 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.635 2.223 . . . . 0.0 112.54 179.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.4 -34.72 64.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.318 1.047 . . . . 99.99 113.624 172.401 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.0 m -68.91 -47.06 66.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.914 0.486 . . . . 99.99 111.698 172.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.4 ' CE3' ' CE1' ' A' ' 30' ' ' TYR . 33.2 t-105 -57.05 -22.28 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.538 0.94 . . . . 99.99 113.538 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.78 -29.2 4.28 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.462 1.282 . . . . 99.99 114.462 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.21 74.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.874 0.869 . . . . 99.99 113.296 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -95.71 18.4 13.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.169 0.988 . . . . 99.99 111.565 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -23.73 23.52 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 115.639 1.015 . . . . 99.99 115.639 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.12 -0.91 44.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 114.888 0.715 . . . . 99.99 114.888 -172.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.09 153.05 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.361 1.864 . . . . 99.99 109.26 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.83 38.05 0.07 OUTLIER Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.263 1.411 . . . . 99.99 116.418 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -57.27 -47.65 98.68 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-O 116.256 -1.83 . . . . 99.99 110.931 172.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -67.55 -28.09 38.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.202 2.601 . . . . 0.0 114.799 173.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.06 72.17 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.435 0.902 . . . . 99.99 113.435 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.87 -34.17 14.63 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.177 1.177 . . . . 99.99 114.177 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.73 20.94 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.511 1.148 . . . . 99.99 111.969 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.8 t -53.78 157.55 2.3 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.02 -1.9 . . . . 99.99 110.388 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.42 -58.13 3.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.309 1.226 . . . . 99.99 114.309 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.75 -19.4 62.73 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.795 1.406 . . . . 99.99 114.795 177.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.46 -38.92 21.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.336 0.655 . . . . 99.99 111.936 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -63.91 -42.85 97.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.752 0.649 . . . . 99.99 112.752 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.0 pt -54.22 -29.79 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.801 1.037 . . . . 99.99 113.801 175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.12 82.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.535 0.734 . . . . 99.99 112.546 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.37 -42.36 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.371 0.668 . . . . 99.99 109.842 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.41 -35.23 76.97 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.129 1.159 . . . . 99.99 114.129 174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.46 -49.38 77.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.72 1.208 . . . . 99.99 110.784 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -65.52 -37.36 86.53 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.208 0.447 . . . . 99.99 112.208 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.28 0.3 OUTLIER -61.29 -22.18 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.365 1.246 . . . . 99.99 114.365 175.913 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.34 -38.96 88.8 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 111.974 0.361 . . . . 99.99 111.974 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.73 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.132 0.79 . . . . 99.99 113.132 173.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -65.23 -54.79 24.19 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.286 1.958 . . . . 99.99 116.286 178.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 -23.56 11.5 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.366 1.247 . . . . 99.99 114.366 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.13 147.99 7.49 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-O 122.038 0.799 . . . . 99.99 111.864 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.46 -29.03 69.65 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.316 -0.942 . . . . 99.99 113.512 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -19.33 15.48 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.373 1.62 . . . . 99.99 115.373 172.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.64 74.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.781 0.832 . . . . 99.99 112.82 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -80.8 140.48 50.74 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.796 0.685 . . . . 99.99 109.214 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -67.55 -170.06 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.966 2.444 . . . . 0.0 111.493 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.7 p -53.35 -31.81 46.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.38 1.472 . . . . 99.99 114.146 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -39.26 -83.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.043 1.737 . . . . 99.99 113.314 169.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 41.51 43.63 3.89 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 115.684 1.034 . . . . 99.99 115.684 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.73 -20.2 0.78 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.52 2.044 . . . . 99.99 116.52 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.57 67.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.159 1.783 . . . . 99.99 113.156 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 m -65.54 -19.33 65.88 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.096 1.147 . . . . 99.99 114.096 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.39 27.03 72.81 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 123.853 0.721 . . . . 99.99 113.547 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.909 -1.043 . . . . 99.99 113.335 177.762 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 CA-C-O 120.871 0.15 . . . . 99.99 113.23 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.97 74.83 0.96 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.492 1.139 . . . . 99.99 109.519 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.9 ttm -69.72 -47.85 61.62 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.171 -1.831 . . . . 99.99 112.75 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.56 90.06 0.08 OUTLIER Glycine 0 CA--C 1.543 1.835 0 CA-C-O 118.166 -1.352 . . . . 99.99 110.866 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.14 140.69 34.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.271 1.981 . . . . 0.0 111.601 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.7 m -62.37 119.61 51.36 Favored Pre-proline 0 N--CA 1.483 1.215 0 N-CA-C 113.091 0.774 . . . . 99.99 113.091 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.93 146.42 65.29 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.003 2.469 . . . . 0.0 112.206 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -114.48 81.18 1.51 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.25 -1.341 . . . . 99.99 114.223 -178.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -57.55 -33.03 67.69 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.911 -1.495 . . . . 99.99 114.044 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.01 -50.75 70.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.739 0.816 . . . . 99.99 112.644 171.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.95 -37.8 88.76 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.382 0.426 . . . . 99.99 111.826 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 51.4 t -61.25 -35.64 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.982 -1.008 . . . . 99.99 112.778 174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.42 90.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 118.939 -0.553 . . . . 99.99 112.351 169.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -71.36 -3.6 21.6 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.931 1.085 . . . . 99.99 113.931 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -98.48 -27.53 14.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.29 1.436 . . . . 99.99 111.46 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -104.55 -43.92 5.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.732 1.012 . . . . 99.99 113.732 179.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 51.6 p -87.18 -37.87 16.91 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.104 0.779 . . . . 99.99 113.104 172.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.15 25.08 59.45 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 124.461 1.101 . . . . 99.99 114.189 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.36 -82.16 0.06 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 123.798 0.352 . . . . 99.99 113.728 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.85 139.3 50.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.458 1.281 . . . . 99.99 114.458 -171.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -69.32 -39.01 78.49 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.447 -1.251 . . . . 99.99 114.328 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.56 13.73 2.38 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.505 0.928 . . . . 99.99 113.505 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 30.3 71.72 0.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.598 1.959 . . . . 99.99 114.298 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -81.55 40.81 0.6 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 112.494 -2.139 . . . . 99.99 112.952 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -116.88 -19.33 9.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.036 2.534 . . . . 99.99 112.801 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.39 40.7 96.56 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.615 0.626 . . . . 99.99 114.622 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -109.44 32.75 4.76 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.931 0.872 . . . . 99.99 112.513 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.5 35.89 62.68 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 115.39 -0.823 . . . . 99.99 114.839 -177.21 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 84.5 mttt -110.98 147.3 35.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.579 0.704 . . . . 99.99 110.586 -176.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 35.6 m-85 -132.56 145.51 51.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.503 -1.68 . . . . 99.99 114.898 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 52.24 29.46 29.64 Favored Glycine 0 N--CA 1.482 1.751 0 O-C-N 125.314 1.634 . . . . 99.99 117.111 176.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 58.99 22.73 55.84 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.848 0.737 . . . . 99.99 114.664 -173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -111.93 16.93 20.13 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.726 2.121 . . . . 99.99 116.726 -175.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 43.39 42.97 4.07 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 124.07 1.89 . . . . 99.99 112.746 -177.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -100.98 108.22 19.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.823 -1.535 . . . . 99.99 111.765 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.6 mmtt -43.77 138.15 3.17 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 112.587 -2.097 . . . . 99.99 113.768 178.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -66.48 -42.34 9.95 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.709 2.273 . . . . 0.0 112.63 -176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.63 -34.32 67.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.405 1.082 . . . . 99.99 112.955 174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -71.76 -49.27 40.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.053 0.541 . . . . 99.99 112.179 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 32.2 t-105 -60.2 -21.9 62.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.128 0.788 . . . . 99.99 113.128 176.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.5 -29.64 17.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.878 1.436 . . . . 99.99 114.878 170.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -29.37 63.44 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.547 0.943 . . . . 99.99 113.547 170.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -105.99 25.69 10.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.416 1.486 . . . . 99.99 111.216 178.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.39 -19.88 52.69 Favored Glycine 0 N--CA 1.479 1.551 0 CA-C-O 119.092 -0.838 . . . . 99.99 115.082 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.65 -5.12 24.72 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 114.947 0.739 . . . . 99.99 114.947 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.89 151.85 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.322 1.849 . . . . 99.99 112.147 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.81 31.34 0.1 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 113.976 -1.466 . . . . 99.99 116.394 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -52.88 -51.51 73.69 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 116.286 -1.816 . . . . 99.99 111.372 169.264 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -66.24 -23.71 51.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.873 2.382 . . . . 0.0 115.652 176.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.07 38.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.142 1.164 . . . . 99.99 114.142 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.53 -36.84 13.48 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.456 1.28 . . . . 99.99 114.456 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 128.05 34.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.989 0.9 . . . . 99.99 110.415 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -52.04 158.34 1.1 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 112.967 -1.924 . . . . 99.99 110.534 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -44.86 -57.62 3.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.516 0.932 . . . . 99.99 113.516 -177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 7.1 tt0 -68.79 -18.79 64.25 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.915 1.45 . . . . 99.99 114.915 176.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -81.67 -40.85 22.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.328 0.651 . . . . 99.99 111.418 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.71 -48.09 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.909 0.884 . . . . 99.99 110.531 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 pt -53.97 -31.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.432 0.901 . . . . 99.99 113.432 178.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.72 72.56 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.252 0.621 . . . . 99.99 111.873 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.61 -48.62 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.899 -0.778 . . . . 99.99 108.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -55.52 -37.83 68.44 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.438 1.273 . . . . 99.99 114.438 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -62.65 -38.32 89.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.755 1.622 . . . . 99.99 113.307 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -81.27 -35.98 30.46 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.259 -0.9 . . . . 99.99 111.741 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 20.0 t -50.72 -32.74 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.059 1.744 . . . . 99.99 112.072 171.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -41.61 76.27 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.742 . . . . 99.99 113.005 172.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.86 -28.93 67.15 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.231 0.826 . . . . 99.99 113.231 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -75.99 -59.91 2.55 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.419 1.266 . . . . 99.99 114.419 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.78 -27.01 36.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.428 1.27 . . . . 99.99 114.428 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.0 168.23 31.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 109.671 -1.371 . . . . 99.99 109.671 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.79 24.77 0.29 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.377 -0.912 . . . . 99.99 113.257 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.8 -45.91 12.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.943 . . . . 99.99 113.03 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.68 -34.3 64.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 99.99 113.152 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.34 94.97 49.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.285 -1.376 . . . . 99.99 107.285 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.61 -89.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.156 2.571 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -64.02 -43.85 94.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.631 0.772 . . . . 99.99 111.998 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.88 140.6 47.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.859 -1.163 . . . . 99.99 107.859 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.15 99.39 0.16 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 124.363 1.039 . . . . 99.99 111.695 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.59 -18.68 54.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.206 1.558 . . . . 99.99 115.206 -179.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -44.17 -48.2 9.19 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 99.99 112.497 165.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 36.5 m -95.08 -29.35 14.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.124 0.97 . . . . 99.99 113.469 171.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.28 67.66 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.169 0.89 . . . . 99.99 113.861 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.006 -1.473 . . . . 99.99 111.83 -178.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 CA-C-O 121.732 0.629 . . . . 99.99 113.116 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.27 -57.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.722 -1.239 . . . . 99.99 111.371 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.6 ttp 67.34 -47.17 0.49 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.251 2.22 . . . . 99.99 114.051 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.18 -87.64 0.27 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-O 118.228 -1.318 . . . . 99.99 110.559 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.19 150.39 65.51 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.567 2.178 . . . . 0.0 112.949 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 m -53.83 147.6 22.97 Favored Pre-proline 0 N--CA 1.486 1.332 0 CA-C-N 114.634 -1.167 . . . . 99.99 114.125 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 116.05 3.41 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.323 2.682 . . . . 0.0 114.016 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.7 m-20 -76.94 72.45 3.51 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.264 1.579 . . . . 99.99 115.264 178.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -61.29 -33.9 74.33 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.728 -1.124 . . . . 99.99 113.831 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.6 -48.88 75.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.927 1.084 . . . . 99.99 113.927 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.84 92.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.913 0.709 . . . . 99.99 112.913 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 44.7 t -62.98 -32.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 112.815 0.672 . . . . 99.99 112.815 173.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.43 -45.46 80.72 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.718 -0.658 . . . . 99.99 111.702 167.125 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -73.88 4.6 5.08 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.185 1.92 . . . . 99.99 116.185 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -110.83 -33.99 6.37 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.569 0.748 . . . . 99.99 112.301 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.33 -48.07 8.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.269 1.581 . . . . 99.99 115.269 168.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 57.2 p -94.35 -29.84 14.81 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.565 1.32 . . . . 99.99 114.565 179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.41 17.94 60.33 Favored Glycine 0 CA--C 1.541 1.68 0 O-C-N 123.994 0.809 . . . . 99.99 113.618 -173.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.61 67.4 0.51 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.113 0.863 . . . . 99.99 111.676 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.79 76.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.807 0.843 . . . . 99.99 112.181 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 82.1 m95 -64.44 -38.27 90.42 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.868 1.062 . . . . 99.99 113.868 177.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.86 -27.9 55.24 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.022 1.119 . . . . 99.99 114.022 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.412 ' C ' ' H ' ' A' ' 25' ' ' THR . . . 46.2 69.9 0.43 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.822 1.649 . . . . 99.99 112.769 -173.17 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -76.0 32.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.518 -1.674 . . . . 99.99 115.319 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.412 ' H ' ' C ' ' A' ' 23' ' ' ALA . 4.4 p -96.54 -17.34 20.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.053 2.941 . . . . 99.99 113.921 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.83 37.17 93.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.8 1.08 . . . . 99.99 115.8 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.92 22.47 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.147 1.166 . . . . 99.99 114.147 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.04 24.75 55.37 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.552 1.072 . . . . 99.99 115.5 -172.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -126.22 142.35 51.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.438 0.695 . . . . 99.99 109.135 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 58.2 m-85 -138.74 166.61 23.95 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.46 1.1 . . . . 99.99 112.507 178.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.37 -1.64 41.86 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 115.193 -0.912 . . . . 99.99 113.17 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.2 12.58 24.47 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 115.136 0.814 . . . . 99.99 115.136 -171.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -84.82 9.95 12.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.673 0.99 . . . . 99.99 113.673 170.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 43.38 41.9 3.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.985 2.114 . . . . 99.99 114.458 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.21 118.49 31.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 111.717 -2.492 . . . . 99.99 110.337 -172.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.52 135.77 5.8 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 113.455 -1.702 . . . . 99.99 114.954 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.99 -39.97 37.14 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.943 2.429 . . . . 0.0 112.939 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.28 -37.19 69.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.291 1.036 . . . . 99.99 113.277 175.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -69.23 -49.71 53.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.365 0.666 . . . . 99.99 110.961 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -59.47 -25.7 64.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.354 0.872 . . . . 99.99 113.354 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -51.28 -27.29 8.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.854 1.427 . . . . 99.99 114.854 170.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.57 73.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.834 0.679 . . . . 99.99 112.834 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -95.31 22.15 7.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.516 1.126 . . . . 99.99 113.581 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.93 -21.23 40.92 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 115.409 0.924 . . . . 99.99 115.409 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 69.81 6.07 54.29 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 114.753 0.661 . . . . 99.99 114.753 -173.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.1 148.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.928 1.691 . . . . 99.99 109.369 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 35.01 0.16 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 124.881 1.229 . . . . 99.99 115.711 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.14 -45.29 99.38 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.184 -1.865 . . . . 99.99 109.966 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -66.18 -9.87 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.16 2.573 . . . . 0.0 118.03 169.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.1 -31.77 19.04 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.171 0.804 . . . . 99.99 113.171 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.97 -36.32 8.24 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.207 1.558 . . . . 99.99 115.207 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.976 0.894 . . . . 99.99 111.602 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m -50.3 152.95 1.63 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.59 -1.641 . . . . 99.99 110.276 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -53.78 17.21 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.322 0.86 . . . . 99.99 113.322 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -70.11 -27.15 64.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.358 1.244 . . . . 99.99 114.358 175.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -42.71 53.96 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.555 0.693 . . . . 99.99 110.907 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -70.54 -35.65 73.26 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.76 1.022 . . . . 99.99 113.76 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.8 pt -56.07 -28.67 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 118.442 -0.79 . . . . 99.99 112.609 172.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.21 77.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.032 0.533 . . . . 99.99 112.376 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.75 -41.31 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 116.109 -0.496 . . . . 99.99 109.89 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -61.37 -35.45 77.5 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.282 1.216 . . . . 99.99 114.282 175.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -64.88 -36.09 83.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.525 1.53 . . . . 99.99 112.61 174.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -37.24 28.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.337 0.866 . . . . 99.99 113.337 171.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.54 -24.6 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.675 0.991 . . . . 99.99 113.675 174.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -56.87 -46.15 82.01 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.334 0.396 . . . . 99.99 111.723 170.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.5 -33.38 69.2 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.328 0.651 . . . . 99.99 112.693 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.789 1.033 . . . . 99.99 113.789 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -27.7 10.57 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.985 1.476 . . . . 99.99 114.985 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.6 149.86 8.74 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.251 -0.74 . . . . 99.99 111.251 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.72 -33.59 71.02 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.065 1.135 . . . . 99.99 114.065 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.45 -23.29 48.82 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.568 1.692 . . . . 99.99 115.568 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.83 94.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 99.99 112.76 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 13.0 m-90 -72.64 149.71 90.8 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.32 -0.854 . . . . 99.99 110.25 172.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.077 2.518 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -54.23 -21.44 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.431 1.271 . . . . 99.99 114.431 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 21.2 m -101.26 152.47 20.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.887 1.275 . . . . 99.99 111.503 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.4 107.79 0.22 Allowed Glycine 0 N--CA 1.476 1.302 0 CA-C-N 112.116 -2.311 . . . . 99.99 109.479 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -54.24 -23.22 13.93 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.937 1.458 . . . . 99.99 114.937 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -45.78 -39.9 8.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.868 1.667 . . . . 99.99 113.704 167.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -109.97 -21.04 12.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.5 1.52 . . . . 99.99 113.218 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.57 3.29 Favored Glycine 0 N--CA 1.48 1.581 0 C-N-CA 124.03 0.824 . . . . 99.99 112.466 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.943 -1.503 . . . . 99.99 114.15 179.872 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.688 0 CA-C-O 121.251 0.362 . . . . 99.99 113.565 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.48 -67.71 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.443 -0.878 . . . . 99.99 111.528 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.2 mtt -128.68 152.86 47.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.995 1.318 . . . . 99.99 110.714 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 152.04 18.04 Favored Glycine 0 CA--C 1.542 1.719 0 O-C-N 124.876 1.36 . . . . 99.99 112.142 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.51 154.93 60.19 Favored 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 122.917 2.411 . . . . 0.0 112.514 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 142.76 80.01 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 115.242 -0.89 . . . . 99.99 112.722 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.68 127.44 15.46 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.357 2.038 . . . . 0.0 112.646 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.79 154.32 33.03 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.013 -1.903 . . . . 99.99 111.338 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -53.64 -32.35 51.08 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.923 1.453 . . . . 99.99 114.923 171.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -54.5 45.39 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.41 0.893 . . . . 99.99 113.41 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.67 79.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.496 0.718 . . . . 99.99 112.246 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 25.6 t -62.14 -31.59 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.372 1.249 . . . . 99.99 114.372 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.36 81.36 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.258 0.466 . . . . 99.99 112.258 168.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.97 5.4 19.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.434 1.272 . . . . 99.99 114.434 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.11 -32.98 7.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.42 1.488 . . . . 99.99 111.448 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -101.79 -27.49 12.99 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.652 1.353 . . . . 99.99 114.652 178.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.6 t -110.8 -38.96 4.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.894 0.877 . . . . 99.99 113.178 174.461 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 31.13 77.2 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 114.808 0.683 . . . . 99.99 114.808 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.78 -95.91 0.1 Allowed Glycine 0 N--CA 1.48 1.576 0 O-C-N 124.075 0.514 . . . . 99.99 112.439 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.0 146.4 30.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.536 1.31 . . . . 99.99 114.536 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -65.88 -58.7 4.98 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.401 -1.272 . . . . 99.99 112.832 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.23 -26.49 66.46 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.254 1.205 . . . . 99.99 114.254 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 40.11 78.12 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.053 1.741 . . . . 99.99 113.433 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -83.88 43.41 0.92 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.402 -1.726 . . . . 99.99 112.393 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 p -104.45 -15.87 15.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.804 2.442 . . . . 99.99 112.729 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.39 39.98 80.32 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.054 0.782 . . . . 99.99 115.054 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -95.2 21.4 7.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.251 1.574 . . . . 99.99 115.251 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.37 29.09 56.39 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 114.677 0.631 . . . . 99.99 114.677 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -113.2 151.36 31.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.643 1.177 . . . . 99.99 110.105 -175.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -132.65 160.7 35.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.455 -1.248 . . . . 99.99 112.236 -177.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 40.12 28.63 0.17 Allowed Glycine 0 N--CA 1.483 1.79 0 N-CA-C 117.494 1.758 . . . . 99.99 117.494 172.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.47 34.23 84.61 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.475 1.35 . . . . 99.99 116.475 -172.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 2.6 mp -108.29 -2.89 18.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 119.197 3.036 . . . . 99.99 119.197 -175.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 42.83 28.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.702 2.112 . . . . 99.99 116.702 -169.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -94.54 108.02 19.99 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.851 -1.068 . . . . 99.99 111.394 -169.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -24.45 126.12 0.16 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-N 112.348 -2.205 . . . . 99.99 114.809 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.44 -35.21 73.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.708 2.272 . . . . 0.0 113.441 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.99 66.89 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.305 1.042 . . . . 99.99 113.394 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.5 m -67.16 -50.12 62.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.966 0.906 . . . . 99.99 111.097 172.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -60.02 -22.49 62.7 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.19 0.811 . . . . 99.99 113.19 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -30.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.702 1.371 . . . . 99.99 114.702 168.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.16 75.15 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.075 0.769 . . . . 99.99 113.075 171.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.1 19.38 9.3 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.163 1.385 . . . . 99.99 113.59 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.21 28.95 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 115.619 1.008 . . . . 99.99 115.619 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.23 -5.88 24.85 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 114.771 0.668 . . . . 99.99 114.771 -173.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.411 ' C ' ' H ' ' A' ' 48' ' ' ASN . 11.2 p -64.99 148.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.539 1.536 . . . . 99.99 111.923 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 31.47 0.1 OUTLIER Glycine 0 CA--C 1.542 1.724 0 C-N-CA 125.086 1.327 . . . . 99.99 116.245 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.411 ' H ' ' C ' ' A' ' 46' ' ' VAL . 64.2 t30 -57.78 -48.64 96.82 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 116.631 -1.652 . . . . 99.99 110.578 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_endo -73.03 -13.88 26.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.417 2.745 . . . . 0.0 116.131 176.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.83 53.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.049 0.759 . . . . 99.99 113.049 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.34 -34.06 11.2 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.815 1.413 . . . . 99.99 114.815 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.63 56.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.285 1.034 . . . . 99.99 111.786 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.3 t -55.97 154.19 7.77 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.615 -1.63 . . . . 99.99 110.486 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -59.1 3.02 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.882 1.068 . . . . 99.99 113.882 -175.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -69.24 -26.23 64.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.553 1.316 . . . . 99.99 114.553 176.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.96 -39.08 63.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.712 -0.618 . . . . 99.99 112.264 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -60.0 -50.72 72.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.595 1.158 . . . . 99.99 109.588 173.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 pt -55.4 -31.57 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.787 1.032 . . . . 99.99 113.787 -179.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.27 77.77 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.916 0.486 . . . . 99.99 112.278 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.02 -40.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 99.99 110.27 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.93 -38.95 83.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.608 1.163 . . . . 99.99 114.138 175.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -60.9 -38.47 85.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.168 1.387 . . . . 99.99 111.677 174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -80.01 -32.2 39.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.912 1.078 . . . . 99.99 113.912 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.07 -22.43 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.441 0.904 . . . . 99.99 113.441 172.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.34 -39.43 87.11 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.548 0.573 . . . . 99.99 112.548 169.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.72 69.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.874 0.694 . . . . 99.99 112.874 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -58.87 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.096 1.147 . . . . 99.99 114.096 177.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 22.6 tp60 -91.48 -36.49 13.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.497 1.295 . . . . 99.99 114.497 -178.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.36 150.32 8.15 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.812 -1.315 . . . . 99.99 109.812 -167.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -84.35 -1.35 55.31 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.474 1.287 . . . . 99.99 114.474 173.296 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -87.99 -23.75 23.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.603 1.161 . . . . 99.99 113.429 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.38 91.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.145 0.978 . . . . 99.99 113.62 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -60.35 150.12 73.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 118.762 -0.637 . . . . 99.99 110.777 169.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.6 Cg_endo -63.25 -159.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.741 2.294 . . . . 0.0 111.066 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.0 p -51.49 -32.2 26.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 117.0 -1.476 . . . . 99.99 113.208 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 85.3 m -52.6 -135.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 128.392 3.557 . . . . 99.99 114.063 168.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 102.14 0.25 Allowed Glycine 0 N--CA 1.483 1.799 0 O-C-N 121.71 -0.619 . . . . 99.99 112.065 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.79 -26.16 3.69 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 116.345 1.98 . . . . 99.99 116.345 178.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.18 -39.15 20.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.784 1.234 . . . . 99.99 113.132 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 m -108.93 -29.65 8.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.289 1.036 . . . . 99.99 113.098 168.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.89 -29.17 5.59 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.236 -0.893 . . . . 99.99 113.649 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 59.5 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.08 -1.438 . . . . 99.99 113.212 173.994 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.987 0 N-CA-C 114.784 0.674 . . . . 99.99 114.784 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.4 108.08 7.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.357 0.663 . . . . 99.99 111.084 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -159.01 104.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.611 -1.177 . . . . 99.99 110.798 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.13 93.61 0.44 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-O 117.824 -1.542 . . . . 99.99 111.477 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.22 156.43 64.78 Favored 'Trans proline' 0 N--CA 1.477 0.541 0 C-N-CA 122.649 2.233 . . . . 0.0 111.544 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.52 95.51 19.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-N 115.696 -0.684 . . . . 99.99 111.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 118.26 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.305 2.67 . . . . 0.0 113.774 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.22 119.15 30.39 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.393 1.257 . . . . 99.99 114.393 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -57.77 -34.99 70.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.111 -1.404 . . . . 99.99 113.798 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -63.57 -48.22 78.32 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.653 0.983 . . . . 99.99 113.653 171.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.88 75.8 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.629 0.603 . . . . 99.99 112.629 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.7 t -62.09 -37.45 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.729 0.811 . . . . 99.99 112.491 174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.55 -48.26 69.26 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.177 0.436 . . . . 99.99 112.177 167.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.24 8.3 5.14 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.65 1.352 . . . . 99.99 114.65 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.0 t -114.8 -30.85 6.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.371 1.068 . . . . 99.99 113.485 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.59 -36.85 11.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.62 1.711 . . . . 99.99 115.62 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 67.1 p -108.63 -23.4 11.83 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.889 1.44 . . . . 99.99 114.889 176.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.3 7.93 69.1 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 114.962 0.745 . . . . 99.99 114.962 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.99 83.22 0.54 Allowed Glycine 0 N--CA 1.479 1.505 0 CA-C-O 121.996 0.776 . . . . 99.99 111.355 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 172.16 108.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.334 2.254 . . . . 99.99 108.647 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -93.22 -44.01 8.54 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.317 1.228 . . . . 99.99 114.317 172.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.67 -39.62 61.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.55 0.574 . . . . 99.99 112.55 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 49.91 84.81 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.577 1.551 . . . . 99.99 111.658 -173.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.47 58.57 0.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.1 1.429 . . . . 99.99 112.154 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.6 p -107.16 -26.6 11.02 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.29 -2.232 . . . . 99.99 111.973 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 34.39 89.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.226 0.917 . . . . 99.99 114.229 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.73 21.07 6.8 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.067 1.136 . . . . 99.99 114.067 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.07 11.49 9.05 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 124.326 0.965 . . . . 99.99 115.433 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 19.5 mtpt -109.34 161.46 15.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.256 1.822 . . . . 99.99 110.247 -175.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.469 ' N ' ' CD1' ' A' ' 30' ' ' TYR . 0.1 OUTLIER -114.17 119.71 37.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 112.882 -1.963 . . . . 99.99 112.964 -175.169 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.28 144.51 48.71 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.073 -1.876 . . . . 99.99 110.702 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 102.19 -36.98 3.9 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 112.943 -1.628 . . . . 99.99 110.806 -178.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 6.4 mp -109.64 -29.37 8.39 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.512 1.301 . . . . 99.99 114.512 177.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 53.76 36.28 23.5 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 123.628 1.68 . . . . 99.99 112.047 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -97.76 129.52 44.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.699 -1.592 . . . . 99.99 109.418 -172.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -47.63 141.2 7.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 113.48 -1.691 . . . . 99.99 114.63 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -60.48 -31.61 92.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.938 2.425 . . . . 0.0 112.868 179.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.14 63.45 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.61 1.164 . . . . 99.99 114.087 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.4 m -67.37 -57.13 7.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.482 0.713 . . . . 99.99 110.472 171.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 23.7 t-105 -56.94 -21.72 32.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.661 0.986 . . . . 99.99 113.661 179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.4 -31.27 5.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.405 1.261 . . . . 99.99 114.405 170.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.42 73.72 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.826 1.047 . . . . 99.99 113.826 171.111 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -95.66 16.69 16.65 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.426 1.49 . . . . 99.99 112.757 172.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.63 -22.32 24.3 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 115.985 1.154 . . . . 99.99 115.985 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.2 -2.9 33.56 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 114.63 0.612 . . . . 99.99 114.63 -173.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -69.22 154.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.733 1.613 . . . . 99.99 111.701 -178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.1 33.84 0.11 Allowed Glycine 0 N--CA 1.484 1.851 0 C-N-CA 125.098 1.333 . . . . 99.99 115.986 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -59.6 -48.68 94.95 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.485 -1.721 . . . . 99.99 111.207 175.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -68.49 -30.86 28.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.603 2.202 . . . . 0.0 114.031 175.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.38 72.49 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.079 1.14 . . . . 99.99 114.079 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.68 -32.44 16.2 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.306 1.224 . . . . 99.99 114.306 174.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 129.72 40.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.14 0.971 . . . . 99.99 111.679 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.1 t -53.77 155.31 3.32 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 113.89 -1.505 . . . . 99.99 109.971 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -46.81 -52.42 14.24 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.886 1.439 . . . . 99.99 114.886 -173.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -69.2 -37.67 78.22 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.53 0.937 . . . . 99.99 113.53 175.038 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -64.26 -35.21 80.1 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.67 -0.644 . . . . 99.99 112.031 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.15 -53.72 48.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.393 1.077 . . . . 99.99 109.936 171.009 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 pt -53.71 -32.07 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.034 0.753 . . . . 99.99 113.034 -179.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.62 -57.91 10.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.029 0.932 . . . . 99.99 113.116 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.08 -38.0 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.185 0.594 . . . . 99.99 110.452 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -59.42 -41.71 90.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.241 1.416 . . . . 99.99 114.021 174.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -61.0 -30.5 70.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.117 1.367 . . . . 99.99 112.255 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -33.8 21.26 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.094 1.146 . . . . 99.99 114.094 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.258 0.8 OUTLIER -59.51 -24.71 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.262 0.838 . . . . 99.99 113.262 172.454 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 1.4 pp -59.13 -44.02 92.0 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.588 0.588 . . . . 99.99 112.588 170.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -31.16 70.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.661 0.615 . . . . 99.99 112.661 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.25 -55.32 14.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.434 1.272 . . . . 99.99 114.434 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -98.54 -26.88 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.153 1.168 . . . . 99.99 114.153 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.75 155.26 8.37 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 110.987 -0.845 . . . . 99.99 110.987 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.06 -35.08 77.56 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 122.399 -0.471 . . . . 99.99 112.163 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.93 -17.84 53.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.618 1.567 . . . . 99.99 114.517 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -44.96 -35.92 3.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.133 1.773 . . . . 99.99 114.38 177.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 12.4 m-90 -115.94 97.73 49.78 Favored Pre-proline 0 N--CA 1.471 0.59 0 N-CA-C 105.881 -1.896 . . . . 99.99 105.881 171.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.37 -35.81 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.585 2.19 . . . . 0.0 114.012 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -61.94 -52.2 65.03 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.999 1.32 . . . . 99.99 113.693 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 m -139.42 -166.1 1.99 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.706 1.202 . . . . 99.99 110.196 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.06 102.21 0.16 Allowed Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.71 -1.356 . . . . 99.99 109.71 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.8 -27.0 10.91 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.605 1.335 . . . . 99.99 114.605 -179.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.97 -38.63 11.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.382 1.473 . . . . 99.99 114.236 168.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -109.5 -19.62 13.17 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.764 1.394 . . . . 99.99 114.764 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.56 4.0 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.492 0.568 . . . . 99.99 113.239 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 115.212 1.56 . . . . 99.99 115.212 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 N-CA-C 114.25 0.46 . . . . 99.99 114.25 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.27 -72.51 0.15 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.732 0.813 . . . . 99.99 111.891 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.0 mtt -169.42 156.46 6.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.615 1.966 . . . . 99.99 110.2 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.67 -81.89 0.33 Allowed Glycine 0 CA--C 1.538 1.518 0 CA-C-O 118.173 -1.349 . . . . 99.99 110.875 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.34 140.52 64.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.425 2.083 . . . . 0.0 112.282 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 m -56.32 148.07 44.58 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.496 -1.229 . . . . 99.99 113.08 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.02 134.95 48.68 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.646 2.231 . . . . 0.0 112.56 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -116.37 126.29 53.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.047 -1.433 . . . . 99.99 111.762 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 11.3 m95 -57.61 -30.69 65.53 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.026 -1.443 . . . . 99.99 114.167 170.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -60.87 -51.04 70.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.212 1.005 . . . . 99.99 112.885 171.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.33 78.12 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.506 0.722 . . . . 99.99 112.513 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.3 t -62.2 -42.97 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.519 1.128 . . . . 99.99 111.985 174.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -53.2 -44.94 68.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.105 0.562 . . . . 99.99 111.73 168.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.09 -5.61 36.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.678 1.733 . . . . 99.99 115.678 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 t -105.33 -26.82 11.83 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.678 1.191 . . . . 99.99 112.596 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.81 -40.95 7.87 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.334 1.235 . . . . 99.99 114.334 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.6 p -104.83 -23.31 13.04 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.807 1.41 . . . . 99.99 114.807 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.4 -25.82 22.64 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.412 -0.813 . . . . 99.99 112.999 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.79 -40.68 0.2 Allowed Glycine 0 N--CA 1.477 1.432 0 CA-C-N 115.524 -0.338 . . . . 99.99 113.394 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -52.22 100.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.565 1.146 . . . . 99.99 113.21 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -73.77 -22.58 59.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.775 1.769 . . . . 99.99 115.775 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.96 -25.43 13.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.679 1.363 . . . . 99.99 114.679 175.192 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.16 74.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.228 2.211 . . . . 99.99 115.479 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 43.06 88.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.986 -1.915 . . . . 99.99 112.367 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 67.8 p -58.69 -26.28 63.7 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.319 -1.764 . . . . 99.99 112.871 177.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.78 -3.54 22.03 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.166 1.365 . . . . 99.99 115.422 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.1 7.91 44.62 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.673 0.99 . . . . 99.99 113.673 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.95 8.16 33.67 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 124.007 0.813 . . . . 99.99 113.516 -172.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.1 mttm -110.7 159.51 17.55 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.749 2.02 . . . . 99.99 110.422 -177.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -122.86 126.48 47.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.169 -2.287 . . . . 99.99 113.363 -175.433 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 151.03 38.8 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 112.031 -2.35 . . . . 99.99 112.71 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.7 -39.22 2.93 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 111.618 -2.291 . . . . 99.99 110.837 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 5.2 mp -107.44 -32.01 7.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.683 -1.258 . . . . 99.99 114.024 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 56.06 34.33 23.57 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.048 1.739 . . . . 99.99 112.193 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -96.24 132.5 41.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.943 -1.48 . . . . 99.99 109.33 -170.509 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.87 142.4 13.01 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 113.071 -1.877 . . . . 99.99 114.907 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -57.97 -33.04 96.68 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.295 2.663 . . . . 0.0 113.499 178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.13 62.53 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.205 1.187 . . . . 99.99 114.205 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -67.24 -56.96 7.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 99.99 110.546 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 21.5 t-105 -60.2 -21.78 62.17 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.904 1.076 . . . . 99.99 113.904 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.61 -30.9 5.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.928 1.291 . . . . 99.99 114.303 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.51 77.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.065 0.765 . . . . 99.99 113.065 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.54 17.64 9.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.156 1.382 . . . . 99.99 113.907 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.48 -21.62 30.24 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.249 1.26 . . . . 99.99 116.249 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.04 49.31 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 114.785 0.674 . . . . 99.99 114.785 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.88 150.2 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.699 1.599 . . . . 99.99 109.135 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.06 40.13 0.07 OUTLIER Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.381 1.467 . . . . 99.99 115.917 170.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.43 -53.46 45.6 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 116.177 -1.868 . . . . 99.99 110.665 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -67.63 -21.15 46.07 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.837 2.358 . . . . 0.0 113.802 175.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -67.32 -35.36 79.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.585 1.554 . . . . 99.99 114.673 173.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.76 -29.5 10.52 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.758 1.392 . . . . 99.99 114.758 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 131.39 50.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.178 0.991 . . . . 99.99 111.21 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -54.19 151.83 6.78 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.608 -1.633 . . . . 99.99 110.072 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -44.69 -57.45 3.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.065 1.505 . . . . 99.99 115.065 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -68.18 -30.17 69.21 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.209 1.188 . . . . 99.99 114.209 174.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.75 -38.75 70.36 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.664 -0.648 . . . . 99.99 112.191 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -59.13 -54.97 40.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.434 1.094 . . . . 99.99 109.466 172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 pt -55.15 -28.4 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.057 1.132 . . . . 99.99 114.057 -177.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.01 75.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.82 0.674 . . . . 99.99 112.82 170.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.47 -39.88 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.737 0.815 . . . . 99.99 109.849 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -58.55 -39.94 81.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.091 1.357 . . . . 99.99 113.715 174.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.39 -45.49 91.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.78 1.232 . . . . 99.99 110.864 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.28 81.96 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.086 0.773 . . . . 99.99 113.086 173.136 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.3 OUTLIER -61.12 -19.95 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.788 1.033 . . . . 99.99 113.788 175.204 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -44.48 86.69 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 118.699 -0.667 . . . . 99.99 111.297 169.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -27.76 69.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.662 0.986 . . . . 99.99 113.662 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.78 80.0 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.198 1.555 . . . . 99.99 115.198 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -103.65 -24.69 13.35 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.106 1.15 . . . . 99.99 114.106 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.79 159.96 10.83 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 110.173 -1.171 . . . . 99.99 110.173 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -56.75 -32.81 65.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.269 -0.548 . . . . 99.99 112.433 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.65 2.24 6.86 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.081 1.752 . . . . 99.99 114.965 175.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.42 -28.15 52.33 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.266 1.21 . . . . 99.99 114.266 176.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 17.8 m-90 -118.21 74.8 11.0 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.251 -0.648 . . . . 99.99 109.251 171.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.8 -21.17 38.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.9 p -57.37 -41.34 79.96 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.182 1.793 . . . . 99.99 113.164 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.07 -86.0 0.17 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.874 -1.512 . . . . 99.99 108.277 178.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 94.87 104.26 1.91 Allowed Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.163 -0.775 . . . . 99.99 111.163 -177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -45.86 -40.08 9.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.515 1.302 . . . . 99.99 114.515 176.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.77 81.69 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.278 1.214 . . . . 99.99 114.278 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 -27.5 30.48 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.438 1.273 . . . . 99.99 114.438 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.59 26.21 69.54 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 124.11 0.862 . . . . 99.99 114.48 -172.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 125.671 1.588 . . . . 99.99 112.877 -178.171 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -60.04 -31.98 70.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.64 -48.92 58.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.69 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.66 79.25 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' H ' ' A' ' 78' ' ' ALA 0.255 50.8 t -64.66 -31.82 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.148 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -60.54 -39.73 88.98 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 167.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.08 6.56 7.69 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -107.33 -34.61 7.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.894 1.278 . . . . 0.0 110.666 176.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.35 -33.82 10.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.499 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 33.1 t -102.35 -36.48 8.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.698 0.799 . . . . 0.0 112.741 173.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.6 66.64 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.55 -90.05 0.08 OUTLIER Glycine 0 CA--C 1.538 1.48 0 CA-C-N 115.51 -0.345 . . . . 0.0 112.707 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -113.72 143.79 44.03 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 41.2 m95 -63.99 -34.55 78.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 171.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.27 64.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.92 71.11 0.34 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.77 1.628 . . . . 0.0 113.902 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -77.05 32.27 0.14 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.551 -2.113 . . . . 0.0 114.725 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -101.48 -14.54 17.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.628 1.971 . . . . 0.0 113.092 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 34.33 85.87 Favored Glycine 0 N--CA 1.48 1.592 0 O-C-N 123.98 0.8 . . . . 0.0 114.961 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -87.08 19.27 3.17 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.44 24.3 45.56 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 124.022 0.82 . . . . 0.0 114.778 -170.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 34' ' ' GLN . 44.3 mmtm -119.63 146.39 45.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.42 0.688 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 79.3 m-85 -134.43 164.96 26.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.211 -176.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.73 30.28 62.48 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.868 -1.514 . . . . 0.0 115.338 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 53.7 23.86 23.09 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.603 1.097 . . . . 0.0 115.782 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HE1' ' A' ' 73' ' ' TRP . 13.2 mt -113.69 10.7 17.99 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.462 ' C ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 43.17 39.56 2.01 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 123.042 1.401 . . . . 0.0 112.648 -175.071 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -99.14 112.0 24.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.448 -172.083 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.36 132.45 4.62 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 113.362 -1.745 . . . . 0.0 113.621 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 66.6 Cg_endo -60.54 -37.05 83.2 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.978 2.452 . . . . 0.0 112.936 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.37 66.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.239 1.015 . . . . 0.0 113.588 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m -72.06 -47.54 50.82 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.651 0.78 . . . . 0.0 111.092 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.465 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -60.11 -23.31 63.74 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.22 -29.54 5.82 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.3 -33.58 69.62 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 64' ' ' VAL . 17.3 m-85 -100.89 22.58 11.9 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.139 1.376 . . . . 0.0 112.711 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.26 -24.29 26.59 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 75.52 -8.32 20.36 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 114.718 0.647 . . . . 0.0 114.718 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 48' ' ' ASN . 24.4 t -62.45 151.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.794 2.038 . . . . 0.0 109.548 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.08 36.16 0.11 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.448 1.499 . . . . 0.0 115.934 174.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 46' ' ' VAL . 12.1 t-20 -57.96 -50.51 87.71 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.502 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 85.7 Cg_endo -72.38 -16.07 27.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.972 2.448 . . . . 0.0 114.983 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -76.6 -34.3 58.4 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.1 -35.94 11.7 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.65 122.43 15.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.066 0.946 . . . . 0.0 111.55 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 m -47.15 159.1 0.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.111 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 mpp_? -41.99 -57.22 2.51 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 19.9 tt0 -67.12 -37.71 84.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -62.11 -39.57 92.97 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.705 0.764 . . . . 0.0 110.887 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -50.93 66.65 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.671 1.188 . . . . 0.0 110.894 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.5 pt -53.83 -33.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 123.644 0.59 . . . . 0.0 112.531 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.19 -54.64 41.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.134 0.974 . . . . 0.0 113.053 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.11 -41.18 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.138 0.575 . . . . 0.0 110.047 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.622 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.04 -38.42 82.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.281 1.432 . . . . 0.0 114.332 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -59.58 -39.62 84.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.785 1.234 . . . . 0.0 111.618 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -78.98 -37.83 38.43 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.268 0.4 OUTLIER -60.84 -23.59 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.625 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -40.24 88.72 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 169.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -31.7 65.35 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.12 -49.6 73.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -108.25 -27.34 10.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.0 147.94 9.05 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.23 -21.24 22.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.076 1.75 . . . . 0.0 114.935 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.64 78.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 112.603 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.472 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 25.1 m-90 -86.02 146.8 43.88 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 124.033 0.833 . . . . 0.0 109.306 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.61 -148.78 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.411 2.741 . . . . 0.0 111.586 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 t -51.38 -30.35 18.63 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.9 m -81.58 131.98 35.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.75 1.22 . . . . 0.0 108.91 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.79 98.98 0.12 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.448 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.534 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -57.91 -20.81 40.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.17 23.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.947 1.299 . . . . 0.0 113.567 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -101.61 -24.17 14.16 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.47 1.108 . . . . 0.0 113.714 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.0 2.91 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.631 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 126.695 1.998 . . . . 99.989999999999995 113.377 -173.697 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.411 ' CH2' HD21 ' A' ' 33' ' ' LEU . 4.5 m95 -57.34 -33.66 67.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.66 -53.49 56.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.364 0.666 . . . . 0.0 111.844 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.49 71.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 78' ' ' ALA . 94.3 t -60.14 -36.21 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 172.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.292 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -0.46 11.59 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -28.74 7.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.49 1.116 . . . . 0.0 113.148 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -100.96 -21.47 15.05 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -122.06 -27.45 4.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.41 6.28 89.36 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 115.962 -0.563 . . . . 0.0 114.354 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.17 76.32 0.27 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 121.775 0.653 . . . . 0.0 112.956 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 1.3 m-20 176.36 119.78 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.604 1.962 . . . . 0.0 109.405 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -90.29 -67.81 0.82 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.96 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.8 64.72 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.16 72.28 0.22 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.068 1.747 . . . . 0.0 113.952 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -81.74 42.64 0.71 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.397 -1.729 . . . . 0.0 113.387 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -111.37 -17.09 13.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.26 2.224 . . . . 0.0 111.938 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 54.27 21.69 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.986 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.2 t-20 -99.05 23.43 9.03 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.82 30.09 56.09 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 124.154 0.883 . . . . 0.0 114.828 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -127.79 146.97 50.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.509 1.123 . . . . 0.0 109.388 -173.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.407 ' CB ' ' HG2' ' A' ' 49' ' ' PRO . 66.4 m-85 -138.55 151.42 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.159 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 64.88 2.94 8.88 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 114.352 -1.294 . . . . 0.0 115.165 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 20' ' ' ASN . . . 65.23 36.12 92.43 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.143 0.877 . . . . 0.0 114.047 -172.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD21 ' CH2' ' A' ' 9' ' ' TRP . 5.9 mp -111.68 19.29 18.2 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 32.54 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -90.99 105.56 17.92 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.173 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -40.41 129.56 1.75 Allowed Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 113.025 -1.898 . . . . 0.0 112.747 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 59.7 Cg_endo -59.72 -32.52 95.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.075 2.517 . . . . 0.0 113.46 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.29 68.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -72.26 -45.03 61.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.893 0.477 . . . . 0.0 111.272 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 39.0 t-105 -58.54 -21.81 53.62 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.03 -29.13 4.58 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 168.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.22 69.09 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.547 ' CE1' HG23 ' A' ' 64' ' ' VAL . 26.3 m-85 -100.07 21.85 12.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.142 1.377 . . . . 0.0 112.779 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.15 30.74 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 -1.28 36.38 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -172.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 48' ' ' ASN . 48.3 t -67.32 152.19 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.409 1.884 . . . . 0.0 109.305 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.22 36.33 0.09 OUTLIER Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.501 1.524 . . . . 0.0 116.1 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 46' ' ' VAL . 2.2 t-20 -58.91 -51.46 81.7 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.225 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.8 Cg_endo -71.78 -11.43 27.73 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.011 2.474 . . . . 0.0 115.442 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.71 -34.29 27.33 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.36 -35.05 10.83 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 129.94 43.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.663 0.785 . . . . 0.0 110.871 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.7 t -53.34 159.88 1.28 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.964 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -43.16 -59.01 2.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.4 1.08 . . . . 0.0 113.7 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.3 tt0 -67.47 -34.81 77.92 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -65.81 -37.55 86.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.601 -0.687 . . . . 0.0 111.674 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -62.6 -52.73 62.21 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 110.127 172.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 8.2 pt -56.06 -30.12 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.64 68.6 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.64 -42.5 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.752 0.821 . . . . 0.0 109.774 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.3 -39.51 87.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.588 1.555 . . . . 0.0 114.369 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -56.77 -46.93 81.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 110.669 173.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -35.07 68.54 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -62.38 -22.4 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.933 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -40.83 89.19 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.582 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.79 -30.87 71.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.66 -56.52 7.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -89.37 -25.16 21.73 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.61 154.0 9.8 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -56.61 -32.12 64.97 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.946 -0.738 . . . . 0.0 112.622 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.35 -2.02 5.54 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.52 -31.77 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 13.1 m-90 -117.71 69.96 6.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.534 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -64.73 -25.38 61.25 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.559 2.173 . . . . 0.0 113.115 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 p -57.73 -28.29 63.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.195 2.198 . . . . 0.0 115.326 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 -60.52 0.19 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.42 99.35 0.19 Allowed Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.154 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.48 -38.59 54.65 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.412 -0.894 . . . . 0.0 113.274 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.038 1.335 . . . . 0.0 114.083 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -22.55 30.03 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.08 28.02 57.95 Favored Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 117.621 -1.18 . . . . 99.989999999999995 113.8 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -52.91 -33.74 51.82 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 176.044 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.34 -42.28 77.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.043 0.937 . . . . 0.0 113.351 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -64.07 -31.13 72.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.678 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.06 -49.23 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.92 94.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.07 10.91 1.66 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -115.8 -31.53 5.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.114 1.366 . . . . 0.0 111.613 177.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.25 -43.37 7.0 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 t -88.33 -39.28 14.47 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.42 1.088 . . . . 0.0 112.861 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.37 18.72 58.83 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.104 -0.953 . . . . 0.0 115.108 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.07 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.477 1.374 0 CA-C-O 121.502 0.501 . . . . 0.0 113.124 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -114.1 144.42 43.18 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -65.95 -44.12 85.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.903 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.66 -31.55 70.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.01 76.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.271 1.828 . . . . 0.0 113.586 -172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -81.96 51.97 1.86 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.786 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -113.65 -23.79 9.54 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 111.642 -2.526 . . . . 0.0 112.356 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.23 36.82 90.47 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.7 29.55 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.468 0.651 . . . . 0.0 112.726 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.1 41.12 92.44 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.354 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -116.48 146.07 42.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.949 0.9 . . . . 0.0 110.381 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 14.9 m-85 -139.26 134.78 33.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.861 -173.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 33' ' ' LEU . . . 52.98 31.73 40.46 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 125.33 1.644 . . . . 0.0 114.781 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.94 17.32 9.29 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.562 HD11 ' CZ3' ' A' ' 9' ' ' TRP . 0.1 OUTLIER -103.14 19.96 18.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.728 0.811 . . . . 0.0 113.055 -176.672 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 36.96 40.96 0.16 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.705 2.002 . . . . 0.0 113.723 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.84 99.49 12.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.891 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -37.06 132.45 0.72 Allowed Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 112.682 -2.054 . . . . 0.0 113.665 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 78.4 Cg_endo -63.35 -39.11 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.212 2.608 . . . . 0.0 113.167 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.55 -35.13 67.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.148 0.979 . . . . 0.0 113.071 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -70.61 -51.07 30.64 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.187 0.995 . . . . 0.0 111.354 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 37.1 t-105 -58.18 -21.1 45.91 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.62 -29.35 4.23 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.42 67.76 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -100.52 21.52 13.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.243 1.417 . . . . 0.0 113.277 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.32 -23.71 26.2 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.78 -6.14 20.37 Favored Glycine 0 N--CA 1.484 1.875 0 CA-C-N 117.321 0.56 . . . . 0.0 114.462 -172.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' ASN . 31.7 t -64.81 150.39 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.076 1.75 . . . . 0.0 109.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 37.28 0.1 OUTLIER Glycine 0 N--CA 1.484 1.879 0 C-N-CA 125.127 1.346 . . . . 0.0 115.748 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' VAL . 14.3 t-20 -56.98 -51.62 80.29 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.465 174.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.1 Cg_endo -70.44 -20.64 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.328 2.685 . . . . 0.0 115.115 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.01 55.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.252 1.021 . . . . 0.0 113.442 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.95 -32.34 15.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -67.47 130.59 43.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 112.525 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -54.73 159.38 2.24 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.742 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.57 -52.27 10.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 21.3 tt0 -63.59 -40.26 96.49 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 43.1 tp60 -63.82 -40.15 95.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.287 0.635 . . . . 0.0 110.774 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -49.9 68.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.627 1.171 . . . . 0.0 111.089 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -55.18 -33.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.117 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.19 69.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.24 -44.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.372 0.669 . . . . 0.0 110.373 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.6 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -64.7 -34.56 78.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -56.3 -50.29 71.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.618 1.167 . . . . 0.0 110.557 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -33.63 70.44 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.286 0.3 OUTLIER -62.5 -21.71 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.914 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -38.86 91.38 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 168.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.78 -31.54 71.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 1.4 mm-40 -73.16 -65.93 0.74 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -81.85 -23.02 36.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.38 -169.31 16.21 Favored Glycine 0 N--CA 1.474 1.187 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 17.73 20.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.871 -1.164 . . . . 0.0 113.32 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.63 -37.75 65.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.31 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.024 0.827 . . . . 0.0 113.039 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -128.56 82.61 68.28 Favored Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.22 -81.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.936 2.424 . . . . 0.0 111.666 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 t -56.22 -44.64 79.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.896 1.278 . . . . 0.0 112.932 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.4 m -80.7 103.4 10.52 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.03 1.332 . . . . 0.0 108.191 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.01 50.55 0.58 Allowed Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.773 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -12.14 27.14 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.77 -30.82 57.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 165.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 m -93.52 -15.27 25.67 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 36.65 23.77 Favored Glycine 0 CA--C 1.54 1.613 0 N-CA-C 115.467 0.947 . . . . 0.0 115.467 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 114.641 1.349 . . . . 99.989999999999995 114.641 178.098 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -50.89 -32.43 20.51 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 173.002 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.64 -34.3 71.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.76 71.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.418 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 78' ' ' ALA . 15.0 t -58.15 -48.75 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 170.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.34 98.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -3.89 22.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -115.73 -29.4 6.44 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 54.6 mm-40 -88.86 -32.21 17.89 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 171.327 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -115.21 -33.99 5.15 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.54 33.97 Favored Glycine 0 CA--C 1.54 1.607 0 O-C-N 123.321 0.388 . . . . 0.0 112.646 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.33 89.83 0.19 Allowed Glycine 0 N--CA 1.476 1.348 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.6 86.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.981 1.313 . . . . 0.0 110.285 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -71.47 -34.4 70.17 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.06 32.18 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.3 66.29 1.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.954 1.701 . . . . 0.0 112.923 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.8 35.52 0.37 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.304 -1.771 . . . . 0.0 113.456 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 p -104.69 -18.69 14.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.02 2.128 . . . . 0.0 112.797 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.27 73.79 Favored Glycine 0 N--CA 1.481 1.639 0 C-N-CA 123.753 0.692 . . . . 0.0 114.59 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 19.93 1.9 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.0 30.28 63.34 Favored Glycine 0 CA--C 1.543 1.839 0 C-N-CA 123.79 0.709 . . . . 0.0 114.258 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -126.02 144.24 50.79 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.458 0.703 . . . . 0.0 109.649 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 94.4 m-85 -142.16 151.76 42.53 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.892 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 -11.81 5.36 Favored Glycine 0 N--CA 1.483 1.772 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.925 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 26.67 74.45 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.27 17.91 20.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER 42.68 40.3 1.96 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.375 2.27 . . . . 0.0 113.836 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -98.01 113.36 25.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.362 -168.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -40.7 127.59 1.89 Allowed Pre-proline 0 N--CA 1.481 1.081 0 CA-C-N 113.414 -1.721 . . . . 0.0 114.072 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 96.2 Cg_endo -64.44 -37.83 36.85 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.797 2.332 . . . . 0.0 112.316 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.89 74.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.274 1.03 . . . . 0.0 113.322 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 90.3 m -68.66 -45.78 70.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.99 0.516 . . . . 0.0 111.5 171.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.407 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 32.0 t-105 -56.53 -22.34 32.37 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.72 -27.03 6.3 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 168.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.68 71.39 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.694 0.798 . . . . 0.0 112.97 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.53 19.46 10.99 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.309 1.044 . . . . 0.0 113.657 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.4 -21.29 31.04 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.22 -3.62 29.79 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 114.53 0.572 . . . . 0.0 114.53 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.82 154.07 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.581 1.552 . . . . 0.0 111.303 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.64 39.33 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 114.332 -1.304 . . . . 0.0 115.544 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -48.51 96.75 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.211 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 28.8 Cg_endo -66.27 -26.2 49.13 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.449 2.099 . . . . 0.0 115.965 171.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -72.95 -37.15 67.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.82 16.23 24.62 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.97 143.02 47.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.091 0.948 . . . . 0.0 110.772 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 33.9 t -62.99 156.84 23.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.3 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -60.34 2.61 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.933 0.893 . . . . 0.0 112.936 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.8 tt0 -70.62 -24.17 62.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.298 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 3.0 tp60 -74.14 -46.67 40.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.621 0.724 . . . . 0.0 111.37 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -69.14 -36.84 77.88 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -53.58 -29.42 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.876 171.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.02 99.53 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.99 -42.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.037 0.535 . . . . 0.0 109.702 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -62.91 -35.76 81.14 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.29 -35.94 80.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.765 1.626 . . . . 0.0 111.844 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -79.17 -37.66 37.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.28 0.5 OUTLIER -60.81 -20.47 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 175.881 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -39.92 81.12 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 168.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.19 69.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.68 -57.62 3.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.313 1.045 . . . . 0.0 113.465 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -87.48 -25.68 23.6 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.79 149.43 8.61 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.84 -26.06 61.51 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 -3.39 23.28 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 172.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -59.58 -32.64 70.57 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.0 m-90 -121.83 76.09 38.07 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.46 -34.04 4.87 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.757 2.304 . . . . 0.0 113.082 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.2 p -61.53 -41.11 96.85 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.106 1.762 . . . . 0.0 113.302 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.69 133.9 13.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 110.377 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.96 57.68 0.55 Allowed Glycine 0 N--CA 1.476 1.317 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.025 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -56.58 -18.71 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.73 11.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.993 1.317 . . . . 0.0 113.868 165.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.4 p -102.07 -13.14 17.63 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.316 1.447 . . . . 0.0 113.993 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 13.43 46.15 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 116.159 1.223 . . . . 0.0 116.159 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 115.56 1.689 . . . . 99.989999999999995 115.56 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.534 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -60.64 -33.6 73.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.117 -1.401 . . . . 0.0 113.483 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.36 -34.88 67.06 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -65.02 -31.54 72.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.54 -47.83 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.277 0.631 . . . . 0.0 109.606 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -59.19 -39.19 81.79 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 173.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.58 0.06 21.47 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.2 t -114.41 -32.93 5.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.788 1.235 . . . . 0.0 111.926 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -98.01 -25.71 14.87 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 3.8 t -121.1 -24.91 5.42 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.35 -25.09 22.28 Favored Glycine 0 N--CA 1.483 1.772 0 O-C-N 122.102 -0.374 . . . . 0.0 113.536 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -46.72 0.15 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.694 0.664 . . . . 0.0 113.621 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.68 101.42 0.11 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -64.13 -34.68 78.61 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 19.0 20.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.83 79.14 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.453 1.901 . . . . 0.0 114.757 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.07 41.22 0.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.566 -2.107 . . . . 0.0 112.741 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 27' ' ' ASN . 10.2 t -114.86 -16.16 11.76 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.572 2.349 . . . . 0.0 112.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 36.67 90.56 Favored Glycine 0 CA--C 1.54 1.622 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.491 ' HB2' HG23 ' A' ' 25' ' ' THR . 1.4 m-20 -97.35 24.75 6.2 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.76 29.99 51.07 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -117.26 154.13 31.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.876 1.271 . . . . 0.0 110.056 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 36.2 m-85 -149.77 166.29 29.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.96 16.98 42.19 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 114.594 -1.185 . . . . 0.0 116.034 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 58.66 24.13 56.43 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.904 0.764 . . . . 0.0 114.424 -171.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 1.3 mt -116.28 14.62 15.83 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -170.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 36.65 27.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.79 98.54 6.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.743 -169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -29.05 132.79 0.2 Allowed Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.626 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.38 -41.02 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.34 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.85 -33.09 68.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.172 0.989 . . . . 0.0 113.45 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -75.38 -43.88 47.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.579 0.752 . . . . 0.0 112.036 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.482 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -61.97 -21.24 64.66 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.95 -29.2 7.96 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.73 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -102.11 21.24 15.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.539 1.535 . . . . 0.0 113.273 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.65 -22.05 31.15 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.24 -0.22 41.35 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -172.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.35 150.51 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.26 1.824 . . . . 0.0 109.331 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.72 37.11 0.08 OUTLIER Glycine 0 CA--C 1.542 1.738 0 C-N-CA 125.446 1.498 . . . . 0.0 116.137 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.81 -53.91 59.73 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 115.177 -2.344 . . . . 0.0 109.744 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -68.49 -10.71 29.84 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.417 2.745 . . . . 0.0 116.273 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -82.9 -35.7 25.92 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.27 -30.87 11.65 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.09 123.36 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.097 1.359 . . . . 0.0 111.637 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.6 t -53.8 152.74 5.17 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.659 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -40.33 -58.29 1.56 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.4 tp10 -70.9 -32.12 68.98 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.68 -37.4 59.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.315 0.646 . . . . 0.0 112.387 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -64.92 -50.76 65.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.506 0.722 . . . . 0.0 112.819 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 55' ' ' GLU . 39.6 pt -53.5 -29.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.89 90.45 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.962 0.905 . . . . 0.0 113.439 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 t -63.39 -44.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.875 0.87 . . . . 0.0 109.55 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 1.3 t30 -58.09 -37.23 74.11 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.158 1.383 . . . . 0.0 112.429 172.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -76.89 -40.52 47.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.436 0.636 . . . . 0.0 111.346 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.275 0.4 OUTLIER -59.94 -21.69 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.394 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.5 pp -58.26 -37.58 75.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.34 -30.81 65.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.456 0.702 . . . . 0.0 112.843 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.16 -60.74 2.36 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -82.63 -37.82 24.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.63 156.18 10.94 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.2 mt -58.42 -15.14 9.56 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -64.49 -21.15 66.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.776 1.63 . . . . 0.0 113.335 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.17 87.97 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 80.52 62.89 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -83.69 -54.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.502 2.135 . . . . 0.0 112.965 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.7 p -64.22 -55.51 21.13 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.836 1.654 . . . . 0.0 111.995 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 86.0 m -90.95 123.73 34.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.074 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.28 46.67 0.32 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.329 1.018 . . . . 0.0 113.599 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.69 18.54 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.14 -43.58 78.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.899 1.28 . . . . 0.0 112.548 168.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 m -79.53 -18.85 50.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.584 1.154 . . . . 0.0 113.778 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.26 -48.27 3.77 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.712 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.032 -1.461 . . . . 99.989999999999995 112.393 -170.297 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.553 0.216 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -47.78 -33.95 7.89 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.61 -33.75 68.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.65 -33.49 74.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.208 1.003 . . . . 0.0 112.317 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.04 -49.53 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -57.4 -42.56 82.46 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.74 4.63 11.17 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.78 -43.47 3.44 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 168.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.55 -44.73 66.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.958 0.903 . . . . 0.0 113.406 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -102.81 -42.79 5.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.036 0.934 . . . . 0.0 112.585 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.52 24.59 64.12 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.15 -93.54 0.1 OUTLIER Glycine 0 N--CA 1.477 1.368 0 O-C-N 124.125 0.544 . . . . 0.0 112.164 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -113.53 147.72 37.42 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 49.8 m95 -71.25 -43.44 67.26 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.287 173.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.2 -24.39 67.35 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.35 71.77 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 113.962 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.0 32.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.896 -1.957 . . . . 0.0 115.004 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.5 p -109.12 -23.4 11.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.218 2.207 . . . . 0.0 113.251 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.89 35.31 72.34 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 115.911 1.124 . . . . 0.0 115.911 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 88.6 m-20 -90.93 28.38 1.58 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.37 40.44 92.02 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-O 121.518 0.51 . . . . 0.0 113.233 -173.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 40.6 mttp -120.53 137.15 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 109.255 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.609 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 99.2 m-85 -138.4 147.81 43.78 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.575 1.172 . . . . 0.0 111.431 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.97 -4.51 7.78 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.546 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 71.31 26.98 72.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.418 0.532 . . . . 0.0 112.833 -173.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.402 HD23 ' OE1' ' A' ' 57' ' ' GLN . 3.4 mm? -111.42 21.6 16.03 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.651 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 1.2 tt0 44.45 35.12 1.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.534 1.635 . . . . 0.0 113.287 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.11 107.5 20.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.72 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -47.37 133.05 9.96 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.884 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 74.2 Cg_endo -62.7 -34.43 73.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.918 2.412 . . . . 0.0 113.326 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.27 70.96 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.042 0.937 . . . . 0.0 113.232 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -66.28 -50.72 62.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.168 0.987 . . . . 0.0 111.794 170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.3 t-105 -57.35 -22.01 39.52 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.64 -29.06 6.63 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 169.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.01 70.49 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.45 25.44 9.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.996 . . . . 0.0 111.761 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.4 -22.84 31.7 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 115.824 1.09 . . . . 0.0 115.824 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.85 -6.0 28.6 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -173.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.89 149.64 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.317 1.847 . . . . 0.0 109.295 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.23 35.86 0.09 OUTLIER Glycine 0 CA--C 1.544 1.866 0 C-N-CA 125.175 1.369 . . . . 0.0 116.218 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.57 -48.34 97.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 116.058 -1.925 . . . . 0.0 110.874 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 72.5 Cg_endo -69.2 -19.81 38.31 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.81 2.34 . . . . 0.0 114.781 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.66 51.19 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.37 -34.12 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 128.05 34.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.949 0.9 . . . . 0.0 111.542 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -50.82 157.7 0.77 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.597 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.675 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 2.6 mpt_? -38.92 -61.02 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.6 ' HA ' HG12 ' A' ' 58' ' ' ILE . 11.0 tt0 -69.79 -24.42 63.49 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -74.51 -41.51 60.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.444 0.698 . . . . 0.0 110.669 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.402 ' OE1' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -61.49 -47.65 84.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.566 1.146 . . . . 0.0 110.572 175.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.6 HG12 ' HA ' ' A' ' 55' ' ' GLU . 10.1 pt -55.31 -31.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.48 68.05 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 112.534 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.32 -41.5 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.794 0.438 . . . . 0.0 110.26 177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -34.12 74.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.71 -44.77 96.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.164 0.985 . . . . 0.0 111.919 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.58 -38.8 80.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.213 0.53 . . . . 0.0 111.943 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 61' ' ' ALA 0.27 0.4 OUTLIER -59.96 -22.99 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.156 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.65 80.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 169.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.0 -29.3 68.28 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -59.97 2.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.52 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -91.18 -21.81 20.96 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 151.58 9.27 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.87 -37.88 86.21 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -7.61 18.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.206 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.7 67.48 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -99.62 141.14 22.27 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 173.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.06 -159.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.684 2.256 . . . . 0.0 111.185 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.2 p -54.14 -24.56 18.32 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.05 67.09 1.69 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.998 1.38 . . . . 0.0 112.494 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.63 50.66 0.84 Allowed Glycine 0 N--CA 1.475 1.243 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.801 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -16.94 27.94 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.65 -33.25 32.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.774 1.23 . . . . 0.0 113.357 165.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.7 m -99.05 -17.36 18.29 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.128 1.371 . . . . 0.0 113.98 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.68 32.54 84.51 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 115.114 0.806 . . . . 0.0 115.114 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' OXT' HD12 ' A' ' 82' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.69 1.737 . . . . 99.989999999999995 115.69 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -56.67 -34.23 67.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.79 -44.59 89.47 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.34 -33.55 74.93 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.916 0.486 . . . . 0.0 112.003 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' ' 78' ' ' ALA . 42.5 t -62.07 -40.46 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.556 1.142 . . . . 0.0 113.128 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.05 93.14 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.787 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.73 0.89 6.12 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.4 -33.12 6.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.113 1.765 . . . . 0.0 111.92 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' GLN . 52.3 mt-10 -104.24 -23.73 13.21 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 53.3 p -117.36 -26.51 6.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 169.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.34 -11.53 65.37 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.396 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.63 -67.42 0.17 Allowed Glycine 0 N--CA 1.477 1.387 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 47.4 m-80 -47.29 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.519 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 41.9 m95 -63.93 -49.32 73.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.55 -2.1 21.37 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 39.19 69.6 0.27 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.122 1.769 . . . . 0.0 114.817 -173.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -82.51 43.81 0.85 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.933 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -114.59 -21.21 10.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.339 2.655 . . . . 0.0 112.128 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.51 32.66 82.32 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.11 24.72 4.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.61 37.66 77.25 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.888 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -118.15 149.07 41.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.244 0.618 . . . . 0.0 109.82 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 62.0 m-85 -144.63 149.96 36.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.454 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 56.67 23.73 45.02 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 59.25 25.94 60.84 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -112.52 13.24 20.06 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -174.576 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 6.6 tt0 44.5 33.18 0.85 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 123.392 1.568 . . . . 0.0 114.334 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.21 109.66 21.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.786 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.31 142.65 4.18 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.277 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 95.5 Cg_endo -65.4 -40.95 17.01 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.741 2.294 . . . . 0.0 112.34 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.01 -29.74 65.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.728 1.211 . . . . 0.0 113.551 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 m -78.03 -45.03 24.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.918 0.887 . . . . 0.0 111.316 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.47 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 43.6 t-105 -59.24 -21.36 59.45 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.18 -28.85 3.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 168.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.56 68.48 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.85 24.84 10.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.451 1.1 . . . . 0.0 111.781 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -23.58 28.42 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.83 -4.21 31.25 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 114.866 0.706 . . . . 0.0 114.866 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.28 158.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.649 1.58 . . . . 0.0 111.716 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.63 32.54 0.13 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 124.949 1.262 . . . . 0.0 116.164 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.76 -51.24 83.19 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.971 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 93.3 Cg_endo -69.72 -19.01 36.89 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.15 2.567 . . . . 0.0 115.195 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.79 -33.66 46.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.83 -35.74 12.58 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.35 128.45 35.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.876 0.871 . . . . 0.0 111.648 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -51.58 159.91 0.69 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.688 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 21' ' ' TRP . 8.1 mtm180 -41.74 -58.26 2.05 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -66.91 -36.97 83.46 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.352 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.72 -37.49 86.56 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.71 -0.619 . . . . 0.0 111.705 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -64.54 -50.76 66.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.228 1.011 . . . . 0.0 110.92 172.415 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.735 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -56.73 -31.46 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.04 -48.31 82.07 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 0.0 112.605 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.65 -42.6 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.986 0.514 . . . . 0.0 110.405 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . . . -58.96 -36.67 75.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.374 1.07 . . . . 0.0 113.667 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.57 -46.09 84.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.035 1.334 . . . . 0.0 111.319 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -33.93 62.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.4 OUTLIER -59.87 -25.68 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 173.847 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -42.09 92.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.927 0.491 . . . . 0.0 112.228 171.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -31.15 66.92 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -67.42 -52.0 44.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.39 10.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.98 155.93 9.22 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.05 0.805 . . . . 0.0 111.515 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.44 16.41 17.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.235 -0.982 . . . . 0.0 113.466 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.46 -29.36 13.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.144 1.378 . . . . 0.0 114.384 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.66 90.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.14 149.31 91.22 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.129 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -64.88 -154.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.891 2.394 . . . . 0.0 111.774 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.2 p -56.03 -29.19 60.04 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.064 0.935 . . . . 0.0 112.98 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 m -68.65 172.23 6.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.484 2.313 . . . . 0.0 110.878 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.23 105.26 1.54 Allowed Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.178 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -60.75 -15.53 30.45 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.73 -41.89 5.1 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.927 1.291 . . . . 0.0 112.501 163.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.8 m -107.29 -28.11 10.1 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.376 1.048 . . . . 0.0 113.588 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.11 25.42 69.55 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 124.147 0.879 . . . . 0.0 113.587 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.252 1.214 0 CA-C-O 116.277 -1.82 . . . . 99.989999999999995 111.887 -177.466 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.47 ' HZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -60.56 -31.56 70.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.341 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -57.34 -35.8 70.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.751 0.821 . . . . 0.0 113.092 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.81 72.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.86 -47.47 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -62.06 -40.6 96.34 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -70.81 -7.49 45.67 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.33 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.587 1.555 . . . . 0.0 111.938 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -80.86 -39.09 27.04 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t -105.88 -37.99 6.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.81 1.244 . . . . 0.0 112.619 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.4 16.72 58.72 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.919 0.728 . . . . 0.0 114.919 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.3 -99.66 0.6 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 121.881 0.712 . . . . 0.0 112.453 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.63 150.89 47.18 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.136 -1.032 . . . . 0.0 113.468 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 39.3 m95 -64.16 -38.69 91.96 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.667 171.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.04 41.06 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.514 1.149 . . . . 0.0 112.39 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 59.52 0.65 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 122.947 1.356 . . . . 0.0 113.104 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.34 52.86 1.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.109 1.433 . . . . 0.0 111.513 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.3 p -82.92 9.38 10.13 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.786 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.84 26.89 70.43 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.266 1.267 . . . . 0.0 116.266 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -87.11 22.43 2.07 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 54.2 30.75 48.34 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.72 -172.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -132.32 143.3 49.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.145 0.978 . . . . 0.0 109.285 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.601 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 62.6 m-85 -146.28 159.39 43.41 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.836 -1.075 . . . . 0.0 113.598 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.96 33.08 56.67 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.449 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 52.28 22.86 11.14 Favored Glycine 0 CA--C 1.545 1.917 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD21 ' HZ3' ' A' ' 9' ' ' TRP . 41.7 mt -109.54 11.46 24.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.131 2.641 . . . . 0.0 118.131 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? 39.11 27.02 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -79.2 106.17 11.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.204 -172.89 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -36.8 129.73 0.72 Allowed Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 113.204 -1.816 . . . . 0.0 113.818 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 91.9 Cg_endo -63.42 -33.41 69.57 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.033 2.489 . . . . 0.0 113.026 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -35.05 66.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.389 1.076 . . . . 0.0 113.145 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.8 m -70.82 -51.18 28.32 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.871 0.868 . . . . 0.0 111.167 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.471 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.8 t-105 -58.61 -21.52 53.77 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.86 -28.06 6.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.03 75.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.3 20.26 8.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.636 1.174 . . . . 0.0 113.959 171.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.88 -20.14 36.85 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.914 1.126 . . . . 0.0 115.914 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.86 -6.56 25.68 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 -174.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.9 p -64.5 154.94 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.087 1.755 . . . . 0.0 111.951 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.91 35.82 0.14 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 125.02 1.295 . . . . 0.0 115.538 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.579 ' HB2' HG13 ' A' ' 46' ' ' VAL . 4.3 t-20 -58.42 -51.01 84.89 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 116.159 -1.877 . . . . 0.0 110.068 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 71.0 Cg_endo -68.39 -21.4 40.93 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.04 2.494 . . . . 0.0 115.183 174.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -77.02 -33.44 57.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 1.5 43.01 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.06 125.0 48.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.039 0.936 . . . . 0.0 109.206 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -53.2 155.36 2.7 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.055 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 51.5 mtt85 -37.36 -55.66 1.02 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.308 1.443 . . . . 0.0 114.247 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.3 tt0 -69.27 -42.36 75.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.7 -39.24 73.51 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.664 0.785 . . . . 0.0 110.826 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -65.53 -53.74 37.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.17 173.033 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.9 pt -51.73 -34.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -55.04 40.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.066 0.947 . . . . 0.0 113.297 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.52 -37.67 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.165 0.586 . . . . 0.0 110.516 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.15 -42.26 94.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.116 1.367 . . . . 0.0 113.791 174.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.4 -40.94 88.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.005 1.322 . . . . 0.0 111.922 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -71.39 -40.18 70.7 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.994 -0.441 . . . . 0.0 112.148 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.272 0.3 OUTLIER -63.51 -20.3 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.199 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -44.01 88.23 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 168.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.1 69.09 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.71 -49.04 33.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -102.09 -25.82 13.6 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.62 154.77 8.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.078 0.847 . . . . 0.0 111.098 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.46 -32.36 72.35 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -11.68 17.62 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -53.61 -33.61 55.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.674 1.19 . . . . 0.0 114.063 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.441 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 21.1 m-90 -113.99 141.09 25.69 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.46 -159.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.034 2.489 . . . . 0.0 112.095 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -52.28 -25.23 8.92 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.2 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.744 2.018 . . . . 0.0 115.214 170.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.56 48.6 1.09 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.317 0.961 . . . . 0.0 111.784 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.92 -15.31 0.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.4 -41.13 13.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 113.305 164.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -95.72 -17.19 21.45 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.858 1.263 . . . . 0.0 113.66 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.31 -44.32 3.33 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 123.921 0.772 . . . . 0.0 112.684 -172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.321 1.848 . . . . 99.989999999999995 112.074 -175.279 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 58' ' ' ILE . 1.2 m95 -59.55 -35.58 74.5 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.326 -1.761 . . . . 0.0 113.744 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -58.57 -52.82 64.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.572 0.749 . . . . 0.0 112.368 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -58.02 -35.46 71.3 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.872 0.733 . . . . 0.0 112.657 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.76 -44.81 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.675 0.79 . . . . 0.0 112.814 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.73 94.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.86 0.362 . . . . 0.0 111.889 171.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.97 15.33 1.86 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.5 t -116.95 -33.63 4.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.884 1.274 . . . . 0.0 111.543 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -88.48 -53.02 4.87 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 168.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -81.21 -42.73 20.32 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.25 19.87 60.08 Favored Glycine 0 N--CA 1.481 1.679 0 O-C-N 124.244 0.965 . . . . 0.0 115.399 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.56 -98.52 0.24 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-O 121.09 0.272 . . . . 0.0 112.88 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -123.96 153.39 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 51.7 m95 -70.71 -42.62 70.36 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.353 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.93 40.67 1.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.432 1.11 . . . . 0.0 112.012 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 63.54 2.31 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 123.732 1.729 . . . . 0.0 111.613 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -82.74 30.48 0.43 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.041 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -80.24 27.66 0.33 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.731 2.012 . . . . 0.0 114.024 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.7 43.67 93.81 Favored Glycine 0 CA--C 1.54 1.615 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.5 m120 -90.96 7.78 38.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.77 10.23 6.17 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 124.273 0.939 . . . . 0.0 115.336 -170.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 27' ' ' ASN . 26.1 mmtp -131.5 148.24 52.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.654 1.182 . . . . 0.0 109.385 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-85 -139.35 160.21 40.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.764 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.75 -10.59 24.08 Favored Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.943 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.08 25.73 54.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.012 0.339 . . . . 0.0 113.543 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.455 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 3.8 mp -115.1 13.01 16.77 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 38.62 52.13 1.78 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 123.75 1.738 . . . . 0.0 113.307 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -105.26 109.39 21.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.798 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -39.94 137.33 1.19 Allowed Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.85 -44.74 12.35 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.516 . . . . 0.0 113.301 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.33 -33.24 67.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.063 0.945 . . . . 0.0 113.506 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -72.12 -48.03 46.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.701 0.8 . . . . 0.0 111.537 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 33.6 t-105 -59.93 -21.87 61.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.92 -28.46 9.76 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.25 -36.12 72.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.5 17.5 13.02 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.727 1.211 . . . . 0.0 113.553 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.29 -22.79 24.21 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.28 -6.19 23.63 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -63.77 154.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.811 1.644 . . . . 0.0 111.721 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.2 0.09 OUTLIER Glycine 0 N--CA 1.482 1.757 0 C-N-CA 124.878 1.228 . . . . 0.0 115.59 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 46' ' ' VAL . 17.9 t30 -58.57 -51.72 79.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 115.94 -1.981 . . . . 0.0 110.384 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.499 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.6 Cg_endo -67.0 -25.07 44.68 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.265 1.977 . . . . 0.0 113.927 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -69.39 -36.21 76.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.68 -33.89 11.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 119.12 9.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.078 0.951 . . . . 0.0 111.6 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 m -46.87 156.41 0.2 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.429 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 2.5 mtt180 -29.34 -67.66 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.726 ' HA ' HG12 ' A' ' 58' ' ' ILE . 22.5 tt0 -63.97 -32.65 74.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -68.89 -40.25 79.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.049 0.54 . . . . 0.0 111.296 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.437 ' OE1' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.84 -50.67 67.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.389 1.076 . . . . 0.0 110.484 173.063 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.726 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -54.82 -32.93 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -53.58 56.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 113.15 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.54 -41.59 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.135 0.574 . . . . 0.0 109.866 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.19 -39.46 82.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.452 1.501 . . . . 0.0 114.533 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 5.5 t-20 -58.29 -37.51 75.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.004 1.322 . . . . 0.0 111.882 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -33.65 27.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.271 0.4 OUTLIER -60.45 -25.19 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 173.912 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.3 pp -61.78 -38.39 87.86 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.2 71.67 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.06 -62.95 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -82.16 -22.77 35.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 -169.08 15.1 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.03 19.69 7.58 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.205 -0.997 . . . . 0.0 113.198 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.92 -33.41 17.29 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.25 -26.33 51.09 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' HE1' HD23 ' A' ' 33' ' ' LEU . 6.3 m-90 -122.79 91.13 49.83 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.04 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.13 -62.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.525 2.15 . . . . 0.0 113.091 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -61.23 -50.37 73.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.888 1.275 . . . . 0.0 113.03 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.8 m -101.04 175.14 5.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.924 170.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.58 93.24 0.09 OUTLIER Glycine 0 N--CA 1.472 1.075 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -28.01 19.86 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.59 -37.81 42.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.636 1.175 . . . . 0.0 113.394 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -99.98 -27.49 13.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.386 1.074 . . . . 0.0 112.227 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.34 -37.14 3.51 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.264 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.817 1.247 . . . . 99.989999999999995 113.529 -175.823 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.093 0.473 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.605 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 1.1 m95 -49.07 -37.88 22.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.31 -43.94 95.88 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.3 -34.63 77.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.923 0.889 . . . . 0.0 112.118 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.87 -37.95 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 112.421 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.92 93.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.55 6.84 7.76 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 t -110.31 -31.96 7.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.934 0.894 . . . . 0.0 112.267 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.66 -32.42 10.34 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 19.8 t -98.52 -35.53 10.21 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 31.08 67.74 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.37 -88.73 0.07 OUTLIER Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.172 0.415 . . . . 0.0 112.509 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -112.83 145.3 40.88 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -66.57 -47.39 72.94 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.107 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 -29.55 69.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 35.35 70.46 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.403 1.881 . . . . 0.0 114.297 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -78.58 56.99 1.91 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.817 1.77 . . . . 0.0 112.401 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -117.53 -24.51 7.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.402 2.681 . . . . 0.0 112.94 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.08 34.42 76.1 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.666 1.026 . . . . 0.0 115.666 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -92.5 25.97 2.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.3 39.17 92.24 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.695 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 34' ' ' GLN . 34.2 mttp -121.18 146.89 46.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.291 1.036 . . . . 0.0 109.742 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 16.1 m-85 -145.23 146.05 31.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.562 -175.523 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 51.18 34.08 31.69 Favored Glycine 0 N--CA 1.483 1.779 0 O-C-N 124.801 1.313 . . . . 0.0 115.843 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 58.12 23.52 52.57 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.356 0.979 . . . . 0.0 115.193 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 18.3 mt -116.71 8.26 13.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -169.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 4.5 tt0 45.07 36.8 2.17 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.817 1.77 . . . . 0.0 113.07 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -89.69 104.68 17.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.6 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -37.75 130.16 0.91 Allowed Pre-proline 0 N--CA 1.484 1.233 0 CA-C-N 112.986 -1.915 . . . . 0.0 113.331 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 89.5 Cg_endo -65.0 -39.22 25.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.772 2.315 . . . . 0.0 112.556 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.38 70.04 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.2 1.0 . . . . 0.0 113.088 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 m -73.63 -44.79 56.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.578 0.751 . . . . 0.0 111.5 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 42.9 t-105 -58.7 -20.21 46.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.39 -28.38 5.04 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 168.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.05 69.74 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -98.36 25.73 6.04 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.017 1.327 . . . . 0.0 113.589 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.34 39.57 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.3 -4.57 32.71 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 115.077 0.791 . . . . 0.0 115.077 -173.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 61.7 t -72.2 152.81 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.011 1.724 . . . . 0.0 109.274 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.5 36.01 0.08 OUTLIER Glycine 0 CA--C 1.542 1.768 0 C-N-CA 125.226 1.393 . . . . 0.0 116.58 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -52.77 -53.94 48.86 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 116.209 -1.853 . . . . 0.0 109.146 171.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 72.5 Cg_endo -67.35 -20.89 48.12 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.536 2.824 . . . . 0.0 116.023 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.52 61.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.66 -35.01 10.72 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.54 126.97 29.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.484 1.114 . . . . 0.0 110.821 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -54.63 156.81 3.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.301 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 26.5 mtt-85 -45.92 -57.74 4.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.146 0.978 . . . . 0.0 112.936 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 58' ' ' ILE . 10.2 tt0 -66.79 -30.79 71.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.44 -41.34 76.44 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.824 -0.547 . . . . 0.0 110.851 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.73 -40.77 98.24 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.251 174.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 55' ' ' GLU . 2.3 pt -54.28 -33.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.945 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.03 82.54 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.15 -42.18 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.362 0.601 . . . . 0.0 109.673 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.563 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.95 -36.39 79.23 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.4 -47.71 81.0 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.407 1.083 . . . . 0.0 111.296 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -39.71 87.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.001 0.429 . . . . 0.0 111.572 173.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.293 0.4 OUTLIER -61.52 -26.03 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.591 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.65 -40.3 91.5 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.16 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.274 0.629 . . . . 0.0 112.607 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -66.91 -43.92 82.1 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.82 -29.23 10.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 112.89 155.68 12.15 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.38 21.1 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 69' ' ' GLY . 7.4 m-20 -88.33 -30.62 19.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.004 1.722 . . . . 0.0 111.866 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.37 -31.23 65.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 0.0 113.33 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -122.75 89.74 50.06 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.08 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.29 1.993 . . . . 0.0 113.537 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -63.19 -49.56 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.855 1.662 . . . . 0.0 112.95 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -109.79 163.43 13.52 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.027 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.55 101.14 0.15 Allowed Glycine 0 N--CA 1.478 1.469 0 O-C-N 124.563 1.165 . . . . 0.0 111.376 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.56 -28.72 14.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.08 -32.84 36.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.016 1.326 . . . . 0.0 114.074 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.8 p -107.97 -22.0 12.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.903 1.281 . . . . 0.0 113.714 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.7 32.71 84.48 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 124.296 0.95 . . . . 0.0 114.062 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 117.042 -1.456 . . . . 99.989999999999995 114.295 178.285 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 19.5 m95 -50.91 -34.36 28.14 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.28 -49.57 77.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.991 0.917 . . . . 0.0 112.688 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.497 0.719 . . . . 0.0 112.142 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 78' ' ' ALA . 77.0 t -63.9 -38.96 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.176 0.991 . . . . 0.0 112.322 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.35 78.77 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.72 6.92 19.3 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -116.38 -35.24 4.35 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.882 0.873 . . . . 0.0 112.888 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 16.9 mm-40 -89.47 -39.27 13.46 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 170.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -106.42 -24.08 12.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.45 3.62 72.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.697 1.039 . . . . 0.0 115.697 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.52 81.18 0.42 Allowed Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.007 0.813 . . . . 0.0 111.49 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 173.77 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.08 1.752 . . . . 0.0 108.939 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -80.37 -79.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.402 0.439 . . . . 0.0 111.745 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -22.15 55.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.8 70.61 0.5 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.321 1.848 . . . . 0.0 114.383 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.55 33.74 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.957 -1.929 . . . . 0.0 115.222 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.4 t -117.13 -18.01 10.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.388 2.275 . . . . 0.0 112.338 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 46.69 40.76 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -89.35 23.24 2.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.1 34.65 58.62 Favored Glycine 0 N--CA 1.482 1.765 0 C-N-CA 123.289 0.471 . . . . 0.0 113.563 -172.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' ' HG2' ' A' ' 34' ' ' GLN . 61.1 mttp -129.5 138.6 51.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.776 1.23 . . . . 0.0 108.809 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 89.4 m-85 -136.87 149.46 47.68 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.565 1.166 . . . . 0.0 112.822 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.54 -14.75 1.77 Allowed Glycine 0 N--CA 1.483 1.786 0 CA-C-N 114.339 -1.3 . . . . 0.0 116.235 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.7 30.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.889 0.757 . . . . 0.0 114.815 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.05 28.08 8.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.584 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 7.7 tm0? 43.91 35.18 1.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.156 1.782 . . . . 0.0 114.171 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.04 110.19 22.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.044 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.92 133.14 29.32 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 112.581 -2.1 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -62.03 -32.23 83.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.171 2.581 . . . . 0.0 113.771 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.02 65.34 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -76.0 -41.04 52.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.705 0.802 . . . . 0.0 111.676 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 38.5 t-105 -58.73 -21.49 55.24 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.86 -29.52 3.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 168.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.06 -38.36 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.31 18.85 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.77 1.228 . . . . 0.0 113.517 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.73 -21.13 32.84 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.56 -2.95 36.34 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.47 156.81 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.49 1.516 . . . . 0.0 111.741 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.38 34.28 0.12 Allowed Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -58.46 -52.61 73.37 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-O 115.719 -2.086 . . . . 0.0 110.603 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 71.9 Cg_endo -68.25 -16.95 44.8 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.135 2.557 . . . . 0.0 115.475 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.58 -33.67 35.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.74 -34.71 10.41 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.73 121.69 13.48 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.154 0.978 . . . . 0.0 110.876 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -50.85 160.09 0.49 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.057 -1.883 . . . . 0.0 110.732 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.19 -56.63 4.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 58' ' ' ILE . 29.1 tt0 -70.11 -30.28 67.44 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -68.01 -45.78 73.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.404 0.681 . . . . 0.0 111.165 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -66.0 -45.07 82.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.778 0.831 . . . . 0.0 113.053 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.643 HG12 ' HA ' ' A' ' 55' ' ' GLU . 26.4 pt -54.67 -28.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.51 85.99 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.03 -42.61 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.252 0.621 . . . . 0.0 109.997 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.74 78.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -61.01 -39.59 90.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.196 1.399 . . . . 0.0 112.183 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -33.85 52.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.5 OUTLIER -57.15 -26.76 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.526 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -59.79 -42.82 94.25 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 171.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.7 66.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -52.11 30.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.37 -25.18 14.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.77 164.81 13.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.83 1.85 1.22 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 170.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -67.05 -32.83 74.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.299 1.84 . . . . 0.0 113.88 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -53.04 -29.68 31.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.533 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 2.2 m-90 -128.36 90.44 46.87 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.83 -65.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.542 2.161 . . . . 0.0 113.253 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -61.6 -42.64 99.15 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 0.0 113.875 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -113.62 -164.88 0.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.232 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.59 101.91 0.25 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -57.49 -25.64 60.09 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.667 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -49.01 -42.38 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 113.554 166.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.2 p -94.2 -20.76 19.55 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.464 1.105 . . . . 0.0 113.131 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 21.3 63.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 124.906 1.241 . . . . 0.0 115.136 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.296 0 N-CA-C 115.252 1.575 . . . . 99.989999999999995 115.252 176.219 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 122.958 1.361 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.419 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -57.57 -32.96 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.417 -1.72 . . . . 0.0 112.97 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.25 -48.0 71.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 0.0 112.105 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.65 66.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 78' ' ' ALA . 89.7 t -63.22 -33.83 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 112.627 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.42 94.07 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.26 -4.71 31.2 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -106.93 -25.52 11.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -104.71 -27.82 11.57 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.4 t -110.75 -31.55 7.16 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.61 -24.6 28.67 Favored Glycine 0 N--CA 1.481 1.693 0 CA-C-N 116.785 -0.189 . . . . 0.0 112.881 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.65 83.44 0.07 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.0 t-20 178.45 98.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.669 1.188 . . . . 0.0 110.869 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 76.3 m95 -75.6 -25.82 57.32 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.75 48.6 0.95 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.847 1.308 . . . . 0.0 111.847 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . -70.05 50.92 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -101.46 26.19 7.53 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.751 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 t -122.75 44.5 2.63 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.424 1.583 . . . . 0.0 111.911 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.95 -93.64 0.1 OUTLIER Glycine 0 N--CA 1.481 1.634 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.824 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 2.0 m-20 -103.86 28.93 6.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.28 33.66 65.87 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.306 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 27' ' ' ASN . 91.2 mttt -79.3 151.03 31.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 0.0 111.2 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.692 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 73.1 m-85 -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.05 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.599 ' HA2' ' HG3' ' A' ' 57' ' ' GLN . . . 77.1 -25.99 1.83 Allowed Glycine 0 N--CA 1.48 1.591 0 CA-C-N 114.13 -1.395 . . . . 0.0 115.342 -176.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.93 22.94 36.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 114.731 -0.734 . . . . 0.0 113.428 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HG ' ' HE1' ' A' ' 73' ' ' TRP . 2.6 mm? -116.71 28.79 8.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 37.19 31.65 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.266 2.226 . . . . 0.0 116.772 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -78.32 109.53 12.54 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.811 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -46.33 132.15 7.68 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.175 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.09 -38.85 84.71 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.91 2.407 . . . . 0.0 113.379 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.68 68.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -76.87 -42.39 40.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.604 0.762 . . . . 0.0 111.069 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 40.1 t-105 -60.83 -21.83 63.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.55 -29.94 3.2 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.41 -35.86 70.58 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 171.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -98.56 25.36 6.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.928 1.291 . . . . 0.0 113.156 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.31 34.27 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.9 -11.02 16.24 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 45.5 t -65.28 151.21 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.472 1.909 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.82 38.48 0.09 OUTLIER Glycine 0 CA--C 1.545 1.93 0 C-N-CA 125.428 1.489 . . . . 0.0 116.332 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.403 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -54.57 -53.89 54.89 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.233 -1.841 . . . . 0.0 108.617 171.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 94.2 Cg_endo -70.66 -9.41 25.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.876 2.384 . . . . 0.0 116.122 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -77.34 -46.4 23.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.798 0.839 . . . . 0.0 113.003 170.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.43 -34.11 15.74 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -61.55 115.1 3.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.006 0.922 . . . . 0.0 110.695 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -44.35 159.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.305 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 16.9 mtt85 -40.91 -59.41 1.44 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.98 1.312 . . . . 0.0 113.269 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.684 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -68.34 -27.17 66.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.255 177.25 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -72.26 -42.48 65.55 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.339 0.59 . . . . 0.0 110.738 175.592 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.599 ' HG3' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -62.75 -48.11 80.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.118 0.967 . . . . 0.0 111.43 176.695 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.684 HG12 ' HA ' ' A' ' 55' ' ' GLU . 24.1 pt -54.35 -33.78 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.4 -50.82 72.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.506 0.722 . . . . 0.0 112.8 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.69 -41.95 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.013 0.525 . . . . 0.0 110.376 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.88 73.44 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 54.9 t30 -62.95 -41.92 99.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.05 1.34 . . . . 0.0 111.931 171.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -71.87 -38.54 70.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.419 0.628 . . . . 0.0 111.318 172.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 67' ' ' GLU 0.27 0.5 OUTLIER -59.37 -26.78 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.327 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.6 pp -62.01 -40.52 95.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.79 67.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 2.4 mm-40 -61.67 -53.81 51.15 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -110.7 -23.47 11.04 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.12 165.04 12.99 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.35 4.67 0.68 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -30.39 71.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.251 1.821 . . . . 0.0 114.203 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.09 -27.04 52.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.2 m-90 -119.02 95.95 49.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.78 -58.96 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.306 2.004 . . . . 0.0 114.126 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 p -64.64 -48.49 74.64 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.403 1.481 . . . . 0.0 113.076 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 m -108.4 -165.69 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.746 170.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.92 97.13 0.12 Allowed Glycine 0 N--CA 1.473 1.113 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -53.91 -25.34 19.77 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -47.11 -40.14 14.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.029 1.332 . . . . 0.0 113.569 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.3 m -102.42 -21.07 14.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.824 1.25 . . . . 0.0 114.362 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -38.31 2.97 Favored Glycine 0 N--CA 1.48 1.58 0 C-N-CA 124.08 0.848 . . . . 0.0 112.332 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 116.057 -1.925 . . . . 99.989999999999995 114.119 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 122.383 1.087 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.579 ' HB3' HG21 ' A' ' 58' ' ' ILE . 31.4 m95 -54.91 -31.54 60.21 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.455 175.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -63.19 -52.61 61.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 0.0 112.388 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.24 65.22 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 78' ' ' ALA . 71.8 t -63.75 -38.4 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.404 1.081 . . . . 0.0 112.668 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.31 93.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.892 168.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.87 -0.25 8.75 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 t -108.51 -29.2 8.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.329 1.451 . . . . 0.0 111.874 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -108.23 -27.31 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.568 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 54.5 p -111.79 -25.74 9.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.47 74.5 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.803 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.17 -77.79 0.21 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 52.2 m-80 -44.47 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 54' ' ' ARG . 40.8 m95 -63.63 -50.15 70.45 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 175.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.77 26.71 0.68 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 16.81 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.193 2.197 . . . . 0.0 116.086 -172.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 34.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 112.124 -2.307 . . . . 0.0 114.988 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -113.7 -14.93 12.55 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.576 1.951 . . . . 0.0 112.674 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.33 39.77 70.35 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.9 m120 -88.89 12.64 14.68 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.7 23.57 50.5 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -171.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 27' ' ' ASN . 52.2 mttt -125.34 150.65 46.97 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.62 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 69.2 m-85 -144.61 174.79 10.66 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 63.72 19.83 63.35 Favored Glycine 0 N--CA 1.48 1.583 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.792 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 62.05 15.36 49.73 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.479 HD12 ' NE1' ' A' ' 73' ' ' TRP . 3.8 mm? -104.74 9.33 35.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 30.89 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.562 1.945 . . . . 0.0 116.034 -169.536 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.69 116.19 23.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.044 -1.434 . . . . 0.0 110.938 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -36.07 126.03 0.68 Allowed Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.67 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.71 -35.61 94.22 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.119 2.546 . . . . 0.0 113.39 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.94 64.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 m -75.21 -42.31 55.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.895 0.478 . . . . 0.0 111.138 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 30.0 t-105 -57.86 -22.63 48.96 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.81 -28.77 3.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.79 78.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -91.52 18.9 6.73 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -21.94 32.22 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 0.0 44.1 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.66 152.8 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.324 1.85 . . . . 0.0 109.361 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 37.18 0.08 OUTLIER Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.505 1.526 . . . . 0.0 116.202 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -57.68 -50.87 85.7 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.151 -1.881 . . . . 0.0 110.365 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 90.6 Cg_endo -71.2 -11.83 29.32 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.081 2.52 . . . . 0.0 115.563 175.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.1 -34.97 32.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 0.0 113.203 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.72 -34.84 10.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.25 118.72 8.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.797 0.839 . . . . 0.0 111.924 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -46.65 161.34 0.06 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -42.73 -60.66 1.49 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.0 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HA ' HG12 ' A' ' 58' ' ' ILE . 15.9 tt0 -67.63 -28.01 67.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -72.4 -43.6 63.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.05 0.453 . . . . 0.0 110.973 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.59 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -63.31 -44.29 95.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.685 176.224 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 55' ' ' GLU . 16.9 pt -55.29 -30.02 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.073 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.91 88.08 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 172.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.36 -42.76 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.763 0.825 . . . . 0.0 110.12 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.99 -36.72 80.21 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.545 1.138 . . . . 0.0 114.047 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -59.55 -41.86 91.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.928 1.291 . . . . 0.0 111.686 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -33.7 57.57 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -61.43 -24.19 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 172.941 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -47.27 79.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.141 0.577 . . . . 0.0 111.337 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -30.13 64.94 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -60.14 -49.53 77.25 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.679 1.191 . . . . 0.0 113.469 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -103.22 -26.55 12.94 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.17 157.39 13.61 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -27.68 15.47 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.52 -21.83 18.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.012 1.725 . . . . 0.0 115.2 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.83 -36.06 58.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.138 0.975 . . . . 0.0 113.583 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.479 ' NE1' HD12 ' A' ' 33' ' ' LEU . 13.2 m-90 -118.82 136.92 24.47 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.93 -85.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.854 2.37 . . . . 0.0 113.885 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -91.55 -53.22 4.41 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.224 1.409 . . . . 0.0 111.477 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.96 160.92 3.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.444 1.898 . . . . 0.0 110.094 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.29 103.81 1.66 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.292 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -59.51 -18.72 42.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -36.62 -45.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.63 1.572 . . . . 0.0 113.165 160.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' HD23 ' A' ' 82' ' ' LEU . 58.6 m -107.29 -30.02 8.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.193 0.997 . . . . 0.0 113.442 170.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.21 11.69 64.57 Favored Glycine 0 N--CA 1.482 1.749 0 C-N-CA 123.941 0.781 . . . . 0.0 114.268 -173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.626 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.2 mm? . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.89 1.276 . . . . 99.989999999999995 113.455 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.403 ' CH2' HD21 ' A' ' 33' ' ' LEU . 3.9 m95 -49.76 -39.47 37.89 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.87 -54.2 49.02 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.96 74.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.128 0.971 . . . . 0.0 112.721 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 78' ' ' ALA . 53.6 t -61.14 -31.38 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.068 1.347 . . . . 0.0 112.62 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.36 76.56 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.349 0.977 . . . . 0.0 112.76 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -77.82 5.42 9.58 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.9 t -116.85 -33.41 4.79 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 12.8 mm-40 -75.77 -43.74 45.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.377 1.071 . . . . 0.0 111.764 171.083 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 t -104.01 -45.17 4.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.011 1.324 . . . . 0.0 113.246 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.89 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 124.179 0.924 . . . . 0.0 114.347 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.77 -100.54 0.15 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 123.992 0.466 . . . . 0.0 112.795 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.38 139.74 33.89 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -66.92 -15.81 63.92 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 167.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' TYR . . . -93.54 -35.35 12.97 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 168.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.73 43.01 9.24 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.93 32.27 4.28 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.919 -175.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -128.36 26.77 5.66 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.708 1.242 . . . . 0.0 113.084 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.31 -95.53 0.39 Allowed Glycine 0 N--CA 1.481 1.656 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 33.2 m-20 -105.69 28.96 6.99 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.11 91.67 Favored Glycine 0 CA--C 1.541 1.711 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.678 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 66.3 mttm -74.69 165.22 25.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.927 0.891 . . . . 0.0 110.703 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 59.7 m-85 -137.43 156.86 47.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.001 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.66 10.14 29.36 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-N 114.272 -1.331 . . . . 0.0 116.147 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 16' ' ' GLU . . . 55.59 29.88 54.87 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 115.536 -0.332 . . . . 0.0 112.302 -167.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -112.32 16.7 19.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.576 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 5.8 pt20 36.0 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 1.9 t80 -98.57 115.31 28.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.35 -168.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.53 130.46 10.6 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.963 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.33 -34.68 98.31 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.917 2.411 . . . . 0.0 113.438 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.66 65.16 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -76.23 -46.53 27.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.434 0.694 . . . . 0.0 111.076 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.439 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -58.51 -22.37 54.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -47.65 -30.35 3.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 169.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.77 72.07 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 64' ' ' VAL . 20.0 m-85 -97.01 19.45 12.79 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.144 1.377 . . . . 0.0 113.219 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.47 -21.72 30.07 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.82 -5.77 29.65 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 114.731 0.653 . . . . 0.0 114.731 -173.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.2 p -64.13 155.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.256 1.823 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 33.96 0.14 Allowed Glycine 0 CA--C 1.541 1.719 0 C-N-CA 124.937 1.256 . . . . 0.0 115.747 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' HG13 ' A' ' 46' ' ' VAL . 5.5 t30 -58.1 -51.44 81.75 Favored Pre-proline 0 N--CA 1.476 0.858 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.241 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.646 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 80.2 Cg_endo -72.95 -10.05 24.27 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.69 2.26 . . . . 0.0 115.254 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -82.43 -33.79 28.45 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.36 -34.06 10.81 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.74 128.0 34.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.874 0.87 . . . . 0.0 111.423 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -49.43 156.09 0.66 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.722 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.74 -57.59 2.69 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.524 1.13 . . . . 0.0 113.994 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HA ' HG12 ' A' ' 58' ' ' ILE . 6.9 tt0 -70.53 -31.5 68.59 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -66.06 -42.07 89.93 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.764 0.826 . . . . 0.0 111.039 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -63.05 -53.74 49.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.06 1.344 . . . . 0.0 110.607 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.779 HG12 ' HA ' ' A' ' 55' ' ' GLU . 20.2 pt -54.31 -31.4 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.19 74.49 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 171.032 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.98 -42.13 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.514 0.726 . . . . 0.0 109.824 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.44 -39.61 84.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.284 1.434 . . . . 0.0 114.041 175.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -59.52 -38.94 82.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.06 1.344 . . . . 0.0 112.132 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -80.74 -36.03 32.54 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -61.9 -20.28 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 172.441 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -40.52 74.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.928 169.109 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.32 -47.32 61.61 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -107.04 -22.71 12.56 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.37 155.15 9.3 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.116 0.865 . . . . 0.0 110.987 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 122.08 -0.659 . . . . 0.0 112.769 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.91 -0.92 8.17 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -57.05 -25.41 58.61 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.421 ' CE2' HD23 ' A' ' 33' ' ' LEU . 12.8 m-90 -118.2 75.53 11.48 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 174.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.17 -20.12 43.91 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.002 2.468 . . . . 0.0 113.828 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.5 p -60.29 -44.38 95.44 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.348 1.859 . . . . 0.0 113.978 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.404 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -139.95 -69.27 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.886 1.274 . . . . 0.0 112.283 172.177 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.76 89.13 0.62 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.32 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.75 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.86 -27.06 11.41 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.61 -43.22 36.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.115 1.366 . . . . 0.0 113.505 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 82' ' ' LEU . 58.5 m -109.03 -20.97 12.84 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.113 0.883 . . . . 0.0 112.628 166.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 -43.6 3.08 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.99 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 80' ' ' SER . 8.2 mp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.848 1.659 . . . . 99.989999999999995 113.632 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 121.332 0.587 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -33.71 58.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.54 -35.84 72.95 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -66.54 -26.6 67.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 118.816 -0.612 . . . . 0.0 112.358 175.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.68 -42.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.388 0.675 . . . . 0.0 110.267 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -84.63 1.28 46.88 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -112.17 -36.53 5.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.228 1.011 . . . . 0.0 112.338 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -79.31 -51.05 9.95 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.71 1.204 . . . . 0.0 112.645 167.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.59 -23.75 12.37 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.81 -28.87 5.71 Favored Glycine 0 N--CA 1.482 1.721 0 C-N-CA 122.83 0.252 . . . . 0.0 113.416 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.04 93.14 0.09 OUTLIER Glycine 0 N--CA 1.474 1.227 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -172.15 81.47 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.24 1.016 . . . . 0.0 112.433 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -73.65 -73.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.32 71.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.52 60.84 3.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.014 1.725 . . . . 0.0 114.316 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -77.45 35.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 113.033 -1.894 . . . . 0.0 115.148 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -112.35 -17.67 12.66 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.634 1.973 . . . . 0.0 112.351 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.71 58.04 7.38 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.621 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.498 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.4 t-20 -104.64 20.65 18.24 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.476 -0.862 . . . . 0.0 112.748 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.06 26.78 49.95 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 124.188 0.899 . . . . 0.0 115.157 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -122.51 150.44 42.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.495 1.118 . . . . 0.0 109.451 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 49' ' ' PRO . 10.7 p90 -152.73 139.68 19.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.552 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.34 -0.43 12.49 Favored Glycine 0 N--CA 1.485 1.907 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.654 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.82 25.83 55.12 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 124.525 1.06 . . . . 0.0 114.775 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.16 14.5 27.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 37.91 36.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.929 2.092 . . . . 0.0 116.068 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CE1' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -94.69 121.76 36.6 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.349 -171.74 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -41.73 136.41 2.01 Favored Pre-proline 0 N--CA 1.482 1.16 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 176.991 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 72.5 Cg_endo -65.23 -32.41 51.71 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.635 2.223 . . . . 0.0 112.54 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.4 -34.72 64.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.318 1.047 . . . . 0.0 113.624 172.401 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.582 HG21 ' CE1' ' A' ' 35' ' ' PHE . 23.0 m -68.91 -47.06 66.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.914 0.486 . . . . 0.0 111.698 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.532 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 33.2 t-105 -57.05 -22.28 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.78 -29.2 4.28 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.21 74.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.874 0.869 . . . . 0.0 113.296 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -95.71 18.4 13.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 111.565 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -23.73 23.52 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.12 -0.91 44.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 -172.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.09 153.05 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.361 1.864 . . . . 0.0 109.26 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.83 38.05 0.07 OUTLIER Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.263 1.411 . . . . 0.0 116.418 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 5.8 t30 -57.27 -47.65 98.68 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-O 116.256 -1.83 . . . . 0.0 110.931 172.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -67.55 -28.09 38.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.202 2.601 . . . . 0.0 114.799 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.06 72.17 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.87 -34.17 14.63 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.73 20.94 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.511 1.148 . . . . 0.0 111.969 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.8 t -53.78 157.55 2.3 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.388 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.42 -58.13 3.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -70.75 -19.4 62.73 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.337 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.46 -38.92 21.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.336 0.655 . . . . 0.0 111.936 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -63.91 -42.85 97.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 55' ' ' GLU . 14.0 pt -54.22 -29.79 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.12 82.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.535 0.734 . . . . 0.0 112.546 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.37 -42.36 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.371 0.668 . . . . 0.0 109.842 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.41 -35.23 76.97 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.46 -49.38 77.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.72 1.208 . . . . 0.0 110.784 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -65.52 -37.36 86.53 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 61' ' ' ALA 0.28 0.3 OUTLIER -61.29 -22.18 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.913 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.34 -38.96 88.8 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.73 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 6.7 mm-40 -65.23 -54.79 24.19 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 -23.56 11.5 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.13 147.99 7.49 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-O 122.038 0.799 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.46 -29.03 69.65 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.316 -0.942 . . . . 0.0 113.512 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -19.33 15.48 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 172.553 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.64 74.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.781 0.832 . . . . 0.0 112.82 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -80.8 140.48 50.74 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.796 0.685 . . . . 0.0 109.214 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 83.9 Cg_endo -67.55 -170.06 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.966 2.444 . . . . 0.0 111.493 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.7 p -53.35 -31.81 46.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.38 1.472 . . . . 0.0 114.146 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 1.2 m -39.26 -83.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.043 1.737 . . . . 0.0 113.314 169.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 41.51 43.63 3.89 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.73 -20.2 0.78 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.57 67.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.159 1.783 . . . . 0.0 113.156 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 m -65.54 -19.33 65.88 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.39 27.03 72.81 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 123.853 0.721 . . . . 0.0 113.547 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.909 -1.043 . . . . 99.989999999999995 113.335 177.762 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -57.55 -33.03 67.69 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.911 -1.495 . . . . 0.0 114.044 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.01 -50.75 70.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.739 0.816 . . . . 0.0 112.644 171.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -63.95 -37.8 88.76 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.382 0.426 . . . . 0.0 111.826 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 78' ' ' ALA . 51.4 t -61.25 -35.64 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.778 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.42 90.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.351 169.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -71.36 -3.6 21.6 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -98.48 -27.53 14.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.29 1.436 . . . . 0.0 111.46 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.5 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 9.2 mt-10 -104.55 -43.92 5.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.603 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.6 p -87.18 -37.87 16.91 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.15 25.08 59.45 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 124.461 1.101 . . . . 0.0 114.189 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.36 -82.16 0.06 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 123.798 0.352 . . . . 0.0 113.728 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.85 139.3 50.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -69.32 -39.01 78.49 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.328 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.56 13.73 2.38 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 30.3 71.72 0.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.598 1.959 . . . . 0.0 114.298 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -81.55 40.81 0.6 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.952 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -116.88 -19.33 9.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.036 2.534 . . . . 0.0 112.801 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.39 40.7 96.56 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.615 0.626 . . . . 0.0 114.622 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -109.44 32.75 4.76 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.931 0.872 . . . . 0.0 112.513 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.5 35.89 62.68 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.839 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 84.5 mttt -110.98 147.3 35.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.579 0.704 . . . . 0.0 110.586 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 35.6 m-85 -132.56 145.51 51.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.898 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 52.24 29.46 29.64 Favored Glycine 0 N--CA 1.482 1.751 0 O-C-N 125.314 1.634 . . . . 0.0 117.111 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 58.99 22.73 55.84 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.848 0.737 . . . . 0.0 114.664 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -111.93 16.93 20.13 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.7 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 38.9 tt0 43.39 42.97 4.07 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 124.07 1.89 . . . . 0.0 112.746 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -100.98 108.22 19.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.765 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 3.6 mmtt -43.77 138.15 3.17 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 112.587 -2.097 . . . . 0.0 113.768 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 98.6 Cg_endo -66.48 -42.34 9.95 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.709 2.273 . . . . 0.0 112.63 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.63 -34.32 67.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.405 1.082 . . . . 0.0 112.955 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -71.76 -49.27 40.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.053 0.541 . . . . 0.0 112.179 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.2 t-105 -60.2 -21.9 62.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 38' ' ' ALA . . . -51.5 -29.64 17.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 170.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -29.37 63.44 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CZ ' HG22 ' A' ' 64' ' ' VAL . 30.0 m-85 -105.99 25.69 10.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.416 1.486 . . . . 0.0 111.216 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.39 -19.88 52.69 Favored Glycine 0 N--CA 1.479 1.551 0 CA-C-O 119.092 -0.838 . . . . 0.0 115.082 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.65 -5.12 24.72 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.89 151.85 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.322 1.849 . . . . 0.0 112.147 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.81 31.34 0.1 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 113.976 -1.466 . . . . 0.0 116.394 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -52.88 -51.51 73.69 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 116.286 -1.816 . . . . 0.0 111.372 169.264 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 71.8 Cg_endo -66.24 -23.71 51.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.873 2.382 . . . . 0.0 115.652 176.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.07 38.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.53 -36.84 13.48 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 128.05 34.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.989 0.9 . . . . 0.0 110.415 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -52.04 158.34 1.1 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.534 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -44.86 -57.62 3.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.1 tt0 -68.79 -18.79 64.25 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.67 -40.85 22.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.328 0.651 . . . . 0.0 111.418 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -60.71 -48.09 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.909 0.884 . . . . 0.0 110.531 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -53.97 -31.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.72 72.56 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.252 0.621 . . . . 0.0 111.873 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.61 -48.62 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.631 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . . . -55.52 -37.83 68.44 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -62.65 -38.32 89.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.755 1.622 . . . . 0.0 113.307 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -81.27 -35.98 30.46 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.259 -0.9 . . . . 0.0 111.741 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.657 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 20.0 t -50.72 -32.74 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.059 1.744 . . . . 0.0 112.072 171.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -56.31 -41.61 76.27 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.86 -28.93 67.15 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -75.99 -59.91 2.55 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.78 -27.01 36.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.0 168.23 31.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.79 24.77 0.29 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.377 -0.912 . . . . 0.0 113.257 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.8 -45.91 12.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.943 . . . . 0.0 113.03 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.68 -34.3 64.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 0.0 113.152 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.34 94.97 49.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.61 -89.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.156 2.571 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -64.02 -43.85 94.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.631 0.772 . . . . 0.0 111.998 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.88 140.6 47.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.15 99.39 0.16 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 124.363 1.039 . . . . 0.0 111.695 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.554 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -60.59 -18.68 54.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -44.17 -48.2 9.19 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 112.497 165.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 82' ' ' LEU . 36.5 m -95.08 -29.35 14.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.124 0.97 . . . . 0.0 113.469 171.194 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.28 67.66 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.169 0.89 . . . . 0.0 113.861 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 80' ' ' SER . 17.7 mt . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.006 -1.473 . . . . 99.989999999999995 111.83 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 7.7 m-20 . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.482 ' HB3' HG21 ' A' ' 58' ' ' ILE . 25.7 m95 -61.29 -33.9 74.33 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.831 172.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.6 -48.88 75.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -65.48 -39.84 92.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 78' ' ' ALA . 44.7 t -62.98 -32.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -56.43 -45.46 80.72 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.702 167.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -73.88 4.6 5.08 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -110.83 -33.99 6.37 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.569 0.748 . . . . 0.0 112.301 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.33 -48.07 8.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 168.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 57.2 p -94.35 -29.84 14.81 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.41 17.94 60.33 Favored Glycine 0 CA--C 1.541 1.68 0 O-C-N 123.994 0.809 . . . . 0.0 113.618 -173.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.61 67.4 0.51 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.113 0.863 . . . . 0.0 111.676 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.79 76.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.807 0.843 . . . . 0.0 112.181 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 82.1 m95 -64.44 -38.27 90.42 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.86 -27.9 55.24 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 25' ' ' THR . . . 46.2 69.9 0.43 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.822 1.649 . . . . 0.0 112.769 -173.17 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -76.0 32.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.319 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' ALA . 4.4 p -96.54 -17.34 20.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.053 2.941 . . . . 0.0 113.921 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.83 37.17 93.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.92 22.47 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.04 24.75 55.37 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.552 1.072 . . . . 0.0 115.5 -172.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -126.22 142.35 51.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.438 0.695 . . . . 0.0 109.135 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 58.2 m-85 -138.74 166.61 23.95 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.46 1.1 . . . . 0.0 112.507 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.37 -1.64 41.86 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.17 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 17' ' ' SER . . . 60.2 12.58 24.47 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -171.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD12 ' HE1' ' A' ' 73' ' ' TRP . 3.6 mm? -84.82 9.95 12.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 43.38 41.9 3.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.985 2.114 . . . . 0.0 114.458 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.21 118.49 31.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 111.717 -2.492 . . . . 0.0 110.337 -172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.52 135.77 5.8 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.954 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.99 -39.97 37.14 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.943 2.429 . . . . 0.0 112.939 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.28 -37.19 69.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.291 1.036 . . . . 0.0 113.277 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -69.23 -49.71 53.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.365 0.666 . . . . 0.0 110.961 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -59.47 -25.7 64.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -51.28 -27.29 8.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 170.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.57 73.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -95.31 22.15 7.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.516 1.126 . . . . 0.0 113.581 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.93 -21.23 40.92 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 69.81 6.07 54.29 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.1 148.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.928 1.691 . . . . 0.0 109.369 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 35.01 0.16 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 124.881 1.229 . . . . 0.0 115.711 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.14 -45.29 99.38 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.184 -1.865 . . . . 0.0 109.966 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 43.2 Cg_endo -66.18 -9.87 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.16 2.573 . . . . 0.0 118.03 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.1 -31.77 19.04 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.97 -36.32 8.24 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.976 0.894 . . . . 0.0 111.602 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m -50.3 152.95 1.63 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.276 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -48.63 -53.78 17.21 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.628 ' HA ' HG12 ' A' ' 58' ' ' ILE . 5.8 tm-20 -70.11 -27.15 64.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -42.71 53.96 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.555 0.693 . . . . 0.0 110.907 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -70.54 -35.65 73.26 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 55' ' ' GLU . 17.8 pt -56.07 -28.67 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.609 172.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.21 77.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.032 0.533 . . . . 0.0 112.376 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.75 -41.31 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.89 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -35.45 77.5 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HA ' HD23 ' A' ' 65' ' ' LEU . 10.8 t-20 -64.88 -36.09 83.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.525 1.53 . . . . 0.0 112.61 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -37.24 28.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -60.54 -24.6 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.668 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -56.87 -46.15 82.01 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.334 0.396 . . . . 0.0 111.723 170.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.5 -33.38 69.2 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.328 0.651 . . . . 0.0 112.693 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -27.7 10.57 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.6 149.86 8.74 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.72 -33.59 71.02 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.45 -23.29 48.82 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.83 94.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 112.76 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CZ3' ' HA ' ' A' ' 65' ' ' LEU . 13.0 m-90 -72.64 149.71 90.8 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.25 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.077 2.518 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -54.23 -21.44 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 21.2 m -101.26 152.47 20.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.887 1.275 . . . . 0.0 111.503 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.4 107.79 0.22 Allowed Glycine 0 N--CA 1.476 1.302 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.479 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.57 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -54.24 -23.22 13.93 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -45.78 -39.9 8.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.868 1.667 . . . . 0.0 113.704 167.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -109.97 -21.04 12.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 113.218 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.57 3.29 Favored Glycine 0 N--CA 1.48 1.581 0 C-N-CA 124.03 0.824 . . . . 0.0 112.466 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.943 -1.503 . . . . 99.989999999999995 114.15 179.872 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.772 0.32 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 26.9 m95 -53.64 -32.35 51.08 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 171.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -54.5 45.39 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.67 79.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.496 0.718 . . . . 0.0 112.246 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 78' ' ' ALA . 25.6 t -62.14 -31.59 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.36 81.36 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 168.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.97 5.4 19.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.11 -32.98 7.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.42 1.488 . . . . 0.0 111.448 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.477 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 91.4 mt-10 -101.79 -27.49 12.99 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.532 ' HB2' ' CA ' ' A' ' 32' ' ' GLY . 8.6 t -110.8 -38.96 4.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.894 0.877 . . . . 0.0 113.178 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 31.13 77.2 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.78 -95.91 0.1 Allowed Glycine 0 N--CA 1.48 1.576 0 O-C-N 124.075 0.514 . . . . 0.0 112.439 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.0 146.4 30.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -65.88 -58.7 4.98 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.832 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.23 -26.49 66.46 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 40.11 78.12 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.053 1.741 . . . . 0.0 113.433 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -83.88 43.41 0.92 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.393 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 p -104.45 -15.87 15.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.804 2.442 . . . . 0.0 112.729 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.39 39.98 80.32 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.054 0.782 . . . . 0.0 115.054 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -95.2 21.4 7.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.37 29.09 56.39 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 83.5 mttt -113.2 151.36 31.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.643 1.177 . . . . 0.0 110.105 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 10.3 p90 -132.65 160.7 35.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.236 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 40.12 28.63 0.17 Allowed Glycine 0 N--CA 1.483 1.79 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 172.443 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 17' ' ' SER . . . 60.47 34.23 84.61 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -172.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 2.6 mp -108.29 -2.89 18.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 pt20 42.83 28.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -169.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 2.0 t80 -94.54 108.02 19.99 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.394 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -24.45 126.12 0.16 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-N 112.348 -2.205 . . . . 0.0 114.809 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.44 -35.21 73.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.708 2.272 . . . . 0.0 113.441 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.99 66.89 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.305 1.042 . . . . 0.0 113.394 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 68' ' ' GLN . 25.5 m -67.16 -50.12 62.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.966 0.906 . . . . 0.0 111.097 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -60.02 -22.49 62.7 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -30.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 168.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.16 75.15 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 171.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.1 19.38 9.3 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.163 1.385 . . . . 0.0 113.59 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.21 28.95 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.23 -5.88 24.85 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 -173.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 48' ' ' ASN . 11.2 p -64.99 148.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.539 1.536 . . . . 0.0 111.923 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 31.47 0.1 OUTLIER Glycine 0 CA--C 1.542 1.724 0 C-N-CA 125.086 1.327 . . . . 0.0 116.245 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.513 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 t30 -57.78 -48.64 96.82 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.578 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB3' HE21 ' A' ' 57' ' ' GLN . 68.2 Cg_endo -73.03 -13.88 26.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.417 2.745 . . . . 0.0 116.131 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.83 53.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.34 -34.06 11.2 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.63 56.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.285 1.034 . . . . 0.0 111.786 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.3 t -55.97 154.19 7.77 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.486 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -59.1 3.02 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 14.9 tt0 -69.24 -26.23 64.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.96 -39.08 63.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.712 -0.618 . . . . 0.0 112.264 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -60.0 -50.72 72.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.595 1.158 . . . . 0.0 109.588 173.649 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -55.4 -31.57 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.27 77.77 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.02 -40.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 0.0 110.27 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -59.93 -38.95 83.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.608 1.163 . . . . 0.0 114.138 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 66.3 t30 -60.9 -38.47 85.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.168 1.387 . . . . 0.0 111.677 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -80.01 -32.2 39.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -61.07 -22.43 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.747 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -60.34 -39.43 87.11 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 169.166 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.72 69.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -65.83 -58.87 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.589 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 39' ' ' THR . 22.6 tp60 -91.48 -36.49 13.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.36 150.32 8.15 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -167.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -84.35 -1.35 55.31 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.296 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -87.99 -23.75 23.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.603 1.161 . . . . 0.0 113.429 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.38 91.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.145 0.978 . . . . 0.0 113.62 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -60.35 150.12 73.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.777 169.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 94.6 Cg_endo -63.25 -159.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.741 2.294 . . . . 0.0 111.066 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.0 p -51.49 -32.2 26.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 117.0 -1.476 . . . . 0.0 113.208 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 85.3 m -52.6 -135.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 128.392 3.557 . . . . 0.0 114.063 168.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 102.14 0.25 Allowed Glycine 0 N--CA 1.483 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 112.065 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -49.79 -26.16 3.69 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.18 -39.15 20.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.784 1.234 . . . . 0.0 113.132 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 m -108.93 -29.65 8.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.289 1.036 . . . . 0.0 113.098 168.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.89 -29.17 5.59 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.649 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 76' ' ' CYS . 59.5 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.08 -1.438 . . . . 99.989999999999995 113.212 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -57.77 -34.99 70.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.798 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 33.0 t70 -63.57 -48.22 78.32 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.88 75.8 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 78' ' ' ALA . 53.7 t -62.09 -37.45 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.729 0.811 . . . . 0.0 112.491 174.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -53.55 -48.26 69.26 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 167.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.24 8.3 5.14 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.0 t -114.8 -30.85 6.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.371 1.068 . . . . 0.0 113.485 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.59 -36.85 11.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 67.1 p -108.63 -23.4 11.83 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.3 7.93 69.1 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 114.962 0.745 . . . . 0.0 114.962 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.99 83.22 0.54 Allowed Glycine 0 N--CA 1.479 1.505 0 CA-C-O 121.996 0.776 . . . . 0.0 111.355 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 23' ' ' ALA . 1.1 m-20 172.16 108.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.334 2.254 . . . . 0.0 108.647 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.507 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 54.8 m95 -93.22 -44.01 8.54 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 172.141 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.67 -39.62 61.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 49.91 84.81 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.577 1.551 . . . . 0.0 111.658 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.47 58.57 0.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.1 1.429 . . . . 0.0 112.154 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.6 p -107.16 -26.6 11.02 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 34.39 89.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.226 0.917 . . . . 0.0 114.229 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.73 21.07 6.8 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.07 11.49 9.05 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 124.326 0.965 . . . . 0.0 115.433 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 19.5 mtpt -109.34 161.46 15.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.256 1.822 . . . . 0.0 110.247 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.624 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -114.17 119.71 37.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 112.882 -1.963 . . . . 0.0 112.964 -175.169 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.28 144.51 48.71 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.702 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.536 ' H ' ' HB3' ' A' ' 17' ' ' SER . . . 102.19 -36.98 3.9 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 112.943 -1.628 . . . . 0.0 110.806 -178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 61' ' ' ALA . 6.4 mp -109.64 -29.37 8.39 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 53.76 36.28 23.5 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 123.628 1.68 . . . . 0.0 112.047 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -97.76 129.52 44.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.418 -172.184 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -47.63 141.2 7.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 113.48 -1.691 . . . . 0.0 114.63 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 68.6 Cg_endo -60.48 -31.61 92.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.938 2.425 . . . . 0.0 112.868 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.14 63.45 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.61 1.164 . . . . 0.0 114.087 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.603 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 70.4 m -67.37 -57.13 7.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.482 0.713 . . . . 0.0 110.472 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.512 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 23.7 t-105 -56.94 -21.72 32.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.4 -31.27 5.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.42 73.72 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 171.111 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -95.66 16.69 16.65 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.426 1.49 . . . . 0.0 112.757 172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.63 -22.32 24.3 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.2 -2.9 33.56 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -69.22 154.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.733 1.613 . . . . 0.0 111.701 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.1 33.84 0.11 Allowed Glycine 0 N--CA 1.484 1.851 0 C-N-CA 125.098 1.333 . . . . 0.0 115.986 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 46' ' ' VAL . 1.9 t-20 -59.6 -48.68 94.95 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.207 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.1 Cg_endo -68.49 -30.86 28.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.603 2.202 . . . . 0.0 114.031 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.38 72.49 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.68 -32.44 16.2 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 129.72 40.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.14 0.971 . . . . 0.0 111.679 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.1 t -53.77 155.31 3.32 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.971 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 72.3 mtt180 -46.81 -52.42 14.24 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -69.2 -37.67 78.22 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.038 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -64.26 -35.21 80.1 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.67 -0.644 . . . . 0.0 112.031 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -63.15 -53.72 48.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.393 1.077 . . . . 0.0 109.936 171.009 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -53.71 -32.07 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.62 -57.91 10.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.029 0.932 . . . . 0.0 113.116 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.08 -38.0 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -59.42 -41.71 90.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.241 1.416 . . . . 0.0 114.021 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -61.0 -30.5 70.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.117 1.367 . . . . 0.0 112.255 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -33.8 21.26 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.258 0.8 OUTLIER -59.51 -24.71 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 172.454 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.4 pp -59.13 -44.02 92.0 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 170.492 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -31.16 70.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.25 -55.32 14.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -98.54 -26.88 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.75 155.26 8.37 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.06 -35.08 77.56 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 122.399 -0.471 . . . . 0.0 112.163 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.93 -17.84 53.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.618 1.567 . . . . 0.0 114.517 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 35' ' ' PHE . . . -44.96 -35.92 3.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.133 1.773 . . . . 0.0 114.38 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.477 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 12.4 m-90 -115.94 97.73 49.78 Favored Pre-proline 0 N--CA 1.471 0.59 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.37 -35.81 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.585 2.19 . . . . 0.0 114.012 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -61.94 -52.2 65.03 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.999 1.32 . . . . 0.0 113.693 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 m -139.42 -166.1 1.99 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.706 1.202 . . . . 0.0 110.196 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.06 102.21 0.16 Allowed Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -51.8 -27.0 10.91 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -46.97 -38.63 11.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.382 1.473 . . . . 0.0 114.236 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -109.5 -19.62 13.17 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.56 4.0 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.492 0.568 . . . . 0.0 113.239 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 115.212 1.56 . . . . 99.989999999999995 115.212 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.103 0.478 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TRP . . . . . 0.509 ' HB3' HG21 ' A' ' 58' ' ' ILE . 11.3 m95 -57.61 -30.69 65.53 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.167 170.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.0 m-20 -60.87 -51.04 70.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.212 1.005 . . . . 0.0 112.885 171.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.33 78.12 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.506 0.722 . . . . 0.0 112.513 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 78' ' ' ALA . 61.3 t -62.2 -42.97 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.519 1.128 . . . . 0.0 111.985 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -53.2 -44.94 68.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.105 0.562 . . . . 0.0 111.73 168.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.09 -5.61 36.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 t -105.33 -26.82 11.83 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.678 1.191 . . . . 0.0 112.596 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.81 -40.95 7.87 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.6 p -104.83 -23.31 13.04 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.4 -25.82 22.64 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.999 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.79 -40.68 0.2 Allowed Glycine 0 N--CA 1.477 1.432 0 CA-C-N 115.524 -0.338 . . . . 0.0 113.394 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -52.22 100.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.565 1.146 . . . . 0.0 113.21 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -73.77 -22.58 59.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -102.96 -25.43 13.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.16 74.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.228 2.211 . . . . 0.0 115.479 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 43.06 88.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.367 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.465 HG23 ' HB1' ' A' ' 22' ' ' ALA . 67.8 p -58.69 -26.28 63.7 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.319 -1.764 . . . . 0.0 112.871 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.78 -3.54 22.03 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.166 1.365 . . . . 0.0 115.422 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.1 7.91 44.62 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.95 8.16 33.67 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 124.007 0.813 . . . . 0.0 113.516 -172.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.636 ' HG3' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mttm -110.7 159.51 17.55 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.749 2.02 . . . . 0.0 110.422 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -122.86 126.48 47.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.363 -175.433 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 151.03 38.8 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 112.031 -2.35 . . . . 0.0 112.71 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 94.7 -39.22 2.93 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 111.618 -2.291 . . . . 0.0 110.837 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD21 ' HB1' ' A' ' 61' ' ' ALA . 5.2 mp -107.44 -32.01 7.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.683 -1.258 . . . . 0.0 114.024 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 56.06 34.33 23.57 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.048 1.739 . . . . 0.0 112.193 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -96.24 132.5 41.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.33 -170.509 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.87 142.4 13.01 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.907 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' A' ' 29' ' ' LYS . 47.6 Cg_endo -57.97 -33.04 96.68 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.295 2.663 . . . . 0.0 113.499 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.13 62.53 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -67.24 -56.96 7.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 110.546 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 21.5 t-105 -60.2 -21.78 62.17 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.61 -30.9 5.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 114.303 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.51 77.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.54 17.64 9.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.156 1.382 . . . . 0.0 113.907 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.48 -21.62 30.24 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.04 49.31 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 114.785 0.674 . . . . 0.0 114.785 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.88 150.2 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.699 1.599 . . . . 0.0 109.135 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.06 40.13 0.07 OUTLIER Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.381 1.467 . . . . 0.0 115.917 170.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.43 -53.46 45.6 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 116.177 -1.868 . . . . 0.0 110.665 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HB3' HE21 ' A' ' 57' ' ' GLN . 83.8 Cg_endo -67.63 -21.15 46.07 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.837 2.358 . . . . 0.0 113.802 175.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -67.32 -35.36 79.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.585 1.554 . . . . 0.0 114.673 173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.76 -29.5 10.52 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 131.39 50.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 111.21 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -54.19 151.83 6.78 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.072 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -44.69 -57.45 3.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 40.9 tt0 -68.18 -30.17 69.21 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.75 -38.75 70.36 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.664 -0.648 . . . . 0.0 112.191 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.641 HE21 ' HB3' ' A' ' 49' ' ' PRO . 1.7 tm0? -59.13 -54.97 40.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.434 1.094 . . . . 0.0 109.466 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -55.15 -28.4 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.01 75.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 170.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.47 -39.88 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.737 0.815 . . . . 0.0 109.849 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -58.55 -39.94 81.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.091 1.357 . . . . 0.0 113.715 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.39 -45.49 91.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.78 1.232 . . . . 0.0 110.864 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.28 81.96 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 173.136 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.273 0.3 OUTLIER -61.12 -19.95 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 175.204 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -44.48 86.69 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.297 169.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -27.76 69.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.78 80.0 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -103.65 -24.69 13.35 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.79 159.96 10.83 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -56.75 -32.81 65.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.269 -0.548 . . . . 0.0 112.433 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.65 2.24 6.86 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.081 1.752 . . . . 0.0 114.965 175.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -55.42 -28.15 52.33 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 17.8 m-90 -118.21 74.8 11.0 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.8 -21.17 38.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.9 p -57.37 -41.34 79.96 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.182 1.793 . . . . 0.0 113.164 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -142.07 -86.0 0.17 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.277 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' CYS . . . 94.87 104.26 1.91 Allowed Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' A' ' 12' ' ' VAL . . . -45.86 -40.08 9.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.77 81.69 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 -27.5 30.48 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.59 26.21 69.54 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 124.11 0.862 . . . . 0.0 114.48 -172.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 125.671 1.588 . . . . 99.989999999999995 112.877 -178.171 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.773 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.73 -64.85 0.86 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.99 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 tpt -112.06 -69.21 0.88 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 110.495 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.82 97.11 0.12 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 117.811 -1.55 . . . . 0.0 110.0 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 134.23 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.079 1.853 . . . . 0.0 112.279 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.7 m -59.99 145.07 85.53 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.617 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -60.46 139.06 84.42 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.103 2.535 . . . . 0.0 111.55 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -133.46 95.0 3.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -60.04 -31.98 70.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.64 -48.92 58.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.69 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.66 79.25 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' H ' ' A' ' 78' ' ' ALA 0.255 50.8 t -64.66 -31.82 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.148 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -60.54 -39.73 88.98 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 167.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.08 6.56 7.69 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -107.33 -34.61 7.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.894 1.278 . . . . 0.0 110.666 176.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.35 -33.82 10.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.499 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 33.1 t -102.35 -36.48 8.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.698 0.799 . . . . 0.0 112.741 173.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.6 66.64 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.55 -90.05 0.08 OUTLIER Glycine 0 CA--C 1.538 1.48 0 CA-C-N 115.51 -0.345 . . . . 0.0 112.707 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -113.72 143.79 44.03 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 41.2 m95 -63.99 -34.55 78.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 171.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.27 64.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.92 71.11 0.34 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.77 1.628 . . . . 0.0 113.902 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -77.05 32.27 0.14 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.551 -2.113 . . . . 0.0 114.725 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -101.48 -14.54 17.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.628 1.971 . . . . 0.0 113.092 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 34.33 85.87 Favored Glycine 0 N--CA 1.48 1.592 0 O-C-N 123.98 0.8 . . . . 0.0 114.961 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -87.08 19.27 3.17 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.44 24.3 45.56 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 124.022 0.82 . . . . 0.0 114.778 -170.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 34' ' ' GLN . 44.3 mmtm -119.63 146.39 45.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.42 0.688 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 79.3 m-85 -134.43 164.96 26.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.211 -176.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.73 30.28 62.48 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.868 -1.514 . . . . 0.0 115.338 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 53.7 23.86 23.09 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.603 1.097 . . . . 0.0 115.782 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HE1' ' A' ' 73' ' ' TRP . 13.2 mt -113.69 10.7 17.99 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.462 ' C ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 43.17 39.56 2.01 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 123.042 1.401 . . . . 0.0 112.648 -175.071 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -99.14 112.0 24.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.448 -172.083 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.36 132.45 4.62 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 113.362 -1.745 . . . . 0.0 113.621 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 66.6 Cg_endo -60.54 -37.05 83.2 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.978 2.452 . . . . 0.0 112.936 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.37 66.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.239 1.015 . . . . 0.0 113.588 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m -72.06 -47.54 50.82 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.651 0.78 . . . . 0.0 111.092 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.465 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -60.11 -23.31 63.74 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.22 -29.54 5.82 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.3 -33.58 69.62 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 64' ' ' VAL . 17.3 m-85 -100.89 22.58 11.9 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.139 1.376 . . . . 0.0 112.711 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.26 -24.29 26.59 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 75.52 -8.32 20.36 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 114.718 0.647 . . . . 0.0 114.718 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 48' ' ' ASN . 24.4 t -62.45 151.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.794 2.038 . . . . 0.0 109.548 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.08 36.16 0.11 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.448 1.499 . . . . 0.0 115.934 174.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 46' ' ' VAL . 12.1 t-20 -57.96 -50.51 87.71 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.502 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 85.7 Cg_endo -72.38 -16.07 27.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.972 2.448 . . . . 0.0 114.983 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -76.6 -34.3 58.4 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.1 -35.94 11.7 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.65 122.43 15.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.066 0.946 . . . . 0.0 111.55 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 m -47.15 159.1 0.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.111 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 mpp_? -41.99 -57.22 2.51 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 19.9 tt0 -67.12 -37.71 84.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -62.11 -39.57 92.97 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.705 0.764 . . . . 0.0 110.887 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -50.93 66.65 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.671 1.188 . . . . 0.0 110.894 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.5 pt -53.83 -33.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 123.644 0.59 . . . . 0.0 112.531 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.19 -54.64 41.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.134 0.974 . . . . 0.0 113.053 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.11 -41.18 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.138 0.575 . . . . 0.0 110.047 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.622 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.04 -38.42 82.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.281 1.432 . . . . 0.0 114.332 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -59.58 -39.62 84.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.785 1.234 . . . . 0.0 111.618 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -78.98 -37.83 38.43 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.268 0.4 OUTLIER -60.84 -23.59 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.625 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -40.24 88.72 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 169.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -31.7 65.35 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.12 -49.6 73.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -108.25 -27.34 10.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.0 147.94 9.05 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.23 -21.24 22.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.076 1.75 . . . . 0.0 114.935 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.64 78.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 112.603 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.472 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 25.1 m-90 -86.02 146.8 43.88 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 124.033 0.833 . . . . 0.0 109.306 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.61 -148.78 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.411 2.741 . . . . 0.0 111.586 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 t -51.38 -30.35 18.63 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.9 m -81.58 131.98 35.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.75 1.22 . . . . 0.0 108.91 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.79 98.98 0.12 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.448 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -57.91 -20.81 40.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.17 23.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.947 1.299 . . . . 0.0 113.567 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -101.61 -24.17 14.16 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.47 1.108 . . . . 0.0 113.714 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.0 2.91 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.631 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 126.695 1.998 . . . . 99.989999999999995 113.377 -173.697 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.291 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.98 164.01 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.617 1.167 . . . . 0.0 112.593 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.07 -61.67 1.65 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.69 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.19 89.16 2.02 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.52 152.4 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.243 1.962 . . . . 0.0 111.698 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -54.12 139.23 55.25 Favored Pre-proline 0 N--CA 1.483 1.212 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.777 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.73 135.12 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.886 2.391 . . . . 0.0 112.513 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -104.48 90.92 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.685 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.411 ' CH2' HD21 ' A' ' 33' ' ' LEU . 4.5 m95 -57.34 -33.66 67.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.66 -53.49 56.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.364 0.666 . . . . 0.0 111.844 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.49 71.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 78' ' ' ALA . 94.3 t -60.14 -36.21 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 172.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.292 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -0.46 11.59 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -28.74 7.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.49 1.116 . . . . 0.0 113.148 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -100.96 -21.47 15.05 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -122.06 -27.45 4.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.41 6.28 89.36 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 115.962 -0.563 . . . . 0.0 114.354 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.17 76.32 0.27 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 121.775 0.653 . . . . 0.0 112.956 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 1.3 m-20 176.36 119.78 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.604 1.962 . . . . 0.0 109.405 179.627 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -90.29 -67.81 0.82 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.96 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.8 64.72 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.16 72.28 0.22 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.068 1.747 . . . . 0.0 113.952 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -81.74 42.64 0.71 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.397 -1.729 . . . . 0.0 113.387 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -111.37 -17.09 13.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.26 2.224 . . . . 0.0 111.938 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 54.27 21.69 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.986 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.2 t-20 -99.05 23.43 9.03 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.82 30.09 56.09 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 124.154 0.883 . . . . 0.0 114.828 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -127.79 146.97 50.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.509 1.123 . . . . 0.0 109.388 -173.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.407 ' CB ' ' HG2' ' A' ' 49' ' ' PRO . 66.4 m-85 -138.55 151.42 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.159 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 64.88 2.94 8.88 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 114.352 -1.294 . . . . 0.0 115.165 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 20' ' ' ASN . . . 65.23 36.12 92.43 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.143 0.877 . . . . 0.0 114.047 -172.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD21 ' CH2' ' A' ' 9' ' ' TRP . 5.9 mp -111.68 19.29 18.2 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 32.54 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -90.99 105.56 17.92 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.173 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -40.41 129.56 1.75 Allowed Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 113.025 -1.898 . . . . 0.0 112.747 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 59.7 Cg_endo -59.72 -32.52 95.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.075 2.517 . . . . 0.0 113.46 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.29 68.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -72.26 -45.03 61.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.893 0.477 . . . . 0.0 111.272 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 39.0 t-105 -58.54 -21.81 53.62 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.03 -29.13 4.58 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 168.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.22 69.09 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.547 ' CE1' HG23 ' A' ' 64' ' ' VAL . 26.3 m-85 -100.07 21.85 12.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.142 1.377 . . . . 0.0 112.779 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.15 30.74 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 -1.28 36.38 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -172.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 48' ' ' ASN . 48.3 t -67.32 152.19 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.409 1.884 . . . . 0.0 109.305 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.22 36.33 0.09 OUTLIER Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.501 1.524 . . . . 0.0 116.1 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 46' ' ' VAL . 2.2 t-20 -58.91 -51.46 81.7 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.225 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.8 Cg_endo -71.78 -11.43 27.73 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.011 2.474 . . . . 0.0 115.442 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.71 -34.29 27.33 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.36 -35.05 10.83 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 129.94 43.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.663 0.785 . . . . 0.0 110.871 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.7 t -53.34 159.88 1.28 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.964 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -43.16 -59.01 2.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.4 1.08 . . . . 0.0 113.7 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.3 tt0 -67.47 -34.81 77.92 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -65.81 -37.55 86.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.601 -0.687 . . . . 0.0 111.674 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -62.6 -52.73 62.21 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 110.127 172.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 8.2 pt -56.06 -30.12 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.64 68.6 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.64 -42.5 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.752 0.821 . . . . 0.0 109.774 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.3 -39.51 87.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.588 1.555 . . . . 0.0 114.369 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -56.77 -46.93 81.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 110.669 173.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -35.07 68.54 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -62.38 -22.4 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.933 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -40.83 89.19 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.582 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.79 -30.87 71.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.66 -56.52 7.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -89.37 -25.16 21.73 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.61 154.0 9.8 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -56.61 -32.12 64.97 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.946 -0.738 . . . . 0.0 112.622 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.35 -2.02 5.54 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.52 -31.77 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 13.1 m-90 -117.71 69.96 6.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.534 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -64.73 -25.38 61.25 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.559 2.173 . . . . 0.0 113.115 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 p -57.73 -28.29 63.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.195 2.198 . . . . 0.0 115.326 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 -60.52 0.19 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.42 99.35 0.19 Allowed Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.154 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.48 -38.59 54.65 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.412 -0.894 . . . . 0.0 113.274 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.038 1.335 . . . . 0.0 114.083 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -22.55 30.03 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.08 28.02 57.95 Favored Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 117.621 -1.18 . . . . 99.989999999999995 113.8 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.778 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 3' ' ' MET . . . -154.73 101.88 2.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 0.0 110.14 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 69.7 mtp -156.26 -56.49 0.09 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.425 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.17 150.56 36.67 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.51 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -63.94 148.01 91.81 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.705 2.27 . . . . 0.0 111.434 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -100.37 131.64 23.68 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.492 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.82 138.83 49.98 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.636 2.224 . . . . 0.0 112.594 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.0 169.99 10.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.312 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -52.91 -33.74 51.82 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 176.044 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.34 -42.28 77.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.043 0.937 . . . . 0.0 113.351 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -64.07 -31.13 72.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.678 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.06 -49.23 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.92 94.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.07 10.91 1.66 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -115.8 -31.53 5.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.114 1.366 . . . . 0.0 111.613 177.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.25 -43.37 7.0 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 t -88.33 -39.28 14.47 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.42 1.088 . . . . 0.0 112.861 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.37 18.72 58.83 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.104 -0.953 . . . . 0.0 115.108 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.07 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.477 1.374 0 CA-C-O 121.502 0.501 . . . . 0.0 113.124 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -114.1 144.42 43.18 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -65.95 -44.12 85.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.903 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.66 -31.55 70.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.01 76.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.271 1.828 . . . . 0.0 113.586 -172.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -81.96 51.97 1.86 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.786 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -113.65 -23.79 9.54 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 111.642 -2.526 . . . . 0.0 112.356 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.23 36.82 90.47 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.7 29.55 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.468 0.651 . . . . 0.0 112.726 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.1 41.12 92.44 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.354 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -116.48 146.07 42.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.949 0.9 . . . . 0.0 110.381 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 14.9 m-85 -139.26 134.78 33.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.861 -173.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 33' ' ' LEU . . . 52.98 31.73 40.46 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 125.33 1.644 . . . . 0.0 114.781 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.94 17.32 9.29 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.562 HD11 ' CZ3' ' A' ' 9' ' ' TRP . 0.1 OUTLIER -103.14 19.96 18.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.728 0.811 . . . . 0.0 113.055 -176.672 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 36.96 40.96 0.16 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.705 2.002 . . . . 0.0 113.723 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.84 99.49 12.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.891 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -37.06 132.45 0.72 Allowed Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 112.682 -2.054 . . . . 0.0 113.665 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 78.4 Cg_endo -63.35 -39.11 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.212 2.608 . . . . 0.0 113.167 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.55 -35.13 67.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.148 0.979 . . . . 0.0 113.071 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -70.61 -51.07 30.64 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.187 0.995 . . . . 0.0 111.354 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 37.1 t-105 -58.18 -21.1 45.91 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.62 -29.35 4.23 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.42 67.76 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -100.52 21.52 13.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.243 1.417 . . . . 0.0 113.277 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.32 -23.71 26.2 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.78 -6.14 20.37 Favored Glycine 0 N--CA 1.484 1.875 0 CA-C-N 117.321 0.56 . . . . 0.0 114.462 -172.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' ASN . 31.7 t -64.81 150.39 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.076 1.75 . . . . 0.0 109.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 37.28 0.1 OUTLIER Glycine 0 N--CA 1.484 1.879 0 C-N-CA 125.127 1.346 . . . . 0.0 115.748 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' VAL . 14.3 t-20 -56.98 -51.62 80.29 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.465 174.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.1 Cg_endo -70.44 -20.64 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.328 2.685 . . . . 0.0 115.115 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.01 55.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.252 1.021 . . . . 0.0 113.442 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.95 -32.34 15.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -67.47 130.59 43.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 112.525 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -54.73 159.38 2.24 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.742 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.57 -52.27 10.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 21.3 tt0 -63.59 -40.26 96.49 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 43.1 tp60 -63.82 -40.15 95.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.287 0.635 . . . . 0.0 110.774 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -49.9 68.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.627 1.171 . . . . 0.0 111.089 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -55.18 -33.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.117 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.19 69.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.24 -44.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.372 0.669 . . . . 0.0 110.373 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.6 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -64.7 -34.56 78.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -56.3 -50.29 71.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.618 1.167 . . . . 0.0 110.557 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -33.63 70.44 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.286 0.3 OUTLIER -62.5 -21.71 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.914 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -38.86 91.38 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 168.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.78 -31.54 71.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 1.4 mm-40 -73.16 -65.93 0.74 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -81.85 -23.02 36.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.38 -169.31 16.21 Favored Glycine 0 N--CA 1.474 1.187 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 17.73 20.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.871 -1.164 . . . . 0.0 113.32 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.63 -37.75 65.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.31 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.024 0.827 . . . . 0.0 113.039 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -128.56 82.61 68.28 Favored Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.22 -81.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.936 2.424 . . . . 0.0 111.666 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 t -56.22 -44.64 79.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.896 1.278 . . . . 0.0 112.932 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.4 m -80.7 103.4 10.52 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.03 1.332 . . . . 0.0 108.191 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.01 50.55 0.58 Allowed Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.773 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -12.14 27.14 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.77 -30.82 57.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 165.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 m -93.52 -15.27 25.67 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 36.65 23.77 Favored Glycine 0 CA--C 1.54 1.613 0 N-CA-C 115.467 0.947 . . . . 0.0 115.467 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 114.641 1.349 . . . . 99.989999999999995 114.641 178.098 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 CA-C-O 121.096 0.276 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.52 -69.01 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.526 1.13 . . . . 0.0 111.031 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 45.28 85.76 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.942 1.697 . . . . 0.0 113.663 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.01 -91.28 0.08 OUTLIER Glycine 0 CA--C 1.541 1.669 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.935 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.87 130.32 21.55 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.164 1.909 . . . . 0.0 111.407 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -103.16 132.23 21.33 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.074 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.97 114.11 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.513 2.142 . . . . 0.0 112.441 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -72.23 164.68 25.83 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.471 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -50.89 -32.43 20.51 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 173.002 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.64 -34.3 71.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.76 71.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.418 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 78' ' ' ALA . 15.0 t -58.15 -48.75 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 170.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.34 98.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -3.89 22.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -115.73 -29.4 6.44 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 54.6 mm-40 -88.86 -32.21 17.89 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 171.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -115.21 -33.99 5.15 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.54 33.97 Favored Glycine 0 CA--C 1.54 1.607 0 O-C-N 123.321 0.388 . . . . 0.0 112.646 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.33 89.83 0.19 Allowed Glycine 0 N--CA 1.476 1.348 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.6 86.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.981 1.313 . . . . 0.0 110.285 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -71.47 -34.4 70.17 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.06 32.18 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.3 66.29 1.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.954 1.701 . . . . 0.0 112.923 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.8 35.52 0.37 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.304 -1.771 . . . . 0.0 113.456 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 p -104.69 -18.69 14.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.02 2.128 . . . . 0.0 112.797 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.27 73.79 Favored Glycine 0 N--CA 1.481 1.639 0 C-N-CA 123.753 0.692 . . . . 0.0 114.59 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 19.93 1.9 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.0 30.28 63.34 Favored Glycine 0 CA--C 1.543 1.839 0 C-N-CA 123.79 0.709 . . . . 0.0 114.258 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -126.02 144.24 50.79 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.458 0.703 . . . . 0.0 109.649 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 94.4 m-85 -142.16 151.76 42.53 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.892 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 -11.81 5.36 Favored Glycine 0 N--CA 1.483 1.772 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.925 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 26.67 74.45 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.27 17.91 20.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER 42.68 40.3 1.96 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.375 2.27 . . . . 0.0 113.836 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -98.01 113.36 25.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.362 -168.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -40.7 127.59 1.89 Allowed Pre-proline 0 N--CA 1.481 1.081 0 CA-C-N 113.414 -1.721 . . . . 0.0 114.072 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 96.2 Cg_endo -64.44 -37.83 36.85 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.797 2.332 . . . . 0.0 112.316 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.89 74.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.274 1.03 . . . . 0.0 113.322 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 90.3 m -68.66 -45.78 70.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.99 0.516 . . . . 0.0 111.5 171.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.407 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 32.0 t-105 -56.53 -22.34 32.37 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.72 -27.03 6.3 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 168.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.68 71.39 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.694 0.798 . . . . 0.0 112.97 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.53 19.46 10.99 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.309 1.044 . . . . 0.0 113.657 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.4 -21.29 31.04 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.22 -3.62 29.79 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 114.53 0.572 . . . . 0.0 114.53 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.82 154.07 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.581 1.552 . . . . 0.0 111.303 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.64 39.33 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 114.332 -1.304 . . . . 0.0 115.544 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -48.51 96.75 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.211 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 28.8 Cg_endo -66.27 -26.2 49.13 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.449 2.099 . . . . 0.0 115.965 171.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -72.95 -37.15 67.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.82 16.23 24.62 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.97 143.02 47.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.091 0.948 . . . . 0.0 110.772 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 33.9 t -62.99 156.84 23.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.3 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -60.34 2.61 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.933 0.893 . . . . 0.0 112.936 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.8 tt0 -70.62 -24.17 62.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.298 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 3.0 tp60 -74.14 -46.67 40.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.621 0.724 . . . . 0.0 111.37 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -69.14 -36.84 77.88 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -53.58 -29.42 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.876 171.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.02 99.53 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.99 -42.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.037 0.535 . . . . 0.0 109.702 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -62.91 -35.76 81.14 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.29 -35.94 80.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.765 1.626 . . . . 0.0 111.844 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -79.17 -37.66 37.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.28 0.5 OUTLIER -60.81 -20.47 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 175.881 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -39.92 81.12 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 168.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.19 69.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.68 -57.62 3.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.313 1.045 . . . . 0.0 113.465 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -87.48 -25.68 23.6 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.79 149.43 8.61 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.84 -26.06 61.51 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 -3.39 23.28 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 172.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -59.58 -32.64 70.57 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.0 m-90 -121.83 76.09 38.07 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.46 -34.04 4.87 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.757 2.304 . . . . 0.0 113.082 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.2 p -61.53 -41.11 96.85 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.106 1.762 . . . . 0.0 113.302 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.69 133.9 13.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 110.377 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.96 57.68 0.55 Allowed Glycine 0 N--CA 1.476 1.317 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.025 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -56.58 -18.71 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.73 11.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.993 1.317 . . . . 0.0 113.868 165.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.4 p -102.07 -13.14 17.63 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.316 1.447 . . . . 0.0 113.993 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 13.43 46.15 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 116.159 1.223 . . . . 0.0 116.159 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 115.56 1.689 . . . . 99.989999999999995 115.56 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 2.008 0 N-CA-C 115.159 0.824 . . . . 0.0 115.159 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.98 108.02 9.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.632 0.773 . . . . 0.0 110.566 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.62 156.85 17.08 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.146 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.66 -111.59 1.51 Allowed Glycine 0 N--CA 1.477 1.415 0 CA-C-O 118.048 -1.418 . . . . 0.0 111.131 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.41 144.79 57.06 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -74.95 125.88 88.86 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.513 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.54 132.24 28.49 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.198 2.599 . . . . 0.0 113.136 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -121.25 119.6 32.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.16 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.534 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -60.64 -33.6 73.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.117 -1.401 . . . . 0.0 113.483 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.36 -34.88 67.06 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -65.02 -31.54 72.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.54 -47.83 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.277 0.631 . . . . 0.0 109.606 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -59.19 -39.19 81.79 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 173.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.58 0.06 21.47 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.2 t -114.41 -32.93 5.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.788 1.235 . . . . 0.0 111.926 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -98.01 -25.71 14.87 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 3.8 t -121.1 -24.91 5.42 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.35 -25.09 22.28 Favored Glycine 0 N--CA 1.483 1.772 0 O-C-N 122.102 -0.374 . . . . 0.0 113.536 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -46.72 0.15 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.694 0.664 . . . . 0.0 113.621 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.68 101.42 0.11 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -64.13 -34.68 78.61 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 19.0 20.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.83 79.14 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.453 1.901 . . . . 0.0 114.757 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.07 41.22 0.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.566 -2.107 . . . . 0.0 112.741 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 27' ' ' ASN . 10.2 t -114.86 -16.16 11.76 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.572 2.349 . . . . 0.0 112.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 36.67 90.56 Favored Glycine 0 CA--C 1.54 1.622 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.491 ' HB2' HG23 ' A' ' 25' ' ' THR . 1.4 m-20 -97.35 24.75 6.2 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.76 29.99 51.07 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -117.26 154.13 31.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.876 1.271 . . . . 0.0 110.056 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 36.2 m-85 -149.77 166.29 29.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.96 16.98 42.19 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 114.594 -1.185 . . . . 0.0 116.034 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 58.66 24.13 56.43 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.904 0.764 . . . . 0.0 114.424 -171.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 1.3 mt -116.28 14.62 15.83 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -170.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 36.65 27.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.79 98.54 6.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.743 -169.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -29.05 132.79 0.2 Allowed Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.626 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.38 -41.02 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.34 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.85 -33.09 68.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.172 0.989 . . . . 0.0 113.45 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -75.38 -43.88 47.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.579 0.752 . . . . 0.0 112.036 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.482 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -61.97 -21.24 64.66 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.95 -29.2 7.96 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.73 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -102.11 21.24 15.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.539 1.535 . . . . 0.0 113.273 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.65 -22.05 31.15 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.24 -0.22 41.35 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -172.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.35 150.51 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.26 1.824 . . . . 0.0 109.331 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.72 37.11 0.08 OUTLIER Glycine 0 CA--C 1.542 1.738 0 C-N-CA 125.446 1.498 . . . . 0.0 116.137 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.81 -53.91 59.73 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 115.177 -2.344 . . . . 0.0 109.744 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -68.49 -10.71 29.84 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.417 2.745 . . . . 0.0 116.273 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -82.9 -35.7 25.92 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.27 -30.87 11.65 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.09 123.36 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.097 1.359 . . . . 0.0 111.637 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.6 t -53.8 152.74 5.17 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.659 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -40.33 -58.29 1.56 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.4 tp10 -70.9 -32.12 68.98 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.68 -37.4 59.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.315 0.646 . . . . 0.0 112.387 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -64.92 -50.76 65.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.506 0.722 . . . . 0.0 112.819 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 55' ' ' GLU . 39.6 pt -53.5 -29.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.89 90.45 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.962 0.905 . . . . 0.0 113.439 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 t -63.39 -44.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.875 0.87 . . . . 0.0 109.55 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 1.3 t30 -58.09 -37.23 74.11 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.158 1.383 . . . . 0.0 112.429 172.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -76.89 -40.52 47.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.436 0.636 . . . . 0.0 111.346 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.275 0.4 OUTLIER -59.94 -21.69 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.394 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.5 pp -58.26 -37.58 75.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.34 -30.81 65.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.456 0.702 . . . . 0.0 112.843 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.16 -60.74 2.36 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -82.63 -37.82 24.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.63 156.18 10.94 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.2 mt -58.42 -15.14 9.56 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -64.49 -21.15 66.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.776 1.63 . . . . 0.0 113.335 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.17 87.97 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 80.52 62.89 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -83.69 -54.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.502 2.135 . . . . 0.0 112.965 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.7 p -64.22 -55.51 21.13 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.836 1.654 . . . . 0.0 111.995 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 86.0 m -90.95 123.73 34.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.074 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.28 46.67 0.32 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.329 1.018 . . . . 0.0 113.599 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.69 18.54 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.14 -43.58 78.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.899 1.28 . . . . 0.0 112.548 168.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 m -79.53 -18.85 50.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.584 1.154 . . . . 0.0 113.778 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.26 -48.27 3.77 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.712 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.032 -1.461 . . . . 99.989999999999995 112.393 -170.297 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 CA-C-O 121.689 0.605 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.88 154.98 34.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.228 1.011 . . . . 0.0 109.992 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 mtp -62.49 161.9 11.15 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.884 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.77 88.41 0.54 Allowed Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.009 -1.439 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.84 145.32 31.97 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.326 2.017 . . . . 0.0 110.596 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.8 m -87.39 108.25 18.81 Favored Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.381 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.33 130.02 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.175 1.917 . . . . 0.0 111.276 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -108.46 172.43 6.84 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.941 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -47.78 -33.95 7.89 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.61 -33.75 68.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.65 -33.49 74.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.208 1.003 . . . . 0.0 112.317 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.04 -49.53 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -57.4 -42.56 82.46 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.74 4.63 11.17 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.78 -43.47 3.44 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 168.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.55 -44.73 66.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.958 0.903 . . . . 0.0 113.406 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -102.81 -42.79 5.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.036 0.934 . . . . 0.0 112.585 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.52 24.59 64.12 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.15 -93.54 0.1 OUTLIER Glycine 0 N--CA 1.477 1.368 0 O-C-N 124.125 0.544 . . . . 0.0 112.164 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -113.53 147.72 37.42 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -174.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 49.8 m95 -71.25 -43.44 67.26 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.287 173.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.2 -24.39 67.35 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.35 71.77 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 113.962 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.0 32.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.896 -1.957 . . . . 0.0 115.004 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.5 p -109.12 -23.4 11.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.218 2.207 . . . . 0.0 113.251 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.89 35.31 72.34 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 115.911 1.124 . . . . 0.0 115.911 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 88.6 m-20 -90.93 28.38 1.58 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.37 40.44 92.02 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-O 121.518 0.51 . . . . 0.0 113.233 -173.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 40.6 mttp -120.53 137.15 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 109.255 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.609 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 99.2 m-85 -138.4 147.81 43.78 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.575 1.172 . . . . 0.0 111.431 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.97 -4.51 7.78 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.546 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 71.31 26.98 72.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.418 0.532 . . . . 0.0 112.833 -173.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.402 HD23 ' OE1' ' A' ' 57' ' ' GLN . 3.4 mm? -111.42 21.6 16.03 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.651 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 1.2 tt0 44.45 35.12 1.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.534 1.635 . . . . 0.0 113.287 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.11 107.5 20.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.72 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -47.37 133.05 9.96 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.884 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 74.2 Cg_endo -62.7 -34.43 73.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.918 2.412 . . . . 0.0 113.326 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.27 70.96 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.042 0.937 . . . . 0.0 113.232 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -66.28 -50.72 62.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.168 0.987 . . . . 0.0 111.794 170.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.3 t-105 -57.35 -22.01 39.52 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.64 -29.06 6.63 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 169.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.01 70.49 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.45 25.44 9.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.996 . . . . 0.0 111.761 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.4 -22.84 31.7 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 115.824 1.09 . . . . 0.0 115.824 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.85 -6.0 28.6 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -173.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.89 149.64 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.317 1.847 . . . . 0.0 109.295 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.23 35.86 0.09 OUTLIER Glycine 0 CA--C 1.544 1.866 0 C-N-CA 125.175 1.369 . . . . 0.0 116.218 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.57 -48.34 97.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 116.058 -1.925 . . . . 0.0 110.874 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 72.5 Cg_endo -69.2 -19.81 38.31 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.81 2.34 . . . . 0.0 114.781 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.66 51.19 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.37 -34.12 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 128.05 34.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.949 0.9 . . . . 0.0 111.542 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -50.82 157.7 0.77 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.597 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.675 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 2.6 mpt_? -38.92 -61.02 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.6 ' HA ' HG12 ' A' ' 58' ' ' ILE . 11.0 tt0 -69.79 -24.42 63.49 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -74.51 -41.51 60.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.444 0.698 . . . . 0.0 110.669 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.402 ' OE1' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -61.49 -47.65 84.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.566 1.146 . . . . 0.0 110.572 175.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.6 HG12 ' HA ' ' A' ' 55' ' ' GLU . 10.1 pt -55.31 -31.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.48 68.05 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 112.534 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.32 -41.5 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.794 0.438 . . . . 0.0 110.26 177.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -34.12 74.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 175.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.71 -44.77 96.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.164 0.985 . . . . 0.0 111.919 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.58 -38.8 80.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.213 0.53 . . . . 0.0 111.943 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 61' ' ' ALA 0.27 0.4 OUTLIER -59.96 -22.99 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.156 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.65 80.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 169.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.0 -29.3 68.28 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -59.97 2.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.52 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -91.18 -21.81 20.96 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 151.58 9.27 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.87 -37.88 86.21 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -7.61 18.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.206 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.7 67.48 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -99.62 141.14 22.27 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 173.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.06 -159.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.684 2.256 . . . . 0.0 111.185 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.2 p -54.14 -24.56 18.32 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.05 67.09 1.69 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.998 1.38 . . . . 0.0 112.494 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.63 50.66 0.84 Allowed Glycine 0 N--CA 1.475 1.243 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.801 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -16.94 27.94 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.65 -33.25 32.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.774 1.23 . . . . 0.0 113.357 165.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.7 m -99.05 -17.36 18.29 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.128 1.371 . . . . 0.0 113.98 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.68 32.54 84.51 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 115.114 0.806 . . . . 0.0 115.114 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' OXT' HD12 ' A' ' 82' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.69 1.737 . . . . 99.989999999999995 115.69 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.829 0 CA-C-O 121.161 0.312 . . . . 0.0 113.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.01 135.8 12.64 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.451 1.101 . . . . 0.0 109.057 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.4 ttt -119.11 83.27 2.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.664 0.745 . . . . 0.0 109.674 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.78 -155.46 11.61 Favored Glycine 0 CA--C 1.544 1.891 0 CA-C-N 113.212 -1.813 . . . . 0.0 113.743 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.01 145.47 17.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.365 2.044 . . . . 0.0 111.685 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.29 94.49 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.595 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.29 142.98 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.147 2.565 . . . . 0.0 113.699 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -117.46 97.53 5.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -56.67 -34.23 67.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.79 -44.59 89.47 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.34 -33.55 74.93 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.916 0.486 . . . . 0.0 112.003 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' ' 78' ' ' ALA . 42.5 t -62.07 -40.46 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.556 1.142 . . . . 0.0 113.128 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.05 93.14 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.787 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.73 0.89 6.12 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.4 -33.12 6.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.113 1.765 . . . . 0.0 111.92 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' GLN . 52.3 mt-10 -104.24 -23.73 13.21 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 53.3 p -117.36 -26.51 6.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 169.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.34 -11.53 65.37 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.396 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.63 -67.42 0.17 Allowed Glycine 0 N--CA 1.477 1.387 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 47.4 m-80 -47.29 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.519 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 41.9 m95 -63.93 -49.32 73.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.55 -2.1 21.37 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 39.19 69.6 0.27 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.122 1.769 . . . . 0.0 114.817 -173.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -82.51 43.81 0.85 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.933 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -114.59 -21.21 10.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.339 2.655 . . . . 0.0 112.128 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.51 32.66 82.32 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.11 24.72 4.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.61 37.66 77.25 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.888 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -118.15 149.07 41.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.244 0.618 . . . . 0.0 109.82 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 62.0 m-85 -144.63 149.96 36.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.454 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 56.67 23.73 45.02 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 59.25 25.94 60.84 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -112.52 13.24 20.06 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -174.576 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 6.6 tt0 44.5 33.18 0.85 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 123.392 1.568 . . . . 0.0 114.334 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.21 109.66 21.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.786 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.31 142.65 4.18 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.277 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 95.5 Cg_endo -65.4 -40.95 17.01 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.741 2.294 . . . . 0.0 112.34 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.01 -29.74 65.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.728 1.211 . . . . 0.0 113.551 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 m -78.03 -45.03 24.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.918 0.887 . . . . 0.0 111.316 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.47 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 43.6 t-105 -59.24 -21.36 59.45 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.18 -28.85 3.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 168.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.56 68.48 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.85 24.84 10.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.451 1.1 . . . . 0.0 111.781 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -23.58 28.42 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.83 -4.21 31.25 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 114.866 0.706 . . . . 0.0 114.866 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.28 158.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.649 1.58 . . . . 0.0 111.716 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.63 32.54 0.13 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 124.949 1.262 . . . . 0.0 116.164 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.76 -51.24 83.19 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.971 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 93.3 Cg_endo -69.72 -19.01 36.89 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.15 2.567 . . . . 0.0 115.195 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.79 -33.66 46.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.83 -35.74 12.58 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.35 128.45 35.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.876 0.871 . . . . 0.0 111.648 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -51.58 159.91 0.69 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.688 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 21' ' ' TRP . 8.1 mtm180 -41.74 -58.26 2.05 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -66.91 -36.97 83.46 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.352 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.72 -37.49 86.56 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.71 -0.619 . . . . 0.0 111.705 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -64.54 -50.76 66.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.228 1.011 . . . . 0.0 110.92 172.415 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.735 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -56.73 -31.46 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.04 -48.31 82.07 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 0.0 112.605 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.65 -42.6 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.986 0.514 . . . . 0.0 110.405 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . . . -58.96 -36.67 75.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.374 1.07 . . . . 0.0 113.667 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.57 -46.09 84.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.035 1.334 . . . . 0.0 111.319 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -33.93 62.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.4 OUTLIER -59.87 -25.68 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 173.847 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -42.09 92.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.927 0.491 . . . . 0.0 112.228 171.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -31.15 66.92 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -67.42 -52.0 44.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.39 10.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.98 155.93 9.22 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.05 0.805 . . . . 0.0 111.515 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.44 16.41 17.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.235 -0.982 . . . . 0.0 113.466 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.46 -29.36 13.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.144 1.378 . . . . 0.0 114.384 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.66 90.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.14 149.31 91.22 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.129 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -64.88 -154.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.891 2.394 . . . . 0.0 111.774 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.2 p -56.03 -29.19 60.04 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.064 0.935 . . . . 0.0 112.98 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 m -68.65 172.23 6.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.484 2.313 . . . . 0.0 110.878 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.23 105.26 1.54 Allowed Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.178 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -60.75 -15.53 30.45 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.73 -41.89 5.1 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.927 1.291 . . . . 0.0 112.501 163.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.8 m -107.29 -28.11 10.1 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.376 1.048 . . . . 0.0 113.588 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.11 25.42 69.55 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 124.147 0.879 . . . . 0.0 113.587 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.252 1.214 0 CA-C-O 116.277 -1.82 . . . . 99.989999999999995 111.887 -177.466 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.25 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.242 1.417 . . . . 0.0 113.658 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -73.72 150.31 41.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.097 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.42 -134.63 3.49 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.583 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -65.98 167.59 17.52 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.939 2.426 . . . . 0.0 112.092 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.4 m -46.58 134.99 7.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.666 1.186 . . . . 0.0 113.069 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HB2' ' O ' ' A' ' 78' ' ' ALA . 61.1 Cg_endo -63.25 144.03 90.77 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.82 2.347 . . . . 0.0 112.54 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.53 121.33 43.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.692 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.47 ' HZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -60.56 -31.56 70.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.341 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -57.34 -35.8 70.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.751 0.821 . . . . 0.0 113.092 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.81 72.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.86 -47.47 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -62.06 -40.6 96.34 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -70.81 -7.49 45.67 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.33 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.587 1.555 . . . . 0.0 111.938 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -80.86 -39.09 27.04 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t -105.88 -37.99 6.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.81 1.244 . . . . 0.0 112.619 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.4 16.72 58.72 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.919 0.728 . . . . 0.0 114.919 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.3 -99.66 0.6 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 121.881 0.712 . . . . 0.0 112.453 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.63 150.89 47.18 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.136 -1.032 . . . . 0.0 113.468 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 39.3 m95 -64.16 -38.69 91.96 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.667 171.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.04 41.06 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.514 1.149 . . . . 0.0 112.39 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 59.52 0.65 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 122.947 1.356 . . . . 0.0 113.104 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.34 52.86 1.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.109 1.433 . . . . 0.0 111.513 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.3 p -82.92 9.38 10.13 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.786 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.84 26.89 70.43 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.266 1.267 . . . . 0.0 116.266 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -87.11 22.43 2.07 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 54.2 30.75 48.34 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.72 -172.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -132.32 143.3 49.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.145 0.978 . . . . 0.0 109.285 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.601 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 62.6 m-85 -146.28 159.39 43.41 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.836 -1.075 . . . . 0.0 113.598 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.96 33.08 56.67 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.449 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 52.28 22.86 11.14 Favored Glycine 0 CA--C 1.545 1.917 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD21 ' HZ3' ' A' ' 9' ' ' TRP . 41.7 mt -109.54 11.46 24.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.131 2.641 . . . . 0.0 118.131 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? 39.11 27.02 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -79.2 106.17 11.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.204 -172.89 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -36.8 129.73 0.72 Allowed Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 113.204 -1.816 . . . . 0.0 113.818 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 91.9 Cg_endo -63.42 -33.41 69.57 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.033 2.489 . . . . 0.0 113.026 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -35.05 66.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.389 1.076 . . . . 0.0 113.145 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.8 m -70.82 -51.18 28.32 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.871 0.868 . . . . 0.0 111.167 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.471 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.8 t-105 -58.61 -21.52 53.77 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.86 -28.06 6.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.03 75.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.3 20.26 8.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.636 1.174 . . . . 0.0 113.959 171.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.88 -20.14 36.85 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.914 1.126 . . . . 0.0 115.914 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.86 -6.56 25.68 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 -174.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.9 p -64.5 154.94 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.087 1.755 . . . . 0.0 111.951 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.91 35.82 0.14 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 125.02 1.295 . . . . 0.0 115.538 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.579 ' HB2' HG13 ' A' ' 46' ' ' VAL . 4.3 t-20 -58.42 -51.01 84.89 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 116.159 -1.877 . . . . 0.0 110.068 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 71.0 Cg_endo -68.39 -21.4 40.93 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.04 2.494 . . . . 0.0 115.183 174.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -77.02 -33.44 57.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 1.5 43.01 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.06 125.0 48.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.039 0.936 . . . . 0.0 109.206 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -53.2 155.36 2.7 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.055 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 51.5 mtt85 -37.36 -55.66 1.02 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.308 1.443 . . . . 0.0 114.247 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.3 tt0 -69.27 -42.36 75.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.7 -39.24 73.51 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.664 0.785 . . . . 0.0 110.826 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -65.53 -53.74 37.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.17 173.033 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.9 pt -51.73 -34.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -55.04 40.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.066 0.947 . . . . 0.0 113.297 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.52 -37.67 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.165 0.586 . . . . 0.0 110.516 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.15 -42.26 94.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.116 1.367 . . . . 0.0 113.791 174.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.4 -40.94 88.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.005 1.322 . . . . 0.0 111.922 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -71.39 -40.18 70.7 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.994 -0.441 . . . . 0.0 112.148 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.272 0.3 OUTLIER -63.51 -20.3 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.199 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -44.01 88.23 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 168.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.1 69.09 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.71 -49.04 33.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -102.09 -25.82 13.6 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.62 154.77 8.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.078 0.847 . . . . 0.0 111.098 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.46 -32.36 72.35 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -11.68 17.62 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -53.61 -33.61 55.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.674 1.19 . . . . 0.0 114.063 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.441 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 21.1 m-90 -113.99 141.09 25.69 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.46 -159.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.034 2.489 . . . . 0.0 112.095 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -52.28 -25.23 8.92 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.2 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.744 2.018 . . . . 0.0 115.214 170.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.56 48.6 1.09 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.317 0.961 . . . . 0.0 111.784 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' PRO . . . -52.92 -15.31 0.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.4 -41.13 13.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 113.305 164.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -95.72 -17.19 21.45 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.858 1.263 . . . . 0.0 113.66 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.31 -44.32 3.33 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 123.921 0.772 . . . . 0.0 112.684 -172.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.321 1.848 . . . . 99.989999999999995 112.074 -175.279 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.907 0 N-CA-C 113.91 0.324 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.82 97.04 2.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 0.0 110.142 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpp? 49.78 86.61 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.194 1.398 . . . . 0.0 114.664 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.55 -86.82 0.52 Allowed Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.579 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.99 151.03 78.16 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.716 2.278 . . . . 0.0 112.139 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m -56.11 144.84 58.17 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -63.98 130.75 28.43 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.936 2.424 . . . . 0.0 113.013 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -99.22 78.78 2.26 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 58' ' ' ILE . 1.2 m95 -59.55 -35.58 74.5 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.326 -1.761 . . . . 0.0 113.744 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -58.57 -52.82 64.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.572 0.749 . . . . 0.0 112.368 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -58.02 -35.46 71.3 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.872 0.733 . . . . 0.0 112.657 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.76 -44.81 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.675 0.79 . . . . 0.0 112.814 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.73 94.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.86 0.362 . . . . 0.0 111.889 171.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.97 15.33 1.86 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.5 t -116.95 -33.63 4.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.884 1.274 . . . . 0.0 111.543 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -88.48 -53.02 4.87 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 168.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -81.21 -42.73 20.32 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.25 19.87 60.08 Favored Glycine 0 N--CA 1.481 1.679 0 O-C-N 124.244 0.965 . . . . 0.0 115.399 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.56 -98.52 0.24 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-O 121.09 0.272 . . . . 0.0 112.88 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -123.96 153.39 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 51.7 m95 -70.71 -42.62 70.36 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.353 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.93 40.67 1.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.432 1.11 . . . . 0.0 112.012 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 63.54 2.31 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 123.732 1.729 . . . . 0.0 111.613 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -82.74 30.48 0.43 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.041 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -80.24 27.66 0.33 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.731 2.012 . . . . 0.0 114.024 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.7 43.67 93.81 Favored Glycine 0 CA--C 1.54 1.615 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.5 m120 -90.96 7.78 38.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 175.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.77 10.23 6.17 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 124.273 0.939 . . . . 0.0 115.336 -170.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 27' ' ' ASN . 26.1 mmtp -131.5 148.24 52.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.654 1.182 . . . . 0.0 109.385 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-85 -139.35 160.21 40.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.764 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.75 -10.59 24.08 Favored Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.943 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.08 25.73 54.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.012 0.339 . . . . 0.0 113.543 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.455 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 3.8 mp -115.1 13.01 16.77 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 38.62 52.13 1.78 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 123.75 1.738 . . . . 0.0 113.307 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -105.26 109.39 21.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.798 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -39.94 137.33 1.19 Allowed Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.85 -44.74 12.35 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.516 . . . . 0.0 113.301 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.33 -33.24 67.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.063 0.945 . . . . 0.0 113.506 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -72.12 -48.03 46.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.701 0.8 . . . . 0.0 111.537 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 33.6 t-105 -59.93 -21.87 61.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.92 -28.46 9.76 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.25 -36.12 72.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.5 17.5 13.02 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.727 1.211 . . . . 0.0 113.553 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.29 -22.79 24.21 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.28 -6.19 23.63 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -63.77 154.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.811 1.644 . . . . 0.0 111.721 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.2 0.09 OUTLIER Glycine 0 N--CA 1.482 1.757 0 C-N-CA 124.878 1.228 . . . . 0.0 115.59 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 46' ' ' VAL . 17.9 t30 -58.57 -51.72 79.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 115.94 -1.981 . . . . 0.0 110.384 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.499 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.6 Cg_endo -67.0 -25.07 44.68 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.265 1.977 . . . . 0.0 113.927 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -69.39 -36.21 76.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.68 -33.89 11.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 119.12 9.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.078 0.951 . . . . 0.0 111.6 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 m -46.87 156.41 0.2 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.429 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 2.5 mtt180 -29.34 -67.66 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.726 ' HA ' HG12 ' A' ' 58' ' ' ILE . 22.5 tt0 -63.97 -32.65 74.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -68.89 -40.25 79.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.049 0.54 . . . . 0.0 111.296 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.437 ' OE1' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.84 -50.67 67.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.389 1.076 . . . . 0.0 110.484 173.063 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.726 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -54.82 -32.93 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -53.58 56.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 113.15 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.54 -41.59 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.135 0.574 . . . . 0.0 109.866 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.19 -39.46 82.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.452 1.501 . . . . 0.0 114.533 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 5.5 t-20 -58.29 -37.51 75.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.004 1.322 . . . . 0.0 111.882 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -33.65 27.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.271 0.4 OUTLIER -60.45 -25.19 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 173.912 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.3 pp -61.78 -38.39 87.86 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.2 71.67 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.06 -62.95 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -82.16 -22.77 35.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 -169.08 15.1 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.03 19.69 7.58 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.205 -0.997 . . . . 0.0 113.198 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.92 -33.41 17.29 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.25 -26.33 51.09 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' HE1' HD23 ' A' ' 33' ' ' LEU . 6.3 m-90 -122.79 91.13 49.83 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.13 -62.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.525 2.15 . . . . 0.0 113.091 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -61.23 -50.37 73.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.888 1.275 . . . . 0.0 113.03 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.8 m -101.04 175.14 5.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.924 170.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.58 93.24 0.09 OUTLIER Glycine 0 N--CA 1.472 1.075 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -28.01 19.86 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.59 -37.81 42.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.636 1.175 . . . . 0.0 113.394 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -99.98 -27.49 13.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.386 1.074 . . . . 0.0 112.227 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.34 -37.14 3.51 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.264 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.817 1.247 . . . . 99.989999999999995 113.529 -175.823 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 CA-C-O 121.578 0.543 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.42 147.5 29.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.36 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mtt 61.85 -174.91 0.13 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.402 1.481 . . . . 0.0 112.821 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.14 101.2 2.47 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.431 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.08 143.12 52.96 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.455 2.103 . . . . 0.0 111.912 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 143.15 74.84 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.798 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.26 133.22 27.86 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.065 1.844 . . . . 0.0 112.694 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -101.23 174.38 6.02 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.556 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.605 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 1.1 m95 -49.07 -37.88 22.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.31 -43.94 95.88 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.3 -34.63 77.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.923 0.889 . . . . 0.0 112.118 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.87 -37.95 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 112.421 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.92 93.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.55 6.84 7.76 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 t -110.31 -31.96 7.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.934 0.894 . . . . 0.0 112.267 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.66 -32.42 10.34 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 19.8 t -98.52 -35.53 10.21 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 31.08 67.74 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.37 -88.73 0.07 OUTLIER Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.172 0.415 . . . . 0.0 112.509 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -112.83 145.3 40.88 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -66.57 -47.39 72.94 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.107 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 -29.55 69.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 35.35 70.46 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.403 1.881 . . . . 0.0 114.297 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -78.58 56.99 1.91 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.817 1.77 . . . . 0.0 112.401 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -117.53 -24.51 7.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.402 2.681 . . . . 0.0 112.94 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.08 34.42 76.1 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.666 1.026 . . . . 0.0 115.666 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -92.5 25.97 2.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.3 39.17 92.24 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.695 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 34' ' ' GLN . 34.2 mttp -121.18 146.89 46.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.291 1.036 . . . . 0.0 109.742 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 16.1 m-85 -145.23 146.05 31.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.562 -175.523 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 51.18 34.08 31.69 Favored Glycine 0 N--CA 1.483 1.779 0 O-C-N 124.801 1.313 . . . . 0.0 115.843 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 58.12 23.52 52.57 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.356 0.979 . . . . 0.0 115.193 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 18.3 mt -116.71 8.26 13.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -169.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 4.5 tt0 45.07 36.8 2.17 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.817 1.77 . . . . 0.0 113.07 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -89.69 104.68 17.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.6 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -37.75 130.16 0.91 Allowed Pre-proline 0 N--CA 1.484 1.233 0 CA-C-N 112.986 -1.915 . . . . 0.0 113.331 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 89.5 Cg_endo -65.0 -39.22 25.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.772 2.315 . . . . 0.0 112.556 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.38 70.04 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.2 1.0 . . . . 0.0 113.088 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 m -73.63 -44.79 56.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.578 0.751 . . . . 0.0 111.5 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 42.9 t-105 -58.7 -20.21 46.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.39 -28.38 5.04 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 168.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.05 69.74 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -98.36 25.73 6.04 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.017 1.327 . . . . 0.0 113.589 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.34 39.57 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.3 -4.57 32.71 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 115.077 0.791 . . . . 0.0 115.077 -173.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 61.7 t -72.2 152.81 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.011 1.724 . . . . 0.0 109.274 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.5 36.01 0.08 OUTLIER Glycine 0 CA--C 1.542 1.768 0 C-N-CA 125.226 1.393 . . . . 0.0 116.58 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -52.77 -53.94 48.86 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 116.209 -1.853 . . . . 0.0 109.146 171.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 72.5 Cg_endo -67.35 -20.89 48.12 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.536 2.824 . . . . 0.0 116.023 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.52 61.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.66 -35.01 10.72 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.54 126.97 29.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.484 1.114 . . . . 0.0 110.821 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -54.63 156.81 3.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.301 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 26.5 mtt-85 -45.92 -57.74 4.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.146 0.978 . . . . 0.0 112.936 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 58' ' ' ILE . 10.2 tt0 -66.79 -30.79 71.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.44 -41.34 76.44 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.824 -0.547 . . . . 0.0 110.851 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.73 -40.77 98.24 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.251 174.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 55' ' ' GLU . 2.3 pt -54.28 -33.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.945 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.03 82.54 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.15 -42.18 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.362 0.601 . . . . 0.0 109.673 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.563 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.95 -36.39 79.23 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.4 -47.71 81.0 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.407 1.083 . . . . 0.0 111.296 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -39.71 87.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.001 0.429 . . . . 0.0 111.572 173.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.293 0.4 OUTLIER -61.52 -26.03 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.591 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.65 -40.3 91.5 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.16 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.274 0.629 . . . . 0.0 112.607 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -66.91 -43.92 82.1 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.82 -29.23 10.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 112.89 155.68 12.15 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.38 21.1 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 69' ' ' GLY . 7.4 m-20 -88.33 -30.62 19.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.004 1.722 . . . . 0.0 111.866 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.37 -31.23 65.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 0.0 113.33 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -122.75 89.74 50.06 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.08 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.29 1.993 . . . . 0.0 113.537 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -63.19 -49.56 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.855 1.662 . . . . 0.0 112.95 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -109.79 163.43 13.52 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.027 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.55 101.14 0.15 Allowed Glycine 0 N--CA 1.478 1.469 0 O-C-N 124.563 1.165 . . . . 0.0 111.376 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.56 -28.72 14.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.08 -32.84 36.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.016 1.326 . . . . 0.0 114.074 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.8 p -107.97 -22.0 12.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.903 1.281 . . . . 0.0 113.714 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.7 32.71 84.48 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 124.296 0.95 . . . . 0.0 114.062 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 117.042 -1.456 . . . . 99.989999999999995 114.295 178.285 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.897 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.44 93.27 2.95 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.245 0.618 . . . . 0.0 111.558 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -85.84 141.71 29.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.211 -1.358 . . . . 0.0 111.638 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.94 106.21 0.22 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-O 118.189 -1.339 . . . . 0.0 111.559 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.66 140.6 47.53 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.325 2.016 . . . . 0.0 111.661 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 0.6 OUTLIER -62.11 136.89 95.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.505 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' SER . 72.3 Cg_exo -59.61 139.55 89.51 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.73 2.287 . . . . 0.0 112.584 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -125.31 -178.43 4.21 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.022 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 19.5 m95 -50.91 -34.36 28.14 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.28 -49.57 77.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.991 0.917 . . . . 0.0 112.688 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.497 0.719 . . . . 0.0 112.142 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 78' ' ' ALA . 77.0 t -63.9 -38.96 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.176 0.991 . . . . 0.0 112.322 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.35 78.77 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.72 6.92 19.3 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -116.38 -35.24 4.35 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.882 0.873 . . . . 0.0 112.888 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 16.9 mm-40 -89.47 -39.27 13.46 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 170.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -106.42 -24.08 12.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.45 3.62 72.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.697 1.039 . . . . 0.0 115.697 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.52 81.18 0.42 Allowed Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.007 0.813 . . . . 0.0 111.49 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 173.77 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.08 1.752 . . . . 0.0 108.939 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -80.37 -79.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.402 0.439 . . . . 0.0 111.745 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -22.15 55.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.8 70.61 0.5 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.321 1.848 . . . . 0.0 114.383 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.55 33.74 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.957 -1.929 . . . . 0.0 115.222 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.4 t -117.13 -18.01 10.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.388 2.275 . . . . 0.0 112.338 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 46.69 40.76 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -89.35 23.24 2.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.1 34.65 58.62 Favored Glycine 0 N--CA 1.482 1.765 0 C-N-CA 123.289 0.471 . . . . 0.0 113.563 -172.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' ' HG2' ' A' ' 34' ' ' GLN . 61.1 mttp -129.5 138.6 51.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.776 1.23 . . . . 0.0 108.809 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 89.4 m-85 -136.87 149.46 47.68 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.565 1.166 . . . . 0.0 112.822 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.54 -14.75 1.77 Allowed Glycine 0 N--CA 1.483 1.786 0 CA-C-N 114.339 -1.3 . . . . 0.0 116.235 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.7 30.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.889 0.757 . . . . 0.0 114.815 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.05 28.08 8.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.584 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 7.7 tm0? 43.91 35.18 1.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.156 1.782 . . . . 0.0 114.171 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.04 110.19 22.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.044 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.92 133.14 29.32 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 112.581 -2.1 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -62.03 -32.23 83.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.171 2.581 . . . . 0.0 113.771 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.02 65.34 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -76.0 -41.04 52.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.705 0.802 . . . . 0.0 111.676 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 38.5 t-105 -58.73 -21.49 55.24 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.86 -29.52 3.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 168.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.06 -38.36 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.31 18.85 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.77 1.228 . . . . 0.0 113.517 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.73 -21.13 32.84 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.56 -2.95 36.34 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.47 156.81 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.49 1.516 . . . . 0.0 111.741 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.38 34.28 0.12 Allowed Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -58.46 -52.61 73.37 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-O 115.719 -2.086 . . . . 0.0 110.603 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 71.9 Cg_endo -68.25 -16.95 44.8 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.135 2.557 . . . . 0.0 115.475 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.58 -33.67 35.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.74 -34.71 10.41 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.73 121.69 13.48 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.154 0.978 . . . . 0.0 110.876 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -50.85 160.09 0.49 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.057 -1.883 . . . . 0.0 110.732 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.19 -56.63 4.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 58' ' ' ILE . 29.1 tt0 -70.11 -30.28 67.44 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -68.01 -45.78 73.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.404 0.681 . . . . 0.0 111.165 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -66.0 -45.07 82.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.778 0.831 . . . . 0.0 113.053 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.643 HG12 ' HA ' ' A' ' 55' ' ' GLU . 26.4 pt -54.67 -28.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.51 85.99 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.03 -42.61 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.252 0.621 . . . . 0.0 109.997 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.74 78.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -61.01 -39.59 90.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.196 1.399 . . . . 0.0 112.183 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -33.85 52.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.5 OUTLIER -57.15 -26.76 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.526 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -59.79 -42.82 94.25 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 171.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.7 66.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 173.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -52.11 30.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.37 -25.18 14.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.77 164.81 13.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.83 1.85 1.22 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 170.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -67.05 -32.83 74.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.299 1.84 . . . . 0.0 113.88 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -53.04 -29.68 31.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.533 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 2.2 m-90 -128.36 90.44 46.87 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.83 -65.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.542 2.161 . . . . 0.0 113.253 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -61.6 -42.64 99.15 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 0.0 113.875 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -113.62 -164.88 0.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.232 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.59 101.91 0.25 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -57.49 -25.64 60.09 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.667 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -49.01 -42.38 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 113.554 166.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.2 p -94.2 -20.76 19.55 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.464 1.105 . . . . 0.0 113.131 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 21.3 63.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 124.906 1.241 . . . . 0.0 115.136 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.296 0 N-CA-C 115.252 1.575 . . . . 99.989999999999995 115.252 176.219 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.8 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 157.6 41.11 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.895 0.878 . . . . 0.0 111.317 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ttm -94.03 95.74 9.22 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.273 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.99 172.16 43.71 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.164 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.57 152.46 78.27 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.118 2.545 . . . . 0.0 112.084 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.3 m -57.38 108.92 1.41 Allowed Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.922 0.889 . . . . 0.0 113.05 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.24 137.73 44.69 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.745 2.297 . . . . 0.0 111.083 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -95.78 74.4 3.14 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.958 1.361 . . . . 0.0 112.033 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.419 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -57.57 -32.96 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.417 -1.72 . . . . 0.0 112.97 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.25 -48.0 71.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 0.0 112.105 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.65 66.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 78' ' ' ALA . 89.7 t -63.22 -33.83 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 112.627 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.42 94.07 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.26 -4.71 31.2 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -106.93 -25.52 11.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -104.71 -27.82 11.57 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.4 t -110.75 -31.55 7.16 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.61 -24.6 28.67 Favored Glycine 0 N--CA 1.481 1.693 0 CA-C-N 116.785 -0.189 . . . . 0.0 112.881 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.65 83.44 0.07 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.0 t-20 178.45 98.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.669 1.188 . . . . 0.0 110.869 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 76.3 m95 -75.6 -25.82 57.32 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.75 48.6 0.95 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.847 1.308 . . . . 0.0 111.847 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . -70.05 50.92 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 19.5 t30 -101.46 26.19 7.53 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.751 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 t -122.75 44.5 2.63 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.424 1.583 . . . . 0.0 111.911 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.95 -93.64 0.1 OUTLIER Glycine 0 N--CA 1.481 1.634 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.824 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 2.0 m-20 -103.86 28.93 6.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.28 33.66 65.87 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.306 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 27' ' ' ASN . 91.2 mttt -79.3 151.03 31.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 0.0 111.2 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.692 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 73.1 m-85 -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.05 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.599 ' HA2' ' HG3' ' A' ' 57' ' ' GLN . . . 77.1 -25.99 1.83 Allowed Glycine 0 N--CA 1.48 1.591 0 CA-C-N 114.13 -1.395 . . . . 0.0 115.342 -176.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.93 22.94 36.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 114.731 -0.734 . . . . 0.0 113.428 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HG ' ' HE1' ' A' ' 73' ' ' TRP . 2.6 mm? -116.71 28.79 8.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 37.19 31.65 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.266 2.226 . . . . 0.0 116.772 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -78.32 109.53 12.54 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.811 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -46.33 132.15 7.68 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.175 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.09 -38.85 84.71 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.91 2.407 . . . . 0.0 113.379 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.68 68.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -76.87 -42.39 40.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.604 0.762 . . . . 0.0 111.069 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 40.1 t-105 -60.83 -21.83 63.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.55 -29.94 3.2 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.41 -35.86 70.58 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 171.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -98.56 25.36 6.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.928 1.291 . . . . 0.0 113.156 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.31 34.27 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.9 -11.02 16.24 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 45.5 t -65.28 151.21 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.472 1.909 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.82 38.48 0.09 OUTLIER Glycine 0 CA--C 1.545 1.93 0 C-N-CA 125.428 1.489 . . . . 0.0 116.332 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -54.57 -53.89 54.89 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.233 -1.841 . . . . 0.0 108.617 171.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 94.2 Cg_endo -70.66 -9.41 25.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.876 2.384 . . . . 0.0 116.122 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -77.34 -46.4 23.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.798 0.839 . . . . 0.0 113.003 170.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.43 -34.11 15.74 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -61.55 115.1 3.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.006 0.922 . . . . 0.0 110.695 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -44.35 159.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.305 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 16.9 mtt85 -40.91 -59.41 1.44 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.98 1.312 . . . . 0.0 113.269 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.684 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -68.34 -27.17 66.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.255 177.25 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -72.26 -42.48 65.55 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.339 0.59 . . . . 0.0 110.738 175.592 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.599 ' HG3' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -62.75 -48.11 80.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.118 0.967 . . . . 0.0 111.43 176.695 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.684 HG12 ' HA ' ' A' ' 55' ' ' GLU . 24.1 pt -54.35 -33.78 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.4 -50.82 72.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.506 0.722 . . . . 0.0 112.8 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.69 -41.95 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.013 0.525 . . . . 0.0 110.376 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.88 73.44 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 54.9 t30 -62.95 -41.92 99.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.05 1.34 . . . . 0.0 111.931 171.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -71.87 -38.54 70.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.419 0.628 . . . . 0.0 111.318 172.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 67' ' ' GLU 0.27 0.5 OUTLIER -59.37 -26.78 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.327 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.6 pp -62.01 -40.52 95.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.79 67.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 2.4 mm-40 -61.67 -53.81 51.15 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -110.7 -23.47 11.04 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.12 165.04 12.99 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.35 4.67 0.68 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -30.39 71.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.251 1.821 . . . . 0.0 114.203 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.09 -27.04 52.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.2 m-90 -119.02 95.95 49.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.78 -58.96 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.306 2.004 . . . . 0.0 114.126 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 p -64.64 -48.49 74.64 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.403 1.481 . . . . 0.0 113.076 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 m -108.4 -165.69 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.746 170.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.92 97.13 0.12 Allowed Glycine 0 N--CA 1.473 1.113 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -53.91 -25.34 19.77 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -47.11 -40.14 14.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.029 1.332 . . . . 0.0 113.569 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.3 m -102.42 -21.07 14.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.824 1.25 . . . . 0.0 114.362 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -38.31 2.97 Favored Glycine 0 N--CA 1.48 1.58 0 C-N-CA 124.08 0.848 . . . . 0.0 112.332 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 116.057 -1.925 . . . . 99.989999999999995 114.119 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.706 0 N-CA-C 114.29 0.476 . . . . 0.0 114.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 150.73 30.66 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.931 1.292 . . . . 0.0 109.205 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.5 mtt 49.65 84.98 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.293 1.437 . . . . 0.0 113.518 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.8 -73.63 0.08 OUTLIER Glycine 0 CA--C 1.542 1.746 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.289 -173.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.16 131.96 32.37 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.204 1.936 . . . . 0.0 111.471 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.2 m -55.96 141.72 66.66 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.945 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.38 135.1 59.23 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 122.812 2.341 . . . . 0.0 111.287 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.28 94.1 4.65 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.745 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.579 ' HB3' HG21 ' A' ' 58' ' ' ILE . 31.4 m95 -54.91 -31.54 60.21 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.455 175.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -63.19 -52.61 61.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 0.0 112.388 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.24 65.22 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 78' ' ' ALA . 71.8 t -63.75 -38.4 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.404 1.081 . . . . 0.0 112.668 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.31 93.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.892 168.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.87 -0.25 8.75 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 t -108.51 -29.2 8.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.329 1.451 . . . . 0.0 111.874 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -108.23 -27.31 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.568 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 54.5 p -111.79 -25.74 9.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.47 74.5 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.803 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.17 -77.79 0.21 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 52.2 m-80 -44.47 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 54' ' ' ARG . 40.8 m95 -63.63 -50.15 70.45 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 175.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.77 26.71 0.68 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 16.81 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.193 2.197 . . . . 0.0 116.086 -172.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 34.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 112.124 -2.307 . . . . 0.0 114.988 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -113.7 -14.93 12.55 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.576 1.951 . . . . 0.0 112.674 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.33 39.77 70.35 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.9 m120 -88.89 12.64 14.68 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.7 23.57 50.5 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -171.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 27' ' ' ASN . 52.2 mttt -125.34 150.65 46.97 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.62 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 69.2 m-85 -144.61 174.79 10.66 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 63.72 19.83 63.35 Favored Glycine 0 N--CA 1.48 1.583 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.792 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 62.05 15.36 49.73 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.479 HD12 ' NE1' ' A' ' 73' ' ' TRP . 3.8 mm? -104.74 9.33 35.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 30.89 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.562 1.945 . . . . 0.0 116.034 -169.536 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.69 116.19 23.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.044 -1.434 . . . . 0.0 110.938 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -36.07 126.03 0.68 Allowed Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.67 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.71 -35.61 94.22 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.119 2.546 . . . . 0.0 113.39 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.94 64.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 m -75.21 -42.31 55.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.895 0.478 . . . . 0.0 111.138 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 30.0 t-105 -57.86 -22.63 48.96 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.81 -28.77 3.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.79 78.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -91.52 18.9 6.73 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -21.94 32.22 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 0.0 44.1 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -173.183 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.66 152.8 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.324 1.85 . . . . 0.0 109.361 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 37.18 0.08 OUTLIER Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.505 1.526 . . . . 0.0 116.202 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -57.68 -50.87 85.7 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.151 -1.881 . . . . 0.0 110.365 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 90.6 Cg_endo -71.2 -11.83 29.32 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.081 2.52 . . . . 0.0 115.563 175.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.1 -34.97 32.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 0.0 113.203 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.72 -34.84 10.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.25 118.72 8.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.797 0.839 . . . . 0.0 111.924 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -46.65 161.34 0.06 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -42.73 -60.66 1.49 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.0 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HA ' HG12 ' A' ' 58' ' ' ILE . 15.9 tt0 -67.63 -28.01 67.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -72.4 -43.6 63.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.05 0.453 . . . . 0.0 110.973 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.59 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -63.31 -44.29 95.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.685 176.224 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 55' ' ' GLU . 16.9 pt -55.29 -30.02 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.073 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.91 88.08 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 172.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.36 -42.76 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.763 0.825 . . . . 0.0 110.12 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.99 -36.72 80.21 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.545 1.138 . . . . 0.0 114.047 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -59.55 -41.86 91.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.928 1.291 . . . . 0.0 111.686 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -33.7 57.57 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -61.43 -24.19 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 172.941 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -47.27 79.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.141 0.577 . . . . 0.0 111.337 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -30.13 64.94 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -60.14 -49.53 77.25 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.679 1.191 . . . . 0.0 113.469 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -103.22 -26.55 12.94 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.17 157.39 13.61 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -27.68 15.47 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.52 -21.83 18.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.012 1.725 . . . . 0.0 115.2 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.83 -36.06 58.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.138 0.975 . . . . 0.0 113.583 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.479 ' NE1' HD12 ' A' ' 33' ' ' LEU . 13.2 m-90 -118.82 136.92 24.47 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.93 -85.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.854 2.37 . . . . 0.0 113.885 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -91.55 -53.22 4.41 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.224 1.409 . . . . 0.0 111.477 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.96 160.92 3.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.444 1.898 . . . . 0.0 110.094 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.29 103.81 1.66 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.292 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -59.51 -18.72 42.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -36.62 -45.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.63 1.572 . . . . 0.0 113.165 160.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' HD23 ' A' ' 82' ' ' LEU . 58.6 m -107.29 -30.02 8.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.193 0.997 . . . . 0.0 113.442 170.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.21 11.69 64.57 Favored Glycine 0 N--CA 1.482 1.749 0 C-N-CA 123.941 0.781 . . . . 0.0 114.268 -173.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.626 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.2 mm? . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.89 1.276 . . . . 99.989999999999995 113.455 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.835 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.63 167.3 21.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.059 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.9 ttt -53.66 143.08 21.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.188 0.595 . . . . 0.0 110.954 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.51 -73.75 0.04 OUTLIER Glycine 0 CA--C 1.542 1.778 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.272 -173.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.4 146.13 73.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.447 2.098 . . . . 0.0 112.455 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.1 m -68.58 136.08 90.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.829 176.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.09 126.38 14.36 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.624 2.216 . . . . 0.0 111.46 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -127.12 156.54 41.59 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.993 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' CH2' HD21 ' A' ' 33' ' ' LEU . 3.9 m95 -49.76 -39.47 37.89 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.87 -54.2 49.02 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.96 74.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.128 0.971 . . . . 0.0 112.721 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 78' ' ' ALA . 53.6 t -61.14 -31.38 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.068 1.347 . . . . 0.0 112.62 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.36 76.56 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.349 0.977 . . . . 0.0 112.76 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -77.82 5.42 9.58 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.9 t -116.85 -33.41 4.79 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 12.8 mm-40 -75.77 -43.74 45.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.377 1.071 . . . . 0.0 111.764 171.083 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 t -104.01 -45.17 4.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.011 1.324 . . . . 0.0 113.246 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.89 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 124.179 0.924 . . . . 0.0 114.347 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.77 -100.54 0.15 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 123.992 0.466 . . . . 0.0 112.795 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.38 139.74 33.89 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -66.92 -15.81 63.92 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 167.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' TYR . . . -93.54 -35.35 12.97 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 168.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.73 43.01 9.24 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.93 32.27 4.28 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.919 -175.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -128.36 26.77 5.66 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.708 1.242 . . . . 0.0 113.084 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.31 -95.53 0.39 Allowed Glycine 0 N--CA 1.481 1.656 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 33.2 m-20 -105.69 28.96 6.99 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.11 91.67 Favored Glycine 0 CA--C 1.541 1.711 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.678 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 66.3 mttm -74.69 165.22 25.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.927 0.891 . . . . 0.0 110.703 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 59.7 m-85 -137.43 156.86 47.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.001 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.66 10.14 29.36 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-N 114.272 -1.331 . . . . 0.0 116.147 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 16' ' ' GLU . . . 55.59 29.88 54.87 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 115.536 -0.332 . . . . 0.0 112.302 -167.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -112.32 16.7 19.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.576 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 5.8 pt20 36.0 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 1.9 t80 -98.57 115.31 28.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.35 -168.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.53 130.46 10.6 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.963 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.33 -34.68 98.31 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.917 2.411 . . . . 0.0 113.438 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.66 65.16 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -76.23 -46.53 27.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.434 0.694 . . . . 0.0 111.076 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.439 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -58.51 -22.37 54.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -47.65 -30.35 3.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 169.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.77 72.07 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 64' ' ' VAL . 20.0 m-85 -97.01 19.45 12.79 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.144 1.377 . . . . 0.0 113.219 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.47 -21.72 30.07 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.82 -5.77 29.65 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 114.731 0.653 . . . . 0.0 114.731 -173.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.2 p -64.13 155.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.256 1.823 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 33.96 0.14 Allowed Glycine 0 CA--C 1.541 1.719 0 C-N-CA 124.937 1.256 . . . . 0.0 115.747 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' HG13 ' A' ' 46' ' ' VAL . 5.5 t30 -58.1 -51.44 81.75 Favored Pre-proline 0 N--CA 1.476 0.858 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.241 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.646 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 80.2 Cg_endo -72.95 -10.05 24.27 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.69 2.26 . . . . 0.0 115.254 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -82.43 -33.79 28.45 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.36 -34.06 10.81 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.74 128.0 34.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.874 0.87 . . . . 0.0 111.423 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -49.43 156.09 0.66 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.722 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.74 -57.59 2.69 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.524 1.13 . . . . 0.0 113.994 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HA ' HG12 ' A' ' 58' ' ' ILE . 6.9 tt0 -70.53 -31.5 68.59 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -66.06 -42.07 89.93 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.764 0.826 . . . . 0.0 111.039 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -63.05 -53.74 49.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.06 1.344 . . . . 0.0 110.607 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.779 HG12 ' HA ' ' A' ' 55' ' ' GLU . 20.2 pt -54.31 -31.4 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.19 74.49 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 171.032 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.98 -42.13 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.514 0.726 . . . . 0.0 109.824 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.44 -39.61 84.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.284 1.434 . . . . 0.0 114.041 175.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -59.52 -38.94 82.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.06 1.344 . . . . 0.0 112.132 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -80.74 -36.03 32.54 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -61.9 -20.28 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 172.441 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -40.52 74.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.928 169.109 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.32 -47.32 61.61 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -107.04 -22.71 12.56 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.37 155.15 9.3 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.116 0.865 . . . . 0.0 110.987 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 122.08 -0.659 . . . . 0.0 112.769 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.91 -0.92 8.17 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -57.05 -25.41 58.61 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.421 ' CE2' HD23 ' A' ' 33' ' ' LEU . 12.8 m-90 -118.2 75.53 11.48 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 174.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.17 -20.12 43.91 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.002 2.468 . . . . 0.0 113.828 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.5 p -60.29 -44.38 95.44 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.348 1.859 . . . . 0.0 113.978 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.404 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -139.95 -69.27 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.886 1.274 . . . . 0.0 112.283 172.177 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.76 89.13 0.62 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.32 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.75 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.86 -27.06 11.41 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.61 -43.22 36.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.115 1.366 . . . . 0.0 113.505 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 82' ' ' LEU . 58.5 m -109.03 -20.97 12.84 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.113 0.883 . . . . 0.0 112.628 166.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 -43.6 3.08 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.99 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 80' ' ' SER . 8.2 mp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.848 1.659 . . . . 99.989999999999995 113.632 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 CA-C-O 120.333 -0.148 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.07 80.15 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.372 1.469 . . . . 0.0 112.917 -173.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.1 ttt -115.69 125.62 53.07 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.508 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.28 164.94 11.7 Favored Glycine 0 CA--C 1.547 2.063 0 O-C-N 125.518 1.761 . . . . 0.0 111.958 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.12 149.64 64.89 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.683 2.255 . . . . 0.0 112.713 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -56.37 145.43 58.13 Favored Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HB2' ' HB1' ' A' ' 78' ' ' ALA . 61.3 Cg_endo -67.49 138.44 45.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.322 2.015 . . . . 0.0 111.834 174.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.57 174.54 5.96 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.248 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -33.71 58.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.54 -35.84 72.95 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -66.54 -26.6 67.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 118.816 -0.612 . . . . 0.0 112.358 175.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.68 -42.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.388 0.675 . . . . 0.0 110.267 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -84.63 1.28 46.88 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -112.17 -36.53 5.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.228 1.011 . . . . 0.0 112.338 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -79.31 -51.05 9.95 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.71 1.204 . . . . 0.0 112.645 167.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.59 -23.75 12.37 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -174.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.81 -28.87 5.71 Favored Glycine 0 N--CA 1.482 1.721 0 C-N-CA 122.83 0.252 . . . . 0.0 113.416 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.04 93.14 0.09 OUTLIER Glycine 0 N--CA 1.474 1.227 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -172.15 81.47 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.24 1.016 . . . . 0.0 112.433 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -73.65 -73.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.32 71.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.52 60.84 3.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.014 1.725 . . . . 0.0 114.316 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -77.45 35.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 113.033 -1.894 . . . . 0.0 115.148 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -112.35 -17.67 12.66 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.634 1.973 . . . . 0.0 112.351 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.71 58.04 7.38 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.621 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.498 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.4 t-20 -104.64 20.65 18.24 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.476 -0.862 . . . . 0.0 112.748 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.06 26.78 49.95 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 124.188 0.899 . . . . 0.0 115.157 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -122.51 150.44 42.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.495 1.118 . . . . 0.0 109.451 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 49' ' ' PRO . 10.7 p90 -152.73 139.68 19.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.552 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.34 -0.43 12.49 Favored Glycine 0 N--CA 1.485 1.907 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.654 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.82 25.83 55.12 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 124.525 1.06 . . . . 0.0 114.775 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.16 14.5 27.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 3.7 mt-30 37.91 36.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.929 2.092 . . . . 0.0 116.068 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CE1' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -94.69 121.76 36.6 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.349 -171.74 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -41.73 136.41 2.01 Favored Pre-proline 0 N--CA 1.482 1.16 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 176.991 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 72.5 Cg_endo -65.23 -32.41 51.71 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.635 2.223 . . . . 0.0 112.54 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.4 -34.72 64.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.318 1.047 . . . . 0.0 113.624 172.401 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.582 HG21 ' CE1' ' A' ' 35' ' ' PHE . 23.0 m -68.91 -47.06 66.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.914 0.486 . . . . 0.0 111.698 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.532 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 33.2 t-105 -57.05 -22.28 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.78 -29.2 4.28 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.21 74.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.874 0.869 . . . . 0.0 113.296 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -95.71 18.4 13.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 111.565 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -23.73 23.52 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.12 -0.91 44.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 -172.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.09 153.05 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.361 1.864 . . . . 0.0 109.26 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.83 38.05 0.07 OUTLIER Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.263 1.411 . . . . 0.0 116.418 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 5.8 t30 -57.27 -47.65 98.68 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-O 116.256 -1.83 . . . . 0.0 110.931 172.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -67.55 -28.09 38.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.202 2.601 . . . . 0.0 114.799 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.06 72.17 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.87 -34.17 14.63 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.73 20.94 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.511 1.148 . . . . 0.0 111.969 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.8 t -53.78 157.55 2.3 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.388 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.42 -58.13 3.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -70.75 -19.4 62.73 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.46 -38.92 21.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.336 0.655 . . . . 0.0 111.936 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -63.91 -42.85 97.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 55' ' ' GLU . 14.0 pt -54.22 -29.79 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.12 82.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.535 0.734 . . . . 0.0 112.546 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.37 -42.36 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.371 0.668 . . . . 0.0 109.842 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.41 -35.23 76.97 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.46 -49.38 77.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.72 1.208 . . . . 0.0 110.784 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -65.52 -37.36 86.53 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 61' ' ' ALA 0.28 0.3 OUTLIER -61.29 -22.18 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.913 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.34 -38.96 88.8 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.73 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 6.7 mm-40 -65.23 -54.79 24.19 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 -23.56 11.5 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.13 147.99 7.49 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-O 122.038 0.799 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.46 -29.03 69.65 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.316 -0.942 . . . . 0.0 113.512 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -19.33 15.48 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 172.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.64 74.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.781 0.832 . . . . 0.0 112.82 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -80.8 140.48 50.74 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.796 0.685 . . . . 0.0 109.214 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 83.9 Cg_endo -67.55 -170.06 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.966 2.444 . . . . 0.0 111.493 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.7 p -53.35 -31.81 46.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.38 1.472 . . . . 0.0 114.146 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 1.2 m -39.26 -83.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.043 1.737 . . . . 0.0 113.314 169.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 41.51 43.63 3.89 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 7' ' ' PRO . . . -49.73 -20.2 0.78 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.57 67.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.159 1.783 . . . . 0.0 113.156 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 m -65.54 -19.33 65.88 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.39 27.03 72.81 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 123.853 0.721 . . . . 0.0 113.547 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.909 -1.043 . . . . 99.989999999999995 113.335 177.762 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 CA-C-O 120.871 0.15 . . . . 0.0 113.23 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.97 74.83 0.96 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.492 1.139 . . . . 0.0 109.519 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.9 ttm -69.72 -47.85 61.62 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.171 -1.831 . . . . 0.0 112.75 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.56 90.06 0.08 OUTLIER Glycine 0 CA--C 1.543 1.835 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.866 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.14 140.69 34.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.271 1.981 . . . . 0.0 111.601 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.7 m -62.37 119.61 51.36 Favored Pre-proline 0 N--CA 1.483 1.215 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.93 146.42 65.29 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.003 2.469 . . . . 0.0 112.206 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -114.48 81.18 1.51 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.25 -1.341 . . . . 0.0 114.223 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -57.55 -33.03 67.69 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.911 -1.495 . . . . 0.0 114.044 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.01 -50.75 70.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.739 0.816 . . . . 0.0 112.644 171.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -63.95 -37.8 88.76 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.382 0.426 . . . . 0.0 111.826 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 78' ' ' ALA . 51.4 t -61.25 -35.64 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.778 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.42 90.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.351 169.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -71.36 -3.6 21.6 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -98.48 -27.53 14.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.29 1.436 . . . . 0.0 111.46 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 9.2 mt-10 -104.55 -43.92 5.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.603 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.6 p -87.18 -37.87 16.91 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.15 25.08 59.45 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 124.461 1.101 . . . . 0.0 114.189 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.36 -82.16 0.06 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 123.798 0.352 . . . . 0.0 113.728 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.85 139.3 50.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -69.32 -39.01 78.49 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.328 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.56 13.73 2.38 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 30.3 71.72 0.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.598 1.959 . . . . 0.0 114.298 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -81.55 40.81 0.6 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.952 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -116.88 -19.33 9.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.036 2.534 . . . . 0.0 112.801 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.39 40.7 96.56 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.615 0.626 . . . . 0.0 114.622 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -109.44 32.75 4.76 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.931 0.872 . . . . 0.0 112.513 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.5 35.89 62.68 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.839 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 84.5 mttt -110.98 147.3 35.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.579 0.704 . . . . 0.0 110.586 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 35.6 m-85 -132.56 145.51 51.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.898 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 52.24 29.46 29.64 Favored Glycine 0 N--CA 1.482 1.751 0 O-C-N 125.314 1.634 . . . . 0.0 117.111 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 58.99 22.73 55.84 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.848 0.737 . . . . 0.0 114.664 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -111.93 16.93 20.13 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.7 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 38.9 tt0 43.39 42.97 4.07 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 124.07 1.89 . . . . 0.0 112.746 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -100.98 108.22 19.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.765 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 3.6 mmtt -43.77 138.15 3.17 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 112.587 -2.097 . . . . 0.0 113.768 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 98.6 Cg_endo -66.48 -42.34 9.95 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.709 2.273 . . . . 0.0 112.63 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.63 -34.32 67.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.405 1.082 . . . . 0.0 112.955 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -71.76 -49.27 40.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.053 0.541 . . . . 0.0 112.179 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.2 t-105 -60.2 -21.9 62.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 38' ' ' ALA . . . -51.5 -29.64 17.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 170.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -29.37 63.44 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CZ ' HG22 ' A' ' 64' ' ' VAL . 30.0 m-85 -105.99 25.69 10.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.416 1.486 . . . . 0.0 111.216 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.39 -19.88 52.69 Favored Glycine 0 N--CA 1.479 1.551 0 CA-C-O 119.092 -0.838 . . . . 0.0 115.082 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.65 -5.12 24.72 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.89 151.85 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.322 1.849 . . . . 0.0 112.147 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.81 31.34 0.1 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 113.976 -1.466 . . . . 0.0 116.394 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -52.88 -51.51 73.69 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 116.286 -1.816 . . . . 0.0 111.372 169.264 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 71.8 Cg_endo -66.24 -23.71 51.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.873 2.382 . . . . 0.0 115.652 176.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.07 38.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.53 -36.84 13.48 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 128.05 34.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.989 0.9 . . . . 0.0 110.415 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -52.04 158.34 1.1 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.534 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -44.86 -57.62 3.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.1 tt0 -68.79 -18.79 64.25 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -81.67 -40.85 22.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.328 0.651 . . . . 0.0 111.418 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -60.71 -48.09 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.909 0.884 . . . . 0.0 110.531 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -53.97 -31.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.72 72.56 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.252 0.621 . . . . 0.0 111.873 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.61 -48.62 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.631 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . . . -55.52 -37.83 68.44 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -62.65 -38.32 89.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.755 1.622 . . . . 0.0 113.307 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -81.27 -35.98 30.46 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.259 -0.9 . . . . 0.0 111.741 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.657 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 20.0 t -50.72 -32.74 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.059 1.744 . . . . 0.0 112.072 171.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -56.31 -41.61 76.27 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.86 -28.93 67.15 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -75.99 -59.91 2.55 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.78 -27.01 36.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.0 168.23 31.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.79 24.77 0.29 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.377 -0.912 . . . . 0.0 113.257 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.8 -45.91 12.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.943 . . . . 0.0 113.03 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.68 -34.3 64.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 0.0 113.152 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.34 94.97 49.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.61 -89.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.156 2.571 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -64.02 -43.85 94.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.631 0.772 . . . . 0.0 111.998 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.88 140.6 47.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.15 99.39 0.16 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 124.363 1.039 . . . . 0.0 111.695 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.554 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -60.59 -18.68 54.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -44.17 -48.2 9.19 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 112.497 165.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 82' ' ' LEU . 36.5 m -95.08 -29.35 14.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.124 0.97 . . . . 0.0 113.469 171.194 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.28 67.66 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.169 0.89 . . . . 0.0 113.861 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 80' ' ' SER . 17.7 mt . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.006 -1.473 . . . . 99.989999999999995 111.83 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 CA-C-O 121.732 0.629 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.27 -57.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.722 -1.239 . . . . 0.0 111.371 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.6 ttp 67.34 -47.17 0.49 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.251 2.22 . . . . 0.0 114.051 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.18 -87.64 0.27 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-O 118.228 -1.318 . . . . 0.0 110.559 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.19 150.39 65.51 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.567 2.178 . . . . 0.0 112.949 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 m -53.83 147.6 22.97 Favored Pre-proline 0 N--CA 1.486 1.332 0 CA-C-N 114.634 -1.167 . . . . 0.0 114.125 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 116.05 3.41 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.323 2.682 . . . . 0.0 114.016 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 7.7 m-20 -76.94 72.45 3.51 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.482 ' HB3' HG21 ' A' ' 58' ' ' ILE . 25.7 m95 -61.29 -33.9 74.33 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.831 172.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.6 -48.88 75.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -65.48 -39.84 92.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 78' ' ' ALA . 44.7 t -62.98 -32.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -56.43 -45.46 80.72 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.702 167.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -73.88 4.6 5.08 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -110.83 -33.99 6.37 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.569 0.748 . . . . 0.0 112.301 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.33 -48.07 8.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 168.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 57.2 p -94.35 -29.84 14.81 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.41 17.94 60.33 Favored Glycine 0 CA--C 1.541 1.68 0 O-C-N 123.994 0.809 . . . . 0.0 113.618 -173.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.61 67.4 0.51 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.113 0.863 . . . . 0.0 111.676 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.79 76.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.807 0.843 . . . . 0.0 112.181 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 82.1 m95 -64.44 -38.27 90.42 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.86 -27.9 55.24 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 25' ' ' THR . . . 46.2 69.9 0.43 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.822 1.649 . . . . 0.0 112.769 -173.17 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -76.0 32.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.319 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' ALA . 4.4 p -96.54 -17.34 20.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.053 2.941 . . . . 0.0 113.921 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.83 37.17 93.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -91.92 22.47 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.04 24.75 55.37 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.552 1.072 . . . . 0.0 115.5 -172.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -126.22 142.35 51.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.438 0.695 . . . . 0.0 109.135 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 58.2 m-85 -138.74 166.61 23.95 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.46 1.1 . . . . 0.0 112.507 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.37 -1.64 41.86 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.17 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 17' ' ' SER . . . 60.2 12.58 24.47 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -171.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD12 ' HE1' ' A' ' 73' ' ' TRP . 3.6 mm? -84.82 9.95 12.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 43.38 41.9 3.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.985 2.114 . . . . 0.0 114.458 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.21 118.49 31.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 111.717 -2.492 . . . . 0.0 110.337 -172.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.52 135.77 5.8 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.954 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.99 -39.97 37.14 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.943 2.429 . . . . 0.0 112.939 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.28 -37.19 69.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.291 1.036 . . . . 0.0 113.277 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -69.23 -49.71 53.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.365 0.666 . . . . 0.0 110.961 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -59.47 -25.7 64.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -51.28 -27.29 8.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 170.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.57 73.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -95.31 22.15 7.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.516 1.126 . . . . 0.0 113.581 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.93 -21.23 40.92 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 69.81 6.07 54.29 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.1 148.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.928 1.691 . . . . 0.0 109.369 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 35.01 0.16 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 124.881 1.229 . . . . 0.0 115.711 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.14 -45.29 99.38 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.184 -1.865 . . . . 0.0 109.966 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 43.2 Cg_endo -66.18 -9.87 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.16 2.573 . . . . 0.0 118.03 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.1 -31.77 19.04 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.97 -36.32 8.24 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.976 0.894 . . . . 0.0 111.602 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m -50.3 152.95 1.63 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.276 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -48.63 -53.78 17.21 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.628 ' HA ' HG12 ' A' ' 58' ' ' ILE . 5.8 tm-20 -70.11 -27.15 64.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 175.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -42.71 53.96 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.555 0.693 . . . . 0.0 110.907 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -70.54 -35.65 73.26 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 55' ' ' GLU . 17.8 pt -56.07 -28.67 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.609 172.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.21 77.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.032 0.533 . . . . 0.0 112.376 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.75 -41.31 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.89 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -35.45 77.5 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HA ' HD23 ' A' ' 65' ' ' LEU . 10.8 t-20 -64.88 -36.09 83.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.525 1.53 . . . . 0.0 112.61 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -37.24 28.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -60.54 -24.6 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.668 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -56.87 -46.15 82.01 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.334 0.396 . . . . 0.0 111.723 170.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.5 -33.38 69.2 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.328 0.651 . . . . 0.0 112.693 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -27.7 10.57 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.6 149.86 8.74 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.72 -33.59 71.02 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.45 -23.29 48.82 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.83 94.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 112.76 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CZ3' ' HA ' ' A' ' 65' ' ' LEU . 13.0 m-90 -72.64 149.71 90.8 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.25 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.077 2.518 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -54.23 -21.44 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 21.2 m -101.26 152.47 20.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.887 1.275 . . . . 0.0 111.503 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.4 107.79 0.22 Allowed Glycine 0 N--CA 1.476 1.302 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.479 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.57 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -54.24 -23.22 13.93 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -45.78 -39.9 8.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.868 1.667 . . . . 0.0 113.704 167.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -109.97 -21.04 12.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 113.218 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.57 3.29 Favored Glycine 0 N--CA 1.48 1.581 0 C-N-CA 124.03 0.824 . . . . 0.0 112.466 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.943 -1.503 . . . . 99.989999999999995 114.15 179.872 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.688 0 CA-C-O 121.251 0.362 . . . . 0.0 113.565 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.48 -67.71 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.443 -0.878 . . . . 0.0 111.528 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.2 mtt -128.68 152.86 47.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.995 1.318 . . . . 0.0 110.714 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 152.04 18.04 Favored Glycine 0 CA--C 1.542 1.719 0 O-C-N 124.876 1.36 . . . . 0.0 112.142 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.51 154.93 60.19 Favored 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 122.917 2.411 . . . . 0.0 112.514 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 142.76 80.01 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.722 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.68 127.44 15.46 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.357 2.038 . . . . 0.0 112.646 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.79 154.32 33.03 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.338 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 26.9 m95 -53.64 -32.35 51.08 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 171.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -54.5 45.39 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.67 79.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.496 0.718 . . . . 0.0 112.246 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 78' ' ' ALA . 25.6 t -62.14 -31.59 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.36 81.36 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 168.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.97 5.4 19.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.11 -32.98 7.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.42 1.488 . . . . 0.0 111.448 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.477 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 91.4 mt-10 -101.79 -27.49 12.99 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.532 ' HB2' ' CA ' ' A' ' 32' ' ' GLY . 8.6 t -110.8 -38.96 4.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.894 0.877 . . . . 0.0 113.178 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 31.13 77.2 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.78 -95.91 0.1 Allowed Glycine 0 N--CA 1.48 1.576 0 O-C-N 124.075 0.514 . . . . 0.0 112.439 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.0 146.4 30.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -65.88 -58.7 4.98 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.832 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.23 -26.49 66.46 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 40.11 78.12 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.053 1.741 . . . . 0.0 113.433 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -83.88 43.41 0.92 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.393 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 p -104.45 -15.87 15.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.804 2.442 . . . . 0.0 112.729 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.39 39.98 80.32 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.054 0.782 . . . . 0.0 115.054 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -95.2 21.4 7.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.37 29.09 56.39 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 83.5 mttt -113.2 151.36 31.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.643 1.177 . . . . 0.0 110.105 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 10.3 p90 -132.65 160.7 35.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.236 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 40.12 28.63 0.17 Allowed Glycine 0 N--CA 1.483 1.79 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 172.443 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 17' ' ' SER . . . 60.47 34.23 84.61 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -172.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 2.6 mp -108.29 -2.89 18.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 pt20 42.83 28.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -169.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 2.0 t80 -94.54 108.02 19.99 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.394 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -24.45 126.12 0.16 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-N 112.348 -2.205 . . . . 0.0 114.809 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.44 -35.21 73.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.708 2.272 . . . . 0.0 113.441 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.99 66.89 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.305 1.042 . . . . 0.0 113.394 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 68' ' ' GLN . 25.5 m -67.16 -50.12 62.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.966 0.906 . . . . 0.0 111.097 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -60.02 -22.49 62.7 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -30.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 168.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.16 75.15 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 171.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.1 19.38 9.3 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.163 1.385 . . . . 0.0 113.59 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.21 28.95 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.23 -5.88 24.85 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 -173.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 48' ' ' ASN . 11.2 p -64.99 148.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.539 1.536 . . . . 0.0 111.923 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 31.47 0.1 OUTLIER Glycine 0 CA--C 1.542 1.724 0 C-N-CA 125.086 1.327 . . . . 0.0 116.245 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.513 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 t30 -57.78 -48.64 96.82 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.578 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB3' HE21 ' A' ' 57' ' ' GLN . 68.2 Cg_endo -73.03 -13.88 26.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.417 2.745 . . . . 0.0 116.131 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.83 53.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.34 -34.06 11.2 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.63 56.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.285 1.034 . . . . 0.0 111.786 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.3 t -55.97 154.19 7.77 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.486 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -59.1 3.02 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 14.9 tt0 -69.24 -26.23 64.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.96 -39.08 63.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.712 -0.618 . . . . 0.0 112.264 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -60.0 -50.72 72.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.595 1.158 . . . . 0.0 109.588 173.649 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -55.4 -31.57 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.27 77.77 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.02 -40.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 0.0 110.27 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -59.93 -38.95 83.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.608 1.163 . . . . 0.0 114.138 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 66.3 t30 -60.9 -38.47 85.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.168 1.387 . . . . 0.0 111.677 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -80.01 -32.2 39.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -61.07 -22.43 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.747 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -60.34 -39.43 87.11 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 169.166 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.72 69.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -65.83 -58.87 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.589 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 39' ' ' THR . 22.6 tp60 -91.48 -36.49 13.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.36 150.32 8.15 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -167.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -84.35 -1.35 55.31 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.296 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -87.99 -23.75 23.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.603 1.161 . . . . 0.0 113.429 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.38 91.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.145 0.978 . . . . 0.0 113.62 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -60.35 150.12 73.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.777 169.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 94.6 Cg_endo -63.25 -159.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.741 2.294 . . . . 0.0 111.066 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.0 p -51.49 -32.2 26.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 117.0 -1.476 . . . . 0.0 113.208 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 85.3 m -52.6 -135.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 128.392 3.557 . . . . 0.0 114.063 168.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 102.14 0.25 Allowed Glycine 0 N--CA 1.483 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 112.065 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -49.79 -26.16 3.69 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.18 -39.15 20.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.784 1.234 . . . . 0.0 113.132 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 m -108.93 -29.65 8.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.289 1.036 . . . . 0.0 113.098 168.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.89 -29.17 5.59 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.649 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 76' ' ' CYS . 59.5 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.08 -1.438 . . . . 99.989999999999995 113.212 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.987 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.4 108.08 7.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.357 0.663 . . . . 0.0 111.084 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -159.01 104.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.798 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.13 93.61 0.44 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-O 117.824 -1.542 . . . . 0.0 111.477 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.22 156.43 64.78 Favored 'Trans proline' 0 N--CA 1.477 0.541 0 C-N-CA 122.649 2.233 . . . . 0.0 111.544 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.52 95.51 19.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 118.26 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.305 2.67 . . . . 0.0 113.774 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.22 119.15 30.39 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -57.77 -34.99 70.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.798 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 33.0 t70 -63.57 -48.22 78.32 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.88 75.8 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 78' ' ' ALA . 53.7 t -62.09 -37.45 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.729 0.811 . . . . 0.0 112.491 174.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -53.55 -48.26 69.26 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 167.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.24 8.3 5.14 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.0 t -114.8 -30.85 6.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.371 1.068 . . . . 0.0 113.485 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.59 -36.85 11.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 67.1 p -108.63 -23.4 11.83 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.3 7.93 69.1 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 114.962 0.745 . . . . 0.0 114.962 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.99 83.22 0.54 Allowed Glycine 0 N--CA 1.479 1.505 0 CA-C-O 121.996 0.776 . . . . 0.0 111.355 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 23' ' ' ALA . 1.1 m-20 172.16 108.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.334 2.254 . . . . 0.0 108.647 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.507 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 54.8 m95 -93.22 -44.01 8.54 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 172.141 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.67 -39.62 61.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 49.91 84.81 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.577 1.551 . . . . 0.0 111.658 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.47 58.57 0.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.1 1.429 . . . . 0.0 112.154 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.6 p -107.16 -26.6 11.02 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 34.39 89.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.226 0.917 . . . . 0.0 114.229 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.73 21.07 6.8 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.07 11.49 9.05 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 124.326 0.965 . . . . 0.0 115.433 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 19.5 mtpt -109.34 161.46 15.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.256 1.822 . . . . 0.0 110.247 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.624 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -114.17 119.71 37.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 112.882 -1.963 . . . . 0.0 112.964 -175.169 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.28 144.51 48.71 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.702 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.536 ' H ' ' HB3' ' A' ' 17' ' ' SER . . . 102.19 -36.98 3.9 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 112.943 -1.628 . . . . 0.0 110.806 -178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 61' ' ' ALA . 6.4 mp -109.64 -29.37 8.39 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 53.76 36.28 23.5 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 123.628 1.68 . . . . 0.0 112.047 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -97.76 129.52 44.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.418 -172.184 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -47.63 141.2 7.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 113.48 -1.691 . . . . 0.0 114.63 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 68.6 Cg_endo -60.48 -31.61 92.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.938 2.425 . . . . 0.0 112.868 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.14 63.45 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.61 1.164 . . . . 0.0 114.087 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.603 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 70.4 m -67.37 -57.13 7.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.482 0.713 . . . . 0.0 110.472 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.512 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 23.7 t-105 -56.94 -21.72 32.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.4 -31.27 5.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.42 73.72 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 171.111 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -95.66 16.69 16.65 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.426 1.49 . . . . 0.0 112.757 172.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.63 -22.32 24.3 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.2 -2.9 33.56 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -69.22 154.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.733 1.613 . . . . 0.0 111.701 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.1 33.84 0.11 Allowed Glycine 0 N--CA 1.484 1.851 0 C-N-CA 125.098 1.333 . . . . 0.0 115.986 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 46' ' ' VAL . 1.9 t-20 -59.6 -48.68 94.95 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.207 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.1 Cg_endo -68.49 -30.86 28.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.603 2.202 . . . . 0.0 114.031 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.38 72.49 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.68 -32.44 16.2 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 129.72 40.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.14 0.971 . . . . 0.0 111.679 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.1 t -53.77 155.31 3.32 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.971 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 72.3 mtt180 -46.81 -52.42 14.24 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -69.2 -37.67 78.22 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.038 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -64.26 -35.21 80.1 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.67 -0.644 . . . . 0.0 112.031 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -63.15 -53.72 48.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.393 1.077 . . . . 0.0 109.936 171.009 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -53.71 -32.07 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.62 -57.91 10.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.029 0.932 . . . . 0.0 113.116 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.08 -38.0 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -59.42 -41.71 90.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.241 1.416 . . . . 0.0 114.021 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -61.0 -30.5 70.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.117 1.367 . . . . 0.0 112.255 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -33.8 21.26 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.258 0.8 OUTLIER -59.51 -24.71 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 172.454 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.4 pp -59.13 -44.02 92.0 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 170.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -31.16 70.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.25 -55.32 14.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -98.54 -26.88 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.75 155.26 8.37 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.06 -35.08 77.56 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 122.399 -0.471 . . . . 0.0 112.163 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.93 -17.84 53.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.618 1.567 . . . . 0.0 114.517 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 35' ' ' PHE . . . -44.96 -35.92 3.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.133 1.773 . . . . 0.0 114.38 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.477 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 12.4 m-90 -115.94 97.73 49.78 Favored Pre-proline 0 N--CA 1.471 0.59 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.37 -35.81 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.585 2.19 . . . . 0.0 114.012 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -61.94 -52.2 65.03 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.999 1.32 . . . . 0.0 113.693 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 m -139.42 -166.1 1.99 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.706 1.202 . . . . 0.0 110.196 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.06 102.21 0.16 Allowed Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -51.8 -27.0 10.91 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -46.97 -38.63 11.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.382 1.473 . . . . 0.0 114.236 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -109.5 -19.62 13.17 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.56 4.0 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.492 0.568 . . . . 0.0 113.239 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 115.212 1.56 . . . . 99.989999999999995 115.212 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.27 -72.51 0.15 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.732 0.813 . . . . 0.0 111.891 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.0 mtt -169.42 156.46 6.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.615 1.966 . . . . 0.0 110.2 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.67 -81.89 0.33 Allowed Glycine 0 CA--C 1.538 1.518 0 CA-C-O 118.173 -1.349 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.34 140.52 64.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.425 2.083 . . . . 0.0 112.282 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 m -56.32 148.07 44.58 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.08 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.02 134.95 48.68 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.646 2.231 . . . . 0.0 112.56 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -116.37 126.29 53.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.762 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TRP . . . . . 0.509 ' HB3' HG21 ' A' ' 58' ' ' ILE . 11.3 m95 -57.61 -30.69 65.53 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.167 170.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.0 m-20 -60.87 -51.04 70.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.212 1.005 . . . . 0.0 112.885 171.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.33 78.12 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.506 0.722 . . . . 0.0 112.513 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 78' ' ' ALA . 61.3 t -62.2 -42.97 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.519 1.128 . . . . 0.0 111.985 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -53.2 -44.94 68.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.105 0.562 . . . . 0.0 111.73 168.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.09 -5.61 36.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 t -105.33 -26.82 11.83 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.678 1.191 . . . . 0.0 112.596 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.81 -40.95 7.87 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.6 p -104.83 -23.31 13.04 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.4 -25.82 22.64 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.999 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.79 -40.68 0.2 Allowed Glycine 0 N--CA 1.477 1.432 0 CA-C-N 115.524 -0.338 . . . . 0.0 113.394 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -52.22 100.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.565 1.146 . . . . 0.0 113.21 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -73.77 -22.58 59.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -102.96 -25.43 13.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.16 74.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.228 2.211 . . . . 0.0 115.479 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 43.06 88.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.367 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.465 HG23 ' HB1' ' A' ' 22' ' ' ALA . 67.8 p -58.69 -26.28 63.7 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.319 -1.764 . . . . 0.0 112.871 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.78 -3.54 22.03 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.166 1.365 . . . . 0.0 115.422 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -95.1 7.91 44.62 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.95 8.16 33.67 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 124.007 0.813 . . . . 0.0 113.516 -172.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.636 ' HG3' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mttm -110.7 159.51 17.55 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.749 2.02 . . . . 0.0 110.422 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -122.86 126.48 47.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.363 -175.433 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 151.03 38.8 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 112.031 -2.35 . . . . 0.0 112.71 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 94.7 -39.22 2.93 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 111.618 -2.291 . . . . 0.0 110.837 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD21 ' HB1' ' A' ' 61' ' ' ALA . 5.2 mp -107.44 -32.01 7.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.683 -1.258 . . . . 0.0 114.024 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 56.06 34.33 23.57 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.048 1.739 . . . . 0.0 112.193 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -96.24 132.5 41.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.33 -170.509 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.87 142.4 13.01 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.907 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' A' ' 29' ' ' LYS . 47.6 Cg_endo -57.97 -33.04 96.68 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.295 2.663 . . . . 0.0 113.499 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.13 62.53 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -67.24 -56.96 7.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 110.546 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 21.5 t-105 -60.2 -21.78 62.17 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.61 -30.9 5.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 114.303 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.51 77.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.54 17.64 9.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.156 1.382 . . . . 0.0 113.907 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.48 -21.62 30.24 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.04 49.31 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 114.785 0.674 . . . . 0.0 114.785 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.88 150.2 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.699 1.599 . . . . 0.0 109.135 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.06 40.13 0.07 OUTLIER Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.381 1.467 . . . . 0.0 115.917 170.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.43 -53.46 45.6 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 116.177 -1.868 . . . . 0.0 110.665 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HB3' HE21 ' A' ' 57' ' ' GLN . 83.8 Cg_endo -67.63 -21.15 46.07 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.837 2.358 . . . . 0.0 113.802 175.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -67.32 -35.36 79.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.585 1.554 . . . . 0.0 114.673 173.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.76 -29.5 10.52 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 131.39 50.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 111.21 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -54.19 151.83 6.78 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.072 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -44.69 -57.45 3.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 40.9 tt0 -68.18 -30.17 69.21 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.75 -38.75 70.36 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.664 -0.648 . . . . 0.0 112.191 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.641 HE21 ' HB3' ' A' ' 49' ' ' PRO . 1.7 tm0? -59.13 -54.97 40.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.434 1.094 . . . . 0.0 109.466 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -55.15 -28.4 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.01 75.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 170.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.47 -39.88 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.737 0.815 . . . . 0.0 109.849 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -58.55 -39.94 81.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.091 1.357 . . . . 0.0 113.715 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.39 -45.49 91.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.78 1.232 . . . . 0.0 110.864 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.28 81.96 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 173.136 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.273 0.3 OUTLIER -61.12 -19.95 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 175.204 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -44.48 86.69 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.297 169.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -27.76 69.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.78 80.0 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -103.65 -24.69 13.35 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.79 159.96 10.83 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -56.75 -32.81 65.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.269 -0.548 . . . . 0.0 112.433 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.65 2.24 6.86 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.081 1.752 . . . . 0.0 114.965 175.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -55.42 -28.15 52.33 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 17.8 m-90 -118.21 74.8 11.0 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.8 -21.17 38.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.9 p -57.37 -41.34 79.96 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.182 1.793 . . . . 0.0 113.164 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -142.07 -86.0 0.17 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.277 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' CYS . . . 94.87 104.26 1.91 Allowed Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' A' ' 12' ' ' VAL . . . -45.86 -40.08 9.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.77 81.69 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 -27.5 30.48 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.59 26.21 69.54 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 124.11 0.862 . . . . 0.0 114.48 -172.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 125.671 1.588 . . . . 99.989999999999995 112.877 -178.171 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -60.04 -31.98 70.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.64 -48.92 58.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.69 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.66 79.25 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' H ' ' A' ' 78' ' ' ALA 0.255 50.8 t -64.66 -31.82 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -60.54 -39.73 88.98 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 167.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.08 6.56 7.69 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -107.33 -34.61 7.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.894 1.278 . . . . 0.0 110.666 176.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.35 -33.82 10.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.499 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 33.1 t -102.35 -36.48 8.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.698 0.799 . . . . 0.0 112.741 173.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.6 66.64 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.55 -90.05 0.08 OUTLIER Glycine 0 CA--C 1.538 1.48 0 CA-C-N 115.51 -0.345 . . . . 0.0 112.707 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -113.72 143.79 44.03 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 41.2 m95 -63.99 -34.55 78.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 171.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.27 64.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.92 71.11 0.34 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.77 1.628 . . . . 0.0 113.902 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -77.05 32.27 0.14 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.551 -2.113 . . . . 0.0 114.725 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -101.48 -14.54 17.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.628 1.971 . . . . 0.0 113.092 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 34.33 85.87 Favored Glycine 0 N--CA 1.48 1.592 0 O-C-N 123.98 0.8 . . . . 0.0 114.961 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -87.08 19.27 3.17 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.44 24.3 45.56 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 124.022 0.82 . . . . 0.0 114.778 -170.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 34' ' ' GLN . 44.3 mmtm -119.63 146.39 45.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.42 0.688 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 79.3 m-85 -134.43 164.96 26.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.211 -176.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.73 30.28 62.48 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.868 -1.514 . . . . 0.0 115.338 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 53.7 23.86 23.09 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.603 1.097 . . . . 0.0 115.782 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HE1' ' A' ' 73' ' ' TRP . 13.2 mt -113.69 10.7 17.99 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.462 ' C ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 43.17 39.56 2.01 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 123.042 1.401 . . . . 0.0 112.648 -175.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -99.14 112.0 24.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.448 -172.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.36 132.45 4.62 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 113.362 -1.745 . . . . 0.0 113.621 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 66.6 Cg_endo -60.54 -37.05 83.2 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.978 2.452 . . . . 0.0 112.936 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.37 66.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.239 1.015 . . . . 0.0 113.588 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m -72.06 -47.54 50.82 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.651 0.78 . . . . 0.0 111.092 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.465 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -60.11 -23.31 63.74 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.22 -29.54 5.82 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.3 -33.58 69.62 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 64' ' ' VAL . 17.3 m-85 -100.89 22.58 11.9 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.139 1.376 . . . . 0.0 112.711 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.26 -24.29 26.59 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 75.52 -8.32 20.36 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 114.718 0.647 . . . . 0.0 114.718 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 48' ' ' ASN . 24.4 t -62.45 151.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.794 2.038 . . . . 0.0 109.548 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.08 36.16 0.11 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.448 1.499 . . . . 0.0 115.934 174.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 46' ' ' VAL . 12.1 t-20 -57.96 -50.51 87.71 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.502 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 85.7 Cg_endo -72.38 -16.07 27.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.972 2.448 . . . . 0.0 114.983 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -76.6 -34.3 58.4 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.1 -35.94 11.7 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.65 122.43 15.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.066 0.946 . . . . 0.0 111.55 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 m -47.15 159.1 0.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.111 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 mpp_? -41.99 -57.22 2.51 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 19.9 tt0 -67.12 -37.71 84.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -62.11 -39.57 92.97 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.705 0.764 . . . . 0.0 110.887 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -50.93 66.65 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.671 1.188 . . . . 0.0 110.894 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.5 pt -53.83 -33.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 123.644 0.59 . . . . 0.0 112.531 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.19 -54.64 41.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.134 0.974 . . . . 0.0 113.053 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.11 -41.18 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.138 0.575 . . . . 0.0 110.047 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.622 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.04 -38.42 82.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.281 1.432 . . . . 0.0 114.332 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -59.58 -39.62 84.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.785 1.234 . . . . 0.0 111.618 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -78.98 -37.83 38.43 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.622 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.268 0.4 OUTLIER -60.84 -23.59 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.625 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -40.24 88.72 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 169.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -31.7 65.35 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.12 -49.6 73.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -108.25 -27.34 10.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.0 147.94 9.05 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.23 -21.24 22.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.076 1.75 . . . . 0.0 114.935 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.64 78.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 112.603 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.472 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 25.1 m-90 -86.02 146.8 43.88 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 124.033 0.833 . . . . 0.0 109.306 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.61 -148.78 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.411 2.741 . . . . 0.0 111.586 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 t -51.38 -30.35 18.63 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.9 m -81.58 131.98 35.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.75 1.22 . . . . 0.0 108.91 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.79 98.98 0.12 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.448 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.534 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -57.91 -20.81 40.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.17 23.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.947 1.299 . . . . 0.0 113.567 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -101.61 -24.17 14.16 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.47 1.108 . . . . 0.0 113.714 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.0 2.91 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.631 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 126.695 1.998 . . . . 99.989999999999995 113.377 -173.697 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 . . . . . 0 N--CA 1.475 0.824 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.411 ' CH2' HD21 ' A' ' 33' ' ' LEU . 4.5 m95 -57.34 -33.66 67.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.66 -53.49 56.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.364 0.666 . . . . 0.0 111.844 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.49 71.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 78' ' ' ALA . 94.3 t -60.14 -36.21 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 172.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.292 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -0.46 11.59 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -28.74 7.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.49 1.116 . . . . 0.0 113.148 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -100.96 -21.47 15.05 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -122.06 -27.45 4.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.41 6.28 89.36 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 115.962 -0.563 . . . . 0.0 114.354 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.17 76.32 0.27 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 121.775 0.653 . . . . 0.0 112.956 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 176.36 119.78 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.604 1.962 . . . . 0.0 109.405 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -90.29 -67.81 0.82 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.96 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.8 64.72 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.16 72.28 0.22 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.068 1.747 . . . . 0.0 113.952 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -81.74 42.64 0.71 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.397 -1.729 . . . . 0.0 113.387 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -111.37 -17.09 13.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.26 2.224 . . . . 0.0 111.938 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 54.27 21.69 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.986 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.2 t-20 -99.05 23.43 9.03 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.82 30.09 56.09 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 124.154 0.883 . . . . 0.0 114.828 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -127.79 146.97 50.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.509 1.123 . . . . 0.0 109.388 -173.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.407 ' CB ' ' HG2' ' A' ' 49' ' ' PRO . 66.4 m-85 -138.55 151.42 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.159 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 64.88 2.94 8.88 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 114.352 -1.294 . . . . 0.0 115.165 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 20' ' ' ASN . . . 65.23 36.12 92.43 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.143 0.877 . . . . 0.0 114.047 -172.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.411 HD21 ' CH2' ' A' ' 9' ' ' TRP . 5.9 mp -111.68 19.29 18.2 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 32.54 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -90.99 105.56 17.92 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.173 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -40.41 129.56 1.75 Allowed Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 113.025 -1.898 . . . . 0.0 112.747 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 59.7 Cg_endo -59.72 -32.52 95.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.075 2.517 . . . . 0.0 113.46 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.29 68.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -72.26 -45.03 61.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.893 0.477 . . . . 0.0 111.272 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 39.0 t-105 -58.54 -21.81 53.62 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.03 -29.13 4.58 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 168.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.22 69.09 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.547 ' CE1' HG23 ' A' ' 64' ' ' VAL . 26.3 m-85 -100.07 21.85 12.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.142 1.377 . . . . 0.0 112.779 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.15 30.74 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 -1.28 36.38 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -172.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 48' ' ' ASN . 48.3 t -67.32 152.19 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.409 1.884 . . . . 0.0 109.305 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.22 36.33 0.09 OUTLIER Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.501 1.524 . . . . 0.0 116.1 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 46' ' ' VAL . 2.2 t-20 -58.91 -51.46 81.7 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.225 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.8 Cg_endo -71.78 -11.43 27.73 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.011 2.474 . . . . 0.0 115.442 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.71 -34.29 27.33 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.36 -35.05 10.83 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 129.94 43.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.663 0.785 . . . . 0.0 110.871 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.7 t -53.34 159.88 1.28 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.964 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -43.16 -59.01 2.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.4 1.08 . . . . 0.0 113.7 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.3 tt0 -67.47 -34.81 77.92 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -65.81 -37.55 86.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.601 -0.687 . . . . 0.0 111.674 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -62.6 -52.73 62.21 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 110.127 172.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 8.2 pt -56.06 -30.12 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.64 68.6 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.64 -42.5 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.752 0.821 . . . . 0.0 109.774 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.3 -39.51 87.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.588 1.555 . . . . 0.0 114.369 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -56.77 -46.93 81.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 110.669 173.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -35.07 68.54 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -62.38 -22.4 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.933 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -40.83 89.19 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.582 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.79 -30.87 71.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.66 -56.52 7.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -89.37 -25.16 21.73 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.61 154.0 9.8 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -56.61 -32.12 64.97 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.946 -0.738 . . . . 0.0 112.622 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.35 -2.02 5.54 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.52 -31.77 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 13.1 m-90 -117.71 69.96 6.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.534 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -64.73 -25.38 61.25 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.559 2.173 . . . . 0.0 113.115 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 p -57.73 -28.29 63.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.195 2.198 . . . . 0.0 115.326 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 -60.52 0.19 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.42 99.35 0.19 Allowed Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.154 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.48 -38.59 54.65 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.412 -0.894 . . . . 0.0 113.274 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.038 1.335 . . . . 0.0 114.083 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -22.55 30.03 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.08 28.02 57.95 Favored Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 117.621 -1.18 . . . . 99.989999999999995 113.8 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 . . . . . 0 N--CA 1.475 0.814 0 CA-C-O 119.338 -0.363 . . . . 0.0 110.312 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -52.91 -33.74 51.82 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 176.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.34 -42.28 77.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.043 0.937 . . . . 0.0 113.351 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -64.07 -31.13 72.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.678 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.06 -49.23 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.92 94.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.07 10.91 1.66 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -115.8 -31.53 5.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.114 1.366 . . . . 0.0 111.613 177.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.25 -43.37 7.0 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 t -88.33 -39.28 14.47 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.42 1.088 . . . . 0.0 112.861 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.37 18.72 58.83 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.104 -0.953 . . . . 0.0 115.108 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.07 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.477 1.374 0 CA-C-O 121.502 0.501 . . . . 0.0 113.124 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -114.1 144.42 43.18 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -65.95 -44.12 85.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.903 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.66 -31.55 70.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.01 76.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.271 1.828 . . . . 0.0 113.586 -172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -81.96 51.97 1.86 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.786 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -113.65 -23.79 9.54 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 111.642 -2.526 . . . . 0.0 112.356 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.23 36.82 90.47 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.7 29.55 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.468 0.651 . . . . 0.0 112.726 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.1 41.12 92.44 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.354 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -116.48 146.07 42.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.949 0.9 . . . . 0.0 110.381 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 14.9 m-85 -139.26 134.78 33.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.861 -173.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 33' ' ' LEU . . . 52.98 31.73 40.46 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 125.33 1.644 . . . . 0.0 114.781 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.94 17.32 9.29 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.562 HD11 ' CZ3' ' A' ' 9' ' ' TRP . 0.1 OUTLIER -103.14 19.96 18.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.728 0.811 . . . . 0.0 113.055 -176.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 36.96 40.96 0.16 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.705 2.002 . . . . 0.0 113.723 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.84 99.49 12.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.891 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.636 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -37.06 132.45 0.72 Allowed Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 112.682 -2.054 . . . . 0.0 113.665 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 78.4 Cg_endo -63.35 -39.11 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.212 2.608 . . . . 0.0 113.167 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.55 -35.13 67.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.148 0.979 . . . . 0.0 113.071 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -70.61 -51.07 30.64 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.187 0.995 . . . . 0.0 111.354 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 37.1 t-105 -58.18 -21.1 45.91 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.62 -29.35 4.23 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.42 67.76 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -100.52 21.52 13.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.243 1.417 . . . . 0.0 113.277 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.32 -23.71 26.2 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.78 -6.14 20.37 Favored Glycine 0 N--CA 1.484 1.875 0 CA-C-N 117.321 0.56 . . . . 0.0 114.462 -172.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' ASN . 31.7 t -64.81 150.39 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.076 1.75 . . . . 0.0 109.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 37.28 0.1 OUTLIER Glycine 0 N--CA 1.484 1.879 0 C-N-CA 125.127 1.346 . . . . 0.0 115.748 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' VAL . 14.3 t-20 -56.98 -51.62 80.29 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.465 174.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.1 Cg_endo -70.44 -20.64 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.328 2.685 . . . . 0.0 115.115 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.01 55.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.252 1.021 . . . . 0.0 113.442 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.95 -32.34 15.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -67.47 130.59 43.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 112.525 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -54.73 159.38 2.24 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.742 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.57 -52.27 10.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 21.3 tt0 -63.59 -40.26 96.49 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.418 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 43.1 tp60 -63.82 -40.15 95.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.287 0.635 . . . . 0.0 110.774 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -49.9 68.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.627 1.171 . . . . 0.0 111.089 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -55.18 -33.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.117 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.19 69.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.24 -44.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.372 0.669 . . . . 0.0 110.373 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.6 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -64.7 -34.56 78.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -56.3 -50.29 71.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.618 1.167 . . . . 0.0 110.557 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -33.63 70.44 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.286 0.3 OUTLIER -62.5 -21.71 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.914 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -38.86 91.38 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 168.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.78 -31.54 71.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 1.4 mm-40 -73.16 -65.93 0.74 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -81.85 -23.02 36.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.38 -169.31 16.21 Favored Glycine 0 N--CA 1.474 1.187 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 17.73 20.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.871 -1.164 . . . . 0.0 113.32 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.63 -37.75 65.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.31 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.024 0.827 . . . . 0.0 113.039 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -128.56 82.61 68.28 Favored Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.22 -81.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.936 2.424 . . . . 0.0 111.666 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 t -56.22 -44.64 79.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.896 1.278 . . . . 0.0 112.932 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.4 m -80.7 103.4 10.52 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.03 1.332 . . . . 0.0 108.191 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.01 50.55 0.58 Allowed Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.773 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -12.14 27.14 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.77 -30.82 57.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 165.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 m -93.52 -15.27 25.67 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 36.65 23.77 Favored Glycine 0 CA--C 1.54 1.613 0 N-CA-C 115.467 0.947 . . . . 0.0 115.467 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 114.641 1.349 . . . . 99.989999999999995 114.641 178.098 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t30 . . . . . 0 N--CA 1.482 1.162 0 CA-C-O 119.701 -0.19 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -50.89 -32.43 20.51 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 173.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.64 -34.3 71.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.76 71.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.418 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 78' ' ' ALA . 15.0 t -58.15 -48.75 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 170.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.34 98.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -3.89 22.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -115.73 -29.4 6.44 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 54.6 mm-40 -88.86 -32.21 17.89 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 171.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -115.21 -33.99 5.15 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.54 33.97 Favored Glycine 0 CA--C 1.54 1.607 0 O-C-N 123.321 0.388 . . . . 0.0 112.646 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.33 89.83 0.19 Allowed Glycine 0 N--CA 1.476 1.348 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.6 86.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.981 1.313 . . . . 0.0 110.285 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -71.47 -34.4 70.17 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.06 32.18 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.3 66.29 1.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.954 1.701 . . . . 0.0 112.923 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.8 35.52 0.37 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.304 -1.771 . . . . 0.0 113.456 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 p -104.69 -18.69 14.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.02 2.128 . . . . 0.0 112.797 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.27 73.79 Favored Glycine 0 N--CA 1.481 1.639 0 C-N-CA 123.753 0.692 . . . . 0.0 114.59 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 19.93 1.9 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.0 30.28 63.34 Favored Glycine 0 CA--C 1.543 1.839 0 C-N-CA 123.79 0.709 . . . . 0.0 114.258 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -126.02 144.24 50.79 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.458 0.703 . . . . 0.0 109.649 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 94.4 m-85 -142.16 151.76 42.53 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.892 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 -11.81 5.36 Favored Glycine 0 N--CA 1.483 1.772 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.925 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 26.67 74.45 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.27 17.91 20.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER 42.68 40.3 1.96 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.375 2.27 . . . . 0.0 113.836 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -98.01 113.36 25.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.362 -168.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -40.7 127.59 1.89 Allowed Pre-proline 0 N--CA 1.481 1.081 0 CA-C-N 113.414 -1.721 . . . . 0.0 114.072 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 96.2 Cg_endo -64.44 -37.83 36.85 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.797 2.332 . . . . 0.0 112.316 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.89 74.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.274 1.03 . . . . 0.0 113.322 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 90.3 m -68.66 -45.78 70.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.99 0.516 . . . . 0.0 111.5 171.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.407 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 32.0 t-105 -56.53 -22.34 32.37 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.499 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.72 -27.03 6.3 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 168.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.68 71.39 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.694 0.798 . . . . 0.0 112.97 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.53 19.46 10.99 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.309 1.044 . . . . 0.0 113.657 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.4 -21.29 31.04 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.22 -3.62 29.79 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 114.53 0.572 . . . . 0.0 114.53 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.82 154.07 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.581 1.552 . . . . 0.0 111.303 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.64 39.33 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 114.332 -1.304 . . . . 0.0 115.544 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -48.51 96.75 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.211 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 28.8 Cg_endo -66.27 -26.2 49.13 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.449 2.099 . . . . 0.0 115.965 171.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -72.95 -37.15 67.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.82 16.23 24.62 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.97 143.02 47.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.091 0.948 . . . . 0.0 110.772 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 33.9 t -62.99 156.84 23.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.3 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -60.34 2.61 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.933 0.893 . . . . 0.0 112.936 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.8 tt0 -70.62 -24.17 62.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.298 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 3.0 tp60 -74.14 -46.67 40.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.621 0.724 . . . . 0.0 111.37 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -69.14 -36.84 77.88 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -53.58 -29.42 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.876 171.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.02 99.53 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.99 -42.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.037 0.535 . . . . 0.0 109.702 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -62.91 -35.76 81.14 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.29 -35.94 80.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.765 1.626 . . . . 0.0 111.844 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -79.17 -37.66 37.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.28 0.5 OUTLIER -60.81 -20.47 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 175.881 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -39.92 81.12 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 168.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.19 69.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.68 -57.62 3.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.313 1.045 . . . . 0.0 113.465 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -87.48 -25.68 23.6 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.79 149.43 8.61 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.84 -26.06 61.51 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 -3.39 23.28 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 172.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -59.58 -32.64 70.57 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.0 m-90 -121.83 76.09 38.07 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.46 -34.04 4.87 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.757 2.304 . . . . 0.0 113.082 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.2 p -61.53 -41.11 96.85 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.106 1.762 . . . . 0.0 113.302 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.69 133.9 13.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 110.377 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.96 57.68 0.55 Allowed Glycine 0 N--CA 1.476 1.317 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.025 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -56.58 -18.71 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.73 11.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.993 1.317 . . . . 0.0 113.868 165.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.4 p -102.07 -13.14 17.63 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.316 1.447 . . . . 0.0 113.993 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 13.43 46.15 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 116.159 1.223 . . . . 0.0 116.159 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 115.56 1.689 . . . . 99.989999999999995 115.56 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.471 0.603 0 N-CA-C 113.16 0.8 . . . . 0.0 113.16 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.534 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -60.64 -33.6 73.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.117 -1.401 . . . . 0.0 113.483 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.36 -34.88 67.06 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -65.02 -31.54 72.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.54 -47.83 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.277 0.631 . . . . 0.0 109.606 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -59.19 -39.19 81.79 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 173.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.58 0.06 21.47 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.2 t -114.41 -32.93 5.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.788 1.235 . . . . 0.0 111.926 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -98.01 -25.71 14.87 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 3.8 t -121.1 -24.91 5.42 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.35 -25.09 22.28 Favored Glycine 0 N--CA 1.483 1.772 0 O-C-N 122.102 -0.374 . . . . 0.0 113.536 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -46.72 0.15 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.694 0.664 . . . . 0.0 113.621 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.68 101.42 0.11 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -64.13 -34.68 78.61 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 19.0 20.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.83 79.14 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.453 1.901 . . . . 0.0 114.757 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.07 41.22 0.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.566 -2.107 . . . . 0.0 112.741 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 27' ' ' ASN . 10.2 t -114.86 -16.16 11.76 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.572 2.349 . . . . 0.0 112.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 36.67 90.56 Favored Glycine 0 CA--C 1.54 1.622 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.491 ' HB2' HG23 ' A' ' 25' ' ' THR . 1.4 m-20 -97.35 24.75 6.2 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.76 29.99 51.07 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -117.26 154.13 31.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.876 1.271 . . . . 0.0 110.056 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 36.2 m-85 -149.77 166.29 29.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.96 16.98 42.19 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 114.594 -1.185 . . . . 0.0 116.034 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 58.66 24.13 56.43 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.904 0.764 . . . . 0.0 114.424 -171.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.534 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 1.3 mt -116.28 14.62 15.83 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -170.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 36.65 27.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.79 98.54 6.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.743 -169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -29.05 132.79 0.2 Allowed Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.626 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.38 -41.02 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.34 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.85 -33.09 68.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.172 0.989 . . . . 0.0 113.45 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -75.38 -43.88 47.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.579 0.752 . . . . 0.0 112.036 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.482 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -61.97 -21.24 64.66 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.95 -29.2 7.96 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.73 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -102.11 21.24 15.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.539 1.535 . . . . 0.0 113.273 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.65 -22.05 31.15 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.24 -0.22 41.35 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -172.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.35 150.51 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.26 1.824 . . . . 0.0 109.331 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.72 37.11 0.08 OUTLIER Glycine 0 CA--C 1.542 1.738 0 C-N-CA 125.446 1.498 . . . . 0.0 116.137 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.81 -53.91 59.73 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 115.177 -2.344 . . . . 0.0 109.744 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -68.49 -10.71 29.84 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.417 2.745 . . . . 0.0 116.273 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -82.9 -35.7 25.92 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.27 -30.87 11.65 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.09 123.36 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.097 1.359 . . . . 0.0 111.637 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.6 t -53.8 152.74 5.17 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.659 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -40.33 -58.29 1.56 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.4 tp10 -70.9 -32.12 68.98 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.68 -37.4 59.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.315 0.646 . . . . 0.0 112.387 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -64.92 -50.76 65.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.506 0.722 . . . . 0.0 112.819 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 55' ' ' GLU . 39.6 pt -53.5 -29.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.89 90.45 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.962 0.905 . . . . 0.0 113.439 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 t -63.39 -44.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.875 0.87 . . . . 0.0 109.55 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 1.3 t30 -58.09 -37.23 74.11 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.158 1.383 . . . . 0.0 112.429 172.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -76.89 -40.52 47.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.436 0.636 . . . . 0.0 111.346 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.275 0.4 OUTLIER -59.94 -21.69 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.394 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.5 pp -58.26 -37.58 75.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.34 -30.81 65.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.456 0.702 . . . . 0.0 112.843 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.16 -60.74 2.36 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -82.63 -37.82 24.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.63 156.18 10.94 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.2 mt -58.42 -15.14 9.56 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -64.49 -21.15 66.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.776 1.63 . . . . 0.0 113.335 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.17 87.97 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 80.52 62.89 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -83.69 -54.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.502 2.135 . . . . 0.0 112.965 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.7 p -64.22 -55.51 21.13 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.836 1.654 . . . . 0.0 111.995 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 86.0 m -90.95 123.73 34.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.074 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.28 46.67 0.32 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.329 1.018 . . . . 0.0 113.599 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.69 18.54 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.14 -43.58 78.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.899 1.28 . . . . 0.0 112.548 168.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 m -79.53 -18.85 50.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.584 1.154 . . . . 0.0 113.778 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.26 -48.27 3.77 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.712 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.032 -1.461 . . . . 99.989999999999995 112.393 -170.297 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 N--CA 1.479 0.997 0 CA-C-O 120.553 0.216 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -47.78 -33.95 7.89 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.61 -33.75 68.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.65 -33.49 74.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.208 1.003 . . . . 0.0 112.317 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.04 -49.53 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -57.4 -42.56 82.46 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.74 4.63 11.17 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.78 -43.47 3.44 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 168.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.55 -44.73 66.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.958 0.903 . . . . 0.0 113.406 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -102.81 -42.79 5.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.036 0.934 . . . . 0.0 112.585 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.52 24.59 64.12 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.15 -93.54 0.1 OUTLIER Glycine 0 N--CA 1.477 1.368 0 O-C-N 124.125 0.544 . . . . 0.0 112.164 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -113.53 147.72 37.42 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 49.8 m95 -71.25 -43.44 67.26 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.287 173.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.2 -24.39 67.35 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.35 71.77 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 113.962 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.0 32.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.896 -1.957 . . . . 0.0 115.004 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.5 p -109.12 -23.4 11.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.218 2.207 . . . . 0.0 113.251 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.89 35.31 72.34 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 115.911 1.124 . . . . 0.0 115.911 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 88.6 m-20 -90.93 28.38 1.58 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.37 40.44 92.02 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-O 121.518 0.51 . . . . 0.0 113.233 -173.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 40.6 mttp -120.53 137.15 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 109.255 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.609 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 99.2 m-85 -138.4 147.81 43.78 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.575 1.172 . . . . 0.0 111.431 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.97 -4.51 7.78 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.546 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 71.31 26.98 72.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.418 0.532 . . . . 0.0 112.833 -173.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.402 HD23 ' OE1' ' A' ' 57' ' ' GLN . 3.4 mm? -111.42 21.6 16.03 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.651 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 1.2 tt0 44.45 35.12 1.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.534 1.635 . . . . 0.0 113.287 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.11 107.5 20.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.72 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -47.37 133.05 9.96 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.884 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 74.2 Cg_endo -62.7 -34.43 73.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.918 2.412 . . . . 0.0 113.326 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.27 70.96 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.042 0.937 . . . . 0.0 113.232 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -66.28 -50.72 62.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.168 0.987 . . . . 0.0 111.794 170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.3 t-105 -57.35 -22.01 39.52 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.64 -29.06 6.63 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 169.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.01 70.49 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.45 25.44 9.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.996 . . . . 0.0 111.761 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.4 -22.84 31.7 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 115.824 1.09 . . . . 0.0 115.824 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.85 -6.0 28.6 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -173.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.89 149.64 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.317 1.847 . . . . 0.0 109.295 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.23 35.86 0.09 OUTLIER Glycine 0 CA--C 1.544 1.866 0 C-N-CA 125.175 1.369 . . . . 0.0 116.218 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.57 -48.34 97.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 116.058 -1.925 . . . . 0.0 110.874 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 72.5 Cg_endo -69.2 -19.81 38.31 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.81 2.34 . . . . 0.0 114.781 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.66 51.19 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.37 -34.12 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 128.05 34.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.949 0.9 . . . . 0.0 111.542 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -50.82 157.7 0.77 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.597 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.675 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 2.6 mpt_? -38.92 -61.02 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.6 ' HA ' HG12 ' A' ' 58' ' ' ILE . 11.0 tt0 -69.79 -24.42 63.49 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -74.51 -41.51 60.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.444 0.698 . . . . 0.0 110.669 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.402 ' OE1' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -61.49 -47.65 84.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.566 1.146 . . . . 0.0 110.572 175.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.6 HG12 ' HA ' ' A' ' 55' ' ' GLU . 10.1 pt -55.31 -31.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.48 68.05 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 112.534 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.32 -41.5 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.794 0.438 . . . . 0.0 110.26 177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -34.12 74.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.71 -44.77 96.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.164 0.985 . . . . 0.0 111.919 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.58 -38.8 80.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.213 0.53 . . . . 0.0 111.943 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 61' ' ' ALA 0.27 0.4 OUTLIER -59.96 -22.99 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.156 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.65 80.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 169.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.0 -29.3 68.28 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -59.97 2.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.52 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -91.18 -21.81 20.96 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 151.58 9.27 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.87 -37.88 86.21 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -7.61 18.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.7 67.48 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -99.62 141.14 22.27 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 173.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.06 -159.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.684 2.256 . . . . 0.0 111.185 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.2 p -54.14 -24.56 18.32 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.05 67.09 1.69 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.998 1.38 . . . . 0.0 112.494 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.63 50.66 0.84 Allowed Glycine 0 N--CA 1.475 1.243 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.801 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -16.94 27.94 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.65 -33.25 32.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.774 1.23 . . . . 0.0 113.357 165.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.7 m -99.05 -17.36 18.29 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.128 1.371 . . . . 0.0 113.98 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.68 32.54 84.51 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 115.114 0.806 . . . . 0.0 115.114 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.445 ' OXT' HD12 ' A' ' 82' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.69 1.737 . . . . 99.989999999999995 115.69 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m120 . . . . . 0 N--CA 1.476 0.859 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -56.67 -34.23 67.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.79 -44.59 89.47 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.34 -33.55 74.93 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.916 0.486 . . . . 0.0 112.003 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' ' 78' ' ' ALA . 42.5 t -62.07 -40.46 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.556 1.142 . . . . 0.0 113.128 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.05 93.14 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.787 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.73 0.89 6.12 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.4 -33.12 6.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.113 1.765 . . . . 0.0 111.92 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' GLN . 52.3 mt-10 -104.24 -23.73 13.21 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 53.3 p -117.36 -26.51 6.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 169.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.34 -11.53 65.37 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.396 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.63 -67.42 0.17 Allowed Glycine 0 N--CA 1.477 1.387 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 47.4 m-80 -47.29 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.519 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 41.9 m95 -63.93 -49.32 73.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.55 -2.1 21.37 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 39.19 69.6 0.27 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.122 1.769 . . . . 0.0 114.817 -173.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -82.51 43.81 0.85 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.933 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -114.59 -21.21 10.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.339 2.655 . . . . 0.0 112.128 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.51 32.66 82.32 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.11 24.72 4.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.61 37.66 77.25 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.888 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -118.15 149.07 41.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.244 0.618 . . . . 0.0 109.82 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 62.0 m-85 -144.63 149.96 36.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.454 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 56.67 23.73 45.02 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 59.25 25.94 60.84 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -112.52 13.24 20.06 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -174.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 35.0 tt0 44.5 33.18 0.85 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 123.392 1.568 . . . . 0.0 114.334 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.21 109.66 21.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.786 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.31 142.65 4.18 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.277 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 95.5 Cg_endo -65.4 -40.95 17.01 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.741 2.294 . . . . 0.0 112.34 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.01 -29.74 65.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.728 1.211 . . . . 0.0 113.551 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 m -78.03 -45.03 24.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.918 0.887 . . . . 0.0 111.316 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.47 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 43.6 t-105 -59.24 -21.36 59.45 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.18 -28.85 3.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 168.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.56 68.48 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.85 24.84 10.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.451 1.1 . . . . 0.0 111.781 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -23.58 28.42 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.83 -4.21 31.25 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 114.866 0.706 . . . . 0.0 114.866 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.28 158.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.649 1.58 . . . . 0.0 111.716 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.63 32.54 0.13 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 124.949 1.262 . . . . 0.0 116.164 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.76 -51.24 83.19 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.971 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 93.3 Cg_endo -69.72 -19.01 36.89 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.15 2.567 . . . . 0.0 115.195 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.79 -33.66 46.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.83 -35.74 12.58 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.35 128.45 35.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.876 0.871 . . . . 0.0 111.648 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -51.58 159.91 0.69 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.688 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 21' ' ' TRP . 8.1 mtm180 -41.74 -58.26 2.05 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -66.91 -36.97 83.46 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.72 -37.49 86.56 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.71 -0.619 . . . . 0.0 111.705 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -64.54 -50.76 66.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.228 1.011 . . . . 0.0 110.92 172.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.735 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -56.73 -31.46 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.04 -48.31 82.07 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 0.0 112.605 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.65 -42.6 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.986 0.514 . . . . 0.0 110.405 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . . . -58.96 -36.67 75.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.374 1.07 . . . . 0.0 113.667 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.57 -46.09 84.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.035 1.334 . . . . 0.0 111.319 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -33.93 62.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.4 OUTLIER -59.87 -25.68 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 173.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -42.09 92.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.927 0.491 . . . . 0.0 112.228 171.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -31.15 66.92 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -67.42 -52.0 44.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.39 10.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.98 155.93 9.22 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.05 0.805 . . . . 0.0 111.515 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.44 16.41 17.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.235 -0.982 . . . . 0.0 113.466 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.46 -29.36 13.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.144 1.378 . . . . 0.0 114.384 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.66 90.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.14 149.31 91.22 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.129 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -64.88 -154.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.891 2.394 . . . . 0.0 111.774 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.2 p -56.03 -29.19 60.04 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.064 0.935 . . . . 0.0 112.98 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 m -68.65 172.23 6.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.484 2.313 . . . . 0.0 110.878 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.23 105.26 1.54 Allowed Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.178 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -60.75 -15.53 30.45 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.73 -41.89 5.1 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.927 1.291 . . . . 0.0 112.501 163.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.8 m -107.29 -28.11 10.1 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.376 1.048 . . . . 0.0 113.588 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.11 25.42 69.55 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 124.147 0.879 . . . . 0.0 113.587 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.252 1.214 0 CA-C-O 116.277 -1.82 . . . . 99.989999999999995 111.887 -177.466 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 121.343 0.592 . . . . 0.0 111.692 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.47 ' HZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -60.56 -31.56 70.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.341 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -57.34 -35.8 70.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.751 0.821 . . . . 0.0 113.092 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.81 72.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.86 -47.47 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -62.06 -40.6 96.34 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -70.81 -7.49 45.67 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.33 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.587 1.555 . . . . 0.0 111.938 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -80.86 -39.09 27.04 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t -105.88 -37.99 6.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.81 1.244 . . . . 0.0 112.619 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.4 16.72 58.72 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.919 0.728 . . . . 0.0 114.919 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.3 -99.66 0.6 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 121.881 0.712 . . . . 0.0 112.453 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.63 150.89 47.18 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.136 -1.032 . . . . 0.0 113.468 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 39.3 m95 -64.16 -38.69 91.96 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.667 171.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.04 41.06 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.514 1.149 . . . . 0.0 112.39 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 59.52 0.65 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 122.947 1.356 . . . . 0.0 113.104 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.34 52.86 1.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.109 1.433 . . . . 0.0 111.513 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.3 p -82.92 9.38 10.13 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.786 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.84 26.89 70.43 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.266 1.267 . . . . 0.0 116.266 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -87.11 22.43 2.07 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 54.2 30.75 48.34 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.72 -172.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -132.32 143.3 49.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.145 0.978 . . . . 0.0 109.285 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.601 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 62.6 m-85 -146.28 159.39 43.41 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.836 -1.075 . . . . 0.0 113.598 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.96 33.08 56.67 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.449 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 52.28 22.86 11.14 Favored Glycine 0 CA--C 1.545 1.917 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.47 HD21 ' HZ3' ' A' ' 9' ' ' TRP . 41.7 mt -109.54 11.46 24.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.131 2.641 . . . . 0.0 118.131 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? 39.11 27.02 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -79.2 106.17 11.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.204 -172.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -36.8 129.73 0.72 Allowed Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 113.204 -1.816 . . . . 0.0 113.818 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 91.9 Cg_endo -63.42 -33.41 69.57 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.033 2.489 . . . . 0.0 113.026 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -35.05 66.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.389 1.076 . . . . 0.0 113.145 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.8 m -70.82 -51.18 28.32 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.871 0.868 . . . . 0.0 111.167 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.471 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.8 t-105 -58.61 -21.52 53.77 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.86 -28.06 6.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.03 75.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.3 20.26 8.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.636 1.174 . . . . 0.0 113.959 171.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.88 -20.14 36.85 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.914 1.126 . . . . 0.0 115.914 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.86 -6.56 25.68 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 -174.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.9 p -64.5 154.94 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.087 1.755 . . . . 0.0 111.951 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.91 35.82 0.14 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 125.02 1.295 . . . . 0.0 115.538 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.579 ' HB2' HG13 ' A' ' 46' ' ' VAL . 4.3 t-20 -58.42 -51.01 84.89 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 116.159 -1.877 . . . . 0.0 110.068 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 71.0 Cg_endo -68.39 -21.4 40.93 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.04 2.494 . . . . 0.0 115.183 174.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -77.02 -33.44 57.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 1.5 43.01 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.06 125.0 48.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.039 0.936 . . . . 0.0 109.206 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -53.2 155.36 2.7 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.055 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 51.5 mtt85 -37.36 -55.66 1.02 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.308 1.443 . . . . 0.0 114.247 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.3 tt0 -69.27 -42.36 75.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.7 -39.24 73.51 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.664 0.785 . . . . 0.0 110.826 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -65.53 -53.74 37.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.17 173.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.9 pt -51.73 -34.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -55.04 40.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.066 0.947 . . . . 0.0 113.297 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.52 -37.67 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.165 0.586 . . . . 0.0 110.516 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.15 -42.26 94.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.116 1.367 . . . . 0.0 113.791 174.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.4 -40.94 88.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.005 1.322 . . . . 0.0 111.922 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -71.39 -40.18 70.7 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.994 -0.441 . . . . 0.0 112.148 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.272 0.3 OUTLIER -63.51 -20.3 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.199 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -44.01 88.23 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 168.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.1 69.09 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.71 -49.04 33.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -102.09 -25.82 13.6 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.62 154.77 8.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.078 0.847 . . . . 0.0 111.098 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.46 -32.36 72.35 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -11.68 17.62 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -53.61 -33.61 55.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.674 1.19 . . . . 0.0 114.063 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.441 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 21.1 m-90 -113.99 141.09 25.69 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.46 -159.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.034 2.489 . . . . 0.0 112.095 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -52.28 -25.23 8.92 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.2 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.744 2.018 . . . . 0.0 115.214 170.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.56 48.6 1.09 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.317 0.961 . . . . 0.0 111.784 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.92 -15.31 0.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.4 -41.13 13.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 113.305 164.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -95.72 -17.19 21.45 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.858 1.263 . . . . 0.0 113.66 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.31 -44.32 3.33 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 123.921 0.772 . . . . 0.0 112.684 -172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.321 1.848 . . . . 99.989999999999995 112.074 -175.279 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.0 m120 . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 58' ' ' ILE . 1.2 m95 -59.55 -35.58 74.5 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.326 -1.761 . . . . 0.0 113.744 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -58.57 -52.82 64.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.572 0.749 . . . . 0.0 112.368 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -58.02 -35.46 71.3 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.872 0.733 . . . . 0.0 112.657 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.76 -44.81 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.675 0.79 . . . . 0.0 112.814 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.73 94.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.86 0.362 . . . . 0.0 111.889 171.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.97 15.33 1.86 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.5 t -116.95 -33.63 4.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.884 1.274 . . . . 0.0 111.543 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -88.48 -53.02 4.87 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 168.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -81.21 -42.73 20.32 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.25 19.87 60.08 Favored Glycine 0 N--CA 1.481 1.679 0 O-C-N 124.244 0.965 . . . . 0.0 115.399 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.56 -98.52 0.24 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-O 121.09 0.272 . . . . 0.0 112.88 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -123.96 153.39 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 51.7 m95 -70.71 -42.62 70.36 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.353 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.93 40.67 1.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.432 1.11 . . . . 0.0 112.012 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 63.54 2.31 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 123.732 1.729 . . . . 0.0 111.613 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -82.74 30.48 0.43 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.041 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -80.24 27.66 0.33 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.731 2.012 . . . . 0.0 114.024 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.7 43.67 93.81 Favored Glycine 0 CA--C 1.54 1.615 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.5 m120 -90.96 7.78 38.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.77 10.23 6.17 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 124.273 0.939 . . . . 0.0 115.336 -170.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 27' ' ' ASN . 26.1 mmtp -131.5 148.24 52.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.654 1.182 . . . . 0.0 109.385 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-85 -139.35 160.21 40.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.764 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.75 -10.59 24.08 Favored Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.943 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.08 25.73 54.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.012 0.339 . . . . 0.0 113.543 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.455 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 3.8 mp -115.1 13.01 16.77 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 38.62 52.13 1.78 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 123.75 1.738 . . . . 0.0 113.307 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -105.26 109.39 21.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.798 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -39.94 137.33 1.19 Allowed Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.85 -44.74 12.35 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.516 . . . . 0.0 113.301 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.33 -33.24 67.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.063 0.945 . . . . 0.0 113.506 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -72.12 -48.03 46.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.701 0.8 . . . . 0.0 111.537 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 33.6 t-105 -59.93 -21.87 61.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.92 -28.46 9.76 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.25 -36.12 72.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.5 17.5 13.02 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.727 1.211 . . . . 0.0 113.553 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.29 -22.79 24.21 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.28 -6.19 23.63 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -63.77 154.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.811 1.644 . . . . 0.0 111.721 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.2 0.09 OUTLIER Glycine 0 N--CA 1.482 1.757 0 C-N-CA 124.878 1.228 . . . . 0.0 115.59 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 46' ' ' VAL . 17.9 t30 -58.57 -51.72 79.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 115.94 -1.981 . . . . 0.0 110.384 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.499 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.6 Cg_endo -67.0 -25.07 44.68 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.265 1.977 . . . . 0.0 113.927 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -69.39 -36.21 76.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.68 -33.89 11.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 119.12 9.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.078 0.951 . . . . 0.0 111.6 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 m -46.87 156.41 0.2 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.429 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 2.5 mtt180 -29.34 -67.66 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.726 ' HA ' HG12 ' A' ' 58' ' ' ILE . 22.5 tt0 -63.97 -32.65 74.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -68.89 -40.25 79.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.049 0.54 . . . . 0.0 111.296 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.437 ' OE1' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.84 -50.67 67.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.389 1.076 . . . . 0.0 110.484 173.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.726 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -54.82 -32.93 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -53.58 56.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 113.15 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.54 -41.59 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.135 0.574 . . . . 0.0 109.866 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.19 -39.46 82.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.452 1.501 . . . . 0.0 114.533 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 5.5 t-20 -58.29 -37.51 75.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.004 1.322 . . . . 0.0 111.882 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -33.65 27.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.271 0.4 OUTLIER -60.45 -25.19 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 173.912 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.3 pp -61.78 -38.39 87.86 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.2 71.67 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.06 -62.95 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -82.16 -22.77 35.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 -169.08 15.1 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.03 19.69 7.58 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.205 -0.997 . . . . 0.0 113.198 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.92 -33.41 17.29 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.25 -26.33 51.09 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.429 ' HE1' HD23 ' A' ' 33' ' ' LEU . 6.3 m-90 -122.79 91.13 49.83 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.13 -62.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.525 2.15 . . . . 0.0 113.091 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -61.23 -50.37 73.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.888 1.275 . . . . 0.0 113.03 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.8 m -101.04 175.14 5.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.924 170.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.58 93.24 0.09 OUTLIER Glycine 0 N--CA 1.472 1.075 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -28.01 19.86 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.59 -37.81 42.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.636 1.175 . . . . 0.0 113.394 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -99.98 -27.49 13.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.386 1.074 . . . . 0.0 112.227 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.34 -37.14 3.51 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.264 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.817 1.247 . . . . 99.989999999999995 113.529 -175.823 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 . . . . . 0 N--CA 1.478 0.936 0 CA-C-O 121.093 0.473 . . . . 0.0 111.556 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.605 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 1.1 m95 -49.07 -37.88 22.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.31 -43.94 95.88 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.3 -34.63 77.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.923 0.889 . . . . 0.0 112.118 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.87 -37.95 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 112.421 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.92 93.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.55 6.84 7.76 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 t -110.31 -31.96 7.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.934 0.894 . . . . 0.0 112.267 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.66 -32.42 10.34 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 19.8 t -98.52 -35.53 10.21 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 31.08 67.74 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.37 -88.73 0.07 OUTLIER Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.172 0.415 . . . . 0.0 112.509 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -112.83 145.3 40.88 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -66.57 -47.39 72.94 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.107 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 -29.55 69.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 35.35 70.46 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.403 1.881 . . . . 0.0 114.297 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -78.58 56.99 1.91 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.817 1.77 . . . . 0.0 112.401 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -117.53 -24.51 7.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.402 2.681 . . . . 0.0 112.94 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.08 34.42 76.1 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.666 1.026 . . . . 0.0 115.666 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -92.5 25.97 2.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.3 39.17 92.24 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.695 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 34' ' ' GLN . 34.2 mttp -121.18 146.89 46.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.291 1.036 . . . . 0.0 109.742 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 16.1 m-85 -145.23 146.05 31.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.562 -175.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 51.18 34.08 31.69 Favored Glycine 0 N--CA 1.483 1.779 0 O-C-N 124.801 1.313 . . . . 0.0 115.843 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 58.12 23.52 52.57 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.356 0.979 . . . . 0.0 115.193 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 18.3 mt -116.71 8.26 13.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -169.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 4.5 tt0 45.07 36.8 2.17 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.817 1.77 . . . . 0.0 113.07 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -89.69 104.68 17.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.6 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -37.75 130.16 0.91 Allowed Pre-proline 0 N--CA 1.484 1.233 0 CA-C-N 112.986 -1.915 . . . . 0.0 113.331 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 89.5 Cg_endo -65.0 -39.22 25.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.772 2.315 . . . . 0.0 112.556 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.38 70.04 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.2 1.0 . . . . 0.0 113.088 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 m -73.63 -44.79 56.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.578 0.751 . . . . 0.0 111.5 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 42.9 t-105 -58.7 -20.21 46.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.39 -28.38 5.04 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 168.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.05 69.74 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -98.36 25.73 6.04 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.017 1.327 . . . . 0.0 113.589 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.34 39.57 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.3 -4.57 32.71 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 115.077 0.791 . . . . 0.0 115.077 -173.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 61.7 t -72.2 152.81 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.011 1.724 . . . . 0.0 109.274 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.5 36.01 0.08 OUTLIER Glycine 0 CA--C 1.542 1.768 0 C-N-CA 125.226 1.393 . . . . 0.0 116.58 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -52.77 -53.94 48.86 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 116.209 -1.853 . . . . 0.0 109.146 171.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 72.5 Cg_endo -67.35 -20.89 48.12 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.536 2.824 . . . . 0.0 116.023 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.52 61.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.66 -35.01 10.72 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.54 126.97 29.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.484 1.114 . . . . 0.0 110.821 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -54.63 156.81 3.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.301 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 26.5 mtt-85 -45.92 -57.74 4.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.146 0.978 . . . . 0.0 112.936 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 58' ' ' ILE . 10.2 tt0 -66.79 -30.79 71.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.44 -41.34 76.44 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.824 -0.547 . . . . 0.0 110.851 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.496 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.73 -40.77 98.24 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.251 174.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 55' ' ' GLU . 2.3 pt -54.28 -33.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.945 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.03 82.54 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.15 -42.18 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.362 0.601 . . . . 0.0 109.673 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.563 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.95 -36.39 79.23 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.4 -47.71 81.0 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.407 1.083 . . . . 0.0 111.296 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -39.71 87.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.001 0.429 . . . . 0.0 111.572 173.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.293 0.4 OUTLIER -61.52 -26.03 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.591 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.65 -40.3 91.5 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.16 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.274 0.629 . . . . 0.0 112.607 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -66.91 -43.92 82.1 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.82 -29.23 10.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 112.89 155.68 12.15 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.38 21.1 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 69' ' ' GLY . 7.4 m-20 -88.33 -30.62 19.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.004 1.722 . . . . 0.0 111.866 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.37 -31.23 65.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 0.0 113.33 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -122.75 89.74 50.06 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.08 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.29 1.993 . . . . 0.0 113.537 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -63.19 -49.56 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.855 1.662 . . . . 0.0 112.95 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -109.79 163.43 13.52 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.027 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.55 101.14 0.15 Allowed Glycine 0 N--CA 1.478 1.469 0 O-C-N 124.563 1.165 . . . . 0.0 111.376 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.56 -28.72 14.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.08 -32.84 36.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.016 1.326 . . . . 0.0 114.074 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.8 p -107.97 -22.0 12.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.903 1.281 . . . . 0.0 113.714 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.7 32.71 84.48 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 124.296 0.95 . . . . 0.0 114.062 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 117.042 -1.456 . . . . 99.989999999999995 114.295 178.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 19.5 m95 -50.91 -34.36 28.14 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.28 -49.57 77.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.991 0.917 . . . . 0.0 112.688 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.497 0.719 . . . . 0.0 112.142 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 78' ' ' ALA . 77.0 t -63.9 -38.96 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.176 0.991 . . . . 0.0 112.322 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.35 78.77 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.72 6.92 19.3 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -116.38 -35.24 4.35 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.882 0.873 . . . . 0.0 112.888 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 16.9 mm-40 -89.47 -39.27 13.46 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 170.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -106.42 -24.08 12.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.45 3.62 72.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.697 1.039 . . . . 0.0 115.697 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.52 81.18 0.42 Allowed Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.007 0.813 . . . . 0.0 111.49 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 173.77 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.08 1.752 . . . . 0.0 108.939 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -80.37 -79.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.402 0.439 . . . . 0.0 111.745 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -22.15 55.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.8 70.61 0.5 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.321 1.848 . . . . 0.0 114.383 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.55 33.74 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.957 -1.929 . . . . 0.0 115.222 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.4 t -117.13 -18.01 10.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.388 2.275 . . . . 0.0 112.338 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 46.69 40.76 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -89.35 23.24 2.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.1 34.65 58.62 Favored Glycine 0 N--CA 1.482 1.765 0 C-N-CA 123.289 0.471 . . . . 0.0 113.563 -172.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' ' HG2' ' A' ' 34' ' ' GLN . 61.1 mttp -129.5 138.6 51.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.776 1.23 . . . . 0.0 108.809 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 89.4 m-85 -136.87 149.46 47.68 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.565 1.166 . . . . 0.0 112.822 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.54 -14.75 1.77 Allowed Glycine 0 N--CA 1.483 1.786 0 CA-C-N 114.339 -1.3 . . . . 0.0 116.235 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.7 30.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.889 0.757 . . . . 0.0 114.815 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.05 28.08 8.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.584 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 7.7 tm0? 43.91 35.18 1.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.156 1.782 . . . . 0.0 114.171 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.04 110.19 22.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.044 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.92 133.14 29.32 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 112.581 -2.1 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -62.03 -32.23 83.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.171 2.581 . . . . 0.0 113.771 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.02 65.34 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -76.0 -41.04 52.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.705 0.802 . . . . 0.0 111.676 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 38.5 t-105 -58.73 -21.49 55.24 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.86 -29.52 3.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 168.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.06 -38.36 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.31 18.85 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.77 1.228 . . . . 0.0 113.517 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.73 -21.13 32.84 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.56 -2.95 36.34 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.47 156.81 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.49 1.516 . . . . 0.0 111.741 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.38 34.28 0.12 Allowed Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -58.46 -52.61 73.37 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-O 115.719 -2.086 . . . . 0.0 110.603 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 71.9 Cg_endo -68.25 -16.95 44.8 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.135 2.557 . . . . 0.0 115.475 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.58 -33.67 35.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.74 -34.71 10.41 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.73 121.69 13.48 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.154 0.978 . . . . 0.0 110.876 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -50.85 160.09 0.49 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.057 -1.883 . . . . 0.0 110.732 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.19 -56.63 4.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 58' ' ' ILE . 29.1 tt0 -70.11 -30.28 67.44 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -68.01 -45.78 73.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.404 0.681 . . . . 0.0 111.165 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -66.0 -45.07 82.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.778 0.831 . . . . 0.0 113.053 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.643 HG12 ' HA ' ' A' ' 55' ' ' GLU . 26.4 pt -54.67 -28.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.51 85.99 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.03 -42.61 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.252 0.621 . . . . 0.0 109.997 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.74 78.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -61.01 -39.59 90.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.196 1.399 . . . . 0.0 112.183 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -33.85 52.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.5 OUTLIER -57.15 -26.76 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -59.79 -42.82 94.25 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 171.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.7 66.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -52.11 30.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.37 -25.18 14.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.77 164.81 13.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.83 1.85 1.22 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 170.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -67.05 -32.83 74.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.299 1.84 . . . . 0.0 113.88 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -53.04 -29.68 31.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.533 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 2.2 m-90 -128.36 90.44 46.87 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.83 -65.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.542 2.161 . . . . 0.0 113.253 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -61.6 -42.64 99.15 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 0.0 113.875 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -113.62 -164.88 0.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.232 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.59 101.91 0.25 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -57.49 -25.64 60.09 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.667 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -49.01 -42.38 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 113.554 166.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.2 p -94.2 -20.76 19.55 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.464 1.105 . . . . 0.0 113.131 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 21.3 63.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 124.906 1.241 . . . . 0.0 115.136 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.296 0 N-CA-C 115.252 1.575 . . . . 99.989999999999995 115.252 176.219 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 . . . . . 0 N--CA 1.473 0.68 0 CA-C-O 122.958 1.361 . . . . 0.0 112.033 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.419 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -57.57 -32.96 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.417 -1.72 . . . . 0.0 112.97 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.25 -48.0 71.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 0.0 112.105 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.65 66.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 78' ' ' ALA . 89.7 t -63.22 -33.83 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 112.627 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.42 94.07 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.26 -4.71 31.2 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -106.93 -25.52 11.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -104.71 -27.82 11.57 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.4 t -110.75 -31.55 7.16 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.61 -24.6 28.67 Favored Glycine 0 N--CA 1.481 1.693 0 CA-C-N 116.785 -0.189 . . . . 0.0 112.881 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.65 83.44 0.07 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.0 t-20 178.45 98.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.669 1.188 . . . . 0.0 110.869 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 76.3 m95 -75.6 -25.82 57.32 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.75 48.6 0.95 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.847 1.308 . . . . 0.0 111.847 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . -70.05 50.92 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.46 26.19 7.53 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.751 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 t -122.75 44.5 2.63 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.424 1.583 . . . . 0.0 111.911 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.95 -93.64 0.1 OUTLIER Glycine 0 N--CA 1.481 1.634 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.824 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 2.0 m-20 -103.86 28.93 6.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.28 33.66 65.87 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.306 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 27' ' ' ASN . 91.2 mttt -79.3 151.03 31.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 0.0 111.2 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.692 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 73.1 m-85 -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.05 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.599 ' HA2' ' HG3' ' A' ' 57' ' ' GLN . . . 77.1 -25.99 1.83 Allowed Glycine 0 N--CA 1.48 1.591 0 CA-C-N 114.13 -1.395 . . . . 0.0 115.342 -176.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.93 22.94 36.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 114.731 -0.734 . . . . 0.0 113.428 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HG ' ' HE1' ' A' ' 73' ' ' TRP . 2.6 mm? -116.71 28.79 8.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 37.19 31.65 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.266 2.226 . . . . 0.0 116.772 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -78.32 109.53 12.54 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.811 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -46.33 132.15 7.68 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.175 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.09 -38.85 84.71 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.91 2.407 . . . . 0.0 113.379 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.68 68.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -76.87 -42.39 40.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.604 0.762 . . . . 0.0 111.069 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 40.1 t-105 -60.83 -21.83 63.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.55 -29.94 3.2 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.41 -35.86 70.58 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 171.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -98.56 25.36 6.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.928 1.291 . . . . 0.0 113.156 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.31 34.27 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.9 -11.02 16.24 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 45.5 t -65.28 151.21 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.472 1.909 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.82 38.48 0.09 OUTLIER Glycine 0 CA--C 1.545 1.93 0 C-N-CA 125.428 1.489 . . . . 0.0 116.332 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.403 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -54.57 -53.89 54.89 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.233 -1.841 . . . . 0.0 108.617 171.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 94.2 Cg_endo -70.66 -9.41 25.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.876 2.384 . . . . 0.0 116.122 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -77.34 -46.4 23.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.798 0.839 . . . . 0.0 113.003 170.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.43 -34.11 15.74 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -61.55 115.1 3.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.006 0.922 . . . . 0.0 110.695 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -44.35 159.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.305 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 16.9 mtt85 -40.91 -59.41 1.44 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.98 1.312 . . . . 0.0 113.269 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.684 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -68.34 -27.17 66.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.255 177.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -72.26 -42.48 65.55 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.339 0.59 . . . . 0.0 110.738 175.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.599 ' HG3' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -62.75 -48.11 80.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.118 0.967 . . . . 0.0 111.43 176.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.684 HG12 ' HA ' ' A' ' 55' ' ' GLU . 24.1 pt -54.35 -33.78 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.4 -50.82 72.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.506 0.722 . . . . 0.0 112.8 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.69 -41.95 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.013 0.525 . . . . 0.0 110.376 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.88 73.44 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 54.9 t30 -62.95 -41.92 99.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.05 1.34 . . . . 0.0 111.931 171.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -71.87 -38.54 70.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.419 0.628 . . . . 0.0 111.318 172.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 67' ' ' GLU 0.27 0.5 OUTLIER -59.37 -26.78 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.327 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.6 pp -62.01 -40.52 95.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.79 67.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 2.4 mm-40 -61.67 -53.81 51.15 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -110.7 -23.47 11.04 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.12 165.04 12.99 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.35 4.67 0.68 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -30.39 71.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.251 1.821 . . . . 0.0 114.203 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.09 -27.04 52.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.2 m-90 -119.02 95.95 49.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.78 -58.96 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.306 2.004 . . . . 0.0 114.126 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 p -64.64 -48.49 74.64 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.403 1.481 . . . . 0.0 113.076 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 m -108.4 -165.69 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.746 170.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.92 97.13 0.12 Allowed Glycine 0 N--CA 1.473 1.113 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -53.91 -25.34 19.77 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -47.11 -40.14 14.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.029 1.332 . . . . 0.0 113.569 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.3 m -102.42 -21.07 14.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.824 1.25 . . . . 0.0 114.362 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -38.31 2.97 Favored Glycine 0 N--CA 1.48 1.58 0 C-N-CA 124.08 0.848 . . . . 0.0 112.332 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 116.057 -1.925 . . . . 99.989999999999995 114.119 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 . . . . . 0 N--CA 1.472 0.643 0 CA-C-O 122.383 1.087 . . . . 0.0 112.745 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.579 ' HB3' HG21 ' A' ' 58' ' ' ILE . 31.4 m95 -54.91 -31.54 60.21 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.455 175.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -63.19 -52.61 61.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 0.0 112.388 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.24 65.22 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 78' ' ' ALA . 71.8 t -63.75 -38.4 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.404 1.081 . . . . 0.0 112.668 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.31 93.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.892 168.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.87 -0.25 8.75 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 t -108.51 -29.2 8.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.329 1.451 . . . . 0.0 111.874 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -108.23 -27.31 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.568 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 54.5 p -111.79 -25.74 9.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.47 74.5 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.803 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.17 -77.79 0.21 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 52.2 m-80 -44.47 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 54' ' ' ARG . 40.8 m95 -63.63 -50.15 70.45 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 175.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.77 26.71 0.68 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 16.81 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.193 2.197 . . . . 0.0 116.086 -172.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 34.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 112.124 -2.307 . . . . 0.0 114.988 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -113.7 -14.93 12.55 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.576 1.951 . . . . 0.0 112.674 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.33 39.77 70.35 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.9 m120 -88.89 12.64 14.68 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.7 23.57 50.5 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -171.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 27' ' ' ASN . 52.2 mttt -125.34 150.65 46.97 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.62 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 69.2 m-85 -144.61 174.79 10.66 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 63.72 19.83 63.35 Favored Glycine 0 N--CA 1.48 1.583 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.792 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 62.05 15.36 49.73 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.479 HD12 ' NE1' ' A' ' 73' ' ' TRP . 3.8 mm? -104.74 9.33 35.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.43 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 30.89 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.562 1.945 . . . . 0.0 116.034 -169.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.69 116.19 23.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.044 -1.434 . . . . 0.0 110.938 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -36.07 126.03 0.68 Allowed Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.67 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.71 -35.61 94.22 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.119 2.546 . . . . 0.0 113.39 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.94 64.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 m -75.21 -42.31 55.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.895 0.478 . . . . 0.0 111.138 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 30.0 t-105 -57.86 -22.63 48.96 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.81 -28.77 3.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.79 78.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -91.52 18.9 6.73 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -21.94 32.22 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 0.0 44.1 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.66 152.8 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.324 1.85 . . . . 0.0 109.361 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 37.18 0.08 OUTLIER Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.505 1.526 . . . . 0.0 116.202 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -57.68 -50.87 85.7 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.151 -1.881 . . . . 0.0 110.365 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 90.6 Cg_endo -71.2 -11.83 29.32 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.081 2.52 . . . . 0.0 115.563 175.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.1 -34.97 32.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 0.0 113.203 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.72 -34.84 10.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.25 118.72 8.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.797 0.839 . . . . 0.0 111.924 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -46.65 161.34 0.06 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -42.73 -60.66 1.49 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HA ' HG12 ' A' ' 58' ' ' ILE . 15.9 tt0 -67.63 -28.01 67.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -72.4 -43.6 63.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.05 0.453 . . . . 0.0 110.973 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.59 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -63.31 -44.29 95.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.685 176.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 55' ' ' GLU . 16.9 pt -55.29 -30.02 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.073 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.91 88.08 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 172.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.36 -42.76 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.763 0.825 . . . . 0.0 110.12 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.99 -36.72 80.21 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.545 1.138 . . . . 0.0 114.047 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -59.55 -41.86 91.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.928 1.291 . . . . 0.0 111.686 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -33.7 57.57 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -61.43 -24.19 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 172.941 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -47.27 79.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.141 0.577 . . . . 0.0 111.337 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -30.13 64.94 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -60.14 -49.53 77.25 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.679 1.191 . . . . 0.0 113.469 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -103.22 -26.55 12.94 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.17 157.39 13.61 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -27.68 15.47 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.52 -21.83 18.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.012 1.725 . . . . 0.0 115.2 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.83 -36.06 58.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.138 0.975 . . . . 0.0 113.583 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.479 ' NE1' HD12 ' A' ' 33' ' ' LEU . 13.2 m-90 -118.82 136.92 24.47 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.93 -85.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.854 2.37 . . . . 0.0 113.885 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -91.55 -53.22 4.41 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.224 1.409 . . . . 0.0 111.477 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.96 160.92 3.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.444 1.898 . . . . 0.0 110.094 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.29 103.81 1.66 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.292 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -59.51 -18.72 42.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -36.62 -45.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.63 1.572 . . . . 0.0 113.165 160.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' HD23 ' A' ' 82' ' ' LEU . 58.6 m -107.29 -30.02 8.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.193 0.997 . . . . 0.0 113.442 170.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.21 11.69 64.57 Favored Glycine 0 N--CA 1.482 1.749 0 C-N-CA 123.941 0.781 . . . . 0.0 114.268 -173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.626 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.2 mm? . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.89 1.276 . . . . 99.989999999999995 113.455 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 . . . . . 0 N--CA 1.477 0.909 0 CA-C-O 118.879 -0.581 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.403 ' CH2' HD21 ' A' ' 33' ' ' LEU . 3.9 m95 -49.76 -39.47 37.89 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.87 -54.2 49.02 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.96 74.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.128 0.971 . . . . 0.0 112.721 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 78' ' ' ALA . 53.6 t -61.14 -31.38 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.068 1.347 . . . . 0.0 112.62 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.36 76.56 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.349 0.977 . . . . 0.0 112.76 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -77.82 5.42 9.58 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.9 t -116.85 -33.41 4.79 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 12.8 mm-40 -75.77 -43.74 45.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.377 1.071 . . . . 0.0 111.764 171.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 t -104.01 -45.17 4.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.011 1.324 . . . . 0.0 113.246 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.89 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 124.179 0.924 . . . . 0.0 114.347 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.77 -100.54 0.15 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 123.992 0.466 . . . . 0.0 112.795 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.38 139.74 33.89 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -66.92 -15.81 63.92 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 167.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' TYR . . . -93.54 -35.35 12.97 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 168.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.73 43.01 9.24 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.93 32.27 4.28 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.919 -175.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -128.36 26.77 5.66 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.708 1.242 . . . . 0.0 113.084 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.31 -95.53 0.39 Allowed Glycine 0 N--CA 1.481 1.656 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 33.2 m-20 -105.69 28.96 6.99 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.11 91.67 Favored Glycine 0 CA--C 1.541 1.711 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.678 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 66.3 mttm -74.69 165.22 25.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.927 0.891 . . . . 0.0 110.703 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 59.7 m-85 -137.43 156.86 47.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.001 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.66 10.14 29.36 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-N 114.272 -1.331 . . . . 0.0 116.147 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 16' ' ' GLU . . . 55.59 29.88 54.87 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 115.536 -0.332 . . . . 0.0 112.302 -167.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -112.32 16.7 19.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.576 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 5.8 pt20 36.0 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 1.9 t80 -98.57 115.31 28.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.35 -168.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.53 130.46 10.6 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.963 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.33 -34.68 98.31 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.917 2.411 . . . . 0.0 113.438 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.66 65.16 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -76.23 -46.53 27.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.434 0.694 . . . . 0.0 111.076 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.439 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -58.51 -22.37 54.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -47.65 -30.35 3.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 169.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.77 72.07 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 64' ' ' VAL . 20.0 m-85 -97.01 19.45 12.79 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.144 1.377 . . . . 0.0 113.219 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.47 -21.72 30.07 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.82 -5.77 29.65 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 114.731 0.653 . . . . 0.0 114.731 -173.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.2 p -64.13 155.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.256 1.823 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 33.96 0.14 Allowed Glycine 0 CA--C 1.541 1.719 0 C-N-CA 124.937 1.256 . . . . 0.0 115.747 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' HG13 ' A' ' 46' ' ' VAL . 5.5 t30 -58.1 -51.44 81.75 Favored Pre-proline 0 N--CA 1.476 0.858 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.241 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.646 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 80.2 Cg_endo -72.95 -10.05 24.27 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.69 2.26 . . . . 0.0 115.254 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -82.43 -33.79 28.45 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.36 -34.06 10.81 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.74 128.0 34.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.874 0.87 . . . . 0.0 111.423 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -49.43 156.09 0.66 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.722 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.74 -57.59 2.69 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.524 1.13 . . . . 0.0 113.994 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HA ' HG12 ' A' ' 58' ' ' ILE . 6.9 tt0 -70.53 -31.5 68.59 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -66.06 -42.07 89.93 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.764 0.826 . . . . 0.0 111.039 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.436 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -63.05 -53.74 49.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.06 1.344 . . . . 0.0 110.607 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.779 HG12 ' HA ' ' A' ' 55' ' ' GLU . 20.2 pt -54.31 -31.4 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.19 74.49 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 171.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.98 -42.13 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.514 0.726 . . . . 0.0 109.824 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.44 -39.61 84.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.284 1.434 . . . . 0.0 114.041 175.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -59.52 -38.94 82.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.06 1.344 . . . . 0.0 112.132 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -80.74 -36.03 32.54 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -61.9 -20.28 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 172.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -40.52 74.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.928 169.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.32 -47.32 61.61 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -107.04 -22.71 12.56 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.37 155.15 9.3 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.116 0.865 . . . . 0.0 110.987 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 122.08 -0.659 . . . . 0.0 112.769 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.91 -0.92 8.17 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -57.05 -25.41 58.61 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.421 ' CE2' HD23 ' A' ' 33' ' ' LEU . 12.8 m-90 -118.2 75.53 11.48 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 174.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.17 -20.12 43.91 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.002 2.468 . . . . 0.0 113.828 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.5 p -60.29 -44.38 95.44 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.348 1.859 . . . . 0.0 113.978 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.404 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -139.95 -69.27 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.886 1.274 . . . . 0.0 112.283 172.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.76 89.13 0.62 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.32 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.75 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.86 -27.06 11.41 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.61 -43.22 36.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.115 1.366 . . . . 0.0 113.505 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 82' ' ' LEU . 58.5 m -109.03 -20.97 12.84 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.113 0.883 . . . . 0.0 112.628 166.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 -43.6 3.08 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.99 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 80' ' ' SER . 8.2 mp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.848 1.659 . . . . 99.989999999999995 113.632 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 N--CA 1.477 0.877 0 CA-C-O 121.332 0.587 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -33.71 58.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.54 -35.84 72.95 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -66.54 -26.6 67.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 118.816 -0.612 . . . . 0.0 112.358 175.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.68 -42.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.388 0.675 . . . . 0.0 110.267 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -84.63 1.28 46.88 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -112.17 -36.53 5.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.228 1.011 . . . . 0.0 112.338 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -79.31 -51.05 9.95 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.71 1.204 . . . . 0.0 112.645 167.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -106.59 -23.75 12.37 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -174.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.81 -28.87 5.71 Favored Glycine 0 N--CA 1.482 1.721 0 C-N-CA 122.83 0.252 . . . . 0.0 113.416 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.04 93.14 0.09 OUTLIER Glycine 0 N--CA 1.474 1.227 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -172.15 81.47 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.24 1.016 . . . . 0.0 112.433 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -73.65 -73.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.32 71.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.52 60.84 3.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.014 1.725 . . . . 0.0 114.316 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -77.45 35.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 113.033 -1.894 . . . . 0.0 115.148 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -112.35 -17.67 12.66 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.634 1.973 . . . . 0.0 112.351 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.71 58.04 7.38 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.621 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.498 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.4 t-20 -104.64 20.65 18.24 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.476 -0.862 . . . . 0.0 112.748 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.06 26.78 49.95 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 124.188 0.899 . . . . 0.0 115.157 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -122.51 150.44 42.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.495 1.118 . . . . 0.0 109.451 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 49' ' ' PRO . 10.7 p90 -152.73 139.68 19.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.552 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.34 -0.43 12.49 Favored Glycine 0 N--CA 1.485 1.907 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.654 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.82 25.83 55.12 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 124.525 1.06 . . . . 0.0 114.775 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.16 14.5 27.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 17' ' ' SER . 11.4 mt-30 37.91 36.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.929 2.092 . . . . 0.0 116.068 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CE1' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -94.69 121.76 36.6 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.349 -171.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -41.73 136.41 2.01 Favored Pre-proline 0 N--CA 1.482 1.16 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 176.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 72.5 Cg_endo -65.23 -32.41 51.71 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.635 2.223 . . . . 0.0 112.54 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.4 -34.72 64.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.318 1.047 . . . . 0.0 113.624 172.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.582 HG21 ' CE1' ' A' ' 35' ' ' PHE . 23.0 m -68.91 -47.06 66.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.914 0.486 . . . . 0.0 111.698 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.532 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 33.2 t-105 -57.05 -22.28 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.78 -29.2 4.28 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.21 74.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.874 0.869 . . . . 0.0 113.296 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -95.71 18.4 13.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 111.565 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -23.73 23.52 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.12 -0.91 44.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 -172.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.09 153.05 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.361 1.864 . . . . 0.0 109.26 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.83 38.05 0.07 OUTLIER Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.263 1.411 . . . . 0.0 116.418 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 5.8 t30 -57.27 -47.65 98.68 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-O 116.256 -1.83 . . . . 0.0 110.931 172.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -67.55 -28.09 38.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.202 2.601 . . . . 0.0 114.799 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.06 72.17 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.87 -34.17 14.63 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.73 20.94 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.511 1.148 . . . . 0.0 111.969 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.8 t -53.78 157.55 2.3 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.388 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.42 -58.13 3.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -70.75 -19.4 62.73 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.46 -38.92 21.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.336 0.655 . . . . 0.0 111.936 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -63.91 -42.85 97.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 55' ' ' GLU . 14.0 pt -54.22 -29.79 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.12 82.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.535 0.734 . . . . 0.0 112.546 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.37 -42.36 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.371 0.668 . . . . 0.0 109.842 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.41 -35.23 76.97 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.46 -49.38 77.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.72 1.208 . . . . 0.0 110.784 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -65.52 -37.36 86.53 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 61' ' ' ALA 0.28 0.3 OUTLIER -61.29 -22.18 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.913 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.34 -38.96 88.8 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.73 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 6.7 mm-40 -65.23 -54.79 24.19 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 -23.56 11.5 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.13 147.99 7.49 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-O 122.038 0.799 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.46 -29.03 69.65 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.316 -0.942 . . . . 0.0 113.512 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -19.33 15.48 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 172.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.64 74.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.781 0.832 . . . . 0.0 112.82 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -80.8 140.48 50.74 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.796 0.685 . . . . 0.0 109.214 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 83.9 Cg_endo -67.55 -170.06 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.966 2.444 . . . . 0.0 111.493 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.7 p -53.35 -31.81 46.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.38 1.472 . . . . 0.0 114.146 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 1.2 m -39.26 -83.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.043 1.737 . . . . 0.0 113.314 169.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 41.51 43.63 3.89 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -49.73 -20.2 0.78 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.57 67.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.159 1.783 . . . . 0.0 113.156 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 m -65.54 -19.33 65.88 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.39 27.03 72.81 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 123.853 0.721 . . . . 0.0 113.547 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.909 -1.043 . . . . 99.989999999999995 113.335 177.762 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -57.55 -33.03 67.69 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.911 -1.495 . . . . 0.0 114.044 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.01 -50.75 70.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.739 0.816 . . . . 0.0 112.644 171.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -63.95 -37.8 88.76 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.382 0.426 . . . . 0.0 111.826 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 78' ' ' ALA . 51.4 t -61.25 -35.64 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.778 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.42 90.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.351 169.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -71.36 -3.6 21.6 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -98.48 -27.53 14.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.29 1.436 . . . . 0.0 111.46 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.5 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 9.2 mt-10 -104.55 -43.92 5.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.603 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.6 p -87.18 -37.87 16.91 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.15 25.08 59.45 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 124.461 1.101 . . . . 0.0 114.189 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.36 -82.16 0.06 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 123.798 0.352 . . . . 0.0 113.728 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.85 139.3 50.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -69.32 -39.01 78.49 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.328 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.56 13.73 2.38 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 30.3 71.72 0.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.598 1.959 . . . . 0.0 114.298 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -81.55 40.81 0.6 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.952 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -116.88 -19.33 9.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.036 2.534 . . . . 0.0 112.801 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.39 40.7 96.56 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.615 0.626 . . . . 0.0 114.622 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -109.44 32.75 4.76 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.931 0.872 . . . . 0.0 112.513 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.5 35.89 62.68 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.839 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 84.5 mttt -110.98 147.3 35.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.579 0.704 . . . . 0.0 110.586 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 35.6 m-85 -132.56 145.51 51.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.898 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 52.24 29.46 29.64 Favored Glycine 0 N--CA 1.482 1.751 0 O-C-N 125.314 1.634 . . . . 0.0 117.111 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 58.99 22.73 55.84 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.848 0.737 . . . . 0.0 114.664 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -111.93 16.93 20.13 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 38.9 tt0 43.39 42.97 4.07 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 124.07 1.89 . . . . 0.0 112.746 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -100.98 108.22 19.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.765 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 3.6 mmtt -43.77 138.15 3.17 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 112.587 -2.097 . . . . 0.0 113.768 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 98.6 Cg_endo -66.48 -42.34 9.95 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.709 2.273 . . . . 0.0 112.63 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.63 -34.32 67.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.405 1.082 . . . . 0.0 112.955 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -71.76 -49.27 40.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.053 0.541 . . . . 0.0 112.179 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.2 t-105 -60.2 -21.9 62.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 38' ' ' ALA . . . -51.5 -29.64 17.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 170.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -29.37 63.44 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CZ ' HG22 ' A' ' 64' ' ' VAL . 30.0 m-85 -105.99 25.69 10.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.416 1.486 . . . . 0.0 111.216 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.39 -19.88 52.69 Favored Glycine 0 N--CA 1.479 1.551 0 CA-C-O 119.092 -0.838 . . . . 0.0 115.082 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.65 -5.12 24.72 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.89 151.85 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.322 1.849 . . . . 0.0 112.147 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.81 31.34 0.1 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 113.976 -1.466 . . . . 0.0 116.394 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -52.88 -51.51 73.69 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 116.286 -1.816 . . . . 0.0 111.372 169.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 71.8 Cg_endo -66.24 -23.71 51.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.873 2.382 . . . . 0.0 115.652 176.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.07 38.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.53 -36.84 13.48 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 128.05 34.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.989 0.9 . . . . 0.0 110.415 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -52.04 158.34 1.1 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.534 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -44.86 -57.62 3.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.1 tt0 -68.79 -18.79 64.25 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -81.67 -40.85 22.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.328 0.651 . . . . 0.0 111.418 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -60.71 -48.09 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.909 0.884 . . . . 0.0 110.531 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -53.97 -31.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.72 72.56 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.252 0.621 . . . . 0.0 111.873 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.61 -48.62 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.631 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . . . -55.52 -37.83 68.44 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -62.65 -38.32 89.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.755 1.622 . . . . 0.0 113.307 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -81.27 -35.98 30.46 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.259 -0.9 . . . . 0.0 111.741 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.657 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 20.0 t -50.72 -32.74 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.059 1.744 . . . . 0.0 112.072 171.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -56.31 -41.61 76.27 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.86 -28.93 67.15 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -75.99 -59.91 2.55 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.78 -27.01 36.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.0 168.23 31.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.79 24.77 0.29 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.377 -0.912 . . . . 0.0 113.257 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.8 -45.91 12.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.943 . . . . 0.0 113.03 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.68 -34.3 64.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 0.0 113.152 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.34 94.97 49.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.61 -89.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.156 2.571 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -64.02 -43.85 94.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.631 0.772 . . . . 0.0 111.998 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.88 140.6 47.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.15 99.39 0.16 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 124.363 1.039 . . . . 0.0 111.695 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.554 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -60.59 -18.68 54.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -44.17 -48.2 9.19 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 112.497 165.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 82' ' ' LEU . 36.5 m -95.08 -29.35 14.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.124 0.97 . . . . 0.0 113.469 171.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.28 67.66 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.169 0.89 . . . . 0.0 113.861 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 80' ' ' SER . 17.7 mt . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.006 -1.473 . . . . 99.989999999999995 111.83 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 7.7 m-20 . . . . . 0 N--CA 1.479 0.975 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.482 ' HB3' HG21 ' A' ' 58' ' ' ILE . 25.7 m95 -61.29 -33.9 74.33 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.831 172.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.6 -48.88 75.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -65.48 -39.84 92.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 78' ' ' ALA . 44.7 t -62.98 -32.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -56.43 -45.46 80.72 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.702 167.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -73.88 4.6 5.08 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -110.83 -33.99 6.37 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.569 0.748 . . . . 0.0 112.301 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.33 -48.07 8.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 168.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 57.2 p -94.35 -29.84 14.81 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.41 17.94 60.33 Favored Glycine 0 CA--C 1.541 1.68 0 O-C-N 123.994 0.809 . . . . 0.0 113.618 -173.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.61 67.4 0.51 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.113 0.863 . . . . 0.0 111.676 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.79 76.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.807 0.843 . . . . 0.0 112.181 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 82.1 m95 -64.44 -38.27 90.42 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.86 -27.9 55.24 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 25' ' ' THR . . . 46.2 69.9 0.43 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.822 1.649 . . . . 0.0 112.769 -173.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -76.0 32.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.319 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' ALA . 4.4 p -96.54 -17.34 20.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.053 2.941 . . . . 0.0 113.921 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.83 37.17 93.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.92 22.47 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.04 24.75 55.37 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.552 1.072 . . . . 0.0 115.5 -172.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -126.22 142.35 51.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.438 0.695 . . . . 0.0 109.135 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 58.2 m-85 -138.74 166.61 23.95 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.46 1.1 . . . . 0.0 112.507 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.37 -1.64 41.86 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.17 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 17' ' ' SER . . . 60.2 12.58 24.47 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -171.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.465 HD12 ' HE1' ' A' ' 73' ' ' TRP . 3.6 mm? -84.82 9.95 12.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 43.38 41.9 3.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.985 2.114 . . . . 0.0 114.458 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.21 118.49 31.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 111.717 -2.492 . . . . 0.0 110.337 -172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.52 135.77 5.8 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.954 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.99 -39.97 37.14 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.943 2.429 . . . . 0.0 112.939 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.28 -37.19 69.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.291 1.036 . . . . 0.0 113.277 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -69.23 -49.71 53.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.365 0.666 . . . . 0.0 110.961 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -59.47 -25.7 64.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -51.28 -27.29 8.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 170.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.57 73.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -95.31 22.15 7.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.516 1.126 . . . . 0.0 113.581 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.93 -21.23 40.92 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.445 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 69.81 6.07 54.29 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.1 148.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.928 1.691 . . . . 0.0 109.369 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 35.01 0.16 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 124.881 1.229 . . . . 0.0 115.711 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.14 -45.29 99.38 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.184 -1.865 . . . . 0.0 109.966 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 43.2 Cg_endo -66.18 -9.87 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.16 2.573 . . . . 0.0 118.03 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.1 -31.77 19.04 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.97 -36.32 8.24 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.976 0.894 . . . . 0.0 111.602 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m -50.3 152.95 1.63 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.276 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -48.63 -53.78 17.21 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.628 ' HA ' HG12 ' A' ' 58' ' ' ILE . 5.8 tm-20 -70.11 -27.15 64.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -42.71 53.96 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.555 0.693 . . . . 0.0 110.907 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -70.54 -35.65 73.26 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 55' ' ' GLU . 17.8 pt -56.07 -28.67 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.609 172.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.21 77.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.032 0.533 . . . . 0.0 112.376 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.75 -41.31 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.89 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -35.45 77.5 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HA ' HD23 ' A' ' 65' ' ' LEU . 10.8 t-20 -64.88 -36.09 83.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.525 1.53 . . . . 0.0 112.61 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -37.24 28.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -60.54 -24.6 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -56.87 -46.15 82.01 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.334 0.396 . . . . 0.0 111.723 170.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.5 -33.38 69.2 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.328 0.651 . . . . 0.0 112.693 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -27.7 10.57 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.6 149.86 8.74 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.72 -33.59 71.02 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.45 -23.29 48.82 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.83 94.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 112.76 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CZ3' ' HA ' ' A' ' 65' ' ' LEU . 13.0 m-90 -72.64 149.71 90.8 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.25 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.077 2.518 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -54.23 -21.44 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 21.2 m -101.26 152.47 20.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.887 1.275 . . . . 0.0 111.503 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.4 107.79 0.22 Allowed Glycine 0 N--CA 1.476 1.302 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.479 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.57 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -54.24 -23.22 13.93 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -45.78 -39.9 8.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.868 1.667 . . . . 0.0 113.704 167.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -109.97 -21.04 12.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 113.218 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.57 3.29 Favored Glycine 0 N--CA 1.48 1.581 0 C-N-CA 124.03 0.824 . . . . 0.0 112.466 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.943 -1.503 . . . . 99.989999999999995 114.15 179.872 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 N--CA 1.476 0.836 0 CA-C-O 120.772 0.32 . . . . 0.0 111.338 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 26.9 m95 -53.64 -32.35 51.08 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 171.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -54.5 45.39 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.67 79.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.496 0.718 . . . . 0.0 112.246 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 78' ' ' ALA . 25.6 t -62.14 -31.59 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.36 81.36 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 168.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.97 5.4 19.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.11 -32.98 7.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.42 1.488 . . . . 0.0 111.448 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.477 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 91.4 mt-10 -101.79 -27.49 12.99 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.532 ' HB2' ' CA ' ' A' ' 32' ' ' GLY . 8.6 t -110.8 -38.96 4.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.894 0.877 . . . . 0.0 113.178 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 31.13 77.2 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.78 -95.91 0.1 Allowed Glycine 0 N--CA 1.48 1.576 0 O-C-N 124.075 0.514 . . . . 0.0 112.439 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.0 146.4 30.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -65.88 -58.7 4.98 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.832 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.23 -26.49 66.46 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 40.11 78.12 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.053 1.741 . . . . 0.0 113.433 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -83.88 43.41 0.92 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.393 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 p -104.45 -15.87 15.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.804 2.442 . . . . 0.0 112.729 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.39 39.98 80.32 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.054 0.782 . . . . 0.0 115.054 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -95.2 21.4 7.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.37 29.09 56.39 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 83.5 mttt -113.2 151.36 31.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.643 1.177 . . . . 0.0 110.105 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 10.3 p90 -132.65 160.7 35.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.236 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 40.12 28.63 0.17 Allowed Glycine 0 N--CA 1.483 1.79 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 172.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 17' ' ' SER . . . 60.47 34.23 84.61 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -172.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 2.6 mp -108.29 -2.89 18.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 pt20 42.83 28.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -169.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 2.0 t80 -94.54 108.02 19.99 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.394 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -24.45 126.12 0.16 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-N 112.348 -2.205 . . . . 0.0 114.809 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.44 -35.21 73.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.708 2.272 . . . . 0.0 113.441 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.99 66.89 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.305 1.042 . . . . 0.0 113.394 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 68' ' ' GLN . 25.5 m -67.16 -50.12 62.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.966 0.906 . . . . 0.0 111.097 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -60.02 -22.49 62.7 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -30.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 168.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.16 75.15 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 171.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.1 19.38 9.3 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.163 1.385 . . . . 0.0 113.59 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.21 28.95 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.23 -5.88 24.85 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 -173.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 48' ' ' ASN . 11.2 p -64.99 148.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.539 1.536 . . . . 0.0 111.923 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 31.47 0.1 OUTLIER Glycine 0 CA--C 1.542 1.724 0 C-N-CA 125.086 1.327 . . . . 0.0 116.245 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.513 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 t30 -57.78 -48.64 96.82 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.578 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB3' HE21 ' A' ' 57' ' ' GLN . 68.2 Cg_endo -73.03 -13.88 26.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.417 2.745 . . . . 0.0 116.131 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.83 53.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.34 -34.06 11.2 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.63 56.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.285 1.034 . . . . 0.0 111.786 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.3 t -55.97 154.19 7.77 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.486 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -59.1 3.02 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 14.9 tt0 -69.24 -26.23 64.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.96 -39.08 63.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.712 -0.618 . . . . 0.0 112.264 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -60.0 -50.72 72.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.595 1.158 . . . . 0.0 109.588 173.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -55.4 -31.57 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.27 77.77 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.02 -40.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 0.0 110.27 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -59.93 -38.95 83.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.608 1.163 . . . . 0.0 114.138 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 66.3 t30 -60.9 -38.47 85.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.168 1.387 . . . . 0.0 111.677 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -80.01 -32.2 39.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -61.07 -22.43 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -60.34 -39.43 87.11 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 169.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.72 69.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -65.83 -58.87 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 39' ' ' THR . 22.6 tp60 -91.48 -36.49 13.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.36 150.32 8.15 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -167.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -84.35 -1.35 55.31 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -87.99 -23.75 23.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.603 1.161 . . . . 0.0 113.429 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.38 91.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.145 0.978 . . . . 0.0 113.62 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -60.35 150.12 73.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.777 169.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 94.6 Cg_endo -63.25 -159.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.741 2.294 . . . . 0.0 111.066 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.0 p -51.49 -32.2 26.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 117.0 -1.476 . . . . 0.0 113.208 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 85.3 m -52.6 -135.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 128.392 3.557 . . . . 0.0 114.063 168.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 102.14 0.25 Allowed Glycine 0 N--CA 1.483 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 112.065 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -49.79 -26.16 3.69 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.18 -39.15 20.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.784 1.234 . . . . 0.0 113.132 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 m -108.93 -29.65 8.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.289 1.036 . . . . 0.0 113.098 168.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.89 -29.17 5.59 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.649 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 76' ' ' CYS . 59.5 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.08 -1.438 . . . . 99.989999999999995 113.212 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 m120 . . . . . 0 N--CA 1.476 0.869 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -57.77 -34.99 70.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.798 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 33.0 t70 -63.57 -48.22 78.32 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.88 75.8 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 78' ' ' ALA . 53.7 t -62.09 -37.45 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.729 0.811 . . . . 0.0 112.491 174.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -53.55 -48.26 69.26 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 167.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.24 8.3 5.14 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.0 t -114.8 -30.85 6.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.371 1.068 . . . . 0.0 113.485 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.59 -36.85 11.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 67.1 p -108.63 -23.4 11.83 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.3 7.93 69.1 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 114.962 0.745 . . . . 0.0 114.962 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.99 83.22 0.54 Allowed Glycine 0 N--CA 1.479 1.505 0 CA-C-O 121.996 0.776 . . . . 0.0 111.355 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 23' ' ' ALA . 1.1 m-20 172.16 108.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.334 2.254 . . . . 0.0 108.647 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.507 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 54.8 m95 -93.22 -44.01 8.54 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 172.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.67 -39.62 61.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 49.91 84.81 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.577 1.551 . . . . 0.0 111.658 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.47 58.57 0.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.1 1.429 . . . . 0.0 112.154 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.6 p -107.16 -26.6 11.02 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 34.39 89.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.226 0.917 . . . . 0.0 114.229 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.73 21.07 6.8 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.07 11.49 9.05 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 124.326 0.965 . . . . 0.0 115.433 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 19.5 mtpt -109.34 161.46 15.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.256 1.822 . . . . 0.0 110.247 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.624 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -114.17 119.71 37.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 112.882 -1.963 . . . . 0.0 112.964 -175.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.28 144.51 48.71 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.702 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.536 ' H ' ' HB3' ' A' ' 17' ' ' SER . . . 102.19 -36.98 3.9 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 112.943 -1.628 . . . . 0.0 110.806 -178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 61' ' ' ALA . 6.4 mp -109.64 -29.37 8.39 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 53.76 36.28 23.5 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 123.628 1.68 . . . . 0.0 112.047 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -97.76 129.52 44.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.418 -172.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -47.63 141.2 7.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 113.48 -1.691 . . . . 0.0 114.63 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 68.6 Cg_endo -60.48 -31.61 92.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.938 2.425 . . . . 0.0 112.868 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.14 63.45 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.61 1.164 . . . . 0.0 114.087 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.603 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 70.4 m -67.37 -57.13 7.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.482 0.713 . . . . 0.0 110.472 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.512 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 23.7 t-105 -56.94 -21.72 32.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.4 -31.27 5.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.42 73.72 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 171.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -95.66 16.69 16.65 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.426 1.49 . . . . 0.0 112.757 172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.63 -22.32 24.3 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.2 -2.9 33.56 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -69.22 154.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.733 1.613 . . . . 0.0 111.701 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.1 33.84 0.11 Allowed Glycine 0 N--CA 1.484 1.851 0 C-N-CA 125.098 1.333 . . . . 0.0 115.986 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 46' ' ' VAL . 1.9 t-20 -59.6 -48.68 94.95 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.207 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.1 Cg_endo -68.49 -30.86 28.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.603 2.202 . . . . 0.0 114.031 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.38 72.49 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.68 -32.44 16.2 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 129.72 40.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.14 0.971 . . . . 0.0 111.679 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.1 t -53.77 155.31 3.32 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.971 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 72.3 mtt180 -46.81 -52.42 14.24 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -69.2 -37.67 78.22 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -64.26 -35.21 80.1 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.67 -0.644 . . . . 0.0 112.031 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -63.15 -53.72 48.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.393 1.077 . . . . 0.0 109.936 171.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -53.71 -32.07 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.62 -57.91 10.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.029 0.932 . . . . 0.0 113.116 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.08 -38.0 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -59.42 -41.71 90.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.241 1.416 . . . . 0.0 114.021 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -61.0 -30.5 70.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.117 1.367 . . . . 0.0 112.255 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -33.8 21.26 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.258 0.8 OUTLIER -59.51 -24.71 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 172.454 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.4 pp -59.13 -44.02 92.0 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 170.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -31.16 70.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.25 -55.32 14.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -98.54 -26.88 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.75 155.26 8.37 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.06 -35.08 77.56 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 122.399 -0.471 . . . . 0.0 112.163 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.93 -17.84 53.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.618 1.567 . . . . 0.0 114.517 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 35' ' ' PHE . . . -44.96 -35.92 3.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.133 1.773 . . . . 0.0 114.38 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.477 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 12.4 m-90 -115.94 97.73 49.78 Favored Pre-proline 0 N--CA 1.471 0.59 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.37 -35.81 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.585 2.19 . . . . 0.0 114.012 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -61.94 -52.2 65.03 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.999 1.32 . . . . 0.0 113.693 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 m -139.42 -166.1 1.99 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.706 1.202 . . . . 0.0 110.196 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.06 102.21 0.16 Allowed Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -51.8 -27.0 10.91 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -46.97 -38.63 11.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.382 1.473 . . . . 0.0 114.236 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -109.5 -19.62 13.17 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.56 4.0 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.492 0.568 . . . . 0.0 113.239 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 115.212 1.56 . . . . 99.989999999999995 115.212 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.0 m120 . . . . . 0 N--CA 1.474 0.762 0 CA-C-O 121.103 0.478 . . . . 0.0 111.762 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TRP . . . . . 0.509 ' HB3' HG21 ' A' ' 58' ' ' ILE . 11.3 m95 -57.61 -30.69 65.53 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.167 170.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.0 m-20 -60.87 -51.04 70.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.212 1.005 . . . . 0.0 112.885 171.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.33 78.12 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.506 0.722 . . . . 0.0 112.513 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 78' ' ' ALA . 61.3 t -62.2 -42.97 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.519 1.128 . . . . 0.0 111.985 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -53.2 -44.94 68.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.105 0.562 . . . . 0.0 111.73 168.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.09 -5.61 36.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 t -105.33 -26.82 11.83 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.678 1.191 . . . . 0.0 112.596 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.81 -40.95 7.87 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.6 p -104.83 -23.31 13.04 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.4 -25.82 22.64 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.999 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.79 -40.68 0.2 Allowed Glycine 0 N--CA 1.477 1.432 0 CA-C-N 115.524 -0.338 . . . . 0.0 113.394 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -52.22 100.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.565 1.146 . . . . 0.0 113.21 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -73.77 -22.58 59.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -102.96 -25.43 13.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.16 74.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.228 2.211 . . . . 0.0 115.479 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 43.06 88.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.367 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.465 HG23 ' HB1' ' A' ' 22' ' ' ALA . 67.8 p -58.69 -26.28 63.7 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.319 -1.764 . . . . 0.0 112.871 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.78 -3.54 22.03 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.166 1.365 . . . . 0.0 115.422 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.1 7.91 44.62 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.95 8.16 33.67 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 124.007 0.813 . . . . 0.0 113.516 -172.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.636 ' HG3' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mttm -110.7 159.51 17.55 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.749 2.02 . . . . 0.0 110.422 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -122.86 126.48 47.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.363 -175.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 151.03 38.8 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 112.031 -2.35 . . . . 0.0 112.71 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 94.7 -39.22 2.93 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 111.618 -2.291 . . . . 0.0 110.837 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.613 HD21 ' HB1' ' A' ' 61' ' ' ALA . 5.2 mp -107.44 -32.01 7.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.683 -1.258 . . . . 0.0 114.024 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 56.06 34.33 23.57 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.048 1.739 . . . . 0.0 112.193 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -96.24 132.5 41.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.33 -170.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.87 142.4 13.01 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.907 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' A' ' 29' ' ' LYS . 47.6 Cg_endo -57.97 -33.04 96.68 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.295 2.663 . . . . 0.0 113.499 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.13 62.53 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -67.24 -56.96 7.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 110.546 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 21.5 t-105 -60.2 -21.78 62.17 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.61 -30.9 5.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 114.303 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.51 77.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.54 17.64 9.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.156 1.382 . . . . 0.0 113.907 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.48 -21.62 30.24 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.04 49.31 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 114.785 0.674 . . . . 0.0 114.785 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.88 150.2 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.699 1.599 . . . . 0.0 109.135 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.06 40.13 0.07 OUTLIER Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.381 1.467 . . . . 0.0 115.917 170.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.43 -53.46 45.6 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 116.177 -1.868 . . . . 0.0 110.665 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HB3' HE21 ' A' ' 57' ' ' GLN . 83.8 Cg_endo -67.63 -21.15 46.07 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.837 2.358 . . . . 0.0 113.802 175.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -67.32 -35.36 79.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.585 1.554 . . . . 0.0 114.673 173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.76 -29.5 10.52 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 131.39 50.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 111.21 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -54.19 151.83 6.78 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.072 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -44.69 -57.45 3.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 40.9 tt0 -68.18 -30.17 69.21 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.75 -38.75 70.36 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.664 -0.648 . . . . 0.0 112.191 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.641 HE21 ' HB3' ' A' ' 49' ' ' PRO . 1.7 tm0? -59.13 -54.97 40.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.434 1.094 . . . . 0.0 109.466 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -55.15 -28.4 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.01 75.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 170.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.47 -39.88 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.737 0.815 . . . . 0.0 109.849 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -58.55 -39.94 81.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.091 1.357 . . . . 0.0 113.715 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.39 -45.49 91.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.78 1.232 . . . . 0.0 110.864 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.28 81.96 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 173.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.273 0.3 OUTLIER -61.12 -19.95 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 175.204 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -44.48 86.69 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.297 169.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -27.76 69.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.78 80.0 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -103.65 -24.69 13.35 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.79 159.96 10.83 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -56.75 -32.81 65.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.269 -0.548 . . . . 0.0 112.433 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.65 2.24 6.86 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.081 1.752 . . . . 0.0 114.965 175.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -55.42 -28.15 52.33 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 17.8 m-90 -118.21 74.8 11.0 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.8 -21.17 38.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.9 p -57.37 -41.34 79.96 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.182 1.793 . . . . 0.0 113.164 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -142.07 -86.0 0.17 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.277 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' CYS . . . 94.87 104.26 1.91 Allowed Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' A' ' 12' ' ' VAL . . . -45.86 -40.08 9.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.77 81.69 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 -27.5 30.48 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.59 26.21 69.54 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 124.11 0.862 . . . . 0.0 114.48 -172.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 125.671 1.588 . . . . 99.989999999999995 112.877 -178.171 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.773 0 N-CA-C 114.748 0.659 . . . . 0.0 114.748 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.73 -64.85 0.86 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.485 -0.857 . . . . 0.0 112.99 179.084 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.4 tpt -112.06 -69.21 0.88 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 123.875 0.87 . . . . 0.0 110.495 179.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 160.82 97.11 0.12 Allowed Glycine 0 CA--C 1.544 1.849 0 CA-C-O 117.811 -1.55 . . . . 0.0 110.0 176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -69.99 134.23 27.01 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.079 1.853 . . . . 0.0 112.279 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 38.7 m -59.99 145.07 85.53 Favored Pre-proline 0 N--CA 1.485 1.297 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.617 176.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -60.46 139.06 84.42 Favored 'Trans proline' 0 N--CA 1.48 0.715 0 C-N-CA 123.103 2.535 . . . . 0.0 111.55 177.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -133.46 95.0 3.41 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 -177.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 5.6 m95 -60.04 -31.98 70.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.866 1.432 . . . . 0.0 114.866 175.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -69.64 -48.92 58.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.69 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.66 79.25 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 176.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.534 HG11 ' H ' ' A' ' 78' ' ' ALA 0.255 50.8 t -64.66 -31.82 55.3 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 113.632 0.975 . . . . 0.0 113.632 174.148 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.494 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -60.54 -39.73 88.98 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.194 0.442 . . . . 0.0 112.194 167.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.08 6.56 7.69 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 115.578 1.695 . . . . 0.0 115.578 172.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' HB2' ' HA ' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -107.33 -34.61 7.03 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.894 1.278 . . . . 0.0 110.666 176.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -98.35 -33.82 10.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 116.841 2.163 . . . . 0.0 116.841 174.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.499 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 33.1 t -102.35 -36.48 8.44 Favored 'General case' 0 N--CA 1.484 1.237 0 C-N-CA 123.698 0.799 . . . . 0.0 112.741 173.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 60.06 28.6 66.64 Favored Glycine 0 CA--C 1.539 1.579 0 N-CA-C 114.958 0.743 . . . . 0.0 114.958 -178.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -171.55 -90.05 0.08 OUTLIER Glycine 0 CA--C 1.538 1.48 0 CA-C-N 115.51 -0.345 . . . . 0.0 112.707 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -113.72 143.79 44.03 Favored 'General case' 0 N--CA 1.482 1.151 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 -172.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.494 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 41.2 m95 -63.99 -34.55 78.25 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 171.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.82 -24.27 64.36 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 46.92 71.11 0.34 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 125.77 1.628 . . . . 0.0 113.902 -172.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -77.05 32.27 0.14 Allowed 'General case' 0 N--CA 1.485 1.305 0 CA-C-N 112.551 -2.113 . . . . 0.0 114.725 -179.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 24.5 p -101.48 -14.54 17.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.628 1.971 . . . . 0.0 113.092 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.15 34.33 85.87 Favored Glycine 0 N--CA 1.48 1.592 0 O-C-N 123.98 0.8 . . . . 0.0 114.961 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.445 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 1.0 OUTLIER -87.08 19.27 3.17 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 178.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.44 24.3 45.56 Favored Glycine 0 N--CA 1.482 1.712 0 C-N-CA 124.022 0.82 . . . . 0.0 114.778 -170.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.462 ' HD2' ' C ' ' A' ' 34' ' ' GLN . 44.3 mmtm -119.63 146.39 45.6 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.42 0.688 . . . . 0.0 110.147 -171.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.51 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 79.3 m-85 -134.43 164.96 26.28 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-N 114.508 -1.224 . . . . 0.0 114.211 -176.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 57.73 30.28 62.48 Favored Glycine 0 N--CA 1.48 1.579 0 CA-C-N 113.868 -1.514 . . . . 0.0 115.338 177.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 53.7 23.86 23.09 Favored Glycine 0 CA--C 1.538 1.497 0 C-N-CA 124.603 1.097 . . . . 0.0 115.782 -178.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.472 ' HB3' ' HE1' ' A' ' 73' ' ' TRP . 13.2 mt -113.69 10.7 17.99 Favored 'General case' 0 N--CA 1.473 0.709 0 N-CA-C 118.373 2.731 . . . . 0.0 118.373 -174.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.462 ' C ' ' HD2' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 43.17 39.56 2.01 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-O 123.042 1.401 . . . . 0.0 112.648 -175.071 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -99.14 112.0 24.25 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 114.334 -1.303 . . . . 0.0 110.448 -172.083 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -44.36 132.45 4.62 Favored Pre-proline 0 N--CA 1.482 1.158 0 CA-C-N 113.362 -1.745 . . . . 0.0 113.621 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 66.6 Cg_endo -60.54 -37.05 83.2 Favored 'Trans proline' 0 N--CA 1.481 0.787 0 C-N-CA 122.978 2.452 . . . . 0.0 112.936 -177.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.43 -34.37 66.74 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.239 1.015 . . . . 0.0 113.588 172.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.0 m -72.06 -47.54 50.82 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.651 0.78 . . . . 0.0 111.092 173.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.465 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -60.11 -23.31 63.74 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.292 0.849 . . . . 0.0 113.292 176.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.22 -29.54 5.82 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.855 1.428 . . . . 0.0 114.855 169.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.3 -33.58 69.62 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 171.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.45 ' CE1' HG23 ' A' ' 64' ' ' VAL . 17.3 m-85 -100.89 22.58 11.9 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.139 1.376 . . . . 0.0 112.711 174.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.26 -24.29 26.59 Favored Glycine 0 N--CA 1.479 1.504 0 N-CA-C 115.692 1.037 . . . . 0.0 115.692 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.42 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 75.52 -8.32 20.36 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 114.718 0.647 . . . . 0.0 114.718 -172.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.401 ' C ' ' H ' ' A' ' 48' ' ' ASN . 24.4 t -62.45 151.81 7.52 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 C-N-CA 126.794 2.038 . . . . 0.0 109.548 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.08 36.16 0.11 Allowed Glycine 0 CA--C 1.545 1.945 0 C-N-CA 125.448 1.499 . . . . 0.0 115.934 174.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 46' ' ' VAL . 12.1 t-20 -57.96 -50.51 87.71 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.251 -1.833 . . . . 0.0 110.502 174.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 85.7 Cg_endo -72.38 -16.07 27.85 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 122.972 2.448 . . . . 0.0 114.983 176.091 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.465 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -76.6 -34.3 58.4 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -95.1 -35.94 11.7 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.346 1.239 . . . . 0.0 114.346 177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.65 122.43 15.82 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.066 0.946 . . . . 0.0 111.55 176.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.1 m -47.15 159.1 0.12 Allowed 'General case' 0 N--CA 1.483 1.181 0 CA-C-N 114.558 -1.201 . . . . 0.0 111.111 173.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.562 ' O ' HG23 ' A' ' 58' ' ' ILE . 2.6 mpp_? -41.99 -57.22 2.51 Favored 'General case' 0 N--CA 1.485 1.286 0 N-CA-C 113.743 1.016 . . . . 0.0 113.743 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 19.9 tt0 -67.12 -37.71 84.32 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 114.194 1.183 . . . . 0.0 114.194 176.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.9 tp-100 -62.11 -39.57 92.97 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-O 121.705 0.764 . . . . 0.0 110.887 176.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -50.93 66.65 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.671 1.188 . . . . 0.0 110.894 173.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.5 pt -53.83 -33.0 22.67 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.307 0 O-C-N 123.644 0.59 . . . . 0.0 112.531 179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.19 -54.64 41.76 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.134 0.974 . . . . 0.0 113.053 173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 6.6 t -64.11 -41.18 91.64 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 C-N-CA 123.138 0.575 . . . . 0.0 110.047 177.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.622 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.04 -38.42 82.72 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.281 1.432 . . . . 0.0 114.332 174.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -59.58 -39.62 84.72 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.785 1.234 . . . . 0.0 111.618 174.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -78.98 -37.83 38.43 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 112.656 0.613 . . . . 0.0 112.656 174.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.622 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.268 0.4 OUTLIER -60.84 -23.59 29.84 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.976 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 174.625 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.04 -40.24 88.72 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 169.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.62 -31.7 65.35 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 173.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -63.12 -49.6 73.77 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -108.25 -27.34 10.09 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 115.097 1.518 . . . . 0.0 115.097 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 116.0 147.94 9.05 Favored Glycine 0 N--CA 1.477 1.406 0 N-CA-C 110.548 -1.021 . . . . 0.0 110.548 -174.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.7 pp -63.54 -33.51 75.75 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 173.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -56.23 -21.24 22.27 Favored 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 126.076 1.75 . . . . 0.0 114.935 176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.32 -37.64 78.29 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 112.603 175.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.472 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 25.1 m-90 -86.02 146.8 43.88 Favored Pre-proline 0 CA--C 1.545 0.765 0 O-C-N 124.033 0.833 . . . . 0.0 109.306 171.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.61 -148.78 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.411 2.741 . . . . 0.0 111.586 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.6 t -51.38 -30.35 18.63 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 173.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 33.9 m -81.58 131.98 35.29 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.75 1.22 . . . . 0.0 108.91 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -178.79 98.98 0.12 Allowed Glycine 0 N--CA 1.477 1.403 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.448 -178.434 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.534 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -57.91 -20.81 40.0 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.02 -35.17 23.73 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 124.947 1.299 . . . . 0.0 113.567 166.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 9.5 m -101.61 -24.17 14.16 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.47 1.108 . . . . 0.0 113.714 169.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 83.34 -34.0 2.91 Favored Glycine 0 CA--C 1.538 1.487 0 CA-C-O 118.933 -0.926 . . . . 0.0 113.631 -176.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 6.4 mt . . . . . 0 N--CA 1.489 1.478 0 C-N-CA 126.695 1.998 . . . . 99.989999999999995 113.377 -173.697 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.291 0 N-CA-C 111.894 -0.482 . . . . 0.0 111.894 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.98 164.01 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.617 1.167 . . . . 0.0 112.593 -177.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -118.07 -61.67 1.65 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.384 -1.28 . . . . 0.0 112.69 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 100.19 89.16 2.02 Favored Glycine 0 CA--C 1.542 1.759 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -68.52 152.4 74.94 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.243 1.962 . . . . 0.0 111.698 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -54.12 139.23 55.25 Favored Pre-proline 0 N--CA 1.483 1.212 0 CA-C-N 114.913 -1.039 . . . . 0.0 112.777 177.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -63.73 135.12 47.11 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.886 2.391 . . . . 0.0 112.513 178.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -104.48 90.92 3.68 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.685 -178.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.411 ' CH2' HD21 ' A' ' 33' ' ' LEU . 4.5 m95 -57.34 -33.66 67.97 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 174.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -60.66 -53.49 56.85 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 123.364 0.666 . . . . 0.0 111.844 171.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.56 -33.49 71.49 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 113.032 0.753 . . . . 0.0 113.032 175.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.581 HG11 ' HB2' ' A' ' 78' ' ' ALA . 94.3 t -60.14 -36.21 66.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 172.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.76 -44.65 90.65 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.292 169.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -71.97 -0.46 11.59 Favored 'General case' 0 N--CA 1.481 1.107 0 N-CA-C 115.459 1.652 . . . . 0.0 115.459 174.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -113.31 -28.74 7.48 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.49 1.116 . . . . 0.0 113.148 178.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -100.96 -21.47 15.05 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.181 1.549 . . . . 0.0 115.181 176.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.2 p -122.06 -27.45 4.57 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 166.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 80.41 6.28 89.36 Favored Glycine 0 CA--C 1.54 1.647 0 CA-C-N 115.962 -0.563 . . . . 0.0 114.354 -174.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.17 76.32 0.27 Allowed Glycine 0 N--CA 1.478 1.494 0 CA-C-O 121.775 0.653 . . . . 0.0 112.956 179.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.402 ' O ' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER 176.36 119.78 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 126.604 1.962 . . . . 0.0 109.405 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -90.29 -67.81 0.82 Allowed 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.96 171.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -57.99 -28.8 64.72 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.811 1.411 . . . . 0.0 114.811 172.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.16 72.28 0.22 Allowed 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 126.068 1.747 . . . . 0.0 113.952 -177.289 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -81.74 42.64 0.71 Allowed 'General case' 0 N--CA 1.483 1.193 0 CA-C-N 113.397 -1.729 . . . . 0.0 113.387 -175.598 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.1 t -111.37 -17.09 13.21 Favored 'General case' 0 N--CA 1.481 1.081 0 C-N-CA 127.26 2.224 . . . . 0.0 111.938 176.496 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 54.27 21.69 Favored Glycine 0 N--CA 1.48 1.6 0 CA-C-N 115.632 -0.713 . . . . 0.0 113.986 -177.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.477 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 6.2 t-20 -99.05 23.43 9.03 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.82 30.09 56.09 Favored Glycine 0 N--CA 1.484 1.843 0 C-N-CA 124.154 0.883 . . . . 0.0 114.828 -174.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.477 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -127.79 146.97 50.42 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.509 1.123 . . . . 0.0 109.388 -173.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.407 ' CB ' ' HG2' ' A' ' 49' ' ' PRO . 66.4 m-85 -138.55 151.42 47.3 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 114.755 -1.111 . . . . 0.0 112.159 178.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.407 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 64.88 2.94 8.88 Favored Glycine 0 N--CA 1.482 1.764 0 CA-C-N 114.352 -1.294 . . . . 0.0 115.165 -174.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 20' ' ' ASN . . . 65.23 36.12 92.43 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.143 0.877 . . . . 0.0 114.047 -172.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.411 HD21 ' CH2' ' A' ' 9' ' ' TRP . 5.9 mp -111.68 19.29 18.2 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 115.601 1.704 . . . . 0.0 115.601 178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 32.54 31.52 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 -168.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -90.99 105.56 17.92 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.173 -168.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.5 OUTLIER -40.41 129.56 1.75 Allowed Pre-proline 0 N--CA 1.482 1.163 0 CA-C-N 113.025 -1.898 . . . . 0.0 112.747 179.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 59.7 Cg_endo -59.72 -32.52 95.83 Favored 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.075 2.517 . . . . 0.0 113.46 -178.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.29 68.93 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.3 m -72.26 -45.03 61.86 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 122.893 0.477 . . . . 0.0 111.272 172.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.42 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 39.0 t-105 -58.54 -21.81 53.62 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 113.479 0.918 . . . . 0.0 113.479 177.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.409 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.03 -29.13 4.58 Favored 'General case' 0 N--CA 1.478 0.94 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 168.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.07 -35.22 69.09 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 113.252 0.834 . . . . 0.0 113.252 171.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.547 ' CE1' HG23 ' A' ' 64' ' ' VAL . 26.3 m-85 -100.07 21.85 12.18 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.142 1.377 . . . . 0.0 112.779 174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.51 -23.15 30.74 Favored Glycine 0 CA--C 1.538 1.483 0 N-CA-C 115.658 1.023 . . . . 0.0 115.658 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.409 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 -1.28 36.38 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 114.827 0.691 . . . . 0.0 114.827 -172.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' C ' ' H ' ' A' ' 48' ' ' ASN . 48.3 t -67.32 152.19 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 C-N-CA 126.409 1.884 . . . . 0.0 109.305 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.22 36.33 0.09 OUTLIER Glycine 0 CA--C 1.544 1.845 0 C-N-CA 125.501 1.524 . . . . 0.0 116.1 174.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.408 ' H ' ' C ' ' A' ' 46' ' ' VAL . 2.2 t-20 -58.91 -51.46 81.7 Favored Pre-proline 0 CA--C 1.551 1.014 0 CA-C-O 115.954 -1.974 . . . . 0.0 110.225 174.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.42 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.8 Cg_endo -71.78 -11.43 27.73 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.011 2.474 . . . . 0.0 115.442 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -82.71 -34.29 27.33 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 113.315 0.857 . . . . 0.0 113.315 173.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.36 -35.05 10.83 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 177.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.03 129.94 43.92 Favored 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 123.663 0.785 . . . . 0.0 110.871 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.7 t -53.34 159.88 1.28 Allowed 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 113.879 -1.51 . . . . 0.0 110.964 178.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -43.16 -59.01 2.23 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.4 1.08 . . . . 0.0 113.7 -178.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.3 tt0 -67.47 -34.81 77.92 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.569 0.952 . . . . 0.0 113.569 175.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -65.81 -37.55 86.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 121.601 -0.687 . . . . 0.0 111.674 178.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.407 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.2 OUTLIER -62.6 -52.73 62.21 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.528 1.131 . . . . 0.0 110.127 172.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 8.2 pt -56.06 -30.12 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 N-CA-C 113.467 0.914 . . . . 0.0 113.467 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.5 -51.64 68.6 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -65.64 -42.5 92.9 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 123.752 0.821 . . . . 0.0 109.774 177.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.568 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.3 -39.51 87.21 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 125.588 1.555 . . . . 0.0 114.369 175.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -56.77 -46.93 81.16 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 124.893 1.277 . . . . 0.0 110.669 173.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.31 -35.07 68.54 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 114.052 1.13 . . . . 0.0 114.052 175.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -62.38 -22.4 29.44 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.979 0 N-CA-C 113.962 1.097 . . . . 0.0 113.962 172.933 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -40.83 89.19 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-O 119.434 -0.317 . . . . 0.0 111.582 170.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -64.79 -30.87 71.89 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 173.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -68.66 -56.52 7.91 Favored 'General case' 0 N--CA 1.478 0.932 0 N-CA-C 116.055 1.872 . . . . 0.0 116.055 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 3.8 tp60 -89.37 -25.16 21.73 Favored 'General case' 0 N--CA 1.481 1.124 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.61 154.0 9.8 Favored Glycine 0 N--CA 1.48 1.576 0 N-CA-C 109.931 -1.268 . . . . 0.0 109.931 -175.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -56.61 -32.12 64.97 Favored 'General case' 0 N--CA 1.486 1.34 0 O-C-N 121.946 -0.738 . . . . 0.0 112.622 171.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -67.35 -2.02 5.54 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 116.09 1.885 . . . . 0.0 116.09 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.52 -31.77 64.44 Favored 'General case' 0 N--CA 1.482 1.138 0 N-CA-C 113.726 1.01 . . . . 0.0 113.726 176.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.454 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 13.1 m-90 -117.71 69.96 6.75 Favored Pre-proline 0 CA--C 1.547 0.863 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.534 174.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -64.73 -25.38 61.25 Favored 'Trans proline' 0 CA--C 1.543 0.933 0 C-N-CA 122.559 2.173 . . . . 0.0 113.115 -176.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 11.6 p -57.73 -28.29 63.75 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 127.195 2.198 . . . . 0.0 115.326 174.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.32 -60.52 0.19 Allowed 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 177.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 77.42 99.35 0.19 Allowed Glycine 0 N--CA 1.475 1.279 0 CA-C-N 114.366 -1.288 . . . . 0.0 112.154 178.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.48 -38.59 54.65 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 114.412 -0.894 . . . . 0.0 113.274 172.506 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.45 -37.08 74.7 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 125.038 1.335 . . . . 0.0 114.083 177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -84.57 -22.55 30.03 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.266 1.58 . . . . 0.0 115.266 175.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 57.08 28.02 57.95 Favored Glycine 0 N--CA 1.479 1.536 0 N-CA-C 116.283 1.273 . . . . 0.0 116.283 -178.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 44.9 mt . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 117.621 -1.18 . . . . 99.989999999999995 113.8 178.703 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 1.778 0 N-CA-C 113.96 0.344 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 3' ' ' MET . . . -154.73 101.88 2.34 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 124.138 0.975 . . . . 0.0 110.14 177.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 69.7 mtp -156.26 -56.49 0.09 Allowed 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 113.801 -1.545 . . . . 0.0 112.425 -178.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -59.17 150.56 36.67 Favored Glycine 0 CA--C 1.542 1.741 0 CA-C-O 118.842 -0.977 . . . . 0.0 113.51 177.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -63.94 148.01 91.81 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.705 2.27 . . . . 0.0 111.434 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.7 t -100.37 131.64 23.68 Favored Pre-proline 0 N--CA 1.471 0.616 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.492 -174.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -66.82 138.83 49.98 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.636 2.224 . . . . 0.0 112.594 -176.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -123.0 169.99 10.6 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.312 -174.01 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.562 ' CZ3' HD11 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -52.91 -33.74 51.82 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 176.044 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 17.6 t70 -56.34 -42.28 77.45 Favored 'General case' 0 N--CA 1.483 1.214 0 C-N-CA 124.043 0.937 . . . . 0.0 113.351 169.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -64.07 -31.13 72.21 Favored 'General case' 0 N--CA 1.475 0.792 0 CA-C-O 118.245 -0.884 . . . . 0.0 112.678 178.335 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.3 t -59.06 -49.23 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 C-N-CA 123.318 0.647 . . . . 0.0 109.669 172.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.87 -43.92 94.45 Favored 'General case' 0 N--CA 1.477 0.912 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 173.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -76.07 10.91 1.66 Allowed 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.5 OUTLIER -115.8 -31.53 5.77 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 125.114 1.366 . . . . 0.0 111.613 177.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -98.25 -43.37 7.0 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 115.566 1.691 . . . . 0.0 115.566 172.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.6 t -88.33 -39.28 14.47 Favored 'General case' 0 N--CA 1.486 1.34 0 C-N-CA 124.42 1.088 . . . . 0.0 112.861 171.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.37 18.72 58.83 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 115.104 -0.953 . . . . 0.0 115.108 -175.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.07 -89.72 0.07 OUTLIER Glycine 0 N--CA 1.477 1.374 0 CA-C-O 121.502 0.501 . . . . 0.0 113.124 -178.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.4 m-80 -114.1 144.42 43.18 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -172.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 22.3 m95 -65.95 -44.12 85.95 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 114.224 -1.353 . . . . 0.0 112.903 170.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -68.66 -31.55 70.76 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 171.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.01 76.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 126.271 1.828 . . . . 0.0 113.586 -172.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -81.96 51.97 1.86 Allowed 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 113.649 -1.614 . . . . 0.0 112.786 -174.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 9.3 t -113.65 -23.79 9.54 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 111.642 -2.526 . . . . 0.0 112.356 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.23 36.82 90.47 Favored Glycine 0 CA--C 1.538 1.478 0 N-CA-C 115.273 0.869 . . . . 0.0 115.273 -177.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.7 29.55 2.01 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.468 0.651 . . . . 0.0 112.726 -179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.433 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.1 41.12 92.44 Favored Glycine 0 N--CA 1.481 1.686 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.354 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 51.9 mtpt -116.48 146.07 42.84 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.949 0.9 . . . . 0.0 110.381 -175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 14.9 m-85 -139.26 134.78 33.12 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.027 -1.442 . . . . 0.0 112.861 -173.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD23 ' A' ' 33' ' ' LEU . . . 52.98 31.73 40.46 Favored Glycine 0 CA--C 1.539 1.531 0 O-C-N 125.33 1.644 . . . . 0.0 114.781 179.087 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 54.94 17.32 9.29 Favored Glycine 0 CA--C 1.544 1.851 0 N-CA-C 115.06 0.784 . . . . 0.0 115.06 -171.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.562 HD11 ' CZ3' ' A' ' 9' ' ' TRP . 0.1 OUTLIER -103.14 19.96 18.57 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.728 0.811 . . . . 0.0 113.055 -176.672 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 36.96 40.96 0.16 Allowed 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 126.705 2.002 . . . . 0.0 113.723 -176.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -90.84 99.49 12.52 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 113.827 -1.533 . . . . 0.0 111.891 -171.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.636 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -37.06 132.45 0.72 Allowed Pre-proline 0 N--CA 1.476 0.829 0 CA-C-N 112.682 -2.054 . . . . 0.0 113.665 178.663 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD2' ' HD3' ' A' ' 36' ' ' LYS . 78.4 Cg_endo -63.35 -39.11 39.24 Favored 'Trans proline' 0 CA--C 1.537 0.654 0 C-N-CA 123.212 2.608 . . . . 0.0 113.167 -175.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.55 -35.13 67.78 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.148 0.979 . . . . 0.0 113.071 172.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 30.1 m -70.61 -51.07 30.64 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.187 0.995 . . . . 0.0 111.354 171.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 37.1 t-105 -58.18 -21.1 45.91 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 177.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.62 -29.35 4.23 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.799 1.407 . . . . 0.0 114.799 168.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.4 -35.42 67.76 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 170.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -100.52 21.52 13.14 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 125.243 1.417 . . . . 0.0 113.277 174.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.32 -23.71 26.2 Favored Glycine 0 CA--C 1.54 1.625 0 N-CA-C 115.639 1.016 . . . . 0.0 115.639 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.441 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.78 -6.14 20.37 Favored Glycine 0 N--CA 1.484 1.875 0 CA-C-N 117.321 0.56 . . . . 0.0 114.462 -172.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.415 ' C ' ' H ' ' A' ' 48' ' ' ASN . 31.7 t -64.81 150.39 10.53 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.954 0 C-N-CA 126.076 1.75 . . . . 0.0 109.004 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.62 37.28 0.1 OUTLIER Glycine 0 N--CA 1.484 1.879 0 C-N-CA 125.127 1.346 . . . . 0.0 115.748 173.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.415 ' H ' ' C ' ' A' ' 46' ' ' VAL . 14.3 t-20 -56.98 -51.62 80.29 Favored Pre-proline 0 CA--C 1.548 0.871 0 CA-C-O 116.304 -1.808 . . . . 0.0 110.465 174.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.446 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 97.1 Cg_endo -70.44 -20.64 31.39 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 123.328 2.685 . . . . 0.0 115.115 176.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.22 -32.01 55.61 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.252 1.021 . . . . 0.0 113.442 174.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.95 -32.34 15.29 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.243 1.201 . . . . 0.0 114.243 174.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.418 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -67.47 130.59 43.54 Favored 'General case' 0 N--CA 1.476 0.853 0 C-N-CA 124.48 1.112 . . . . 0.0 112.525 175.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 23.5 m -54.73 159.38 2.24 Favored 'General case' 0 N--CA 1.484 1.24 0 CA-C-N 114.404 -1.271 . . . . 0.0 110.742 172.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.57 -52.27 10.77 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.057 1.503 . . . . 0.0 115.057 179.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 21.3 tt0 -63.59 -40.26 96.49 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 174.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.418 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 43.1 tp60 -63.82 -40.15 95.94 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.287 0.635 . . . . 0.0 110.774 178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.08 -49.9 68.23 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.627 1.171 . . . . 0.0 111.089 172.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -55.18 -33.65 30.78 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 CA-C-O 118.951 -0.547 . . . . 0.0 112.117 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.95 -51.19 69.11 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 173.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.8 t -66.24 -44.12 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 C-N-CA 123.372 0.669 . . . . 0.0 110.373 178.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.6 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -64.7 -34.56 78.6 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 176.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -56.3 -50.29 71.85 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.618 1.167 . . . . 0.0 110.557 168.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.06 -33.63 70.44 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 177.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.6 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.286 0.3 OUTLIER -62.5 -21.71 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 172.914 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.44 -38.86 91.38 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 168.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.78 -31.54 71.49 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 173.302 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.444 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 1.4 mm-40 -73.16 -65.93 0.74 Allowed 'General case' 0 N--CA 1.478 0.943 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 175.785 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 12.9 tp60 -81.85 -23.02 36.65 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -177.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 105.38 -169.31 16.21 Favored Glycine 0 N--CA 1.474 1.187 0 N-CA-C 110.093 -1.203 . . . . 0.0 110.093 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -100.3 17.73 20.66 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 113.871 -1.164 . . . . 0.0 113.32 171.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -73.63 -37.75 65.27 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 174.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -60.69 -35.31 75.97 Favored 'General case' 0 N--CA 1.48 1.069 0 O-C-N 124.024 0.827 . . . . 0.0 113.039 177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -128.56 82.61 68.28 Favored Pre-proline 0 N--CA 1.473 0.712 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -81.22 -81.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 122.936 2.424 . . . . 0.0 111.666 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.6 t -56.22 -44.64 79.76 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 124.896 1.278 . . . . 0.0 112.932 172.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 75.4 m -80.7 103.4 10.52 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.03 1.332 . . . . 0.0 108.191 175.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -148.01 50.55 0.58 Allowed Glycine 0 N--CA 1.479 1.513 0 CA-C-N 116.061 -0.518 . . . . 0.0 113.773 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -63.29 -12.14 27.14 Favored 'General case' 0 N--CA 1.477 0.905 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -178.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -54.77 -30.82 57.71 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 123.974 0.91 . . . . 0.0 113.175 165.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 38.7 m -93.52 -15.27 25.67 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.03 1.492 . . . . 0.0 115.03 169.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 80.19 36.65 23.77 Favored Glycine 0 CA--C 1.54 1.613 0 N-CA-C 115.467 0.947 . . . . 0.0 115.467 -172.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.484 1.225 0 N-CA-C 114.641 1.349 . . . . 99.989999999999995 114.641 178.098 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.634 0 CA-C-O 121.096 0.276 . . . . 0.0 113.372 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -166.52 -69.01 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 124.526 1.13 . . . . 0.0 111.031 -175.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.4 mpp? 45.28 85.76 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 125.942 1.697 . . . . 0.0 113.663 -179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.01 -91.28 0.08 OUTLIER Glycine 0 CA--C 1.541 1.669 0 CA-C-N 114.001 -1.454 . . . . 0.0 111.935 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -67.87 130.32 21.55 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.164 1.909 . . . . 0.0 111.407 177.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -103.16 132.23 21.33 Favored Pre-proline 0 N--CA 1.48 1.059 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.074 178.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -71.97 114.11 3.87 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 122.513 2.142 . . . . 0.0 112.441 179.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -72.23 164.68 25.83 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.471 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.448 ' HB3' HG21 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -50.89 -32.43 20.51 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 173.002 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -58.64 -34.3 71.04 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 113.681 0.993 . . . . 0.0 113.681 170.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.54 -30.76 71.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-O 118.394 -0.812 . . . . 0.0 112.418 175.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.412 HG23 ' HB3' ' A' ' 78' ' ' ALA . 15.0 t -58.15 -48.75 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 170.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.8 -43.34 98.28 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 112.748 0.648 . . . . 0.0 112.748 175.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -71.3 -3.89 22.97 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 175.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.4 t -115.73 -29.4 6.44 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.02 1.118 . . . . 0.0 114.02 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.475 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 54.6 mm-40 -88.86 -32.21 17.89 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 171.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 1.4 t -115.21 -33.99 5.15 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.08 -22.54 33.97 Favored Glycine 0 CA--C 1.54 1.607 0 O-C-N 123.321 0.388 . . . . 0.0 112.646 -173.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.33 89.83 0.19 Allowed Glycine 0 N--CA 1.476 1.348 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -177.6 86.07 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.981 1.313 . . . . 0.0 110.285 -178.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 92.5 m95 -71.47 -34.4 70.17 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.26 0.837 . . . . 0.0 113.26 174.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.09 -35.06 32.18 Favored 'General case' 0 N--CA 1.476 0.874 0 N-CA-C 113.672 0.989 . . . . 0.0 113.672 172.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 51.3 66.29 1.23 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.954 1.701 . . . . 0.0 112.923 -178.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.8 35.52 0.37 Allowed 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.304 -1.771 . . . . 0.0 113.456 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 34.1 p -104.69 -18.69 14.2 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 127.02 2.128 . . . . 0.0 112.797 179.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.44 34.27 73.79 Favored Glycine 0 N--CA 1.481 1.639 0 C-N-CA 123.753 0.692 . . . . 0.0 114.59 -179.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -84.7 19.93 1.9 Allowed 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 178.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.457 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.0 30.28 63.34 Favored Glycine 0 CA--C 1.543 1.839 0 C-N-CA 123.79 0.709 . . . . 0.0 114.258 -171.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -126.02 144.24 50.79 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.458 0.703 . . . . 0.0 109.649 -174.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.516 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 94.4 m-85 -142.16 151.76 42.53 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.367 -1.288 . . . . 0.0 111.892 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.67 -11.81 5.36 Favored Glycine 0 N--CA 1.483 1.772 0 CA-C-N 115.166 -0.924 . . . . 0.0 113.925 -175.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 69.18 26.67 74.45 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 114.704 0.642 . . . . 0.0 114.704 -173.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -100.27 17.91 20.15 Favored 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 112.432 0.53 . . . . 0.0 112.432 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.475 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 0.6 OUTLIER 42.68 40.3 1.96 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 127.375 2.27 . . . . 0.0 113.836 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.1 t80 -98.01 113.36 25.2 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 113.654 -1.612 . . . . 0.0 111.362 -168.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.473 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 0.0 OUTLIER -40.7 127.59 1.89 Allowed Pre-proline 0 N--CA 1.481 1.081 0 CA-C-N 113.414 -1.721 . . . . 0.0 114.072 -179.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.473 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 96.2 Cg_endo -64.44 -37.83 36.85 Favored 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 122.797 2.332 . . . . 0.0 112.316 -175.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 -37.89 74.28 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.274 1.03 . . . . 0.0 113.322 172.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 90.3 m -68.66 -45.78 70.85 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 122.99 0.516 . . . . 0.0 111.5 171.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.407 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 32.0 t-105 -56.53 -22.34 32.37 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 177.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.499 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.72 -27.03 6.3 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 115.075 1.509 . . . . 0.0 115.075 168.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.76 -37.68 71.39 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.694 0.798 . . . . 0.0 112.97 170.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -95.53 19.46 10.99 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.309 1.044 . . . . 0.0 113.657 172.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.4 -21.29 31.04 Favored Glycine 0 N--CA 1.48 1.583 0 N-CA-C 115.351 0.901 . . . . 0.0 115.351 -179.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.499 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.22 -3.62 29.79 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 114.53 0.572 . . . . 0.0 114.53 -173.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 7.4 p -64.82 154.07 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 C-N-CA 125.581 1.552 . . . . 0.0 111.303 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.64 39.33 0.1 Allowed Glycine 0 CA--C 1.541 1.68 0 CA-C-N 114.332 -1.304 . . . . 0.0 115.544 173.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -58.65 -48.51 96.75 Favored Pre-proline 0 CA--C 1.552 1.032 0 CA-C-O 116.455 -1.736 . . . . 0.0 110.211 173.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.407 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 28.8 Cg_endo -66.27 -26.2 49.13 Favored 'Trans proline' 0 CA--C 1.537 0.64 0 C-N-CA 122.449 2.099 . . . . 0.0 115.965 171.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.516 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -72.95 -37.15 67.24 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.946 1.091 . . . . 0.0 113.946 173.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -106.82 16.23 24.62 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 115.055 1.502 . . . . 0.0 115.055 -178.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -118.97 143.02 47.28 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 122.091 0.948 . . . . 0.0 110.772 176.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.654 ' HB3' ' HB2' ' A' ' 56' ' ' GLN . 33.9 t -62.99 156.84 23.45 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.265 -1.789 . . . . 0.0 110.3 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -47.59 -60.34 2.61 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.933 0.893 . . . . 0.0 112.936 -177.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.8 tt0 -70.62 -24.17 62.68 Favored 'General case' 0 N--CA 1.477 0.879 0 CA-C-N 114.308 -1.315 . . . . 0.0 114.298 177.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.654 ' HB2' ' HB3' ' A' ' 53' ' ' SER . 3.0 tp60 -74.14 -46.67 40.98 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.621 0.724 . . . . 0.0 111.37 175.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 53.5 tp60 -69.14 -36.84 77.88 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -178.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -53.58 -29.42 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-O 118.262 -0.875 . . . . 0.0 112.876 171.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.1 -43.02 99.53 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 173.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.2 t -68.99 -42.01 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.156 0 C-N-CA 123.037 0.535 . . . . 0.0 109.702 176.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.698 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -62.91 -35.76 81.14 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 175.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -62.29 -35.94 80.58 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 125.765 1.626 . . . . 0.0 111.844 172.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 13.8 ttt180 -79.17 -37.66 37.83 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.698 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.28 0.5 OUTLIER -60.81 -20.47 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.019 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 175.881 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.43 -39.92 81.12 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 168.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.52 -31.19 69.27 Favored 'General case' 0 N--CA 1.48 1.028 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 173.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -73.68 -57.62 3.87 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 124.313 1.045 . . . . 0.0 113.465 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 44.5 tp60 -87.48 -25.68 23.6 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 -178.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.79 149.43 8.61 Favored Glycine 0 N--CA 1.478 1.474 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.84 -26.06 61.51 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.23 -3.39 23.28 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 172.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.429 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -59.58 -32.64 70.57 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.0 m-90 -121.83 76.09 38.07 Favored Pre-proline 0 CA--C 1.552 1.046 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 173.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.46 -34.04 4.87 Favored 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 122.757 2.304 . . . . 0.0 113.082 -176.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 24.2 p -61.53 -41.11 96.85 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 126.106 1.762 . . . . 0.0 113.302 177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -153.69 133.9 13.36 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.302 1.441 . . . . 0.0 110.377 179.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -142.96 57.68 0.55 Allowed Glycine 0 N--CA 1.476 1.317 0 CA-C-N 113.964 -1.471 . . . . 0.0 112.025 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.412 ' HB3' HG23 ' A' ' 12' ' ' VAL . . . -56.58 -18.71 12.8 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 115.672 1.73 . . . . 0.0 115.672 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.58 -29.73 11.51 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 124.993 1.317 . . . . 0.0 113.868 165.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.4 p -102.07 -13.14 17.63 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 125.316 1.447 . . . . 0.0 113.993 174.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 97.03 13.43 46.15 Favored Glycine 0 N--CA 1.481 1.687 0 N-CA-C 116.159 1.223 . . . . 0.0 116.159 -176.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.8 mt . . . . . 0 N--CA 1.485 1.312 0 N-CA-C 115.56 1.689 . . . . 99.989999999999995 115.56 179.144 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 2.008 0 N-CA-C 115.159 0.824 . . . . 0.0 115.159 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.98 108.02 9.79 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 123.632 0.773 . . . . 0.0 110.566 179.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -100.62 156.85 17.08 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 114.815 -1.084 . . . . 0.0 112.146 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.66 -111.59 1.51 Allowed Glycine 0 N--CA 1.477 1.415 0 CA-C-O 118.048 -1.418 . . . . 0.0 111.131 178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.41 144.79 57.06 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.557 2.171 . . . . 0.0 112.165 178.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 15.6 t -74.95 125.88 88.86 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 115.354 -0.839 . . . . 0.0 111.513 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -66.54 132.24 28.49 Favored 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 123.198 2.599 . . . . 0.0 113.136 177.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -121.25 119.6 32.74 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 114.089 -1.414 . . . . 0.0 113.16 178.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.534 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 0.4 OUTLIER -60.64 -33.6 73.03 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.117 -1.401 . . . . 0.0 113.483 172.684 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.36 -34.88 67.06 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 114.719 1.377 . . . . 0.0 114.719 170.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -65.02 -31.54 72.82 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 112.764 0.653 . . . . 0.0 112.764 175.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 18.0 t -62.54 -47.83 91.12 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 C-N-CA 123.277 0.631 . . . . 0.0 109.606 172.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.459 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -59.19 -39.19 81.79 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 173.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -76.58 0.06 21.47 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.093 1.886 . . . . 0.0 116.093 173.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 1.2 t -114.41 -32.93 5.77 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.788 1.235 . . . . 0.0 111.926 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -98.01 -25.71 14.87 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.402 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 3.8 t -121.1 -24.91 5.42 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 175.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 93.35 -25.09 22.28 Favored Glycine 0 N--CA 1.483 1.772 0 O-C-N 122.102 -0.374 . . . . 0.0 113.536 -178.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.79 -46.72 0.15 Allowed Glycine 0 CA--C 1.538 1.517 0 C-N-CA 123.694 0.664 . . . . 0.0 113.621 -176.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -59.68 101.42 0.11 Allowed 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 114.862 1.431 . . . . 0.0 114.862 -178.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 85.2 m95 -64.13 -34.68 78.61 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 116.68 2.104 . . . . 0.0 116.68 176.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -102.72 19.0 20.03 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 113.442 0.905 . . . . 0.0 113.442 172.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 37.83 79.14 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.453 1.901 . . . . 0.0 114.757 -174.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -87.07 41.22 0.96 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.566 -2.107 . . . . 0.0 112.741 -172.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.491 HG23 ' HB2' ' A' ' 27' ' ' ASN . 10.2 t -114.86 -16.16 11.76 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 127.572 2.349 . . . . 0.0 112.843 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 67.16 36.67 90.56 Favored Glycine 0 CA--C 1.54 1.622 0 N-CA-C 115.292 0.877 . . . . 0.0 115.292 -177.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.491 ' HB2' HG23 ' A' ' 25' ' ' THR . 1.4 m-20 -97.35 24.75 6.2 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.658 1.355 . . . . 0.0 114.658 -179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.76 29.99 51.07 Favored Glycine 0 N--CA 1.485 1.903 0 N-CA-C 114.787 0.675 . . . . 0.0 114.787 -173.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 57.7 mttp -117.26 154.13 31.73 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 124.876 1.271 . . . . 0.0 110.056 -174.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 36.2 m-85 -149.77 166.29 29.88 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 -176.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 59.96 16.98 42.19 Favored Glycine 0 CA--C 1.541 1.665 0 CA-C-N 114.594 -1.185 . . . . 0.0 116.034 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 58.66 24.13 56.43 Favored Glycine 0 CA--C 1.542 1.737 0 C-N-CA 123.904 0.764 . . . . 0.0 114.424 -171.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.534 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 1.3 mt -116.28 14.62 15.83 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.971 2.212 . . . . 0.0 116.971 -170.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 36.65 27.44 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 116.907 2.188 . . . . 0.0 116.907 -169.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 3.9 t80 -78.79 98.54 6.34 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.743 -169.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -29.05 132.79 0.2 Allowed Pre-proline 0 N--CA 1.476 0.843 0 CA-C-N 113.531 -1.668 . . . . 0.0 114.626 174.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -61.38 -41.02 44.22 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 C-N-CA 123.021 2.481 . . . . 0.0 113.34 -177.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.401 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.85 -33.09 68.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.172 0.989 . . . . 0.0 113.45 173.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 m -75.38 -43.88 47.83 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 123.579 0.752 . . . . 0.0 112.036 174.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.482 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -61.97 -21.24 64.66 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 174.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.95 -29.2 7.96 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 114.707 1.373 . . . . 0.0 114.707 169.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.46 -33.73 66.2 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 170.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -102.11 21.24 15.18 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.539 1.535 . . . . 0.0 113.273 174.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.65 -22.05 31.15 Favored Glycine 0 CA--C 1.539 1.591 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.24 -0.22 41.35 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 114.692 0.637 . . . . 0.0 114.692 -172.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -69.35 150.51 10.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 C-N-CA 126.26 1.824 . . . . 0.0 109.331 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.72 37.11 0.08 OUTLIER Glycine 0 CA--C 1.542 1.738 0 C-N-CA 125.446 1.498 . . . . 0.0 116.137 172.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -56.81 -53.91 59.73 Favored Pre-proline 0 CA--C 1.549 0.911 0 CA-C-O 115.177 -2.344 . . . . 0.0 109.744 171.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -68.49 -10.71 29.84 Favored 'Trans proline' 0 CA--C 1.543 0.951 0 C-N-CA 123.417 2.745 . . . . 0.0 116.273 176.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.433 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -82.9 -35.7 25.92 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 113.574 0.953 . . . . 0.0 113.574 172.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -100.27 -30.87 11.65 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 178.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.09 123.36 14.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 125.097 1.359 . . . . 0.0 111.637 177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.6 t -53.8 152.74 5.17 Favored 'General case' 0 N--CA 1.479 0.983 0 CA-C-N 113.45 -1.705 . . . . 0.0 110.659 -178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 9.8 mtp180 -40.33 -58.29 1.56 Allowed 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 -176.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.448 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.4 tp10 -70.9 -32.12 68.98 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 176.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -75.68 -37.4 59.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.315 0.646 . . . . 0.0 112.387 -177.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 18.8 tp60 -64.92 -50.76 65.22 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.506 0.722 . . . . 0.0 112.819 171.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG12 ' HA ' ' A' ' 55' ' ' GLU . 39.6 pt -53.5 -29.2 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 178.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.89 90.45 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.962 0.905 . . . . 0.0 113.439 170.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.2 t -63.39 -44.0 98.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.245 0 C-N-CA 123.875 0.87 . . . . 0.0 109.55 174.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.464 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.99 -39.03 84.34 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 1.3 t30 -58.09 -37.23 74.11 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.158 1.383 . . . . 0.0 112.429 172.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.2 tpt180 -76.89 -40.52 47.14 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-O 121.436 0.636 . . . . 0.0 111.346 172.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.275 0.4 OUTLIER -59.94 -21.69 22.39 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 177.394 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.5 pp -58.26 -37.58 75.23 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 168.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.34 -30.81 65.09 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.456 0.702 . . . . 0.0 112.843 173.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 69.3 mm-40 -67.16 -60.74 2.36 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 176.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 17.0 tm0? -82.63 -37.82 24.39 Favored 'General case' 0 N--CA 1.48 1.037 0 N-CA-C 112.708 0.633 . . . . 0.0 112.708 179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 115.63 156.18 10.94 Favored Glycine 0 CA--C 1.535 1.319 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 66.2 mt -58.42 -15.14 9.56 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 169.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -64.49 -21.15 66.59 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 125.776 1.63 . . . . 0.0 113.335 174.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.17 87.97 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 175.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -132.38 80.52 62.89 Favored Pre-proline 0 CA--C 1.545 0.751 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 176.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -83.69 -54.99 0.03 OUTLIER 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.502 2.135 . . . . 0.0 112.965 -178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 20.7 p -64.22 -55.51 21.13 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.836 1.654 . . . . 0.0 111.995 177.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 86.0 m -90.95 123.73 34.67 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 114.495 -1.229 . . . . 0.0 108.074 172.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -163.28 46.67 0.32 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.329 1.018 . . . . 0.0 113.599 176.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.86 -16.69 18.54 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 115.701 1.741 . . . . 0.0 115.701 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.14 -43.58 78.4 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.899 1.28 . . . . 0.0 112.548 168.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 3.0 m -79.53 -18.85 50.96 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.584 1.154 . . . . 0.0 113.778 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.26 -48.27 3.77 Favored Glycine 0 N--CA 1.476 1.362 0 CA-C-N 114.825 -1.08 . . . . 0.0 111.712 -172.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.0 mt . . . . . 0 N--CA 1.488 1.454 0 CA-C-O 117.032 -1.461 . . . . 99.989999999999995 112.393 -170.297 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.882 0 CA-C-O 121.689 0.605 . . . . 0.0 114.288 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.88 154.98 34.88 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.228 1.011 . . . . 0.0 109.992 -179.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.1 mtp -62.49 161.9 11.15 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.528 -1.214 . . . . 0.0 110.884 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -106.77 88.41 0.54 Allowed Glycine 0 CA--C 1.54 1.634 0 CA-C-O 118.009 -1.439 . . . . 0.0 110.87 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -74.84 145.32 31.97 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.326 2.017 . . . . 0.0 110.596 176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 62.8 m -87.39 108.25 18.81 Favored Pre-proline 0 N--CA 1.479 1.016 0 CA-C-N 115.241 -0.89 . . . . 0.0 111.381 178.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.33 130.02 14.62 Favored 'Trans proline' 0 CA--C 1.537 0.638 0 C-N-CA 122.175 1.917 . . . . 0.0 111.276 178.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -108.46 172.43 6.84 Favored 'General case' 0 N--CA 1.479 0.997 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.941 176.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 1.4 m95 -47.78 -33.95 7.89 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 170.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -57.61 -33.75 68.55 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 170.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -68.65 -33.49 74.1 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 124.208 1.003 . . . . 0.0 112.317 176.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.04 -49.53 84.31 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.283 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 171.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -57.4 -42.56 82.46 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 112.912 0.708 . . . . 0.0 112.912 174.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 27.0 mt-30 -77.74 4.63 11.17 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 173.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 96.8 m -112.78 -43.47 3.44 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 168.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -70.55 -44.73 66.86 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.958 0.903 . . . . 0.0 113.406 176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.8 t -102.81 -42.79 5.74 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 124.036 0.934 . . . . 0.0 112.585 175.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.52 24.59 64.12 Favored Glycine 0 N--CA 1.483 1.769 0 N-CA-C 115.0 0.76 . . . . 0.0 115.0 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -154.15 -93.54 0.1 OUTLIER Glycine 0 N--CA 1.477 1.368 0 O-C-N 124.125 0.544 . . . . 0.0 112.164 179.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -113.53 147.72 37.42 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 -174.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.448 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 49.8 m95 -71.25 -43.44 67.26 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.353 -1.749 . . . . 0.0 112.287 173.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -65.2 -24.39 67.35 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 113.844 1.053 . . . . 0.0 113.844 170.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 39.35 71.77 0.16 Allowed 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 126.005 1.722 . . . . 0.0 113.962 -172.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.9 p-10 -73.0 32.58 0.07 Allowed 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 112.896 -1.957 . . . . 0.0 115.004 -179.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 21.5 p -109.12 -23.4 11.66 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 127.218 2.207 . . . . 0.0 113.251 -177.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.89 35.31 72.34 Favored Glycine 0 N--CA 1.48 1.627 0 N-CA-C 115.911 1.124 . . . . 0.0 115.911 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.432 ' HB2' ' HD2' ' A' ' 29' ' ' LYS . 88.6 m-20 -90.93 28.38 1.58 Allowed 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 176.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.511 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 57.37 40.44 92.02 Favored Glycine 0 N--CA 1.483 1.827 0 CA-C-O 121.518 0.51 . . . . 0.0 113.233 -173.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.651 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 40.6 mttp -120.53 137.15 54.53 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 124.653 1.181 . . . . 0.0 109.255 -176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.609 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 99.2 m-85 -138.4 147.81 43.78 Favored 'General case' 0 N--CA 1.474 0.774 0 O-C-N 124.575 1.172 . . . . 0.0 111.431 177.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 69.97 -4.51 7.78 Favored Glycine 0 CA--C 1.54 1.646 0 CA-C-N 114.478 -1.237 . . . . 0.0 114.546 -176.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 71.31 26.98 72.41 Favored Glycine 0 CA--C 1.535 1.323 0 C-N-CA 123.418 0.532 . . . . 0.0 112.833 -173.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.402 HD23 ' OE1' ' A' ' 57' ' ' GLN . 3.4 mm? -111.42 21.6 16.03 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 114.403 1.26 . . . . 0.0 114.403 176.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.651 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 1.2 tt0 44.45 35.12 1.23 Allowed 'General case' 0 N--CA 1.486 1.367 0 CA-C-O 123.534 1.635 . . . . 0.0 113.287 -177.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -97.11 107.5 20.04 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.294 -1.321 . . . . 0.0 110.72 -168.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 4.9 mttm -47.37 133.05 9.96 Favored Pre-proline 0 N--CA 1.477 0.882 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.884 -178.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 74.2 Cg_endo -62.7 -34.43 73.73 Favored 'Trans proline' 0 CA--C 1.537 0.666 0 C-N-CA 122.918 2.412 . . . . 0.0 113.326 -178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.76 -39.27 70.96 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 124.042 0.937 . . . . 0.0 113.232 173.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.0 m -66.28 -50.72 62.75 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.168 0.987 . . . . 0.0 111.794 170.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.49 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.3 t-105 -57.35 -22.01 39.52 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.439 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.64 -29.06 6.63 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 169.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -59.23 -33.01 70.49 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 113.547 0.944 . . . . 0.0 113.547 171.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -102.45 25.44 9.02 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.191 0.996 . . . . 0.0 111.761 173.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.4 -22.84 31.7 Favored Glycine 0 CA--C 1.539 1.589 0 N-CA-C 115.824 1.09 . . . . 0.0 115.824 178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.439 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.85 -6.0 28.6 Favored Glycine 0 N--CA 1.484 1.848 0 N-CA-C 114.714 0.646 . . . . 0.0 114.714 -173.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.4 t -62.89 149.64 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 126.317 1.847 . . . . 0.0 109.295 -179.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.23 35.86 0.09 OUTLIER Glycine 0 CA--C 1.544 1.866 0 C-N-CA 125.175 1.369 . . . . 0.0 116.218 174.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -58.57 -48.34 97.09 Favored Pre-proline 0 CA--C 1.548 0.884 0 CA-C-O 116.058 -1.925 . . . . 0.0 110.874 173.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.609 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 72.5 Cg_endo -69.2 -19.81 38.31 Favored 'Trans proline' 0 CA--C 1.541 0.847 0 C-N-CA 122.81 2.34 . . . . 0.0 114.781 175.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.92 -34.66 51.19 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.575 0.954 . . . . 0.0 113.575 174.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -92.37 -34.12 14.3 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 114.791 1.404 . . . . 0.0 114.791 176.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.01 128.05 34.53 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 123.949 0.9 . . . . 0.0 111.542 176.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.0 m -50.82 157.7 0.77 Allowed 'General case' 0 N--CA 1.481 1.115 0 CA-C-N 113.849 -1.523 . . . . 0.0 110.597 175.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.675 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 2.6 mpt_? -38.92 -61.02 0.79 Allowed 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 176.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.6 ' HA ' HG12 ' A' ' 58' ' ' ILE . 11.0 tt0 -69.79 -24.42 63.49 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 178.04 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -74.51 -41.51 60.54 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 123.444 0.698 . . . . 0.0 110.669 175.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.402 ' OE1' HD23 ' A' ' 33' ' ' LEU . 0.3 OUTLIER -61.49 -47.65 84.69 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.566 1.146 . . . . 0.0 110.572 175.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.6 HG12 ' HA ' ' A' ' 55' ' ' GLU . 10.1 pt -55.31 -31.84 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.85 -51.48 68.05 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.63 0.772 . . . . 0.0 112.534 173.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -67.32 -41.5 86.54 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 122.794 0.438 . . . . 0.0 110.26 177.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.448 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -34.12 74.8 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 114.085 1.143 . . . . 0.0 114.085 175.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -61.71 -44.77 96.28 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.164 0.985 . . . . 0.0 111.919 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -68.58 -38.8 80.98 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 121.213 0.53 . . . . 0.0 111.943 173.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.448 HG12 ' O ' ' A' ' 61' ' ' ALA 0.27 0.4 OUTLIER -59.96 -22.99 25.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.883 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 177.156 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.2 -37.65 80.9 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 169.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.0 -29.3 68.28 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.75 -59.97 2.47 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.983 1.313 . . . . 0.0 113.52 178.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 69.0 tp60 -91.18 -21.81 20.96 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 -176.061 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 117.81 151.58 9.27 Favored Glycine 0 N--CA 1.477 1.396 0 N-CA-C 111.196 -0.762 . . . . 0.0 111.196 -178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -61.87 -37.88 86.21 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 172.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.15 -7.61 18.99 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 115.885 1.809 . . . . 0.0 115.885 174.206 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.15 -31.7 67.48 Favored 'General case' 0 N--CA 1.482 1.155 0 C-N-CA 123.482 0.713 . . . . 0.0 112.854 176.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 29.2 m-90 -99.62 141.14 22.27 Favored Pre-proline 0 N--CA 1.471 0.606 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 173.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -68.06 -159.01 0.04 OUTLIER 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.684 2.256 . . . . 0.0 111.185 178.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.2 p -54.14 -24.56 18.32 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 114.848 1.425 . . . . 0.0 114.848 175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 64.2 m -75.05 67.09 1.69 Allowed 'General case' 0 N--CA 1.479 1.004 0 CA-C-O 122.998 1.38 . . . . 0.0 112.494 168.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -104.63 50.66 0.84 Allowed Glycine 0 N--CA 1.475 1.243 0 CA-C-N 112.823 -1.989 . . . . 0.0 110.801 177.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.51 -16.94 27.94 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 177.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -51.65 -33.25 32.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 124.774 1.23 . . . . 0.0 113.357 165.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 72.7 m -99.05 -17.36 18.29 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.128 1.371 . . . . 0.0 113.98 171.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.68 32.54 84.51 Favored Glycine 0 N--CA 1.481 1.674 0 N-CA-C 115.114 0.806 . . . . 0.0 115.114 -172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.445 ' OXT' HD12 ' A' ' 82' ' ' LEU . 4.0 pp . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 115.69 1.737 . . . . 99.989999999999995 115.69 -179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.829 0 CA-C-O 121.161 0.312 . . . . 0.0 113.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.01 135.8 12.64 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 124.451 1.101 . . . . 0.0 109.057 174.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.4 ttt -119.11 83.27 2.0 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-O 121.664 0.745 . . . . 0.0 109.674 -178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 55.78 -155.46 11.61 Favored Glycine 0 CA--C 1.544 1.891 0 CA-C-N 113.212 -1.813 . . . . 0.0 113.743 -178.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -80.01 145.47 17.57 Favored 'Trans proline' 0 N--CA 1.476 0.468 0 C-N-CA 122.365 2.044 . . . . 0.0 111.685 171.459 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.4 133.29 94.49 Favored Pre-proline 0 N--CA 1.477 0.894 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.595 179.17 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -68.29 142.98 56.81 Favored 'Trans proline' 0 CA--C 1.536 0.605 0 C-N-CA 123.147 2.565 . . . . 0.0 113.699 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -117.46 97.53 5.93 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.4 m95 -56.67 -34.23 67.16 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.777 1.399 . . . . 0.0 114.777 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -64.79 -44.59 89.47 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.34 -33.55 74.93 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.916 0.486 . . . . 0.0 112.003 173.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.517 HG21 ' N ' ' A' ' 78' ' ' ALA . 42.5 t -62.07 -40.46 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 124.556 1.142 . . . . 0.0 113.128 174.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.48 -44.05 93.14 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 119.45 -0.31 . . . . 0.0 111.787 168.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -70.73 0.89 6.12 Favored 'General case' 0 N--CA 1.481 1.115 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 174.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -112.4 -33.12 6.28 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 126.113 1.765 . . . . 0.0 111.92 179.747 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 34' ' ' GLN . 52.3 mt-10 -104.24 -23.73 13.21 Favored 'General case' 0 N--CA 1.482 1.133 0 N-CA-C 115.649 1.722 . . . . 0.0 115.649 178.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.57 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 53.3 p -117.36 -26.51 6.68 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 169.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.34 -11.53 65.37 Favored Glycine 0 CA--C 1.54 1.629 0 CA-C-N 115.434 -0.803 . . . . 0.0 113.396 -174.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 168.63 -67.42 0.17 Allowed Glycine 0 N--CA 1.477 1.387 0 N-CA-C 111.665 -0.574 . . . . 0.0 111.665 -174.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 47.4 m-80 -47.29 92.84 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 116.498 2.036 . . . . 0.0 116.498 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.519 ' CE2' ' HG2' ' A' ' 54' ' ' ARG . 41.9 m95 -63.93 -49.32 73.07 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.883 1.068 . . . . 0.0 113.883 173.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -73.55 -2.1 21.37 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 114.619 1.34 . . . . 0.0 114.619 172.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.534 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 39.19 69.6 0.27 Allowed 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 126.122 1.769 . . . . 0.0 114.817 -173.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -82.51 43.81 0.85 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.001 -1.909 . . . . 0.0 112.933 -176.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.0 t -114.59 -21.21 10.38 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 128.339 2.655 . . . . 0.0 112.128 -179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 66.51 32.66 82.32 Favored Glycine 0 CA--C 1.54 1.627 0 N-CA-C 115.529 0.972 . . . . 0.0 115.529 -176.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -94.11 24.72 4.15 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.61 37.66 77.25 Favored Glycine 0 N--CA 1.484 1.86 0 CA-C-N 115.855 -0.611 . . . . 0.0 113.888 -173.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -118.15 149.07 41.67 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.244 0.618 . . . . 0.0 109.82 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.416 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 62.0 m-85 -144.63 149.96 36.6 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.319 -1.31 . . . . 0.0 113.454 -173.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.43 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 56.67 23.73 45.02 Favored Glycine 0 CA--C 1.541 1.691 0 N-CA-C 116.759 1.463 . . . . 0.0 116.759 177.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.57 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 59.25 25.94 60.84 Favored Glycine 0 CA--C 1.54 1.594 0 N-CA-C 114.92 0.728 . . . . 0.0 114.92 -171.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 31' ' ' GLY . 0.3 OUTLIER -112.52 13.24 20.06 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 118.369 2.729 . . . . 0.0 118.369 -174.576 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.488 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 35.0 tt0 44.5 33.18 0.85 Allowed 'General case' 0 N--CA 1.485 1.309 0 CA-C-O 123.392 1.568 . . . . 0.0 114.334 -176.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -95.21 109.66 21.73 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.555 -1.202 . . . . 0.0 110.786 -172.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -46.31 142.65 4.18 Favored Pre-proline 0 N--CA 1.479 0.978 0 CA-C-N 114.351 -1.295 . . . . 0.0 114.277 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 95.5 Cg_endo -65.4 -40.95 17.01 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.741 2.294 . . . . 0.0 112.34 -176.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -58.01 -29.74 65.54 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 124.728 1.211 . . . . 0.0 113.551 172.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.4 m -78.03 -45.03 24.77 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 123.918 0.887 . . . . 0.0 111.316 175.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.47 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 43.6 t-105 -59.24 -21.36 59.45 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 174.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.18 -28.85 3.23 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 168.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.63 -35.56 68.48 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 171.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -102.85 24.84 10.05 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.451 1.1 . . . . 0.0 111.781 176.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -23.58 28.42 Favored Glycine 0 CA--C 1.539 1.574 0 N-CA-C 115.808 1.083 . . . . 0.0 115.808 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.433 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.83 -4.21 31.25 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 114.866 0.706 . . . . 0.0 114.866 -174.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -68.28 158.24 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 125.649 1.58 . . . . 0.0 111.716 -178.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.63 32.54 0.13 Allowed Glycine 0 N--CA 1.482 1.752 0 C-N-CA 124.949 1.262 . . . . 0.0 116.164 175.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.2 t30 -57.76 -51.24 83.19 Favored Pre-proline 0 N--CA 1.476 0.826 0 CA-C-O 116.451 -1.738 . . . . 0.0 110.971 174.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 93.3 Cg_endo -69.72 -19.01 36.89 Favored 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 123.15 2.567 . . . . 0.0 115.195 176.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -78.79 -33.66 46.14 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 113.623 0.971 . . . . 0.0 113.623 174.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -93.83 -35.74 12.58 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 176.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.35 128.45 35.85 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.876 0.871 . . . . 0.0 111.648 177.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.2 m -51.58 159.91 0.69 Allowed 'General case' 0 N--CA 1.483 1.177 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.688 175.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HG2' ' CE2' ' A' ' 21' ' ' TRP . 8.1 mtm180 -41.74 -58.26 2.05 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 114.898 1.444 . . . . 0.0 114.898 179.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.6 OUTLIER -66.91 -36.97 83.46 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 175.352 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 46.7 tt0 -65.72 -37.49 86.56 Favored 'General case' 0 N--CA 1.478 0.961 0 O-C-N 121.71 -0.619 . . . . 0.0 111.705 177.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.481 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.2 OUTLIER -64.54 -50.76 66.07 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.228 1.011 . . . . 0.0 110.92 172.415 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.735 HG12 ' HA ' ' A' ' 55' ' ' GLU . 12.7 pt -56.73 -31.46 35.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 N-CA-C 112.996 0.739 . . . . 0.0 112.996 178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.04 -48.31 82.07 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 123.596 0.758 . . . . 0.0 112.605 172.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.65 -42.6 77.88 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 C-N-CA 122.986 0.514 . . . . 0.0 110.405 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.41 ' HB3' ' HA ' ' A' ' 58' ' ' ILE . . . -58.96 -36.67 75.21 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 124.374 1.07 . . . . 0.0 113.667 175.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -57.57 -46.09 84.38 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 125.035 1.334 . . . . 0.0 111.319 171.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.56 -33.93 62.81 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 174.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.262 0.4 OUTLIER -59.87 -25.68 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 173.847 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.76 -42.09 92.46 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 122.927 0.491 . . . . 0.0 112.228 171.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.41 -31.15 66.92 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 173.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 68.8 mt-10 -67.42 -52.0 44.97 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.294 1.59 . . . . 0.0 115.294 179.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.38 -28.39 10.38 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 -179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 124.98 155.93 9.22 Favored Glycine 0 CA--C 1.533 1.176 0 CA-C-O 122.05 0.805 . . . . 0.0 111.515 -175.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -95.44 16.41 17.02 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.235 -0.982 . . . . 0.0 113.466 170.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.46 -29.36 13.15 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.144 1.378 . . . . 0.0 114.384 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -58.87 -43.66 90.9 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 177.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 5.2 m-90 -63.14 149.31 91.22 Favored Pre-proline 0 N--CA 1.472 0.668 0 CA-C-N 115.428 -0.805 . . . . 0.0 111.129 169.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -64.88 -154.57 0.02 OUTLIER 'Trans proline' 0 CA--C 1.539 0.75 0 C-N-CA 122.891 2.394 . . . . 0.0 111.774 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.2 p -56.03 -29.19 60.04 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.064 0.935 . . . . 0.0 112.98 174.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 7.3 m -68.65 172.23 6.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 127.484 2.313 . . . . 0.0 110.878 174.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 125.23 105.26 1.54 Allowed Glycine 0 N--CA 1.475 1.256 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.178 179.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -60.75 -15.53 30.45 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.969 1.47 . . . . 0.0 114.969 -178.234 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -43.73 -41.89 5.1 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 124.927 1.291 . . . . 0.0 112.501 163.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 57.8 m -107.29 -28.11 10.1 Favored 'General case' 0 N--CA 1.481 1.104 0 O-C-N 124.376 1.048 . . . . 0.0 113.588 169.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 64.11 25.42 69.55 Favored Glycine 0 N--CA 1.482 1.751 0 C-N-CA 124.147 0.879 . . . . 0.0 113.587 -174.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 36.7 mt . . . . . 0 C--O 1.252 1.214 0 CA-C-O 116.277 -1.82 . . . . 99.989999999999995 111.887 -177.466 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 N-CA-C 112.209 -0.357 . . . . 0.0 112.209 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 55.25 155.39 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.242 1.417 . . . . 0.0 113.658 -176.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 17.7 mtm -73.72 150.31 41.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.133 -1.394 . . . . 0.0 112.097 176.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.42 -134.63 3.49 Favored Glycine 0 CA--C 1.539 1.57 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.583 -178.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -65.98 167.59 17.52 Favored 'Trans proline' 0 CA--C 1.537 0.648 0 C-N-CA 122.939 2.426 . . . . 0.0 112.092 176.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 39.4 m -46.58 134.99 7.79 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 124.666 1.186 . . . . 0.0 113.069 177.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HB2' ' O ' ' A' ' 78' ' ' ALA . 61.1 Cg_endo -63.25 144.03 90.77 Favored 'Trans proline' 0 CA--C 1.531 0.327 0 C-N-CA 122.82 2.347 . . . . 0.0 112.54 -179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -114.53 121.33 43.16 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 114.079 -1.419 . . . . 0.0 111.692 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.47 ' HZ3' HD21 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -60.56 -31.56 70.66 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.85 -1.068 . . . . 0.0 112.341 171.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -57.34 -35.8 70.37 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.751 0.821 . . . . 0.0 113.092 171.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.47 -31.81 72.59 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 112.875 0.694 . . . . 0.0 112.875 177.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 16.0 t -61.86 -47.47 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 C-N-CA 123.664 0.786 . . . . 0.0 109.737 172.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.451 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -62.06 -40.6 96.34 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.3 tt0 -70.81 -7.49 45.67 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.223 1.194 . . . . 0.0 114.223 173.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -100.65 -44.33 5.87 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.587 1.555 . . . . 0.0 111.938 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -80.86 -39.09 27.04 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 178.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 20.7 t -105.88 -37.99 6.5 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 124.81 1.244 . . . . 0.0 112.619 175.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.4 16.72 58.72 Favored Glycine 0 CA--C 1.538 1.516 0 N-CA-C 114.919 0.728 . . . . 0.0 114.919 -176.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -135.3 -99.66 0.6 Allowed Glycine 0 N--CA 1.476 1.363 0 CA-C-O 121.881 0.712 . . . . 0.0 112.453 -179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -125.63 150.89 47.18 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 114.136 -1.032 . . . . 0.0 113.468 -174.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CG ' ' HG2' ' A' ' 54' ' ' ARG . 39.3 m95 -64.16 -38.69 91.96 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 114.538 -1.21 . . . . 0.0 112.667 171.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -95.04 41.06 1.1 Allowed 'General case' 0 CA--C 1.545 0.784 0 CA-C-O 122.514 1.149 . . . . 0.0 112.39 177.182 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -73.66 59.52 0.65 Allowed 'General case' 0 N--CA 1.481 1.081 0 CA-C-O 122.947 1.356 . . . . 0.0 113.104 177.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -81.34 52.86 1.92 Allowed 'General case' 0 N--CA 1.474 0.769 0 CA-C-O 123.109 1.433 . . . . 0.0 111.513 177.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.3 p -82.92 9.38 10.13 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.349 -1.296 . . . . 0.0 113.786 177.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 63.84 26.89 70.43 Favored Glycine 0 CA--C 1.541 1.677 0 N-CA-C 116.266 1.267 . . . . 0.0 116.266 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 39.1 m-20 -87.11 22.43 2.07 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.683 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 54.2 30.75 48.34 Favored Glycine 0 CA--C 1.542 1.753 0 CA-C-N 115.864 -0.607 . . . . 0.0 113.72 -172.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.4 mttp -132.32 143.3 49.77 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.145 0.978 . . . . 0.0 109.285 -177.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.601 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 62.6 m-85 -146.28 159.39 43.41 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 114.836 -1.075 . . . . 0.0 113.598 -175.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 54.96 33.08 56.67 Favored Glycine 0 N--CA 1.478 1.483 0 CA-C-N 113.731 -1.577 . . . . 0.0 114.449 178.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 52.28 22.86 11.14 Favored Glycine 0 CA--C 1.545 1.917 0 N-CA-C 116.674 1.43 . . . . 0.0 116.674 -176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.47 HD21 ' HZ3' ' A' ' 9' ' ' TRP . 41.7 mt -109.54 11.46 24.84 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 118.131 2.641 . . . . 0.0 118.131 -175.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 1.1 pp0? 39.11 27.02 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.251 0 N-CA-C 115.765 1.765 . . . . 0.0 115.765 -168.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.605 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -79.2 106.17 11.04 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.035 -1.439 . . . . 0.0 112.204 -172.89 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.626 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 0.7 OUTLIER -36.8 129.73 0.72 Allowed Pre-proline 0 N--CA 1.478 0.935 0 CA-C-N 113.204 -1.816 . . . . 0.0 113.818 177.699 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.683 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 91.9 Cg_endo -63.42 -33.41 69.57 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 123.033 2.489 . . . . 0.0 113.026 -175.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.0 -35.05 66.35 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.389 1.076 . . . . 0.0 113.145 172.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 89.8 m -70.82 -51.18 28.32 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.871 0.868 . . . . 0.0 111.167 171.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.471 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.8 t-105 -58.61 -21.52 53.77 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 177.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.86 -28.06 6.0 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 114.724 1.379 . . . . 0.0 114.724 169.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.89 -38.03 75.04 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 170.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -94.3 20.26 8.4 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.636 1.174 . . . . 0.0 113.959 171.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.88 -20.14 36.85 Favored Glycine 0 CA--C 1.537 1.439 0 N-CA-C 115.914 1.126 . . . . 0.0 115.914 -179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.469 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.86 -6.56 25.68 Favored Glycine 0 N--CA 1.485 1.929 0 N-CA-C 114.737 0.655 . . . . 0.0 114.737 -174.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.579 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.9 p -64.5 154.94 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 C-N-CA 126.087 1.755 . . . . 0.0 111.951 -179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.91 35.82 0.14 Allowed Glycine 0 CA--C 1.542 1.759 0 C-N-CA 125.02 1.295 . . . . 0.0 115.538 174.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.579 ' HB2' HG13 ' A' ' 46' ' ' VAL . 4.3 t-20 -58.42 -51.01 84.89 Favored Pre-proline 0 CA--C 1.548 0.894 0 CA-C-O 116.159 -1.877 . . . . 0.0 110.068 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.601 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 71.0 Cg_endo -68.39 -21.4 40.93 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 123.04 2.494 . . . . 0.0 115.183 174.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -77.02 -33.44 57.42 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 174.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -99.86 1.5 43.01 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 175.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -102.06 125.0 48.64 Favored 'General case' 0 N--CA 1.472 0.642 0 C-N-CA 124.039 0.936 . . . . 0.0 109.206 179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 19.4 t -53.2 155.36 2.7 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 113.532 -1.667 . . . . 0.0 110.055 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.52 ' O ' HG23 ' A' ' 58' ' ' ILE . 51.5 mtt85 -37.36 -55.66 1.02 Allowed 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 125.308 1.443 . . . . 0.0 114.247 -176.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.698 ' HA ' HG12 ' A' ' 58' ' ' ILE . 1.3 tt0 -69.27 -42.36 75.66 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 176.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 3.5 tp60 -56.7 -39.24 73.51 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.664 0.785 . . . . 0.0 110.826 174.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.426 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -65.53 -53.74 37.99 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 118.123 -0.941 . . . . 0.0 111.17 173.033 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.698 HG12 ' HA ' ' A' ' 55' ' ' GLU . 3.9 pt -51.73 -34.63 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 N-CA-C 112.454 0.539 . . . . 0.0 112.454 179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.47 -55.04 40.21 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.066 0.947 . . . . 0.0 113.297 173.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.52 -37.67 79.24 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.177 0 C-N-CA 123.165 0.586 . . . . 0.0 110.516 178.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.649 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.15 -42.26 94.51 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 125.116 1.367 . . . . 0.0 113.791 174.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.4 -40.94 88.22 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.005 1.322 . . . . 0.0 111.922 171.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.1 tpt180 -71.39 -40.18 70.7 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 121.994 -0.441 . . . . 0.0 112.148 174.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.649 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.272 0.3 OUTLIER -63.51 -20.3 25.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 N-CA-C 114.392 1.256 . . . . 0.0 114.392 177.199 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -58.28 -44.01 88.23 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 168.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.57 -29.1 69.09 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 113.024 0.749 . . . . 0.0 113.024 174.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.71 -49.04 33.91 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 -178.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 14.0 tm0? -102.09 -25.82 13.6 Favored 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 125.62 154.77 8.81 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 124.078 0.847 . . . . 0.0 111.098 -177.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -61.46 -32.36 72.35 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.33 0.863 . . . . 0.0 113.33 170.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -62.48 -11.68 17.62 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 115.999 1.852 . . . . 0.0 115.999 172.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.605 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -53.61 -33.61 55.63 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.674 1.19 . . . . 0.0 114.063 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.441 ' HE1' ' HB3' ' A' ' 33' ' ' LEU . 21.1 m-90 -113.99 141.09 25.69 Favored Pre-proline 0 N--CA 1.474 0.758 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 172.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.46 -159.57 0.06 OUTLIER 'Trans proline' 0 CA--C 1.543 0.96 0 C-N-CA 123.034 2.489 . . . . 0.0 112.095 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 12.7 t -52.28 -25.23 8.92 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 175.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.9 m -65.2 40.55 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 126.744 2.018 . . . . 0.0 115.214 170.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.56 48.6 1.09 Allowed Glycine 0 CA--C 1.537 1.438 0 C-N-CA 124.317 0.961 . . . . 0.0 111.784 -177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' O ' ' HB2' ' A' ' 7' ' ' PRO . . . -52.92 -15.31 0.73 Allowed 'General case' 0 N--CA 1.482 1.146 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 176.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -46.4 -41.13 13.2 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 126.602 1.961 . . . . 0.0 113.305 164.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 30.2 m -95.72 -17.19 21.45 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 124.858 1.263 . . . . 0.0 113.66 173.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.31 -44.32 3.33 Favored Glycine 0 N--CA 1.475 1.284 0 C-N-CA 123.921 0.772 . . . . 0.0 112.684 -172.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 mp . . . . . 0 N--CA 1.485 1.305 0 C-N-CA 126.321 1.848 . . . . 99.989999999999995 112.074 -175.279 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 1.907 0 N-CA-C 113.91 0.324 . . . . 0.0 113.91 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.82 97.04 2.96 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 123.529 0.732 . . . . 0.0 110.142 176.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.0 mpp? 49.78 86.61 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 125.194 1.398 . . . . 0.0 114.664 -177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -128.55 -86.82 0.52 Allowed Glycine 0 N--CA 1.479 1.533 0 CA-C-N 113.683 -1.599 . . . . 0.0 111.579 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -67.99 151.03 78.16 Favored 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 122.716 2.278 . . . . 0.0 112.139 175.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.7 m -56.11 144.84 58.17 Favored Pre-proline 0 N--CA 1.481 1.076 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -63.98 130.75 28.43 Favored 'Trans proline' 0 CA--C 1.534 0.509 0 C-N-CA 122.936 2.424 . . . . 0.0 113.013 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -99.22 78.78 2.26 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.565 1.321 . . . . 0.0 114.565 178.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.521 ' CE2' ' HB ' ' A' ' 58' ' ' ILE . 1.2 m95 -59.55 -35.58 74.5 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 113.326 -1.761 . . . . 0.0 113.744 173.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -58.57 -52.82 64.04 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.572 0.749 . . . . 0.0 112.368 173.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -58.02 -35.46 71.3 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 123.872 0.733 . . . . 0.0 112.657 176.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 82.2 t -64.76 -44.81 96.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.077 0 C-N-CA 123.675 0.79 . . . . 0.0 112.814 175.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.3 -41.73 94.04 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-O 120.86 0.362 . . . . 0.0 111.889 171.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -80.97 15.33 1.86 Allowed 'General case' 0 CA--C 1.546 0.808 0 N-CA-C 114.655 1.354 . . . . 0.0 114.655 175.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 4.5 t -116.95 -33.63 4.68 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.884 1.274 . . . . 0.0 111.543 177.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 13.0 mm-40 -88.48 -53.02 4.87 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 113.229 0.826 . . . . 0.0 113.229 168.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.7 t -81.21 -42.73 20.32 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 113.189 0.811 . . . . 0.0 113.189 176.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 62.25 19.87 60.08 Favored Glycine 0 N--CA 1.481 1.679 0 O-C-N 124.244 0.965 . . . . 0.0 115.399 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -145.56 -98.52 0.24 Allowed Glycine 0 N--CA 1.477 1.424 0 CA-C-O 121.09 0.272 . . . . 0.0 112.88 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -123.96 153.39 41.29 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.483 1.29 . . . . 0.0 114.483 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.547 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 51.7 m95 -70.71 -42.62 70.36 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 113.353 -1.749 . . . . 0.0 111.353 173.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.93 40.67 1.19 Allowed 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 122.432 1.11 . . . . 0.0 112.012 174.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -76.98 63.54 2.31 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-O 123.732 1.729 . . . . 0.0 111.613 176.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 23.1 p30 -82.74 30.48 0.43 Allowed 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 113.518 -1.674 . . . . 0.0 114.041 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.9 p -80.24 27.66 0.33 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 126.731 2.012 . . . . 0.0 114.024 -178.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.7 43.67 93.81 Favored Glycine 0 CA--C 1.54 1.615 0 N-CA-C 116.127 1.211 . . . . 0.0 116.127 -176.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.463 ' O ' ' HG2' ' A' ' 29' ' ' LYS . 2.5 m120 -90.96 7.78 38.53 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.542 1.682 . . . . 0.0 115.542 175.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.77 10.23 6.17 Favored Glycine 0 CA--C 1.545 1.921 0 C-N-CA 124.273 0.939 . . . . 0.0 115.336 -170.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.463 ' HG2' ' O ' ' A' ' 27' ' ' ASN . 26.1 mmtp -131.5 148.24 52.62 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.654 1.182 . . . . 0.0 109.385 -173.046 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.505 ' CD1' ' HB2' ' A' ' 50' ' ' ALA . 98.3 m-85 -139.35 160.21 40.35 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.411 -1.268 . . . . 0.0 111.764 -178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 77.75 -10.59 24.08 Favored Glycine 0 N--CA 1.477 1.4 0 CA-C-N 114.624 -1.171 . . . . 0.0 114.943 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 81.08 25.73 54.66 Favored Glycine 0 CA--C 1.537 1.436 0 C-N-CA 123.012 0.339 . . . . 0.0 113.543 -177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.455 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 3.8 mp -115.1 13.01 16.77 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 116.779 2.14 . . . . 0.0 116.779 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 38.62 52.13 1.78 Allowed 'General case' 0 N--CA 1.48 1.075 0 CA-C-O 123.75 1.738 . . . . 0.0 113.307 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 8.5 t80 -105.26 109.39 21.35 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-N 112.88 -1.964 . . . . 0.0 109.798 -174.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 8.1 mttt -39.94 137.33 1.19 Allowed Pre-proline 0 N--CA 1.477 0.886 0 N-CA-C 115.34 1.608 . . . . 0.0 115.34 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -63.85 -44.74 12.35 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.075 2.516 . . . . 0.0 113.301 -176.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.413 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -57.33 -33.24 67.53 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 124.063 0.945 . . . . 0.0 113.506 173.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.1 m -72.12 -48.03 46.77 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.701 0.8 . . . . 0.0 111.537 173.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.499 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 33.6 t-105 -59.93 -21.87 61.7 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 112.829 0.678 . . . . 0.0 112.829 175.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -50.92 -28.46 9.76 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 170.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.25 -36.12 72.75 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -94.5 17.5 13.02 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.727 1.211 . . . . 0.0 113.553 173.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.29 -22.79 24.21 Favored Glycine 0 CA--C 1.539 1.582 0 N-CA-C 115.445 0.938 . . . . 0.0 115.445 -178.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.479 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.28 -6.19 23.63 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 114.681 0.632 . . . . 0.0 114.681 -173.772 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.48 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -63.77 154.77 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.811 1.644 . . . . 0.0 111.721 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.28 36.2 0.09 OUTLIER Glycine 0 N--CA 1.482 1.757 0 C-N-CA 124.878 1.228 . . . . 0.0 115.59 172.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.48 ' HB2' HG13 ' A' ' 46' ' ' VAL . 17.9 t30 -58.57 -51.72 79.84 Favored Pre-proline 0 CA--C 1.544 0.724 0 CA-C-O 115.94 -1.981 . . . . 0.0 110.384 174.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.499 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.6 Cg_endo -67.0 -25.07 44.68 Favored 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.265 1.977 . . . . 0.0 113.927 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -69.39 -36.21 76.54 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 176.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -96.68 -33.89 11.58 Favored 'General case' 0 N--CA 1.477 0.906 0 N-CA-C 114.484 1.291 . . . . 0.0 114.484 177.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.64 119.12 9.27 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 124.078 0.951 . . . . 0.0 111.6 176.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.8 m -46.87 156.41 0.2 Allowed 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 114.201 -1.363 . . . . 0.0 111.429 174.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 2.5 mtt180 -29.34 -67.66 0.08 Allowed 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 174.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.726 ' HA ' HG12 ' A' ' 58' ' ' ILE . 22.5 tt0 -63.97 -32.65 74.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 178.039 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 28.7 tp60 -68.89 -40.25 79.28 Favored 'General case' 0 N--CA 1.477 0.885 0 C-N-CA 123.049 0.54 . . . . 0.0 111.296 177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.437 ' OE1' HD13 ' A' ' 33' ' ' LEU . 0.0 OUTLIER -63.84 -50.67 67.97 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.389 1.076 . . . . 0.0 110.484 173.063 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.726 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -54.82 -32.93 27.02 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 N-CA-C 112.648 0.611 . . . . 0.0 112.648 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.87 -53.58 56.22 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 113.15 172.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -65.54 -41.59 91.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.33 0 C-N-CA 123.135 0.574 . . . . 0.0 109.866 177.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.419 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.19 -39.46 82.64 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.452 1.501 . . . . 0.0 114.533 175.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.438 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 5.5 t-20 -58.29 -37.51 75.16 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.004 1.322 . . . . 0.0 111.882 174.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -82.61 -33.65 27.86 Favored 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 173.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.419 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.271 0.4 OUTLIER -60.45 -25.19 33.58 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.861 0 N-CA-C 113.757 1.021 . . . . 0.0 113.757 173.912 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.438 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 1.3 pp -61.78 -38.39 87.86 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 168.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -66.81 -31.2 71.67 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.89 0.7 . . . . 0.0 112.89 173.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 mt-10 -72.06 -62.95 1.24 Allowed 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 175.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 41.0 tp60 -82.16 -22.77 35.9 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 106.44 -169.08 15.1 Favored Glycine 0 CA--C 1.535 1.298 0 N-CA-C 109.391 -1.483 . . . . 0.0 109.391 -176.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.6 pp -93.03 19.69 7.58 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.205 -0.997 . . . . 0.0 113.198 173.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -88.92 -33.41 17.29 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -179.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.25 -26.33 51.09 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.774 1.027 . . . . 0.0 113.774 176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.429 ' HE1' HD23 ' A' ' 33' ' ' LEU . 6.3 m-90 -122.79 91.13 49.83 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 106.238 -1.764 . . . . 0.0 106.238 172.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -82.13 -62.51 0.02 OUTLIER 'Trans proline' 0 CA--C 1.538 0.686 0 C-N-CA 122.525 2.15 . . . . 0.0 113.091 178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.7 t -61.23 -50.37 73.37 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.888 1.275 . . . . 0.0 113.03 175.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 14.8 m -101.04 175.14 5.7 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 114.909 -1.041 . . . . 0.0 110.924 170.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 176.58 93.24 0.09 OUTLIER Glycine 0 N--CA 1.472 1.075 0 N-CA-C 110.249 -1.14 . . . . 0.0 110.249 178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -52.67 -28.01 19.86 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 115.628 1.714 . . . . 0.0 115.628 -179.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -50.59 -37.81 42.06 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.636 1.175 . . . . 0.0 113.394 170.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 99.2 p -99.98 -27.49 13.55 Favored 'General case' 0 N--CA 1.479 1.016 0 C-N-CA 124.386 1.074 . . . . 0.0 112.227 174.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 95.34 -37.14 3.51 Favored Glycine 0 N--CA 1.475 1.243 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.264 178.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 mt . . . . . 0 C--O 1.253 1.243 0 C-N-CA 124.817 1.247 . . . . 99.989999999999995 113.529 -175.823 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 CA-C-O 121.578 0.543 . . . . 0.0 113.998 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.42 147.5 29.23 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.374 -0.913 . . . . 0.0 109.36 176.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 7.4 mtt 61.85 -174.91 0.13 Allowed 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 125.402 1.481 . . . . 0.0 112.821 -173.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -98.14 101.2 2.47 Favored Glycine 0 CA--C 1.542 1.752 0 CA-C-O 117.968 -1.462 . . . . 0.0 110.431 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -69.08 143.12 52.96 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 122.455 2.103 . . . . 0.0 111.912 178.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.0 m -57.38 143.15 74.84 Favored Pre-proline 0 N--CA 1.483 1.198 0 CA-C-N 114.787 -1.097 . . . . 0.0 112.798 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -68.26 133.22 27.86 Favored 'Trans proline' 0 CA--C 1.534 0.524 0 C-N-CA 122.065 1.844 . . . . 0.0 112.694 175.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -101.23 174.38 6.02 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 112.809 -1.996 . . . . 0.0 111.556 175.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.605 ' CZ3' HD21 ' A' ' 33' ' ' LEU . 1.1 m95 -49.07 -37.88 22.55 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 114.465 1.283 . . . . 0.0 114.465 171.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -60.31 -43.94 95.88 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 172.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.3 -34.63 77.79 Favored 'General case' 0 N--CA 1.476 0.825 0 C-N-CA 123.923 0.889 . . . . 0.0 112.118 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 71.0 t -62.87 -37.95 80.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.938 0.895 . . . . 0.0 112.421 174.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.74 -39.92 93.28 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 169.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -78.55 6.84 7.76 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 173.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.8 t -110.31 -31.96 7.12 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.934 0.894 . . . . 0.0 112.267 178.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -101.66 -32.42 10.34 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.828 1.788 . . . . 0.0 115.828 172.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.436 ' HB2' ' HA2' ' A' ' 32' ' ' GLY . 19.8 t -98.52 -35.53 10.21 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 112.816 0.672 . . . . 0.0 112.816 173.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.0 31.08 67.74 Favored Glycine 0 N--CA 1.48 1.632 0 N-CA-C 115.135 0.814 . . . . 0.0 115.135 179.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.37 -88.73 0.07 OUTLIER Glycine 0 N--CA 1.476 1.342 0 C-N-CA 123.172 0.415 . . . . 0.0 112.509 -174.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -112.83 145.3 40.88 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -172.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 28.3 m95 -66.57 -47.39 72.94 Favored 'General case' 0 N--CA 1.482 1.156 0 CA-C-N 114.441 -1.254 . . . . 0.0 113.107 169.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -66.93 -29.55 69.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 172.279 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 35.35 70.46 0.14 Allowed 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 126.403 1.881 . . . . 0.0 114.297 -173.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -78.58 56.99 1.91 Allowed 'General case' 0 N--CA 1.483 1.18 0 CA-C-O 123.817 1.77 . . . . 0.0 112.401 -175.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 42.4 p -117.53 -24.51 7.28 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 128.402 2.681 . . . . 0.0 112.94 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.08 34.42 76.1 Favored Glycine 0 CA--C 1.54 1.6 0 N-CA-C 115.666 1.026 . . . . 0.0 115.666 -177.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -92.5 25.97 2.81 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 114.814 1.413 . . . . 0.0 114.814 179.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 58.3 39.17 92.24 Favored Glycine 0 CA--C 1.545 1.909 0 CA-C-N 116.11 -0.496 . . . . 0.0 113.695 -173.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.438 ' HE3' ' HG3' ' A' ' 34' ' ' GLN . 34.2 mttp -121.18 146.89 46.31 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.291 1.036 . . . . 0.0 109.742 -175.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.414 ' CD1' ' HG2' ' A' ' 49' ' ' PRO . 16.1 m-85 -145.23 146.05 31.55 Favored 'General case' 0 N--CA 1.478 0.959 0 CA-C-N 114.308 -1.315 . . . . 0.0 113.562 -175.523 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.496 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 51.18 34.08 31.69 Favored Glycine 0 N--CA 1.483 1.779 0 O-C-N 124.801 1.313 . . . . 0.0 115.843 176.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' HA2' ' HB2' ' A' ' 17' ' ' SER . . . 58.12 23.52 52.57 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.356 0.979 . . . . 0.0 115.193 -174.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD21 ' CZ3' ' A' ' 9' ' ' TRP . 18.3 mt -116.71 8.26 13.7 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 117.799 2.518 . . . . 0.0 117.799 -169.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.438 ' HG3' ' HE3' ' A' ' 29' ' ' LYS . 4.5 tt0 45.07 36.8 2.17 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 123.817 1.77 . . . . 0.0 113.07 -176.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -89.69 104.68 17.22 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 113.889 -1.505 . . . . 0.0 111.6 -174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -37.75 130.16 0.91 Allowed Pre-proline 0 N--CA 1.484 1.233 0 CA-C-N 112.986 -1.915 . . . . 0.0 113.331 177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 89.5 Cg_endo -65.0 -39.22 25.19 Favored 'Trans proline' 0 CA--C 1.539 0.774 0 C-N-CA 122.772 2.315 . . . . 0.0 112.556 -177.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.38 70.04 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.2 1.0 . . . . 0.0 113.088 172.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 m -73.63 -44.79 56.05 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.578 0.751 . . . . 0.0 111.5 173.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.437 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 42.9 t-105 -58.7 -20.21 46.61 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 175.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.422 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -49.39 -28.38 5.04 Favored 'General case' 0 N--CA 1.48 1.049 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 168.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -56.45 -37.05 69.74 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 170.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 13.3 m-85 -98.36 25.73 6.04 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 125.017 1.327 . . . . 0.0 113.589 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.23 -22.34 39.57 Favored Glycine 0 N--CA 1.481 1.634 0 N-CA-C 115.433 0.933 . . . . 0.0 115.433 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.422 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.3 -4.57 32.71 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 115.077 0.791 . . . . 0.0 115.077 -173.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.44 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 61.7 t -72.2 152.81 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 126.011 1.724 . . . . 0.0 109.274 -177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.5 36.01 0.08 OUTLIER Glycine 0 CA--C 1.542 1.768 0 C-N-CA 125.226 1.393 . . . . 0.0 116.58 176.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -52.77 -53.94 48.86 Favored Pre-proline 0 N--CA 1.481 1.093 0 CA-C-O 116.209 -1.853 . . . . 0.0 109.146 171.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 72.5 Cg_endo -67.35 -20.89 48.12 Favored 'Trans proline' 0 CA--C 1.542 0.922 0 C-N-CA 123.536 2.824 . . . . 0.0 116.023 177.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -75.0 -32.52 61.66 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 113.48 0.918 . . . . 0.0 113.48 174.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.66 -35.01 10.72 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 176.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.54 126.97 29.45 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.484 1.114 . . . . 0.0 110.821 176.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.6 t -54.63 156.81 3.29 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.016 -1.447 . . . . 0.0 110.301 177.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 26.5 mtt-85 -45.92 -57.74 4.12 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 124.146 0.978 . . . . 0.0 112.936 -176.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.592 ' O ' HG12 ' A' ' 58' ' ' ILE . 10.2 tt0 -66.79 -30.79 71.08 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.382 0.882 . . . . 0.0 113.382 176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -69.44 -41.34 76.44 Favored 'General case' 0 N--CA 1.478 0.929 0 O-C-N 121.824 -0.547 . . . . 0.0 110.851 177.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.496 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -62.73 -40.77 98.24 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 123.831 0.852 . . . . 0.0 111.251 174.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.592 HG12 ' O ' ' A' ' 55' ' ' GLU . 2.3 pt -54.28 -33.68 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 CA-C-O 119.358 -0.353 . . . . 0.0 111.945 177.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.03 82.54 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 174.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.15 -42.18 84.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.371 0 CA-C-O 121.362 0.601 . . . . 0.0 109.673 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.563 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.95 -36.39 79.23 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.502 1.297 . . . . 0.0 114.502 174.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -57.4 -47.71 81.0 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.407 1.083 . . . . 0.0 111.296 172.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -66.95 -39.71 87.33 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-O 121.001 0.429 . . . . 0.0 111.572 173.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.293 0.4 OUTLIER -61.52 -26.03 38.4 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 177.591 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.65 -40.3 91.5 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 171.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -75.72 -33.16 60.28 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.274 0.629 . . . . 0.0 112.607 173.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -66.91 -43.92 82.1 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 29.8 tt0 -104.82 -29.23 10.67 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 113.803 1.038 . . . . 0.0 113.803 177.47 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.44 ' C ' ' H ' ' A' ' 71' ' ' ASP . . . 112.89 155.68 12.15 Favored Glycine 0 N--CA 1.476 1.306 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.38 21.1 0.05 OUTLIER 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 172.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.44 ' H ' ' C ' ' A' ' 69' ' ' GLY . 7.4 m-20 -88.33 -30.62 19.44 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 126.004 1.722 . . . . 0.0 111.866 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.37 -31.23 65.57 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 124.4 1.08 . . . . 0.0 113.33 177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 2.9 m-90 -122.75 89.74 50.06 Favored Pre-proline 0 CA--C 1.549 0.918 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 174.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -84.08 -55.86 0.03 OUTLIER 'Trans proline' 0 CA--C 1.542 0.906 0 C-N-CA 122.29 1.993 . . . . 0.0 113.537 179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 18.0 p -63.19 -49.56 73.78 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.855 1.662 . . . . 0.0 112.95 178.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 1.2 m -109.79 163.43 13.52 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.776 -1.556 . . . . 0.0 110.027 171.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -177.55 101.14 0.15 Allowed Glycine 0 N--CA 1.478 1.469 0 O-C-N 124.563 1.165 . . . . 0.0 111.376 173.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -51.56 -28.72 14.69 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -52.08 -32.84 36.66 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 125.016 1.326 . . . . 0.0 114.074 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.8 p -107.97 -22.0 12.6 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.903 1.281 . . . . 0.0 113.714 175.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.7 32.71 84.48 Favored Glycine 0 N--CA 1.48 1.605 0 C-N-CA 124.296 0.95 . . . . 0.0 114.062 -177.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 73.2 mt . . . . . 0 N--CA 1.484 1.239 0 CA-C-O 117.042 -1.456 . . . . 99.989999999999995 114.295 178.285 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 1.897 0 N-CA-C 115.23 0.852 . . . . 0.0 115.23 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.44 93.27 2.95 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.245 0.618 . . . . 0.0 111.558 178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.2 ptt? -85.84 141.71 29.42 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.211 -1.358 . . . . 0.0 111.638 175.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -174.94 106.21 0.22 Allowed Glycine 0 CA--C 1.54 1.648 0 CA-C-O 118.189 -1.339 . . . . 0.0 111.559 178.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -68.66 140.6 47.53 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 122.325 2.016 . . . . 0.0 111.661 176.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.426 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . 0.6 OUTLIER -62.11 136.89 95.54 Favored Pre-proline 0 N--CA 1.482 1.153 0 CA-C-N 114.359 -1.291 . . . . 0.0 112.505 -178.367 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 6' ' ' SER . 72.3 Cg_exo -59.61 139.55 89.51 Favored 'Trans proline' 0 N--CA 1.478 0.588 0 C-N-CA 122.73 2.287 . . . . 0.0 112.584 -176.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -125.31 -178.43 4.21 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.386 -2.188 . . . . 0.0 112.022 179.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.447 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 19.5 m95 -50.91 -34.36 28.14 Favored 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 170.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -60.28 -49.57 77.1 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.991 0.917 . . . . 0.0 112.688 171.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.78 -34.38 77.12 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.497 0.719 . . . . 0.0 112.142 177.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.433 HG21 ' N ' ' A' ' 78' ' ' ALA . 77.0 t -63.9 -38.96 83.73 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 124.176 0.991 . . . . 0.0 112.322 173.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.76 -37.35 78.77 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 168.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -83.72 6.92 19.3 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 114.704 1.372 . . . . 0.0 114.704 174.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 12.9 t -116.38 -35.24 4.35 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 123.882 0.873 . . . . 0.0 112.888 179.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' OE1' ' HB3' ' A' ' 34' ' ' GLN . 16.9 mm-40 -89.47 -39.27 13.46 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 114.174 1.176 . . . . 0.0 114.174 170.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.8 t -106.42 -24.08 12.33 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 -178.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 75.45 3.62 72.01 Favored Glycine 0 CA--C 1.542 1.725 0 N-CA-C 115.697 1.039 . . . . 0.0 115.697 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 125.52 81.18 0.42 Allowed Glycine 0 N--CA 1.477 1.423 0 C-N-CA 124.007 0.813 . . . . 0.0 111.49 -178.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 173.77 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 126.08 1.752 . . . . 0.0 108.939 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.5 m95 -80.37 -79.33 0.15 Allowed 'General case' 0 N--CA 1.481 1.076 0 O-C-N 123.402 0.439 . . . . 0.0 111.745 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -58.57 -22.15 55.04 Favored 'General case' 0 N--CA 1.483 1.209 0 N-CA-C 115.054 1.501 . . . . 0.0 115.054 173.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.8 70.61 0.5 Allowed 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 126.321 1.848 . . . . 0.0 114.383 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -78.55 33.74 0.21 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 112.957 -1.929 . . . . 0.0 115.222 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.4 t -117.13 -18.01 10.12 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 127.388 2.275 . . . . 0.0 112.338 179.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 71.26 46.69 40.76 Favored Glycine 0 N--CA 1.481 1.649 0 N-CA-C 115.669 1.028 . . . . 0.0 115.669 -179.317 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -89.35 23.24 2.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 178.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.1 34.65 58.62 Favored Glycine 0 N--CA 1.482 1.765 0 C-N-CA 123.289 0.471 . . . . 0.0 113.563 -172.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.431 ' HE3' ' HG2' ' A' ' 34' ' ' GLN . 61.1 mttp -129.5 138.6 51.47 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 124.776 1.23 . . . . 0.0 108.809 -174.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.44 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 89.4 m-85 -136.87 149.46 47.68 Favored 'General case' 0 N--CA 1.477 0.907 0 O-C-N 124.565 1.166 . . . . 0.0 112.822 177.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 71.54 -14.75 1.77 Allowed Glycine 0 N--CA 1.483 1.786 0 CA-C-N 114.339 -1.3 . . . . 0.0 116.235 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 94.89 19.7 30.62 Favored Glycine 0 N--CA 1.474 1.183 0 C-N-CA 123.889 0.757 . . . . 0.0 114.815 179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -116.05 28.08 8.84 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.584 ' HB3' ' OE1' ' A' ' 16' ' ' GLU . 7.7 tm0? 43.91 35.18 1.05 Allowed 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 126.156 1.782 . . . . 0.0 114.171 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -99.04 110.19 22.82 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 113.446 -1.706 . . . . 0.0 112.044 -169.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.92 133.14 29.32 Favored Pre-proline 0 N--CA 1.482 1.137 0 CA-C-N 112.581 -2.1 . . . . 0.0 112.78 178.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -62.03 -32.23 83.94 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 123.171 2.581 . . . . 0.0 113.771 -178.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.15 -36.02 65.34 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 113.371 0.878 . . . . 0.0 113.371 172.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 16.8 m -76.0 -41.04 52.34 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.705 0.802 . . . . 0.0 111.676 173.457 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.489 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 38.5 t-105 -58.73 -21.49 55.24 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 176.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.86 -29.52 3.34 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 114.687 1.366 . . . . 0.0 114.687 168.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.06 -38.36 73.13 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.152 0.797 . . . . 0.0 113.152 171.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -94.31 18.85 10.31 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 124.77 1.228 . . . . 0.0 113.517 173.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.73 -21.13 32.84 Favored Glycine 0 CA--C 1.538 1.524 0 N-CA-C 115.594 0.998 . . . . 0.0 115.594 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.56 -2.95 36.34 Favored Glycine 0 N--CA 1.484 1.888 0 N-CA-C 115.044 0.778 . . . . 0.0 115.044 -174.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 9.8 p -66.47 156.81 6.22 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 125.49 1.516 . . . . 0.0 111.741 -179.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.38 34.28 0.12 Allowed Glycine 0 CA--C 1.544 1.896 0 N-CA-C 116.325 1.29 . . . . 0.0 116.325 175.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -58.46 -52.61 73.37 Favored Pre-proline 0 CA--C 1.55 0.968 0 CA-C-O 115.719 -2.086 . . . . 0.0 110.603 175.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 71.9 Cg_endo -68.25 -16.95 44.8 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.135 2.557 . . . . 0.0 115.475 175.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.58 -33.67 35.88 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 175.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.74 -34.71 10.41 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 114.516 1.302 . . . . 0.0 114.516 177.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.73 121.69 13.48 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 122.154 0.978 . . . . 0.0 110.876 176.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.5 t -50.85 160.09 0.49 Allowed 'General case' 0 N--CA 1.482 1.167 0 CA-C-N 113.057 -1.883 . . . . 0.0 110.732 179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -45.19 -56.63 4.61 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.179 1.178 . . . . 0.0 114.179 -176.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.643 ' HA ' HG12 ' A' ' 58' ' ' ILE . 29.1 tt0 -70.11 -30.28 67.44 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 16.1 tp60 -68.01 -45.78 73.08 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.404 0.681 . . . . 0.0 111.165 177.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 21.7 tp60 -66.0 -45.07 82.9 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 123.778 0.831 . . . . 0.0 113.053 177.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.643 HG12 ' HA ' ' A' ' 55' ' ' GLU . 26.4 pt -54.67 -28.8 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.164 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 176.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.78 -47.51 85.99 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 113.097 0.776 . . . . 0.0 113.097 170.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -67.03 -42.61 88.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.298 0 C-N-CA 123.252 0.621 . . . . 0.0 109.997 175.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -60.26 -36.74 78.47 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 175.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -61.01 -39.59 90.33 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.196 1.399 . . . . 0.0 112.183 172.07 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.84 -33.85 52.08 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 172.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . 0.273 0.5 OUTLIER -57.15 -26.76 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 173.526 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.667 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.5 OUTLIER -59.79 -42.82 94.25 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 112.544 0.572 . . . . 0.0 112.544 171.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.7 66.34 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 112.598 0.592 . . . . 0.0 112.598 173.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.31 -52.11 30.63 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 115.114 1.524 . . . . 0.0 115.114 -179.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -101.37 -25.18 14.04 Favored 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 113.533 0.938 . . . . 0.0 113.533 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.77 164.81 13.01 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.802 -1.319 . . . . 0.0 109.802 -174.092 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -65.83 1.85 1.22 Allowed 'General case' 0 N--CA 1.483 1.21 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 170.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 24.8 p-10 -67.05 -32.83 74.29 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 126.299 1.84 . . . . 0.0 113.88 -179.422 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -53.04 -29.68 31.31 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 114.181 1.178 . . . . 0.0 114.181 174.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.533 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 2.2 m-90 -128.36 90.44 46.87 Favored Pre-proline 0 N--CA 1.475 0.825 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 174.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.83 -65.3 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.542 2.161 . . . . 0.0 113.253 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 8.6 t -61.6 -42.64 99.15 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 124.734 1.214 . . . . 0.0 113.875 177.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 19.9 m -113.62 -164.88 0.95 Allowed 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.232 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 149.59 101.91 0.25 Allowed Glycine 0 N--CA 1.477 1.372 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 177.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.433 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -57.49 -25.64 60.09 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 -177.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.667 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -49.01 -42.38 37.79 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.704 1.201 . . . . 0.0 113.554 166.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 92.2 p -94.2 -20.76 19.55 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.464 1.105 . . . . 0.0 113.131 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 62.87 21.3 63.17 Favored Glycine 0 N--CA 1.481 1.668 0 C-N-CA 124.906 1.241 . . . . 0.0 115.136 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 2.8 mm? . . . . . 0 C--O 1.254 1.296 0 N-CA-C 115.252 1.575 . . . . 99.989999999999995 115.252 176.219 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.8 0 N-CA-C 114.37 0.508 . . . . 0.0 114.37 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.89 157.6 41.11 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 123.895 0.878 . . . . 0.0 111.317 -176.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 ttm -94.03 95.74 9.22 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.273 -179.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.99 172.16 43.71 Favored Glycine 0 CA--C 1.544 1.886 0 CA-C-N 113.734 -1.575 . . . . 0.0 113.164 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -67.57 152.46 78.27 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.118 2.545 . . . . 0.0 112.084 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.3 m -57.38 108.92 1.41 Allowed Pre-proline 0 N--CA 1.483 1.19 0 C-N-CA 123.922 0.889 . . . . 0.0 113.05 178.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.24 137.73 44.69 Favored 'Trans proline' 0 N--CA 1.477 0.545 0 C-N-CA 122.745 2.297 . . . . 0.0 111.083 -179.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -95.78 74.4 3.14 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-O 122.958 1.361 . . . . 0.0 112.033 -173.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.419 ' CD2' ' HB ' ' A' ' 58' ' ' ILE . 0.8 OUTLIER -57.57 -32.96 67.66 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-N 113.417 -1.72 . . . . 0.0 112.97 176.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -66.25 -48.0 71.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.25 0.62 . . . . 0.0 112.105 175.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.39 -31.65 66.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 113.503 0.927 . . . . 0.0 113.503 174.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.43 HG21 ' HB2' ' A' ' 78' ' ' ALA . 89.7 t -63.22 -33.83 63.32 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.146 0 C-N-CA 123.383 0.673 . . . . 0.0 112.627 175.41 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.75 -39.42 94.07 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 168.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 45.5 tt0 -72.26 -4.71 31.2 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 172.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 9.4 t -106.93 -25.52 11.61 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 114.112 1.153 . . . . 0.0 114.112 179.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -104.71 -27.82 11.57 Favored 'General case' 0 N--CA 1.483 1.215 0 N-CA-C 115.622 1.712 . . . . 0.0 115.622 173.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.4 t -110.75 -31.55 7.16 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 175.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.61 -24.6 28.67 Favored Glycine 0 N--CA 1.481 1.693 0 CA-C-N 116.785 -0.189 . . . . 0.0 112.881 -176.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 141.65 83.44 0.07 OUTLIER Glycine 0 CA--C 1.533 1.197 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 178.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 23' ' ' ALA . 5.0 t-20 178.45 98.19 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.669 1.188 . . . . 0.0 110.869 -177.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.472 ' CE3' ' HA ' ' A' ' 54' ' ' ARG . 76.3 m95 -75.6 -25.82 57.32 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 177.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.75 48.6 0.95 Allowed 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 122.847 1.308 . . . . 0.0 111.847 175.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 20' ' ' ASN . . . -70.05 50.92 0.11 Allowed 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -179.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -101.46 26.19 7.53 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 114.893 -1.049 . . . . 0.0 113.751 -176.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.1 t -122.75 44.5 2.63 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-O 123.424 1.583 . . . . 0.0 111.911 179.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -159.95 -93.64 0.1 OUTLIER Glycine 0 N--CA 1.481 1.634 0 CA-C-N 113.035 -1.893 . . . . 0.0 110.824 -175.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HB2' ' HE3' ' A' ' 29' ' ' LYS . 2.0 m-20 -103.86 28.93 6.2 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.28 33.66 65.87 Favored Glycine 0 N--CA 1.482 1.701 0 CA-C-N 115.946 -0.57 . . . . 0.0 114.306 -173.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 27' ' ' ASN . 91.2 mttt -79.3 151.03 31.31 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.109 0.964 . . . . 0.0 111.2 -176.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.692 ' CE1' ' HB2' ' A' ' 50' ' ' ALA . 73.1 m-85 -142.05 155.29 45.39 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.607 -1.179 . . . . 0.0 113.05 177.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.599 ' HA2' ' HG3' ' A' ' 57' ' ' GLN . . . 77.1 -25.99 1.83 Allowed Glycine 0 N--CA 1.48 1.591 0 CA-C-N 114.13 -1.395 . . . . 0.0 115.342 -176.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 88.93 22.94 36.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-N 114.731 -0.734 . . . . 0.0 113.428 -172.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HG ' ' HE1' ' A' ' 73' ' ' TRP . 2.6 mm? -116.71 28.79 8.33 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 12.6 pt20 37.19 31.65 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 127.266 2.226 . . . . 0.0 116.772 -174.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -78.32 109.53 12.54 Favored 'General case' 0 CA--C 1.537 0.467 0 CA-C-N 113.979 -1.464 . . . . 0.0 111.811 -169.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.4 mmtp -46.33 132.15 7.68 Favored Pre-proline 0 N--CA 1.479 1.012 0 CA-C-N 113.474 -1.694 . . . . 0.0 113.175 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -59.09 -38.85 84.71 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.91 2.407 . . . . 0.0 113.379 177.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.44 -35.68 68.15 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.6 m -76.87 -42.39 40.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 123.604 0.762 . . . . 0.0 111.069 174.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.423 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 40.1 t-105 -60.83 -21.83 63.58 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -47.55 -29.94 3.2 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 169.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.41 -35.86 70.58 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 113.557 0.947 . . . . 0.0 113.557 171.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.0 m-85 -98.56 25.36 6.48 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.928 1.291 . . . . 0.0 113.156 173.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.75 -23.31 34.27 Favored Glycine 0 N--CA 1.479 1.503 0 N-CA-C 115.246 0.859 . . . . 0.0 115.246 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 76.9 -11.02 16.24 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 114.638 0.615 . . . . 0.0 114.638 -173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.403 ' HB ' ' OD1' ' A' ' 48' ' ' ASN . 45.5 t -65.28 151.21 10.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 126.472 1.909 . . . . 0.0 109.735 -178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.82 38.48 0.09 OUTLIER Glycine 0 CA--C 1.545 1.93 0 C-N-CA 125.428 1.489 . . . . 0.0 116.332 175.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' OD1' ' HB ' ' A' ' 46' ' ' VAL . 0.4 OUTLIER -54.57 -53.89 54.89 Favored Pre-proline 0 CA--C 1.552 1.026 0 CA-C-O 116.233 -1.841 . . . . 0.0 108.617 171.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.439 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 94.2 Cg_endo -70.66 -9.41 25.73 Favored 'Trans proline' 0 CA--C 1.544 1.014 0 C-N-CA 122.876 2.384 . . . . 0.0 116.122 178.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.692 ' HB2' ' CE1' ' A' ' 30' ' ' TYR . . . -77.34 -46.4 23.01 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.798 0.839 . . . . 0.0 113.003 170.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.43 -34.11 15.74 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 114.105 1.15 . . . . 0.0 114.105 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 56' ' ' GLN . . . -61.55 115.1 3.65 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 124.006 0.922 . . . . 0.0 110.695 176.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 40.6 t -44.35 159.6 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 113.457 -1.701 . . . . 0.0 111.305 175.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.472 ' HA ' ' CE3' ' A' ' 21' ' ' TRP . 16.9 mtt85 -40.91 -59.41 1.44 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.98 1.312 . . . . 0.0 113.269 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.684 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -68.34 -27.17 66.03 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 114.329 -1.305 . . . . 0.0 114.255 177.25 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . 0.43 ' HB3' ' HB1' ' A' ' 52' ' ' ALA . 0.8 OUTLIER -72.26 -42.48 65.55 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-O 121.339 0.59 . . . . 0.0 110.738 175.592 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.599 ' HG3' ' HA2' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -62.75 -48.11 80.63 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.118 0.967 . . . . 0.0 111.43 176.695 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.684 HG12 ' HA ' ' A' ' 55' ' ' GLU . 24.1 pt -54.35 -33.78 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.209 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.4 -50.82 72.09 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 123.506 0.722 . . . . 0.0 112.8 173.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.7 t -68.69 -41.95 82.88 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 123.013 0.525 . . . . 0.0 110.376 177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -62.04 -32.88 73.44 Favored 'General case' 0 N--CA 1.478 0.947 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.457 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 54.9 t30 -62.95 -41.92 99.66 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.05 1.34 . . . . 0.0 111.931 171.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.2 tpt180 -71.87 -38.54 70.02 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.419 0.628 . . . . 0.0 111.318 172.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.523 ' HA ' ' HB2' ' A' ' 67' ' ' GLU 0.27 0.5 OUTLIER -59.37 -26.78 35.06 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 N-CA-C 114.356 1.243 . . . . 0.0 114.356 176.327 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.537 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.6 pp -62.01 -40.52 95.95 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 169.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.67 -27.79 67.14 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.133 0.79 . . . . 0.0 113.133 174.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 2.4 mm-40 -61.67 -53.81 51.15 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 115.789 1.774 . . . . 0.0 115.789 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 60.4 tp60 -110.7 -23.47 11.04 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 113.925 1.083 . . . . 0.0 113.925 179.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 119.12 165.04 12.99 Favored Glycine 0 CA--C 1.536 1.344 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 -169.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.2 pp -66.35 4.67 0.68 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.185 1.55 . . . . 0.0 115.185 172.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -63.6 -30.39 71.51 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 126.251 1.821 . . . . 0.0 114.203 178.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -56.09 -27.04 52.03 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 113.341 0.867 . . . . 0.0 113.341 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.483 ' CZ3' ' HB3' ' A' ' 72' ' ' ALA . 7.2 m-90 -119.02 95.95 49.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 174.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -77.78 -58.96 0.04 OUTLIER 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 122.306 2.004 . . . . 0.0 114.126 179.269 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.4 p -64.64 -48.49 74.64 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 125.403 1.481 . . . . 0.0 113.076 179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 16.3 m -108.4 -165.69 1.06 Allowed 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 113.786 -1.552 . . . . 0.0 110.746 170.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 162.92 97.13 0.12 Allowed Glycine 0 N--CA 1.473 1.113 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.43 ' HB2' HG21 ' A' ' 12' ' ' VAL . . . -53.91 -25.34 19.77 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 114.564 1.32 . . . . 0.0 114.564 177.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.537 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -47.11 -40.14 14.8 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 125.029 1.332 . . . . 0.0 113.569 166.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 41.3 m -102.42 -21.07 14.32 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.824 1.25 . . . . 0.0 114.362 172.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.98 -38.31 2.97 Favored Glycine 0 N--CA 1.48 1.58 0 C-N-CA 124.08 0.848 . . . . 0.0 112.332 -175.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.481 1.111 0 CA-C-O 116.057 -1.925 . . . . 99.989999999999995 114.119 175.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.706 0 N-CA-C 114.29 0.476 . . . . 0.0 114.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -151.56 150.73 30.66 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.931 1.292 . . . . 0.0 109.205 -177.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.5 mtt 49.65 84.98 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.293 1.437 . . . . 0.0 113.518 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.8 -73.63 0.08 OUTLIER Glycine 0 CA--C 1.542 1.746 0 CA-C-N 113.387 -1.733 . . . . 0.0 111.289 -173.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -64.16 131.96 32.37 Favored 'Trans proline' 0 CA--C 1.539 0.746 0 C-N-CA 122.204 1.936 . . . . 0.0 111.471 175.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 47.2 m -55.96 141.72 66.66 Favored Pre-proline 0 N--CA 1.483 1.2 0 CA-C-N 114.393 -1.276 . . . . 0.0 112.945 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -60.38 135.1 59.23 Favored 'Trans proline' 0 N--CA 1.478 0.589 0 C-N-CA 122.812 2.341 . . . . 0.0 111.287 -179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -114.28 94.1 4.65 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 114.344 -1.298 . . . . 0.0 112.745 -175.362 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.579 ' HB3' HG21 ' A' ' 58' ' ' ILE . 31.4 m95 -54.91 -31.54 60.21 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.455 175.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -63.19 -52.61 61.63 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 123.548 0.739 . . . . 0.0 112.388 171.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.44 -35.24 65.22 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 174.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.452 HG21 ' N ' ' A' ' 78' ' ' ALA . 71.8 t -63.75 -38.4 82.21 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 C-N-CA 124.404 1.081 . . . . 0.0 112.668 175.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.22 -45.31 93.65 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-O 118.552 -0.737 . . . . 0.0 111.892 168.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 tt0 -70.87 -0.25 8.75 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.5 t -108.51 -29.2 8.91 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.329 1.451 . . . . 0.0 111.874 178.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 49.9 mm-40 -108.23 -27.31 10.11 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 116.562 2.06 . . . . 0.0 116.562 176.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.568 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 54.5 p -111.79 -25.74 9.32 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 114.01 1.115 . . . . 0.0 114.01 171.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 71.78 12.47 74.5 Favored Glycine 0 CA--C 1.541 1.662 0 CA-C-N 115.199 -0.909 . . . . 0.0 113.803 -174.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 153.17 -77.79 0.21 Allowed Glycine 0 CA--C 1.535 1.334 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 -176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.56 ' HB3' ' HA ' ' A' ' 23' ' ' ALA . 52.2 m-80 -44.47 91.38 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 116.993 2.22 . . . . 0.0 116.993 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.415 ' CZ3' ' HA ' ' A' ' 54' ' ' ARG . 40.8 m95 -63.63 -50.15 70.45 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 113.886 1.069 . . . . 0.0 113.886 175.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -83.77 26.71 0.68 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 113.012 0.745 . . . . 0.0 113.012 173.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.56 ' HA ' ' HB3' ' A' ' 20' ' ' ASN . . . 16.81 76.99 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 127.193 2.197 . . . . 0.0 116.086 -172.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -75.7 34.51 0.12 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 112.124 -2.307 . . . . 0.0 114.988 -177.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 14.1 t -113.7 -14.93 12.55 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 126.576 1.951 . . . . 0.0 112.674 179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.33 39.77 70.35 Favored Glycine 0 N--CA 1.48 1.622 0 N-CA-C 115.51 0.964 . . . . 0.0 115.51 -178.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.45 ' HB3' ' HE3' ' A' ' 29' ' ' LYS . 1.9 m120 -88.89 12.64 14.68 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 115.606 1.706 . . . . 0.0 115.606 177.283 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.7 23.57 50.5 Favored Glycine 0 CA--C 1.543 1.817 0 N-CA-C 115.171 0.828 . . . . 0.0 115.171 -171.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.45 ' HE3' ' HB3' ' A' ' 27' ' ' ASN . 52.2 mttt -125.34 150.65 46.97 Favored 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 -173.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.62 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 69.2 m-85 -144.61 174.79 10.66 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.296 1.591 . . . . 0.0 115.296 -177.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.59 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 63.72 19.83 63.35 Favored Glycine 0 N--CA 1.48 1.583 0 CA-C-N 113.777 -1.556 . . . . 0.0 116.792 -179.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.568 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 62.05 15.36 49.73 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 116.532 1.373 . . . . 0.0 116.532 -177.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.479 HD12 ' NE1' ' A' ' 73' ' ' TRP . 3.8 mm? -104.74 9.33 35.06 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 115.438 1.644 . . . . 0.0 115.438 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.43 ' O ' ' HD3' ' A' ' 29' ' ' LYS . 0.8 OUTLIER 30.89 40.71 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 126.562 1.945 . . . . 0.0 116.034 -169.536 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -84.69 116.19 23.08 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-N 114.044 -1.434 . . . . 0.0 110.938 -175.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -36.07 126.03 0.68 Allowed Pre-proline 0 N--CA 1.481 1.115 0 CA-C-N 113.266 -1.788 . . . . 0.0 113.67 173.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -59.71 -35.61 94.22 Favored 'Trans proline' 0 N--CA 1.482 0.837 0 C-N-CA 123.119 2.546 . . . . 0.0 113.39 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.08 -37.94 64.78 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 114.027 1.121 . . . . 0.0 114.027 172.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 m -75.21 -42.31 55.86 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.895 0.478 . . . . 0.0 111.138 173.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.421 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 30.0 t-105 -57.86 -22.63 48.96 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.201 0.815 . . . . 0.0 113.201 177.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.81 -28.77 3.92 Favored 'General case' 0 N--CA 1.48 1.054 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 168.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.54 -38.79 78.53 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 171.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 19.9 m-85 -91.52 18.9 6.73 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 171.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.23 -21.94 32.22 Favored Glycine 0 CA--C 1.538 1.485 0 N-CA-C 115.667 1.027 . . . . 0.0 115.667 -179.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.429 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 72.41 0.0 44.1 Favored Glycine 0 N--CA 1.487 2.073 0 N-CA-C 114.871 0.708 . . . . 0.0 114.871 -173.183 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 44.2 t -69.66 152.8 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.893 0 C-N-CA 126.324 1.85 . . . . 0.0 109.361 -178.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -63.78 37.18 0.08 OUTLIER Glycine 0 CA--C 1.543 1.828 0 C-N-CA 125.505 1.526 . . . . 0.0 116.202 173.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -57.68 -50.87 85.7 Favored Pre-proline 0 CA--C 1.55 0.979 0 CA-C-O 116.151 -1.881 . . . . 0.0 110.365 172.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.62 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 90.6 Cg_endo -71.2 -11.83 29.32 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.081 2.52 . . . . 0.0 115.563 175.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -81.1 -34.97 32.22 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 124.017 0.927 . . . . 0.0 113.203 173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.72 -34.84 10.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 178.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.25 118.72 8.38 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.797 0.839 . . . . 0.0 111.924 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.1 m -46.65 161.34 0.06 Allowed 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 125.165 1.386 . . . . 0.0 111.645 175.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.448 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -42.73 -60.66 1.49 Allowed 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 179.0 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.65 ' HA ' HG12 ' A' ' 58' ' ' ILE . 15.9 tt0 -67.63 -28.01 67.37 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.542 1.312 . . . . 0.0 114.542 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 9.9 tp60 -72.4 -43.6 63.69 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-O 121.05 0.453 . . . . 0.0 110.973 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.59 ' HG3' ' HA3' ' A' ' 31' ' ' GLY . 0.0 OUTLIER -63.31 -44.29 95.39 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 115.465 -0.789 . . . . 0.0 111.685 176.224 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.65 HG12 ' HA ' ' A' ' 55' ' ' GLU . 16.9 pt -55.29 -30.02 24.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.099 0 CA-C-O 118.381 -0.819 . . . . 0.0 113.073 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.46 -46.91 88.08 Favored 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 112.713 0.634 . . . . 0.0 112.713 172.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.5 t -70.36 -42.76 78.66 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.224 0 C-N-CA 123.763 0.825 . . . . 0.0 110.12 177.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.584 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -60.99 -36.72 80.21 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.545 1.138 . . . . 0.0 114.047 174.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.5 t30 -59.55 -41.86 91.09 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 124.928 1.291 . . . . 0.0 111.686 170.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.99 -33.7 57.57 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 174.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.262 0.3 OUTLIER -61.43 -24.19 32.86 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.167 0 N-CA-C 113.45 0.908 . . . . 0.0 113.45 172.941 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.35 -47.27 79.19 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.141 0.577 . . . . 0.0 111.337 169.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.98 -30.13 64.94 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 113.424 0.898 . . . . 0.0 113.424 176.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.9 OUTLIER -60.14 -49.53 77.25 Favored 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 124.679 1.191 . . . . 0.0 113.469 -179.654 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 45.6 tp60 -103.22 -26.55 12.94 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 179.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 112.17 157.39 13.61 Favored Glycine 0 CA--C 1.537 1.424 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -175.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.19 -27.68 15.47 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.066 1.136 . . . . 0.0 114.066 174.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -55.52 -21.83 18.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 126.012 1.725 . . . . 0.0 115.2 174.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.83 -36.06 58.08 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 124.138 0.975 . . . . 0.0 113.583 178.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.479 ' NE1' HD12 ' A' ' 33' ' ' LEU . 13.2 m-90 -118.82 136.92 24.47 Favored Pre-proline 0 N--CA 1.475 0.796 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 175.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 81.1 Cg_endo -69.93 -85.15 0.0 OUTLIER 'Trans proline' 0 CA--C 1.543 0.964 0 C-N-CA 122.854 2.37 . . . . 0.0 113.885 -177.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 21.8 p -91.55 -53.22 4.41 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 125.224 1.409 . . . . 0.0 111.477 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 34.3 m -56.96 160.92 3.25 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 126.444 1.898 . . . . 0.0 110.094 169.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 123.29 103.81 1.66 Allowed Glycine 0 N--CA 1.478 1.493 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.292 176.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.452 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -59.51 -18.72 42.55 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 114.468 1.284 . . . . 0.0 114.468 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -36.62 -45.19 0.5 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 125.63 1.572 . . . . 0.0 113.165 160.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.626 ' HB3' HD23 ' A' ' 82' ' ' LEU . 58.6 m -107.29 -30.02 8.96 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.193 0.997 . . . . 0.0 113.442 170.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 69.21 11.69 64.57 Favored Glycine 0 N--CA 1.482 1.749 0 C-N-CA 123.941 0.781 . . . . 0.0 114.268 -173.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.626 HD23 ' HB3' ' A' ' 80' ' ' SER . 4.2 mm? . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.89 1.276 . . . . 99.989999999999995 113.455 174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.835 0 N-CA-C 114.649 0.62 . . . . 0.0 114.649 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -73.63 167.3 21.64 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.538 -0.831 . . . . 0.0 111.059 175.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.9 ttt -53.66 143.08 21.24 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 123.188 0.595 . . . . 0.0 110.954 177.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.51 -73.75 0.04 OUTLIER Glycine 0 CA--C 1.542 1.778 0 CA-C-N 114.128 -1.396 . . . . 0.0 111.272 -173.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -67.4 146.13 73.77 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 122.447 2.098 . . . . 0.0 112.455 176.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 42.1 m -68.58 136.08 90.57 Favored Pre-proline 0 N--CA 1.48 1.069 0 CA-C-N 114.604 -1.18 . . . . 0.0 112.829 176.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -68.09 126.38 14.36 Favored 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 122.624 2.216 . . . . 0.0 111.46 175.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 26.1 m-80 -127.12 156.54 41.59 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.912 -1.949 . . . . 0.0 109.993 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.403 ' CH2' HD21 ' A' ' 33' ' ' LEU . 3.9 m95 -49.76 -39.47 37.89 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 114.074 1.138 . . . . 0.0 114.074 174.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -59.87 -54.2 49.02 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 114.602 1.334 . . . . 0.0 114.602 171.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.4 -36.96 74.35 Favored 'General case' 0 N--CA 1.479 0.985 0 C-N-CA 124.128 0.971 . . . . 0.0 112.721 172.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.75 HG11 ' HB2' ' A' ' 78' ' ' ALA . 53.6 t -61.14 -31.38 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.82 0 C-N-CA 125.068 1.347 . . . . 0.0 112.62 175.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.19 -38.36 76.56 Favored 'General case' 0 N--CA 1.482 1.14 0 CA-C-N 119.349 0.977 . . . . 0.0 112.76 169.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 tt0 -77.82 5.42 9.58 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 10.9 t -116.85 -33.41 4.79 Favored 'General case' 0 N--CA 1.477 0.898 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 173.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 12.8 mm-40 -75.77 -43.74 45.03 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 124.377 1.071 . . . . 0.0 111.764 171.083 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 27.8 t -104.01 -45.17 4.81 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.011 1.324 . . . . 0.0 113.246 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.93 22.71 66.89 Favored Glycine 0 N--CA 1.481 1.686 0 O-C-N 124.179 0.924 . . . . 0.0 114.347 -172.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -164.77 -100.54 0.15 Allowed Glycine 0 N--CA 1.477 1.377 0 O-C-N 123.992 0.466 . . . . 0.0 112.795 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -82.38 139.74 33.89 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 -176.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 42.1 m95 -66.92 -15.81 63.92 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 115.378 1.622 . . . . 0.0 115.378 167.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.47 ' O ' ' HA ' ' A' ' 30' ' ' TYR . . . -93.54 -35.35 12.97 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 113.338 0.866 . . . . 0.0 113.338 168.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 45.73 43.01 9.24 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 116.572 2.064 . . . . 0.0 116.572 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -104.93 32.27 4.28 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.306 -1.315 . . . . 0.0 112.919 -175.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 6.8 t -128.36 26.77 5.66 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 122.708 1.242 . . . . 0.0 113.084 176.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -137.31 -95.53 0.39 Allowed Glycine 0 N--CA 1.481 1.656 0 CA-C-N 113.994 -1.457 . . . . 0.0 110.154 -179.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB2' ' HE2' ' A' ' 29' ' ' LYS . 33.2 m-20 -105.69 28.96 6.99 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 177.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 57.45 40.11 91.67 Favored Glycine 0 CA--C 1.541 1.711 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.678 -174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HD3' ' HA ' ' A' ' 34' ' ' GLN . 66.3 mttm -74.69 165.22 25.59 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.927 0.891 . . . . 0.0 110.703 -179.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.646 ' HB3' ' HG2' ' A' ' 49' ' ' PRO . 59.7 m-85 -137.43 156.86 47.69 Favored 'General case' 0 N--CA 1.475 0.825 0 CA-C-N 114.32 -1.309 . . . . 0.0 114.001 -176.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 62.66 10.14 29.36 Favored Glycine 0 N--CA 1.481 1.666 0 CA-C-N 114.272 -1.331 . . . . 0.0 116.147 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 16' ' ' GLU . . . 55.59 29.88 54.87 Favored Glycine 0 CA--C 1.539 1.586 0 CA-C-N 115.536 -0.332 . . . . 0.0 112.302 -167.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.421 HD23 ' CE2' ' A' ' 73' ' ' TRP . 0.3 OUTLIER -112.32 16.7 19.89 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 116.193 1.923 . . . . 0.0 116.193 -175.471 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.576 ' HA ' ' HD3' ' A' ' 29' ' ' LYS . 5.8 pt20 36.0 34.3 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 116.072 1.878 . . . . 0.0 116.072 -175.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.484 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 1.9 t80 -98.57 115.31 28.34 Favored 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 114.642 -1.163 . . . . 0.0 110.35 -168.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.53 130.46 10.6 Favored Pre-proline 0 N--CA 1.477 0.915 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.963 -177.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -57.33 -34.68 98.31 Favored 'Trans proline' 0 CA--C 1.539 0.755 0 C-N-CA 122.917 2.411 . . . . 0.0 113.438 179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.65 -34.66 65.16 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 114.145 1.165 . . . . 0.0 114.145 171.776 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.3 m -76.23 -46.53 27.79 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 123.434 0.694 . . . . 0.0 111.076 173.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.439 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 31.6 t-105 -58.51 -22.37 54.97 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 113.248 0.832 . . . . 0.0 113.248 176.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.403 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -47.65 -30.35 3.67 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 169.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.18 -35.77 72.07 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.418 ' CE1' HG23 ' A' ' 64' ' ' VAL . 20.0 m-85 -97.01 19.45 12.79 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 125.144 1.377 . . . . 0.0 113.219 173.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.47 -21.72 30.07 Favored Glycine 0 CA--C 1.538 1.522 0 N-CA-C 115.792 1.077 . . . . 0.0 115.792 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.403 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 74.82 -5.77 29.65 Favored Glycine 0 N--CA 1.484 1.883 0 N-CA-C 114.731 0.653 . . . . 0.0 114.731 -173.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.476 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.2 p -64.13 155.09 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 C-N-CA 126.256 1.823 . . . . 0.0 112.061 -178.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.97 33.96 0.14 Allowed Glycine 0 CA--C 1.541 1.719 0 C-N-CA 124.937 1.256 . . . . 0.0 115.747 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' HG13 ' A' ' 46' ' ' VAL . 5.5 t30 -58.1 -51.44 81.75 Favored Pre-proline 0 N--CA 1.476 0.858 0 CA-C-O 116.323 -1.799 . . . . 0.0 110.241 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.646 ' HG2' ' HB3' ' A' ' 30' ' ' TYR . 80.2 Cg_endo -72.95 -10.05 24.27 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 122.69 2.26 . . . . 0.0 115.254 176.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 30' ' ' TYR . . . -82.43 -33.79 28.45 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.11 0.782 . . . . 0.0 113.11 172.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -98.36 -34.06 10.81 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.93 1.455 . . . . 0.0 114.93 177.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -60.74 128.0 34.43 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 123.874 0.87 . . . . 0.0 111.423 177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 16.3 m -49.43 156.09 0.66 Allowed 'General case' 0 N--CA 1.48 1.067 0 CA-C-N 114.031 -1.44 . . . . 0.0 110.722 177.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -42.74 -57.59 2.69 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.524 1.13 . . . . 0.0 113.994 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.779 ' HA ' HG12 ' A' ' 58' ' ' ILE . 6.9 tt0 -70.53 -31.5 68.59 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 175.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -66.06 -42.07 89.93 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.764 0.826 . . . . 0.0 111.039 174.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.436 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -63.05 -53.74 49.09 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 125.06 1.344 . . . . 0.0 110.607 176.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.779 HG12 ' HA ' ' A' ' 55' ' ' GLU . 20.2 pt -54.31 -31.4 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.7 -50.19 74.49 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 171.032 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.4 t -65.98 -42.13 91.14 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 123.514 0.726 . . . . 0.0 109.824 176.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.666 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -59.44 -39.61 84.14 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.284 1.434 . . . . 0.0 114.041 175.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -59.52 -38.94 82.31 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.06 1.344 . . . . 0.0 112.132 173.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -80.74 -36.03 32.54 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 174.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -61.9 -20.28 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 172.441 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.26 -40.52 74.33 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 119.159 -0.448 . . . . 0.0 111.928 169.109 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -65.7 -27.41 68.32 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -70.32 -47.32 61.61 Favored 'General case' 0 N--CA 1.477 0.901 0 N-CA-C 114.687 1.365 . . . . 0.0 114.687 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.5 tp60 -107.04 -22.71 12.56 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.37 155.15 9.3 Favored Glycine 0 N--CA 1.478 1.439 0 C-N-CA 124.116 0.865 . . . . 0.0 110.987 -178.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.17 -35.13 74.64 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 122.08 -0.659 . . . . 0.0 112.769 169.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -69.91 -0.92 8.17 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 116.308 1.966 . . . . 0.0 116.308 171.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.484 ' HB1' ' HE1' ' A' ' 35' ' ' PHE . . . -57.05 -25.41 58.61 Favored 'General case' 0 N--CA 1.478 0.935 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 175.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.421 ' CE2' HD23 ' A' ' 33' ' ' LEU . 12.8 m-90 -118.2 75.53 11.48 Favored Pre-proline 0 CA--C 1.549 0.906 0 CA-C-N 115.164 -0.925 . . . . 0.0 111.099 174.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -68.17 -20.12 43.91 Favored 'Trans proline' 0 CA--C 1.543 0.958 0 C-N-CA 123.002 2.468 . . . . 0.0 113.828 179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.5 p -60.29 -44.38 95.44 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 126.348 1.859 . . . . 0.0 113.978 177.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.404 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -139.95 -69.27 0.41 Allowed 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.886 1.274 . . . . 0.0 112.283 172.177 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 81.76 89.13 0.62 Allowed Glycine 0 CA--C 1.534 1.261 0 CA-C-N 115.138 -0.937 . . . . 0.0 112.32 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.75 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -51.86 -27.06 11.41 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 115.856 1.798 . . . . 0.0 115.856 177.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.61 -43.22 36.04 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 125.115 1.366 . . . . 0.0 113.505 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.446 ' HB2' HD12 ' A' ' 82' ' ' LEU . 58.5 m -109.03 -20.97 12.84 Favored 'General case' 0 N--CA 1.485 1.294 0 O-C-N 124.113 0.883 . . . . 0.0 112.628 166.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.91 -43.6 3.08 Favored Glycine 0 CA--C 1.532 1.105 0 CA-C-N 114.681 -1.145 . . . . 0.0 110.99 -176.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.446 HD12 ' HB2' ' A' ' 80' ' ' SER . 8.2 mp . . . . . 0 C--O 1.25 1.089 0 C-N-CA 125.848 1.659 . . . . 99.989999999999995 113.632 -174.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.689 0 CA-C-O 120.333 -0.148 . . . . 0.0 112.992 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 46.07 80.15 0.05 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 125.372 1.469 . . . . 0.0 112.917 -173.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.1 ttt -115.69 125.62 53.07 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-N 114.217 -1.356 . . . . 0.0 110.508 -174.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 128.28 164.94 11.7 Favored Glycine 0 CA--C 1.547 2.063 0 O-C-N 125.518 1.761 . . . . 0.0 111.958 -177.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -70.12 149.64 64.89 Favored 'Trans proline' 0 CA--C 1.54 0.787 0 C-N-CA 122.683 2.255 . . . . 0.0 112.713 178.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.2 m -56.37 145.43 58.13 Favored Pre-proline 0 N--CA 1.483 1.199 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 175.084 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.499 ' HB2' ' HB1' ' A' ' 78' ' ' ALA . 61.3 Cg_endo -67.49 138.44 45.99 Favored 'Trans proline' 0 CA--C 1.537 0.643 0 C-N-CA 122.322 2.015 . . . . 0.0 111.834 174.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -115.57 174.54 5.96 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 112.942 -1.935 . . . . 0.0 111.248 176.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -54.17 -33.71 58.72 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 113.625 0.972 . . . . 0.0 113.625 170.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -58.54 -35.84 72.95 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 114.444 1.276 . . . . 0.0 114.444 170.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 15' ' ' CYS . . . -66.54 -26.6 67.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 118.816 -0.612 . . . . 0.0 112.358 175.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 10.2 t -60.68 -42.92 93.73 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 C-N-CA 123.388 0.675 . . . . 0.0 110.267 171.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.75 -37.29 78.59 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 173.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -84.63 1.28 46.88 Favored 'General case' 0 CA--C 1.553 1.058 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 174.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.442 ' HB2' ' O ' ' A' ' 11' ' ' ALA . 0.1 OUTLIER -112.17 -36.53 5.31 Favored 'General case' 0 N--CA 1.478 0.974 0 C-N-CA 124.228 1.011 . . . . 0.0 112.338 179.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -79.31 -51.05 9.95 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 124.71 1.204 . . . . 0.0 112.645 167.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' NE2' ' A' ' 34' ' ' GLN . 0.3 OUTLIER -106.59 -23.75 12.37 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -174.234 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 87.81 -28.87 5.71 Favored Glycine 0 N--CA 1.482 1.721 0 C-N-CA 122.83 0.252 . . . . 0.0 113.416 -177.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 159.04 93.14 0.09 OUTLIER Glycine 0 N--CA 1.474 1.227 0 N-CA-C 110.493 -1.043 . . . . 0.0 110.493 179.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -172.15 81.47 0.06 Allowed 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 124.24 1.016 . . . . 0.0 112.433 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 89.0 m95 -73.65 -73.69 0.21 Allowed 'General case' 0 N--CA 1.478 0.954 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -62.86 -30.32 71.42 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.978 1.103 . . . . 0.0 113.978 173.2 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 50.52 60.84 3.56 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 126.014 1.725 . . . . 0.0 114.316 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.8 p-10 -77.45 35.21 0.18 Allowed 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 113.033 -1.894 . . . . 0.0 115.148 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.2 t -112.35 -17.67 12.66 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.634 1.973 . . . . 0.0 112.351 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 68.71 58.04 7.38 Favored Glycine 0 N--CA 1.48 1.577 0 CA-C-N 115.746 -0.661 . . . . 0.0 113.621 -177.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.498 ' O ' ' HG3' ' A' ' 29' ' ' LYS . 7.4 t-20 -104.64 20.65 18.24 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 114.476 -0.862 . . . . 0.0 112.748 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 56.06 26.78 49.95 Favored Glycine 0 N--CA 1.483 1.808 0 C-N-CA 124.188 0.899 . . . . 0.0 115.157 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.498 ' HG3' ' O ' ' A' ' 27' ' ' ASN . 59.1 mttm -122.51 150.44 42.54 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.495 1.118 . . . . 0.0 109.451 -173.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 49' ' ' PRO . 10.7 p90 -152.73 139.68 19.13 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.011 -1.45 . . . . 0.0 112.552 -175.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 68.34 -0.43 12.49 Favored Glycine 0 N--CA 1.485 1.907 0 CA-C-N 113.572 -1.649 . . . . 0.0 114.654 -176.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.82 25.83 55.12 Favored Glycine 0 N--CA 1.476 1.322 0 C-N-CA 124.525 1.06 . . . . 0.0 114.775 -176.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -106.16 14.5 27.58 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.433 ' NE2' ' HA ' ' A' ' 17' ' ' SER . 11.4 mt-30 37.91 36.66 0.11 Allowed 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 126.929 2.092 . . . . 0.0 116.068 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.582 ' CE1' HG21 ' A' ' 39' ' ' THR . 0.2 OUTLIER -94.69 121.76 36.6 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 112.929 -1.941 . . . . 0.0 108.349 -171.74 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.443 ' HD2' ' HD2' ' A' ' 37' ' ' PRO . 1.0 OUTLIER -41.73 136.41 2.01 Favored Pre-proline 0 N--CA 1.482 1.16 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 176.991 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.443 ' HD2' ' HD2' ' A' ' 36' ' ' LYS . 72.5 Cg_endo -65.23 -32.41 51.71 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 122.635 2.223 . . . . 0.0 112.54 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -55.4 -34.72 64.63 Favored 'General case' 0 N--CA 1.478 0.954 0 C-N-CA 124.318 1.047 . . . . 0.0 113.624 172.401 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.582 HG21 ' CE1' ' A' ' 35' ' ' PHE . 23.0 m -68.91 -47.06 66.72 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.914 0.486 . . . . 0.0 111.698 172.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.532 ' CZ2' ' HD3' ' A' ' 49' ' ' PRO . 33.2 t-105 -57.05 -22.28 37.91 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 113.538 0.94 . . . . 0.0 113.538 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.78 -29.2 4.28 Favored 'General case' 0 N--CA 1.478 0.945 0 N-CA-C 114.462 1.282 . . . . 0.0 114.462 168.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.31 -37.21 74.63 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.874 0.869 . . . . 0.0 113.296 171.683 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -95.71 18.4 13.07 Favored 'General case' 0 N--CA 1.479 1.006 0 C-N-CA 124.169 0.988 . . . . 0.0 111.565 174.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.67 -23.73 23.52 Favored Glycine 0 CA--C 1.539 1.588 0 N-CA-C 115.639 1.015 . . . . 0.0 115.639 -178.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.12 -0.91 44.05 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 114.888 0.715 . . . . 0.0 114.888 -172.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.5 t -71.09 153.05 8.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 C-N-CA 126.361 1.864 . . . . 0.0 109.26 -178.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -62.83 38.05 0.07 OUTLIER Glycine 0 CA--C 1.543 1.837 0 C-N-CA 125.263 1.411 . . . . 0.0 116.418 172.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.432 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 5.8 t30 -57.27 -47.65 98.68 Favored Pre-proline 0 CA--C 1.55 0.954 0 CA-C-O 116.256 -1.83 . . . . 0.0 110.931 172.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD3' ' CZ2' ' A' ' 40' ' ' TRP . 73.1 Cg_endo -67.55 -28.09 38.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.202 2.601 . . . . 0.0 114.799 173.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -69.59 -33.06 72.17 Favored 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 175.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.87 -34.17 14.63 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 174.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.75 123.73 20.94 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 122.511 1.148 . . . . 0.0 111.969 175.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.8 t -53.78 157.55 2.3 Favored 'General case' 0 N--CA 1.482 1.127 0 CA-C-N 113.02 -1.9 . . . . 0.0 110.388 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.42 -58.13 3.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.309 1.226 . . . . 0.0 114.309 -176.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.558 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.7 OUTLIER -70.75 -19.4 62.73 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.795 1.406 . . . . 0.0 114.795 177.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -83.46 -38.92 21.21 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 123.336 0.655 . . . . 0.0 111.936 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 19.5 tp60 -63.91 -42.85 97.3 Favored 'General case' 0 N--CA 1.472 0.674 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 173.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.558 HG12 ' HA ' ' A' ' 55' ' ' GLU . 14.0 pt -54.22 -29.79 19.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -63.55 -47.12 82.88 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.535 0.734 . . . . 0.0 112.546 172.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.5 t -66.37 -42.36 90.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.275 0 C-N-CA 123.371 0.668 . . . . 0.0 109.842 175.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.467 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -61.41 -35.23 76.97 Favored 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 114.129 1.159 . . . . 0.0 114.129 174.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.46 -49.38 77.78 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.72 1.208 . . . . 0.0 110.784 171.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.8 tpt180 -65.52 -37.36 86.53 Favored 'General case' 0 N--CA 1.482 1.127 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 175.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.467 HG12 ' O ' ' A' ' 61' ' ' ALA 0.28 0.3 OUTLIER -61.29 -22.18 26.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 175.913 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -61.34 -38.96 88.8 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 170.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.43 -29.73 68.45 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.132 0.79 . . . . 0.0 113.132 173.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.461 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 6.7 mm-40 -65.23 -54.79 24.19 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 178.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -109.35 -23.56 11.5 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 -178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 123.13 147.99 7.49 Favored Glycine 0 N--CA 1.478 1.437 0 CA-C-O 122.038 0.799 . . . . 0.0 111.864 -175.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 pp -65.46 -29.03 69.65 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 114.316 -0.942 . . . . 0.0 113.512 172.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.6 -19.33 15.48 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 172.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.63 -39.64 74.01 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.781 0.832 . . . . 0.0 112.82 175.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 32.1 m-90 -80.8 140.48 50.74 Favored Pre-proline 0 N--CA 1.476 0.856 0 O-C-N 123.796 0.685 . . . . 0.0 109.214 171.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.488 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 83.9 Cg_endo -67.55 -170.06 0.24 Allowed 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 122.966 2.444 . . . . 0.0 111.493 178.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 25.7 p -53.35 -31.81 46.22 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 125.38 1.472 . . . . 0.0 114.146 179.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.488 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 1.2 m -39.26 -83.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 126.043 1.737 . . . . 0.0 113.314 169.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 41.51 43.63 3.89 Favored Glycine 0 N--CA 1.482 1.722 0 N-CA-C 115.684 1.034 . . . . 0.0 115.684 176.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 7' ' ' PRO . . . -49.73 -20.2 0.78 Allowed 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 116.52 2.044 . . . . 0.0 116.52 -178.551 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -55.21 -37.57 67.29 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 126.159 1.783 . . . . 0.0 113.156 170.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 48.4 m -65.54 -19.33 65.88 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 172.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 66.39 27.03 72.81 Favored Glycine 0 CA--C 1.539 1.546 0 O-C-N 123.853 0.721 . . . . 0.0 113.547 -172.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.6 pp . . . . . 0 C--O 1.253 1.241 0 CA-C-O 117.909 -1.043 . . . . 99.989999999999995 113.335 177.762 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.695 0 CA-C-O 120.871 0.15 . . . . 0.0 113.23 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.97 74.83 0.96 Allowed 'General case' 0 N--CA 1.475 0.789 0 CA-C-O 122.492 1.139 . . . . 0.0 109.519 175.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 18.9 ttm -69.72 -47.85 61.62 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 113.171 -1.831 . . . . 0.0 112.75 -178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.56 90.06 0.08 OUTLIER Glycine 0 CA--C 1.543 1.835 0 CA-C-O 118.166 -1.352 . . . . 0.0 110.866 176.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.14 140.69 34.73 Favored 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 122.271 1.981 . . . . 0.0 111.601 176.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.7 m -62.37 119.61 51.36 Favored Pre-proline 0 N--CA 1.483 1.215 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 177.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -68.93 146.42 65.29 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.003 2.469 . . . . 0.0 112.206 177.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 1.0 OUTLIER -114.48 81.18 1.51 Allowed 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.25 -1.341 . . . . 0.0 114.223 -178.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 8.9 m95 -57.55 -33.03 67.69 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 113.911 -1.495 . . . . 0.0 114.044 172.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -62.01 -50.75 70.79 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.739 0.816 . . . . 0.0 112.644 171.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.427 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -63.95 -37.8 88.76 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 123.382 0.426 . . . . 0.0 111.826 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 78' ' ' ALA . 51.4 t -61.25 -35.64 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.017 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.778 174.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.7 -46.42 90.47 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.351 169.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 25.4 tt0 -71.36 -3.6 21.6 Favored 'General case' 0 N--CA 1.483 1.193 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 174.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 8.9 t -98.48 -27.53 14.02 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.29 1.436 . . . . 0.0 111.46 176.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.5 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 9.2 mt-10 -104.55 -43.92 5.03 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 179.315 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.603 ' HB3' ' HA2' ' A' ' 32' ' ' GLY . 51.6 p -87.18 -37.87 16.91 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 172.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 59.15 25.08 59.45 Favored Glycine 0 N--CA 1.479 1.528 0 O-C-N 124.461 1.101 . . . . 0.0 114.189 -175.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -176.36 -82.16 0.06 OUTLIER Glycine 0 N--CA 1.475 1.266 0 O-C-N 123.798 0.352 . . . . 0.0 113.728 -174.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -115.85 139.3 50.33 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.458 1.281 . . . . 0.0 114.458 -171.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 31.1 m95 -69.32 -39.01 78.49 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 114.447 -1.251 . . . . 0.0 114.328 177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -80.56 13.73 2.38 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 172.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 30.3 71.72 0.07 Allowed 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 126.598 1.959 . . . . 0.0 114.298 -172.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -81.55 40.81 0.6 Allowed 'General case' 0 N--CA 1.48 1.062 0 CA-C-N 112.494 -2.139 . . . . 0.0 112.952 -175.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 25.5 p -116.88 -19.33 9.89 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 128.036 2.534 . . . . 0.0 112.801 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.39 40.7 96.56 Favored Glycine 0 N--CA 1.48 1.629 0 C-N-CA 123.615 0.626 . . . . 0.0 114.622 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -109.44 32.75 4.76 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-O 121.931 0.872 . . . . 0.0 112.513 -178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.552 ' O ' ' HD3' ' A' ' 37' ' ' PRO . . . 55.5 35.89 62.68 Favored Glycine 0 CA--C 1.544 1.895 0 CA-C-N 115.39 -0.823 . . . . 0.0 114.839 -177.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HE2' ' HG3' ' A' ' 34' ' ' GLN . 84.5 mttt -110.98 147.3 35.0 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-O 121.579 0.704 . . . . 0.0 110.586 -176.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.417 ' HB3' ' CG ' ' A' ' 49' ' ' PRO . 35.6 m-85 -132.56 145.51 51.18 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 113.503 -1.68 . . . . 0.0 114.898 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.559 ' HA3' ' HG3' ' A' ' 57' ' ' GLN . . . 52.24 29.46 29.64 Favored Glycine 0 N--CA 1.482 1.751 0 O-C-N 125.314 1.634 . . . . 0.0 117.111 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.603 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 58.99 22.73 55.84 Favored Glycine 0 CA--C 1.539 1.577 0 C-N-CA 123.848 0.737 . . . . 0.0 114.664 -173.211 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.5 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -111.93 16.93 20.13 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -175.7 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.508 ' HG3' ' HE2' ' A' ' 29' ' ' LYS . 38.9 tt0 43.39 42.97 4.07 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-O 124.07 1.89 . . . . 0.0 112.746 -177.443 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 6.0 t80 -100.98 108.22 19.88 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 113.823 -1.535 . . . . 0.0 111.765 -173.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.515 ' HD3' ' HD2' ' A' ' 37' ' ' PRO . 3.6 mmtt -43.77 138.15 3.17 Favored Pre-proline 0 N--CA 1.479 1.021 0 CA-C-N 112.587 -2.097 . . . . 0.0 113.768 178.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' O ' ' A' ' 28' ' ' GLY . 98.6 Cg_endo -66.48 -42.34 9.95 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 122.709 2.273 . . . . 0.0 112.63 -176.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.418 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.63 -34.32 67.16 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.405 1.082 . . . . 0.0 112.955 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 6.2 m -71.76 -49.27 40.52 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.053 0.541 . . . . 0.0 112.179 173.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.408 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 32.2 t-105 -60.2 -21.9 62.31 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 176.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 38' ' ' ALA . . . -51.5 -29.64 17.32 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 114.878 1.436 . . . . 0.0 114.878 170.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -57.09 -29.37 63.44 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 113.547 0.943 . . . . 0.0 113.547 170.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.657 ' CZ ' HG22 ' A' ' 64' ' ' VAL . 30.0 m-85 -105.99 25.69 10.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 125.416 1.486 . . . . 0.0 111.216 178.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 98.39 -19.88 52.69 Favored Glycine 0 N--CA 1.479 1.551 0 CA-C-O 119.092 -0.838 . . . . 0.0 115.082 -178.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 73.65 -5.12 24.72 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 114.947 0.739 . . . . 0.0 114.947 -174.783 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 10.7 p -60.89 151.85 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 126.322 1.849 . . . . 0.0 112.147 -178.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.81 31.34 0.1 Allowed Glycine 0 CA--C 1.542 1.731 0 CA-C-N 113.976 -1.466 . . . . 0.0 116.394 173.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.3 m-20 -52.88 -51.51 73.69 Favored Pre-proline 0 N--CA 1.479 1.017 0 CA-C-O 116.286 -1.816 . . . . 0.0 111.372 169.264 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.568 ' HA ' ' HG2' ' A' ' 57' ' ' GLN . 71.8 Cg_endo -66.24 -23.71 51.89 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 122.873 2.382 . . . . 0.0 115.652 176.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -80.13 -34.07 38.05 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.142 1.164 . . . . 0.0 114.142 175.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -91.53 -36.84 13.48 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 177.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.08 128.05 34.17 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-O 121.989 0.9 . . . . 0.0 110.415 175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.2 t -52.04 158.34 1.1 Allowed 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 112.967 -1.924 . . . . 0.0 110.534 177.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.581 ' H ' ' HD2' ' A' ' 54' ' ' ARG . 0.7 OUTLIER -44.86 -57.62 3.65 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -177.515 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.601 ' HA ' HG12 ' A' ' 58' ' ' ILE . 7.1 tt0 -68.79 -18.79 64.25 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 176.257 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 8.9 tp60 -81.67 -40.85 22.22 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.328 0.651 . . . . 0.0 111.418 176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.568 ' HG2' ' HA ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -60.71 -48.09 83.37 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.909 0.884 . . . . 0.0 110.531 175.734 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.601 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -53.97 -31.65 21.34 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.101 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.19 -50.72 72.56 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.252 0.621 . . . . 0.0 111.873 174.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 t -65.61 -48.62 81.98 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.631 ' HA ' ' HB ' ' A' ' 64' ' ' VAL . . . -55.52 -37.83 68.44 Favored 'General case' 0 N--CA 1.481 1.095 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 16.2 t30 -62.65 -38.32 89.82 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 125.755 1.622 . . . . 0.0 113.307 173.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.0 ttm-85 -81.27 -35.98 30.46 Favored 'General case' 0 N--CA 1.481 1.081 0 O-C-N 121.259 -0.9 . . . . 0.0 111.741 170.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.657 HG22 ' CZ ' ' A' ' 43' ' ' PHE . 20.0 t -50.72 -32.74 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 C-N-CA 126.059 1.744 . . . . 0.0 112.072 171.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.544 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.4 OUTLIER -56.31 -41.61 76.27 Favored 'General case' 0 N--CA 1.479 0.997 0 N-CA-C 113.005 0.742 . . . . 0.0 113.005 172.596 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.86 -28.93 67.15 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.231 0.826 . . . . 0.0 113.231 176.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.7 mm-40 -75.99 -59.91 2.55 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 178.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 32.4 tp60 -80.78 -27.01 36.84 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.428 1.27 . . . . 0.0 114.428 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.0 168.23 31.96 Favored Glycine 0 CA--C 1.535 1.291 0 N-CA-C 109.671 -1.371 . . . . 0.0 109.671 -173.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.2 pp -78.79 24.77 0.29 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.377 -0.912 . . . . 0.0 113.257 171.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -83.8 -45.91 12.78 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.059 0.943 . . . . 0.0 113.03 178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.68 -34.3 64.92 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.007 0.923 . . . . 0.0 113.152 178.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 1.2 m-90 -120.34 94.97 49.02 Favored Pre-proline 0 CA--C 1.546 0.809 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.61 -89.21 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 0.994 0 C-N-CA 123.156 2.571 . . . . 0.0 112.533 -177.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 10.2 t -64.02 -43.85 94.34 Favored 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 123.631 0.772 . . . . 0.0 111.998 173.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 58.0 m -72.88 140.6 47.65 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 174.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 157.15 99.39 0.16 Allowed Glycine 0 N--CA 1.481 1.657 0 O-C-N 124.363 1.039 . . . . 0.0 111.695 173.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.554 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -60.59 -18.68 54.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.206 1.558 . . . . 0.0 115.206 -179.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.544 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -44.17 -48.2 9.19 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.112 1.365 . . . . 0.0 112.497 165.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.653 ' HB3' HD12 ' A' ' 82' ' ' LEU . 36.5 m -95.08 -29.35 14.63 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 124.124 0.97 . . . . 0.0 113.469 171.194 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.54 24.28 67.66 Favored Glycine 0 CA--C 1.542 1.745 0 C-N-CA 124.169 0.89 . . . . 0.0 113.861 -175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.653 HD12 ' HB3' ' A' ' 80' ' ' SER . 17.7 mt . . . . . 0 C--O 1.252 1.223 0 CA-C-O 117.006 -1.473 . . . . 99.989999999999995 111.83 -178.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.656 0 CA-C-O 121.732 0.629 . . . . 0.0 113.116 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -165.27 -57.75 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 113.722 -1.239 . . . . 0.0 111.371 -176.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.6 ttp 67.34 -47.17 0.49 Allowed 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 127.251 2.22 . . . . 0.0 114.051 178.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 133.18 -87.64 0.27 Allowed Glycine 0 CA--C 1.543 1.795 0 CA-C-O 118.228 -1.318 . . . . 0.0 110.559 178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -70.19 150.39 65.51 Favored 'Trans proline' 0 CA--C 1.543 0.957 0 C-N-CA 122.567 2.178 . . . . 0.0 112.949 178.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 33.6 m -53.83 147.6 22.97 Favored Pre-proline 0 N--CA 1.486 1.332 0 CA-C-N 114.634 -1.167 . . . . 0.0 114.125 174.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -63.6 116.05 3.41 Favored 'Trans proline' 0 N--CA 1.48 0.688 0 C-N-CA 123.323 2.682 . . . . 0.0 114.016 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.59 ' HB3' ' HB3' ' A' ' 11' ' ' ALA . 7.7 m-20 -76.94 72.45 3.51 Favored 'General case' 0 N--CA 1.479 0.975 0 N-CA-C 115.264 1.579 . . . . 0.0 115.264 178.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.482 ' HB3' HG21 ' A' ' 58' ' ' ILE . 25.7 m95 -61.29 -33.9 74.33 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 114.728 -1.124 . . . . 0.0 113.831 172.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -63.6 -48.88 75.55 Favored 'General case' 0 N--CA 1.48 1.07 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 172.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.59 ' HB3' ' HB3' ' A' ' 8' ' ' ASN . . . -65.48 -39.84 92.42 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 175.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.57 HG11 ' H ' ' A' ' 78' ' ' ALA . 44.7 t -62.98 -32.66 56.9 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.062 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 173.487 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -56.43 -45.46 80.72 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-O 118.718 -0.658 . . . . 0.0 111.702 167.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -73.88 4.6 5.08 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 116.185 1.92 . . . . 0.0 116.185 173.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 5.8 t -110.83 -33.99 6.37 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.569 0.748 . . . . 0.0 112.301 175.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -87.33 -48.07 8.29 Favored 'General case' 0 N--CA 1.483 1.188 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 168.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.429 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 57.2 p -94.35 -29.84 14.81 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.565 1.32 . . . . 0.0 114.565 179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 63.41 17.94 60.33 Favored Glycine 0 CA--C 1.541 1.68 0 O-C-N 123.994 0.809 . . . . 0.0 113.618 -173.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.61 67.4 0.51 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.113 0.863 . . . . 0.0 111.676 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -169.79 76.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.807 0.843 . . . . 0.0 112.181 175.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.449 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 82.1 m95 -64.44 -38.27 90.42 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 113.868 1.062 . . . . 0.0 113.868 177.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -76.86 -27.9 55.24 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.022 1.119 . . . . 0.0 114.022 171.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 25' ' ' THR . . . 46.2 69.9 0.43 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 125.822 1.649 . . . . 0.0 112.769 -173.17 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -76.0 32.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 113.518 -1.674 . . . . 0.0 115.319 -176.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.408 ' H ' ' C ' ' A' ' 23' ' ' ALA . 4.4 p -96.54 -17.34 20.54 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 129.053 2.941 . . . . 0.0 113.921 179.84 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.83 37.17 93.99 Favored Glycine 0 N--CA 1.482 1.736 0 N-CA-C 115.8 1.08 . . . . 0.0 115.8 -178.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -91.92 22.47 4.24 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 -178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.04 24.75 55.37 Favored Glycine 0 CA--C 1.543 1.794 0 C-N-CA 124.552 1.072 . . . . 0.0 115.5 -172.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -126.22 142.35 51.56 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.438 0.695 . . . . 0.0 109.135 -173.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.413 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 58.2 m-85 -138.74 166.61 23.95 Favored 'General case' 0 N--CA 1.478 0.952 0 O-C-N 124.46 1.1 . . . . 0.0 112.507 178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 73.37 -1.64 41.86 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 115.193 -0.912 . . . . 0.0 113.17 -172.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 17' ' ' SER . . . 60.2 12.58 24.47 Favored Glycine 0 N--CA 1.476 1.365 0 N-CA-C 115.136 0.814 . . . . 0.0 115.136 -171.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.465 HD12 ' HE1' ' A' ' 73' ' ' TRP . 3.6 mm? -84.82 9.95 12.83 Favored 'General case' 0 N--CA 1.475 0.775 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 170.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 43.38 41.9 3.43 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 126.985 2.114 . . . . 0.0 114.458 -179.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -93.21 118.49 31.31 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 111.717 -2.492 . . . . 0.0 110.337 -172.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -45.52 135.77 5.8 Favored Pre-proline 0 N--CA 1.479 0.988 0 CA-C-N 113.455 -1.702 . . . . 0.0 114.954 -178.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -62.99 -39.97 37.14 Favored 'Trans proline' 0 CA--C 1.539 0.735 0 C-N-CA 122.943 2.429 . . . . 0.0 112.939 -176.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.406 ' O ' ' HB3' ' A' ' 41' ' ' ALA . . . -56.28 -37.19 69.5 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.291 1.036 . . . . 0.0 113.277 175.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 19.7 m -69.23 -49.71 53.91 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 123.365 0.666 . . . . 0.0 110.961 173.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 27.6 t-105 -59.47 -25.7 64.62 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 178.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.445 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -51.28 -27.29 8.94 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 170.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.46 -36.57 73.91 Favored 'General case' 0 N--CA 1.48 1.063 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 170.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -95.31 22.15 7.19 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.516 1.126 . . . . 0.0 113.581 172.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.93 -21.23 40.92 Favored Glycine 0 CA--C 1.54 1.611 0 N-CA-C 115.409 0.924 . . . . 0.0 115.409 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.445 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 69.81 6.07 54.29 Favored Glycine 0 N--CA 1.484 1.88 0 N-CA-C 114.753 0.661 . . . . 0.0 114.753 -173.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 41.4 t -68.1 148.88 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.794 0 C-N-CA 125.928 1.691 . . . . 0.0 109.369 -178.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -66.42 35.01 0.16 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 124.881 1.229 . . . . 0.0 115.711 174.029 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -59.14 -45.29 99.38 Favored Pre-proline 0 CA--C 1.553 1.085 0 CA-C-O 116.184 -1.865 . . . . 0.0 109.966 172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 30' ' ' TYR . 43.2 Cg_endo -66.18 -9.87 25.21 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.16 2.573 . . . . 0.0 118.03 169.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -88.1 -31.77 19.04 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 113.171 0.804 . . . . 0.0 113.171 173.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -102.97 -36.32 8.24 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.89 133.84 54.05 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 121.976 0.894 . . . . 0.0 111.602 178.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m -50.3 152.95 1.63 Allowed 'General case' 0 N--CA 1.481 1.108 0 CA-C-N 113.59 -1.641 . . . . 0.0 110.276 179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.539 ' O ' HG23 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -48.63 -53.78 17.21 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.628 ' HA ' HG12 ' A' ' 58' ' ' ILE . 5.8 tm-20 -70.11 -27.15 64.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 175.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -75.31 -42.71 53.96 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.555 0.693 . . . . 0.0 110.907 177.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.5 tp60 -70.54 -35.65 73.26 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.628 HG12 ' HA ' ' A' ' 55' ' ' GLU . 17.8 pt -56.07 -28.67 25.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 CA-C-O 118.442 -0.79 . . . . 0.0 112.609 172.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.51 -49.21 77.65 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.032 0.533 . . . . 0.0 112.376 174.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -66.75 -41.31 87.76 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.256 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.89 176.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.663 ' HA ' HG12 ' A' ' 64' ' ' VAL . . . -61.37 -35.45 77.5 Favored 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 175.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.448 ' HA ' HD23 ' A' ' 65' ' ' LEU . 10.8 t-20 -64.88 -36.09 83.25 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.525 1.53 . . . . 0.0 112.61 174.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -81.36 -37.24 28.56 Favored 'General case' 0 N--CA 1.475 0.825 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 171.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.663 HG12 ' HA ' ' A' ' 61' ' ' ALA . 0.3 OUTLIER -60.54 -24.6 32.05 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.994 0 N-CA-C 113.675 0.991 . . . . 0.0 113.675 174.668 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.637 HD22 ' HB2' ' A' ' 79' ' ' ALA . 0.7 OUTLIER -56.87 -46.15 82.01 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.334 0.396 . . . . 0.0 111.723 170.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.5 -33.38 69.2 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.328 0.651 . . . . 0.0 112.693 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.9 tt0 -61.37 -43.9 98.08 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 178.526 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.84 -27.7 10.57 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 114.985 1.476 . . . . 0.0 114.985 -179.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 118.6 149.86 8.74 Favored Glycine 0 CA--C 1.536 1.362 0 N-CA-C 111.251 -0.74 . . . . 0.0 111.251 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 pp -70.72 -33.59 71.02 Favored 'General case' 0 N--CA 1.478 0.971 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 174.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -57.45 -23.29 48.82 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 115.568 1.692 . . . . 0.0 115.568 174.445 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.89 -42.83 94.68 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 124.234 1.014 . . . . 0.0 112.76 175.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.606 ' CZ3' ' HA ' ' A' ' 65' ' ' LEU . 13.0 m-90 -72.64 149.71 90.8 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-N 115.32 -0.854 . . . . 0.0 110.25 172.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -67.39 -153.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.067 0 C-N-CA 123.077 2.518 . . . . 0.0 111.775 -179.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 14.7 t -54.23 -21.44 9.04 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 21.2 m -101.26 152.47 20.64 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.887 1.275 . . . . 0.0 111.503 176.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 178.4 107.79 0.22 Allowed Glycine 0 N--CA 1.476 1.302 0 CA-C-N 112.116 -2.311 . . . . 0.0 109.479 177.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.57 ' H ' HG11 ' A' ' 12' ' ' VAL . . . -54.24 -23.22 13.93 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 -179.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.637 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -45.78 -39.9 8.91 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 125.868 1.667 . . . . 0.0 113.704 167.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 78.9 p -109.97 -21.04 12.52 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 125.5 1.52 . . . . 0.0 113.218 178.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 88.62 -37.57 3.29 Favored Glycine 0 N--CA 1.48 1.581 0 C-N-CA 124.03 0.824 . . . . 0.0 112.466 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 35.0 mt . . . . . 0 C--O 1.25 1.1 0 CA-C-O 116.943 -1.503 . . . . 99.989999999999995 114.15 179.872 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 1.688 0 CA-C-O 121.251 0.362 . . . . 0.0 113.565 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -132.48 -67.71 0.64 Allowed 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 114.443 -0.878 . . . . 0.0 111.528 175.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.2 mtt -128.68 152.86 47.91 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.995 1.318 . . . . 0.0 110.714 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -170.27 152.04 18.04 Favored Glycine 0 CA--C 1.542 1.719 0 O-C-N 124.876 1.36 . . . . 0.0 112.142 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -71.51 154.93 60.19 Favored 'Trans proline' 0 N--CA 1.478 0.567 0 C-N-CA 122.917 2.411 . . . . 0.0 112.514 176.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.4 m -58.14 142.76 80.01 Favored Pre-proline 0 N--CA 1.478 0.957 0 CA-C-N 115.242 -0.89 . . . . 0.0 112.722 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.68 127.44 15.46 Favored 'Trans proline' 0 CA--C 1.532 0.42 0 C-N-CA 122.357 2.038 . . . . 0.0 112.646 177.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.3 m-20 -118.79 154.32 33.03 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 113.013 -1.903 . . . . 0.0 111.338 179.37 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.419 ' HB3' HG21 ' A' ' 58' ' ' ILE . 26.9 m95 -53.64 -32.35 51.08 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 171.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -59.91 -54.5 45.39 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 170.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.04 -38.67 79.87 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.496 0.718 . . . . 0.0 112.246 173.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.483 HG11 ' HB2' ' A' ' 78' ' ' ALA . 25.6 t -62.14 -31.59 51.91 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 175.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -57.67 -41.36 81.36 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.258 0.466 . . . . 0.0 112.258 168.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -81.97 5.4 19.3 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 174.353 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 1.9 t -107.11 -32.98 7.6 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 125.42 1.488 . . . . 0.0 111.448 175.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.477 ' OE1' ' HG ' ' A' ' 33' ' ' LEU . 91.4 mt-10 -101.79 -27.49 12.99 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 114.652 1.353 . . . . 0.0 114.652 178.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.532 ' HB2' ' CA ' ' A' ' 32' ' ' GLY . 8.6 t -110.8 -38.96 4.98 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.894 0.877 . . . . 0.0 113.178 174.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 61.85 31.13 77.2 Favored Glycine 0 CA--C 1.543 1.818 0 N-CA-C 114.808 0.683 . . . . 0.0 114.808 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -173.78 -95.91 0.1 Allowed Glycine 0 N--CA 1.48 1.576 0 O-C-N 124.075 0.514 . . . . 0.0 112.439 -176.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -106.0 146.4 30.12 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 114.536 1.31 . . . . 0.0 114.536 -175.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 24.0 m95 -65.88 -58.7 4.98 Favored 'General case' 0 N--CA 1.477 0.921 0 CA-C-N 114.401 -1.272 . . . . 0.0 112.832 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -60.23 -26.49 66.46 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 174.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 40.11 78.12 0.05 OUTLIER 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 126.053 1.741 . . . . 0.0 113.433 -174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -83.88 43.41 0.92 Allowed 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.402 -1.726 . . . . 0.0 112.393 -175.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 18.4 p -104.45 -15.87 15.25 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 127.804 2.442 . . . . 0.0 112.729 178.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.39 39.98 80.32 Favored Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.054 0.782 . . . . 0.0 115.054 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -95.2 21.4 7.93 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.251 1.574 . . . . 0.0 115.251 178.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.37 29.09 56.39 Favored Glycine 0 N--CA 1.485 1.924 0 N-CA-C 114.677 0.631 . . . . 0.0 114.677 -173.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.471 ' HG2' ' HA ' ' A' ' 34' ' ' GLN . 83.5 mttt -113.2 151.36 31.06 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 124.643 1.177 . . . . 0.0 110.105 -175.774 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 10.3 p90 -132.65 160.7 35.93 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 114.455 -1.248 . . . . 0.0 112.236 -177.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.404 ' O ' HD12 ' A' ' 33' ' ' LEU . . . 40.12 28.63 0.17 Allowed Glycine 0 N--CA 1.483 1.79 0 N-CA-C 117.494 1.758 . . . . 0.0 117.494 172.443 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.532 ' CA ' ' HB2' ' A' ' 17' ' ' SER . . . 60.47 34.23 84.61 Favored Glycine 0 CA--C 1.539 1.538 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 -172.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' OE1' ' A' ' 16' ' ' GLU . 2.6 mp -108.29 -2.89 18.88 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 119.197 3.036 . . . . 0.0 119.197 -175.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.471 ' HA ' ' HG2' ' A' ' 29' ' ' LYS . 8.5 pt20 42.83 28.52 0.13 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 -169.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.615 ' HB3' ' CE2' ' A' ' 30' ' ' TYR . 2.0 t80 -94.54 108.02 19.99 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.394 -169.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -24.45 126.12 0.16 Allowed Pre-proline 0 N--CA 1.477 0.904 0 CA-C-N 112.348 -2.205 . . . . 0.0 114.809 177.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -62.44 -35.21 73.4 Favored 'Trans proline' 0 CA--C 1.54 0.791 0 C-N-CA 122.708 2.272 . . . . 0.0 113.441 -177.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.11 -32.99 66.89 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.305 1.042 . . . . 0.0 113.394 173.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.454 ' CG2' ' HB2' ' A' ' 68' ' ' GLN . 25.5 m -67.16 -50.12 62.28 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.966 0.906 . . . . 0.0 111.097 172.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 34.4 t-105 -60.02 -22.49 62.7 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -49.33 -30.36 7.45 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 168.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.56 -37.16 75.15 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 113.075 0.769 . . . . 0.0 113.075 171.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -94.1 19.38 9.3 Favored 'General case' 0 N--CA 1.477 0.924 0 C-N-CA 125.163 1.385 . . . . 0.0 113.59 173.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.55 -22.21 28.95 Favored Glycine 0 CA--C 1.54 1.63 0 N-CA-C 115.619 1.008 . . . . 0.0 115.619 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 74.23 -5.88 24.85 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 114.771 0.668 . . . . 0.0 114.771 -173.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.513 HG13 ' HB2' ' A' ' 48' ' ' ASN . 11.2 p -64.99 148.76 11.82 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 125.539 1.536 . . . . 0.0 111.923 -178.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -64.56 31.47 0.1 OUTLIER Glycine 0 CA--C 1.542 1.724 0 C-N-CA 125.086 1.327 . . . . 0.0 116.245 173.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.513 ' HB2' HG13 ' A' ' 46' ' ' VAL . 64.2 t30 -57.78 -48.64 96.82 Favored Pre-proline 0 CA--C 1.546 0.804 0 CA-C-O 116.631 -1.652 . . . . 0.0 110.578 173.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.44 ' HB3' HE21 ' A' ' 57' ' ' GLN . 68.2 Cg_endo -73.03 -13.88 26.19 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.417 2.745 . . . . 0.0 116.131 176.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -77.57 -31.83 53.41 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 170.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -97.34 -34.06 11.2 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 176.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 134.63 56.96 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.285 1.034 . . . . 0.0 111.786 177.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 41.3 t -55.97 154.19 7.77 Favored 'General case' 0 N--CA 1.481 1.076 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.486 179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.91 -59.1 3.02 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 113.882 1.068 . . . . 0.0 113.882 -175.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.681 ' HA ' HG12 ' A' ' 58' ' ' ILE . 14.9 tt0 -69.24 -26.23 64.68 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.553 1.316 . . . . 0.0 114.553 176.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -73.96 -39.08 63.97 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 121.712 -0.618 . . . . 0.0 112.264 175.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.44 HE21 ' HB3' ' A' ' 49' ' ' PRO . 0.3 OUTLIER -60.0 -50.72 72.64 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 124.595 1.158 . . . . 0.0 109.588 173.649 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.681 HG12 ' HA ' ' A' ' 55' ' ' GLU . 6.5 pt -55.4 -31.57 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 N-CA-C 113.787 1.032 . . . . 0.0 113.787 -179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.3 -49.27 77.77 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 122.916 0.486 . . . . 0.0 112.278 173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 5.4 t -70.02 -40.76 78.9 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 C-N-CA 123.787 0.835 . . . . 0.0 110.27 177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.524 ' O ' HG12 ' A' ' 64' ' ' VAL . . . -59.93 -38.95 83.85 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.608 1.163 . . . . 0.0 114.138 175.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.429 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 66.3 t30 -60.9 -38.47 85.81 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.168 1.387 . . . . 0.0 111.677 174.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.0 ttp180 -80.01 -32.2 39.65 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.912 1.078 . . . . 0.0 113.912 173.298 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.555 ' HA ' ' HB2' ' A' ' 67' ' ' GLU . 0.3 OUTLIER -61.07 -22.43 27.06 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 172.747 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 62' ' ' ASN . 0.6 OUTLIER -60.34 -39.43 87.11 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 169.166 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.72 69.35 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 112.874 0.694 . . . . 0.0 112.874 172.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.555 ' HB2' ' HA ' ' A' ' 64' ' ' VAL . 0.0 OUTLIER -65.83 -58.87 4.6 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 177.589 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.454 ' HB2' ' CG2' ' A' ' 39' ' ' THR . 22.6 tp60 -91.48 -36.49 13.72 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 -178.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 122.36 150.32 8.15 Favored Glycine 0 CA--C 1.535 1.284 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -167.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.519 HD23 ' H ' ' A' ' 70' ' ' LEU . 0.8 OUTLIER -84.35 -1.35 55.31 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.474 1.287 . . . . 0.0 114.474 173.296 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -87.99 -23.75 23.74 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 124.603 1.161 . . . . 0.0 113.429 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -59.86 -41.38 91.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 124.145 0.978 . . . . 0.0 113.62 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . . . . . . . . . 3.7 m-90 -60.35 150.12 73.99 Favored Pre-proline 0 N--CA 1.474 0.75 0 CA-C-O 118.762 -0.637 . . . . 0.0 110.777 169.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.564 ' HG2' ' HB2' ' A' ' 76' ' ' CYS . 94.6 Cg_endo -63.25 -159.93 0.03 OUTLIER 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 122.741 2.294 . . . . 0.0 111.066 -179.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.0 p -51.49 -32.2 26.52 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 117.0 -1.476 . . . . 0.0 113.208 176.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.564 ' HB2' ' HG2' ' A' ' 74' ' ' PRO . 85.3 m -52.6 -135.1 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 O-C-N 128.392 3.557 . . . . 0.0 114.063 168.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 79.42 102.14 0.25 Allowed Glycine 0 N--CA 1.483 1.799 0 O-C-N 121.71 -0.619 . . . . 0.0 112.065 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB2' HG11 ' A' ' 12' ' ' VAL . . . -49.79 -26.16 3.69 Favored 'General case' 0 N--CA 1.483 1.186 0 N-CA-C 116.345 1.98 . . . . 0.0 116.345 178.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -48.18 -39.15 20.02 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 124.784 1.234 . . . . 0.0 113.132 173.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 14.5 m -108.93 -29.65 8.5 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.289 1.036 . . . . 0.0 113.098 168.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.89 -29.17 5.59 Favored Glycine 0 CA--C 1.538 1.483 0 CA-C-N 115.236 -0.893 . . . . 0.0 113.649 179.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.431 ' OXT' ' HA ' ' A' ' 76' ' ' CYS . 59.5 mt . . . . . 0 C--O 1.252 1.209 0 CA-C-O 117.08 -1.438 . . . . 99.989999999999995 113.212 173.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 1.987 0 N-CA-C 114.784 0.674 . . . . 0.0 114.784 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -75.4 108.08 7.96 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.357 0.663 . . . . 0.0 111.084 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.9 tmm? -159.01 104.0 1.7 Allowed 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.611 -1.177 . . . . 0.0 110.798 -178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.13 93.61 0.44 Allowed Glycine 0 CA--C 1.539 1.549 0 CA-C-O 117.824 -1.542 . . . . 0.0 111.477 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.22 156.43 64.78 Favored 'Trans proline' 0 N--CA 1.477 0.541 0 C-N-CA 122.649 2.233 . . . . 0.0 111.544 174.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -109.52 95.51 19.55 Favored Pre-proline 0 N--CA 1.476 0.863 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.546 -179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -71.64 118.26 5.56 Favored 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 123.305 2.67 . . . . 0.0 113.774 -178.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.7 m120 -122.22 119.15 30.39 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . . . . . . . . . 18.4 m95 -57.77 -34.99 70.16 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.111 -1.404 . . . . 0.0 113.798 169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 33.0 t70 -63.57 -48.22 78.32 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 113.653 0.983 . . . . 0.0 113.653 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.25 -37.88 75.8 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 112.629 0.603 . . . . 0.0 112.629 174.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG21 ' N ' ' A' ' 78' ' ' ALA . 53.7 t -62.09 -37.45 78.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 123.729 0.811 . . . . 0.0 112.491 174.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.507 ' HB2' ' CZ2' ' A' ' 21' ' ' TRP . . . -53.55 -48.26 69.26 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 167.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -78.24 8.3 5.14 Favored 'General case' 0 CA--C 1.549 0.912 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 178.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 44.0 t -114.8 -30.85 6.32 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.371 1.068 . . . . 0.0 113.485 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -94.59 -36.85 11.63 Favored 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 115.62 1.711 . . . . 0.0 115.62 169.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.536 ' HB3' ' H ' ' A' ' 32' ' ' GLY . 67.1 p -108.63 -23.4 11.83 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 176.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 72.3 7.93 69.1 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 114.962 0.745 . . . . 0.0 114.962 -177.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 124.99 83.22 0.54 Allowed Glycine 0 N--CA 1.479 1.505 0 CA-C-O 121.996 0.776 . . . . 0.0 111.355 -177.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.436 ' OD1' ' HA ' ' A' ' 23' ' ' ALA . 1.1 m-20 172.16 108.01 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 127.334 2.254 . . . . 0.0 108.647 -178.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.507 ' CZ2' ' HB2' ' A' ' 13' ' ' ALA . 54.8 m95 -93.22 -44.01 8.54 Favored 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 114.317 1.228 . . . . 0.0 114.317 172.141 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -74.67 -39.62 61.92 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 169.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.436 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . . . 49.91 84.81 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 125.577 1.551 . . . . 0.0 111.658 -173.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 32.6 t30 -74.47 58.57 0.77 Allowed 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 123.1 1.429 . . . . 0.0 112.154 -177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 82.6 p -107.16 -26.6 11.02 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 112.29 -2.232 . . . . 0.0 111.973 179.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 64.81 34.39 89.77 Favored Glycine 0 CA--C 1.538 1.512 0 C-N-CA 124.226 0.917 . . . . 0.0 114.229 -177.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -93.73 21.07 6.8 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 -177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.07 11.49 9.05 Favored Glycine 0 N--CA 1.487 2.077 0 C-N-CA 124.326 0.965 . . . . 0.0 115.433 -172.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.405 ' CG ' ' HD3' ' A' ' 37' ' ' PRO . 19.5 mtpt -109.34 161.46 15.25 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.256 1.822 . . . . 0.0 110.247 -175.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.624 ' CE2' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -114.17 119.71 37.99 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 112.882 -1.963 . . . . 0.0 112.964 -175.169 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -61.28 144.51 48.71 Favored Glycine 0 CA--C 1.538 1.474 0 CA-C-N 113.073 -1.876 . . . . 0.0 110.702 177.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.536 ' H ' ' HB3' ' A' ' 17' ' ' SER . . . 102.19 -36.98 3.9 Favored Glycine 0 N--CA 1.473 1.164 0 CA-C-N 112.943 -1.628 . . . . 0.0 110.806 -178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.639 HD21 ' HB1' ' A' ' 61' ' ' ALA . 6.4 mp -109.64 -29.37 8.39 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 114.512 1.301 . . . . 0.0 114.512 177.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 53.76 36.28 23.5 Favored 'General case' 0 N--CA 1.485 1.319 0 CA-C-O 123.628 1.68 . . . . 0.0 112.047 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 72' ' ' ALA . 0.5 OUTLIER -97.76 129.52 44.77 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 113.699 -1.592 . . . . 0.0 109.418 -172.184 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 7.9 mtmt -47.63 141.2 7.45 Favored Pre-proline 0 N--CA 1.475 0.822 0 CA-C-N 113.48 -1.691 . . . . 0.0 114.63 -178.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' CG ' ' A' ' 29' ' ' LYS . 68.6 Cg_endo -60.48 -31.61 92.7 Favored 'Trans proline' 0 CA--C 1.536 0.604 0 C-N-CA 122.938 2.425 . . . . 0.0 112.868 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -54.33 -36.14 63.45 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 124.61 1.164 . . . . 0.0 114.087 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.603 HG21 ' CZ ' ' A' ' 35' ' ' PHE . 70.4 m -67.37 -57.13 7.17 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.482 0.713 . . . . 0.0 110.472 171.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.512 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 23.7 t-105 -56.94 -21.72 32.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 179.068 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.405 ' HA ' ' N ' ' A' ' 45' ' ' GLY . . . -48.4 -31.27 5.96 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 170.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.28 -34.42 73.72 Favored 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 171.111 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -95.66 16.69 16.65 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.426 1.49 . . . . 0.0 112.757 172.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.63 -22.32 24.3 Favored Glycine 0 CA--C 1.54 1.65 0 N-CA-C 115.985 1.154 . . . . 0.0 115.985 -179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.405 ' N ' ' HA ' ' A' ' 41' ' ' ALA . . . 73.2 -2.9 33.56 Favored Glycine 0 N--CA 1.486 1.979 0 N-CA-C 114.63 0.612 . . . . 0.0 114.63 -173.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.576 HG13 ' HB2' ' A' ' 48' ' ' ASN . 7.4 p -69.22 154.54 8.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 125.733 1.613 . . . . 0.0 111.701 -178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -65.1 33.84 0.11 Allowed Glycine 0 N--CA 1.484 1.851 0 C-N-CA 125.098 1.333 . . . . 0.0 115.986 174.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.576 ' HB2' HG13 ' A' ' 46' ' ' VAL . 1.9 t-20 -59.6 -48.68 94.95 Favored Pre-proline 0 CA--C 1.545 0.78 0 CA-C-O 116.485 -1.721 . . . . 0.0 111.207 175.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.512 ' HD3' ' CE2' ' A' ' 40' ' ' TRP . 85.1 Cg_endo -68.49 -30.86 28.49 Favored 'Trans proline' 0 CA--C 1.538 0.723 0 C-N-CA 122.603 2.202 . . . . 0.0 114.031 175.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.29 -32.38 72.49 Favored 'General case' 0 N--CA 1.477 0.887 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -90.68 -32.44 16.2 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 174.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.81 129.72 40.82 Favored 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.14 0.971 . . . . 0.0 111.679 176.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.1 t -53.77 155.31 3.32 Favored 'General case' 0 N--CA 1.482 1.138 0 CA-C-N 113.89 -1.505 . . . . 0.0 109.971 174.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.492 ' O ' HG23 ' A' ' 58' ' ' ILE . 72.3 mtt180 -46.81 -52.42 14.24 Favored 'General case' 0 N--CA 1.486 1.327 0 N-CA-C 114.886 1.439 . . . . 0.0 114.886 -173.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.57 ' HA ' HG12 ' A' ' 58' ' ' ILE . 0.4 OUTLIER -69.2 -37.67 78.22 Favored 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 175.038 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -64.26 -35.21 80.1 Favored 'General case' 0 N--CA 1.478 0.951 0 O-C-N 121.67 -0.644 . . . . 0.0 112.031 175.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.41 ' NE2' ' HB3' ' A' ' 49' ' ' PRO . 0.1 OUTLIER -63.15 -53.72 48.96 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.393 1.077 . . . . 0.0 109.936 171.009 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.57 HG12 ' HA ' ' A' ' 55' ' ' GLU . 4.8 pt -53.71 -32.07 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.62 -57.91 10.91 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.029 0.932 . . . . 0.0 113.116 172.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.9 t -64.08 -38.0 81.3 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 C-N-CA 123.185 0.594 . . . . 0.0 110.452 177.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -59.42 -41.71 90.16 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 125.241 1.416 . . . . 0.0 114.021 174.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -61.0 -30.5 70.33 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 125.117 1.367 . . . . 0.0 112.255 173.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.81 -33.8 21.26 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 114.094 1.146 . . . . 0.0 114.094 172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.258 0.8 OUTLIER -59.51 -24.71 29.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 172.454 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.524 HD22 ' HB2' ' A' ' 79' ' ' ALA . 1.4 pp -59.13 -44.02 92.0 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 170.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.71 -31.16 70.04 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 175.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -67.25 -55.32 14.49 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 178.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -98.54 -26.88 14.27 Favored 'General case' 0 N--CA 1.479 1.011 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -176.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 129.75 155.26 8.37 Favored Glycine 0 N--CA 1.474 1.224 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -62.06 -35.08 77.56 Favored 'General case' 0 N--CA 1.482 1.133 0 O-C-N 122.399 -0.471 . . . . 0.0 112.163 169.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -60.93 -17.84 53.49 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 125.618 1.567 . . . . 0.0 114.517 176.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 35' ' ' PHE . . . -44.96 -35.92 3.12 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.133 1.773 . . . . 0.0 114.38 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.477 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 12.4 m-90 -115.94 97.73 49.78 Favored Pre-proline 0 N--CA 1.471 0.59 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 171.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -78.37 -35.81 1.11 Allowed 'Trans proline' 0 CA--C 1.537 0.647 0 C-N-CA 122.585 2.19 . . . . 0.0 114.012 176.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.4 t -61.94 -52.2 65.03 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 124.999 1.32 . . . . 0.0 113.693 177.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . . . . . . . . . 36.0 m -139.42 -166.1 1.99 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.706 1.202 . . . . 0.0 110.196 173.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 164.06 102.21 0.16 Allowed Glycine 0 N--CA 1.47 0.954 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 175.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.461 ' N ' HG21 ' A' ' 12' ' ' VAL . . . -51.8 -27.0 10.91 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.605 1.335 . . . . 0.0 114.605 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.524 ' HB2' HD22 ' A' ' 65' ' ' LEU . . . -46.97 -38.63 11.01 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 125.382 1.473 . . . . 0.0 114.236 168.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 20.4 m -109.5 -19.62 13.17 Favored 'General case' 0 N--CA 1.483 1.178 0 N-CA-C 114.764 1.394 . . . . 0.0 114.764 172.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.47 -35.56 4.0 Favored Glycine 0 N--CA 1.479 1.503 0 C-N-CA 123.492 0.568 . . . . 0.0 113.239 -177.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 74.7 mt . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 115.212 1.56 . . . . 99.989999999999995 115.212 179.841 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 1.814 0 N-CA-C 114.25 0.46 . . . . 0.0 114.25 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -152.27 -72.51 0.15 Allowed 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.732 0.813 . . . . 0.0 111.891 -178.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.0 mtt -169.42 156.46 6.79 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 126.615 1.966 . . . . 0.0 110.2 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.67 -81.89 0.33 Allowed Glycine 0 CA--C 1.538 1.518 0 CA-C-O 118.173 -1.349 . . . . 0.0 110.875 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -65.34 140.52 64.36 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 122.425 2.083 . . . . 0.0 112.282 176.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 69.3 m -56.32 148.07 44.58 Favored Pre-proline 0 N--CA 1.479 1.004 0 CA-C-N 114.496 -1.229 . . . . 0.0 113.08 174.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -63.02 134.95 48.68 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 122.646 2.231 . . . . 0.0 112.56 176.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -116.37 126.29 53.26 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 114.047 -1.433 . . . . 0.0 111.762 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TRP . . . . . 0.509 ' HB3' HG21 ' A' ' 58' ' ' ILE . 11.3 m95 -57.61 -30.69 65.53 Favored 'General case' 0 N--CA 1.479 1.002 0 CA-C-N 114.026 -1.443 . . . . 0.0 114.167 170.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.41 ' O ' ' HB3' ' A' ' 13' ' ' ALA . 5.0 m-20 -60.87 -51.04 70.99 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.212 1.005 . . . . 0.0 112.885 171.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.95 -35.33 78.12 Favored 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 123.506 0.722 . . . . 0.0 112.513 173.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.553 HG21 ' HA ' ' A' ' 78' ' ' ALA . 61.3 t -62.2 -42.97 97.28 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.119 0 C-N-CA 124.519 1.128 . . . . 0.0 111.985 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' A' ' 32' ' ' GLY . . . -53.2 -44.94 68.38 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.105 0.562 . . . . 0.0 111.73 168.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 23.4 mt-30 -72.09 -5.61 36.55 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 115.678 1.733 . . . . 0.0 115.678 176.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 6.3 t -105.33 -26.82 11.83 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 124.678 1.191 . . . . 0.0 112.596 178.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 5.6 mp0 -98.81 -40.95 7.87 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 114.334 1.235 . . . . 0.0 114.334 172.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 36.6 p -104.83 -23.31 13.04 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 178.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . 95.4 -25.82 22.64 Favored Glycine 0 CA--C 1.538 1.481 0 CA-C-N 115.412 -0.813 . . . . 0.0 112.999 -178.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 169.79 -40.68 0.2 Allowed Glycine 0 N--CA 1.477 1.432 0 CA-C-N 115.524 -0.338 . . . . 0.0 113.394 -174.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -52.22 100.29 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 124.565 1.146 . . . . 0.0 113.21 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 57.9 m95 -73.77 -22.58 59.8 Favored 'General case' 0 N--CA 1.482 1.137 0 N-CA-C 115.775 1.769 . . . . 0.0 115.775 171.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HB1' HG23 ' A' ' 25' ' ' THR . . . -102.96 -25.43 13.47 Favored 'General case' 0 N--CA 1.477 0.889 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 175.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . 16.16 74.0 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 127.228 2.211 . . . . 0.0 115.479 -170.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 43.06 88.64 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.986 -1.915 . . . . 0.0 112.367 -172.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.465 HG23 ' HB1' ' A' ' 22' ' ' ALA . 67.8 p -58.69 -26.28 63.7 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 113.319 -1.764 . . . . 0.0 112.871 177.374 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -66.78 -3.54 22.03 Favored Glycine 0 CA--C 1.541 1.704 0 C-N-CA 125.166 1.365 . . . . 0.0 115.422 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -95.1 7.91 44.62 Favored 'General case' 0 N--CA 1.477 0.877 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 174.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 64.95 8.16 33.67 Favored Glycine 0 N--CA 1.484 1.87 0 C-N-CA 124.007 0.813 . . . . 0.0 113.516 -172.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.636 ' HG3' ' HD3' ' A' ' 37' ' ' PRO . 17.1 mttm -110.7 159.51 17.55 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 126.749 2.02 . . . . 0.0 110.422 -177.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 35' ' ' PHE . 0.2 OUTLIER -122.86 126.48 47.42 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 112.169 -2.287 . . . . 0.0 113.363 -175.433 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -59.99 151.03 38.8 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 112.031 -2.35 . . . . 0.0 112.71 175.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 13' ' ' ALA . . . 94.7 -39.22 2.93 Favored Glycine 0 CA--C 1.532 1.103 0 CA-C-N 111.618 -2.291 . . . . 0.0 110.837 -179.359 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.613 HD21 ' HB1' ' A' ' 61' ' ' ALA . 5.2 mp -107.44 -32.01 7.91 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 113.683 -1.258 . . . . 0.0 114.024 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 56.06 34.33 23.57 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 126.048 1.739 . . . . 0.0 112.193 179.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 30' ' ' TYR . 0.2 OUTLIER -96.24 132.5 41.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 113.943 -1.48 . . . . 0.0 109.33 -170.509 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -49.87 142.4 13.01 Favored Pre-proline 0 N--CA 1.475 0.816 0 CA-C-N 113.071 -1.877 . . . . 0.0 114.907 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.636 ' HD3' ' HG3' ' A' ' 29' ' ' LYS . 47.6 Cg_endo -57.97 -33.04 96.68 Favored 'Trans proline' 0 CA--C 1.537 0.635 0 C-N-CA 123.295 2.663 . . . . 0.0 113.499 178.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -53.53 -37.13 62.53 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 173.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 84.9 m -67.24 -56.96 7.67 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.848 0.859 . . . . 0.0 110.546 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CE2' ' HD3' ' A' ' 49' ' ' PRO . 21.5 t-105 -60.2 -21.78 62.17 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -48.61 -30.9 5.88 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.928 1.291 . . . . 0.0 114.303 171.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -58.53 -38.51 77.9 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.065 0.765 . . . . 0.0 113.065 170.521 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -92.54 17.64 9.79 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 125.156 1.382 . . . . 0.0 113.907 171.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 107.48 -21.62 30.24 Favored Glycine 0 CA--C 1.54 1.619 0 N-CA-C 116.249 1.26 . . . . 0.0 116.249 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 71.77 2.04 49.31 Favored Glycine 0 N--CA 1.486 2.014 0 N-CA-C 114.785 0.674 . . . . 0.0 114.785 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 39.7 t -71.88 150.2 8.98 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 125.699 1.599 . . . . 0.0 109.135 -178.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 50' ' ' ALA . . . -63.06 40.13 0.07 OUTLIER Glycine 0 CA--C 1.541 1.694 0 C-N-CA 125.381 1.467 . . . . 0.0 115.917 170.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -64.43 -53.46 45.6 Favored Pre-proline 0 CA--C 1.549 0.932 0 CA-C-O 116.177 -1.868 . . . . 0.0 110.665 174.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.641 ' HB3' HE21 ' A' ' 57' ' ' GLN . 83.8 Cg_endo -67.63 -21.15 46.07 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 122.837 2.358 . . . . 0.0 113.802 175.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 47' ' ' GLY . . . -67.32 -35.36 79.27 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 125.585 1.554 . . . . 0.0 114.673 173.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -104.76 -29.5 10.52 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.32 131.39 50.5 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 124.178 0.991 . . . . 0.0 111.21 177.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 21.5 t -54.19 151.83 6.78 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 113.608 -1.633 . . . . 0.0 110.072 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.5 mtt85 -44.69 -57.45 3.67 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 115.065 1.505 . . . . 0.0 115.065 -173.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.702 ' HA ' HG12 ' A' ' 58' ' ' ILE . 40.9 tt0 -68.18 -30.17 69.21 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.209 1.188 . . . . 0.0 114.209 174.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLN . . . . . . . . . . . . . 37.6 tt0 -71.75 -38.75 70.36 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.664 -0.648 . . . . 0.0 112.191 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.641 HE21 ' HB3' ' A' ' 49' ' ' PRO . 1.7 tm0? -59.13 -54.97 40.95 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.434 1.094 . . . . 0.0 109.466 172.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.702 HG12 ' HA ' ' A' ' 55' ' ' GLU . 9.6 pt -55.15 -28.4 21.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 114.057 1.132 . . . . 0.0 114.057 -177.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.02 -50.01 75.08 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 170.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 2.8 t -67.47 -39.88 83.38 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.293 0 C-N-CA 123.737 0.815 . . . . 0.0 109.849 176.268 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.613 ' HB1' HD21 ' A' ' 33' ' ' LEU . . . -58.55 -39.94 81.62 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.091 1.357 . . . . 0.0 113.715 174.26 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.39 -45.49 91.34 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.78 1.232 . . . . 0.0 110.864 173.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.34 -39.28 81.96 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 173.136 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 61' ' ' ALA 0.273 0.3 OUTLIER -61.12 -19.95 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 N-CA-C 113.788 1.033 . . . . 0.0 113.788 175.204 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.88 -44.48 86.69 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.297 169.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -63.73 -27.76 69.42 Favored 'General case' 0 N--CA 1.479 0.988 0 N-CA-C 113.662 0.986 . . . . 0.0 113.662 176.524 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.09 -45.78 80.0 Favored 'General case' 0 N--CA 1.475 0.816 0 N-CA-C 115.198 1.555 . . . . 0.0 115.198 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -103.65 -24.69 13.35 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 177.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 121.79 159.96 10.83 Favored Glycine 0 CA--C 1.538 1.484 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 -175.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.6 pp -56.75 -32.81 65.95 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 122.269 -0.548 . . . . 0.0 112.433 176.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -72.65 2.24 6.86 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.081 1.752 . . . . 0.0 114.965 175.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.504 ' HB3' ' CZ3' ' A' ' 73' ' ' TRP . . . -55.42 -28.15 52.33 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 114.266 1.21 . . . . 0.0 114.266 176.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TRP . . . . . 0.524 ' CZ2' HD23 ' A' ' 33' ' ' LEU . 17.8 m-90 -118.21 74.8 11.0 Favored Pre-proline 0 N--CA 1.477 0.897 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 171.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -68.8 -21.17 38.67 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 122.93 2.42 . . . . 0.0 113.111 -178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.9 p -57.37 -41.34 79.96 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 126.182 1.793 . . . . 0.0 113.164 176.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' CYS . . . . . 0.406 ' HB3' ' H ' ' A' ' 77' ' ' GLY . 0.1 OUTLIER -142.07 -86.0 0.17 Allowed 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 113.874 -1.512 . . . . 0.0 108.277 178.226 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.406 ' H ' ' HB3' ' A' ' 76' ' ' CYS . . . 94.87 104.26 1.91 Allowed Glycine 0 N--CA 1.474 1.169 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -177.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.553 ' HA ' HG21 ' A' ' 12' ' ' VAL . . . -45.86 -40.08 9.44 Favored 'General case' 0 N--CA 1.481 1.096 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 176.175 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -58.03 -40.77 81.69 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 178.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . . . . . . . . . 70.4 m -82.95 -27.5 30.48 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 173.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.59 26.21 69.54 Favored Glycine 0 N--CA 1.481 1.669 0 C-N-CA 124.11 0.862 . . . . 0.0 114.48 -172.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.1 pp . . . . . 0 N--CA 1.484 1.242 0 C-N-CA 125.671 1.588 . . . . 99.989999999999995 112.877 -178.171 . . . . . . . . 0 0 . 1 stop_ save_